--------------------------------------------------------------- Program Number: 28034 --------------------------------------------------------------- ***Deadlines: 6/4/2012 Sponsor: National Center for Injury Prevention and Control/CDC/DHHS Title: Electronic Learning (E-Learning) Collaborative Resource Center for SV and IPV Prevention Practitioners Contact: Paula Orlosky Williams, Project Officer Tel: 770-488-1659 Email: gvc0@cdc.gov Full Program:          http://www07.grants.gov/search/search.do;jsessionid=kDPTP9hZfTty1sFwQvFg5G7LlQJTsL8xGPnQW1143Mv8HSf0ydR0!-213555334?oppId=161593&mode=VIEW Deadline Note: The deadline for receipt of optional letters of intent is April 19, 2012. The deadline for receipt of full applications is June 4, 2012. SYNOPSIS: National Center for Injury Prevention and Control (NCIPC) invites applications for web-based training that enhances skills and capacity of CDC SV and IPV prevention grantees to prevent SV and IPV; convene an E-Learning Collaborative among CDC funded SV and IPV prevention grantees that enhances training received; and build a broader network of national, state, and local SV and IPV prevention practitioners, regardless of funding sources, using multiple media channels, including interactive web conferences, podcasts, interactive listserv, and social media to share, connect, and enhance their skills and capacity to prevent SV and IPV. A total of approximately $2,075,000 is available. --------------------------------------------------------------- Program Number: 28090 --------------------------------------------------------------- ***Deadlines: 6/4/2012 Sponsor: National Center on Birth Defects and Developmental Disabilities/CDC/DHHS Title: Developing a Plan to Evaluate Delivery of Health Care Treatments and Services for Duchenne Muscular Dystrophy (DMD) Contact: Tiffany Neal, Project Officer Tel: 404-498-3042 Email: tneal@cdc.gov Full Program:          http://www.grants.gov/search/search.do;jsessionid=G61PPCpSRNnSr8Y11pJVQRTYhTMmH1T29JgkKGv7fGLb27ngs43t!-335065855?oppId=162033&mode=VIEW SYNOPSIS: National Center on Birth Defects and Developmental Disabilities (NCBDDD) invites applications for non-research activities to develop a plan for evaluating whether health care treatments and services for people who have Duchenne muscular dystrophy are currently being delivered according to recommendations outlined in the DMD Care Considerations. A total of approximately $150,000 is available. --------------------------------------------------------------- Program Number: 27719 --------------------------------------------------------------- ***Deadlines: 6/4/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: NIDCD Phase I/II/III Clinical Trials in Communication Disorders (U01) Contact: Gordon B. Hughes, M.D. Tel: 301-496-5061 Email: hughesg@nidcd.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-123.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 4, 2012. Optional letters of intent may be submitted 30 days before planned submission date. The deadlines for receipt of full applications are June 4, 2012; October 4, 2012; February 4, 2013; June 4, 2013; October 4, 2013,February 4, 2014; June 4, 2014; October 3, 2014; February 4, 2015 , by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute on Deafness and Other Communication Disorders (NIDCD) invites applications a cooperative agreement between NIDCD project collaborator and investigator to support phase I and II clinical trials of preliminary efficacy and phase III clinical trials of definitive efficacy. Phase III clinical trial applications must include a complete detailed Manual of Procedures (MOP) in the appendix (see http://www.nidcd.nih.gov/research/clinicaltrials for an example of a complete, detailed MOP). The NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34) (PAR-12-124, SPIN Program # 27720) may be used to gather information and prepare the MOP. This program will use the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 27720 --------------------------------------------------------------- ***Deadlines: 6/4/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34) Contact: Gordon B. Hughes, M.D. Tel: 301-496-5061 Email: hughesg@nidcd.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-124.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 4, 2012. Optional letters of intent may be submitted 30 days before planned submission date. The deadlines for receipt of full applications are June 4, 2012; October 4, 2012; February 4, 2013; June 4, 2013; October 4, 2013,February 4, 2014; June 4, 2014; October 3, 2014; February 4, 2015 , by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute on Deafness and Other Communication Disorders (NIDCD) invites applications for a cooperative agreement between NIDCD project collaborator and investigator for a planning grant for phase III clinical trials of definitive efficacy. NIDCD Phase III Clinical Trials in Communication Disorders (U01) applications are accepted only from successful NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34) awardees, unless NIDCD program staff agrees to accept a phase III clinical trial application from an investigator who has not used an NIDCD clinical trial planning grant first. The NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34) is used to gather information and prepare a Manual of Procedures (MOP) (see http://www.nidcd.nih.gov/research/clinicaltrials for an example of a complete, detailed MOP). NIDCD Phase III Clinical Trials in Communication Disorders (U01) (PAR-12-123, SPIN Program # 27719) applications must include a complete detailed MOP in the appendix. This FOA will utilize the NIH U34 Clinical Planning Grant Cooperative Agreement award mechanism. --------------------------------------------------------------- Program Number: 27201 --------------------------------------------------------------- ***Deadlines: 6/4/2012 Sponsor: National Institute on Minority Health and Health Disparities/NIH/DHHS Title: RFA-MD-12-003--NIMHD Social, Behavioral, Health Services, and Policy Research on Minority Health and Health Disparities (R01) Contact: Jennifer Alvidrez, PhD Tel: 301-594-9567 Email: alvidrezjl@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-12-003.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 4, 2012. The deadline for receipt of optional letters of intent is May 4, 2012. The deadline for receipt of full applications is June 4, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute on Minority Health and Health Disparities (NIMHD) invites applications for innovative social, behavioral, health services, and policy research that can directly and demonstrably contribute to the elimination of health disparities. Projects may involve primary data collection or secondary analysis of existing datasets. Projects that examine understudied health conditions; examine the effectiveness of interventions, services, or policies for multiple health disparity populations; and/or directly measure the impact of project activities on levels of health disparities are particularly encouraged. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 01252 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: AHRQ Health Services Research Projects (R01) Contact: Kishena Washwani, Ph.D. Tel: 301-427-1556 Email: Kishena.Wadhwani@ahrq.hhs.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-09-070.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor solicits Large Research (R01) Projects, and expresses AHRQ portfolio priority areas of interest for ongoing extramural health services research, demonstration, dissemination, and evaluation grants. This FOA will use the AHRQ Research Project Grant (R01) award mechanism. --------------------------------------------------------------- Program Number: 21908 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: Understanding User Needs and Context to Inform Consumer Health Information Technology (IT) Design (R01) Contact: Angela Lavanderos Tel: 301-427-1505 Email: Angela.Lavanderos@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-199.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on July 6, 2014. SYNOPSIS: The sponsor invites applications for esearch projects that will build a knowledge base of individuals’ personal health information management (PHIM) needs and practices and the design principles related to these activities. The increased interest in and availability of consumer health information technology (IT) applications meant to assist consumers in managing their personal health information has rapidly increased over the past decade. Many other industries have greatly benefited from design principles that take into account user needs and context, which help designers improve the utility of information management tools among a heterogeneous population of users. Individuals are the end users of consumer health IT; however, there is still a lack of basic research around these end users’ PHIM practices and needs and how these methods are influenced by a multitude of other contextual factors (e.g., care settings, demographics, motivations, user capabilities and limitations, informal caregiving networks, technology sophistication, and access to Internet) that, typically, represent a mixture of facilitators or barriers to adequate PHIM. This FOA looks to bridge the chasm that currently exists between consumer health IT designers and the users themselves, by bolstering basic research to better understand users’ PHIM practices, needs, and goals as they are intrinsically shaped by an array of contextual factors. This FOA will use the Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 21914 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: Understanding Clinical Information Needs and Health Care Decision Making Processes in the Context of Health Information Technology (IT) (R01) Contact: Angela Lavanderos Tel: 301-427-1505 Email: Angela.Lavanderos@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-198.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on July 6, 2014. SYNOPSIS: The sponsor invites applications for research aimed at elucidating the nature of cognition, task distribution, and clinical work in various health care delivery settings. Research projects funded under this FOA will address current knowledge gaps regarding our understanding of health care providers’ information needs and health care decision making processes, both individually and collectively, and as a health care team (composed of doctors, nurses, therapists, and administrative staff). As the U.S. population continues to make strides in longevity, there also are a growing number of chronic conditions that require consideration when seeking medical attention. Accordingly, health care teams are progressively becoming overwhelmed by the mounting number of tasks that require attention during a typical clinical encounter. These conditions and/or set of conditions are often coupled with various clinical guidelines or best practices meant to guide and inform health care providers when caring for their patients. Furthermore, the volume of clinical guidelines that health care teams are expected to incorporate into patient care is also rapidly increasing. Consequently, these teams must balance information, cognitive tasks, and workflow processes as they make health care decisions. While health information technology (IT) has shown the potential to assist and support health care teams with these requisite tasks in a manner that improves the quality of care while minimizing risk and harm to patients, many health care organizations continue to struggle with the implementation and adoption of health IT. This stems from a variety of contextual factors (e.g., workflow integration, usability of the health IT applications, provider dynamics). To better understand provider needs, basic research is needed on how clinical work is actually done and how it could be done, while incorporating a variety of cognitive analyses (e.g., cognitive work analysis, cognitive task analysis), workflow analyses (e.g., hierarchical task analysis, sequence diagrams), and human-centered design evaluations. This FOA will use the Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 02587 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Biomarkers for Early Detection of Hematopoiietic Malignancies (R01) Contact: Lynn Sorbara, Ph.D. Tel: 301-435-0584 Email: lynns@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-197.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites research grant applications from institutions/organizations for the development and validation of biomarkers for: a) early detection, prediction of progression, and recurrence of hematopoietic malignancies, especially in high-risk individuals; and, b) for risk assessment of primary and secondary hematopoietic malignancies. This FOA is also encourages the development and improvement of specific technologies and methods for quantitative detection of novel biomarkers associated with hematopoietic malignancies. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 03691 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Identifying Non-coding RNA Targets for Cancer Early Detection and Prevention (R01) Contact: Wendy Wang, Ph.D., M.Sc. Tel: 301-594-7607 Email: wangw@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-199.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications from institutions/organizations on the discovery and characterization of non-coding (nc) RNAs in preneoplasias and early stage cancers to: 1) improve early cancer detection, intervention, and prevention; 2) predict risk of progression from preneoplasia to cancer, and 3) distinguish benign lesions from precancerous lesions. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 04213 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Diet, Epigenetic Events, and Cancer Prevention (R01) Contact: Sharon A. Ross, PH.D., M.P.H. Tel: 301-594-7547 Email: rosssha@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-234.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications for clinical and preclinical research to determine how diet and dietary factors, including dietary supplements, impact DNA methylation, histone posttranslational modification, noncoding RNA, and other epigenetic processes involved in cancer prevention and development. Another important aim of this FOA is to encourage collaborations between nutrition and epigenetic experts to study bioactive food components with cancer-preventative properties and to examine key epigenetic events in cancer processes (e.g., carcinogen metabolism, cell division, differentiation, and apoptosis) in order to begin to establish linkages between epigenetics, methylation patterns, and tumor incidences/behaviors. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 04579 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Image-Guided Drug Delivery in Cancer (R01) Contact: Pushpa Tandon, Ph.D. Tel: 301-451-2291 Email: tandonp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-253.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications for innovative translational research in the development of quantitative in vivo imaging characterization of image-guided drug delivery (IGDD) in cancer, including characterizations of the target, delivery validation, and therapy response. This FOA will support research in development of integrated imaging-based platforms for multifunctional and multiplexed drug delivery systems in cancer. Validation studies in non-human primates or large animal models and first in human studies directed towards translation of IGDD technology into the clinic will be considered appropriate for this FOA. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05273 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Research On Ethical Issues In Human Subjects Research (R01) Contact: Ann Hardy Tel: 301-435-2690 Email: hardyan@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-180.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications that propose to study high priority bioethical challenges and issues associated with the types of biomedical, social, and behavioral research supported by the participating NIH Institutes/Centers. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this FOA. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05824 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Obesity Policy Research: Evaluation and Meaures (R01) Contact: Robin McKinnon, Ph.D., MPA Tel: 301-594-3599 Email: mckinnonr@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-027.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications that propose to: (1) conduct evaluation research on obesity-related “natural experiments” (defined here as community and other population-level public policy interventions that may affect diet and physical activity behavior), and/or (2) develop and/or validate relevant community-level measures (instruments and methodologies to assess the food and physical activity environments at the community level). The overarching goal of this FOA is to inform public policy and research relevant to (1) diet and physical activity behavior, and (2) weight and health outcomes of Americans. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05909 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Epigenetic Approaches in Cancer Epidemiology (R01) Contact: Mukesh Verma, Ph.D., M.P.H. Tel: 301-594-7344 Email: vermam@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-031.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites research applications that propose to evaluate profiles of methylation, histone modifications and micro RNA (miRNA) and their association with risk of developing cancer in different populations. The overarching goal of this FOA is to provide support for population based studies to define the role of epigenetic markers (methylation, histone and micro RNA profiles) changes to understand cancer etiology. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 09741 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Understanding and Promoting Health Literacy (R01) Contact: Erica Breslau, Ph.D. Tel: 301-435-2839 Email: breslaue@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-133.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors offer support for empirical research on health literacy concepts, theory and interventions as these relate to the U.S. Department of Health and Human Services’ public health priorities that are outlined in its HealthierUS and Healthy People 2010 initiatives. Health literacy is defined as the degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 10731 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R01) Contact: Vickie L. Shavers, Ph.D. Tel: 301-594-1725 Email: shaversv@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-162.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor offers support for research to: improve the measurement of racial /ethnic discrimination in health care delivery systems through improved instrumentation, data collection and statistical/analytical techniques; enhance understanding of the influence of racial/ethnic discrimination in health care delivery and its association with disparities in disease incidence, treatment and outcomes among disadvantaged racial/ethnic minority groups; and reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination on health care delivery systems in the United States. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16329 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Biomarkers of Infection-Associated Cancers (R01) Contact: Karl Krueger, Ph.D. Tel: 301-435-1594 Email: kruegerk@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-158.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor offers support for research proposals focused on identifying protein biomarkers for cancers where etiology of the disease is attributed to infectious agents. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20744 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R01) Contact: Young S. Kim, Ph.D. Tel: 301-496-0126 Email: yk47s@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-160.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications for research efforts aimed at establishing the physiological significance of dietary components in modulating the tumoricidal cell activity of natural killer (NK) cells for cancer prevention. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20887 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R01) Contact: Mukesh Verma, Ph.D. Tel: 301-594-7344 Email: vermam@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-073.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose to develop and validate new mitochondrial-related biomarkers for cancer early detection, diagnosis, prognosis, risk assessment, and response to preventive and ameliorative treatments. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 23222 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Spatial Uncertainty: Data, Modeling, and Communication (R01) Contact: Li Zhu, Ph.D. Tel: 301-594-6546 Email: li.zhu@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-238.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invites applications for innovative research that identifies sources of spatial uncertainty (i.e., inaccuracy or instability of spatial or geographic information) in public health data, incorporates the inaccuracy or instability into statistical methods, and develops novel tools to visualize the nature and consequences of spatial uncertainty. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 26618 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Biomechanisms of Peripheral Nerve Damage by Anti-Cancer Therapy (R01) Contact: Joanna M. Brell, M.D. Tel: 301-496-8541 Email: brelljm@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-082.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadline for receipt of optional letters of intent is May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institutes of Health (NIH) invites basic biologic research on damage to the peripheral nervous system instigated by pharmacologic cancer treatments, known as chemotherapy-induced peripheral neuropathy (CIPN). The majority of acquired peripheral neuropathy research has focused on diabetic and inherited diseases; this FOA intends to stimulate neuroscience researchers to apply their expertise from studying these other neuropathies to the injuries incurred by cancer treatments. More data is necessary to understand the mechanisms of neuronal damage and to identify the targets instrumental to CIPN initiation and maintenance. Preclinical research that focuses not only on peripheral neuropathic pain but also on neurosensory symptoms such as paresthesias and peripheral anesthesias is invited. The ultimate goal of this FOA is to lead to a molecular understanding of CIPN that allows for the rational development of interventions that will treat or prevent CIPN. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 70390 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Improving Diet and Physical Activity Assessment (R01) Contact: Amy Subar, Ph.D. Tel: 301-594-0831 Email: subara@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-224.html Deadline Note: The deadline for receipt of optional letters of intent is May 5, 2012. The deadline for receipt of full applications is June 5, 2012. This FOA will expire on September 8, 2012. SYNOPSIS: The sponsors provide support for innovative research to enhance the quality of measurements of dietary intake and physical activity. Applications may include development of: novel assessment approaches; better methods to evaluate instruments; assessment tools for culturally diverse populations; across various age-groups including older adults; improved technology or applications of existing technology; or statistical methods to assess or correct for measurement errors or biases. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 72509 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials (R01) Contact: Magdalena Thurin, Ph.D. Tel: 301-496-1591 Email: thurinm@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-013.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI) encourages the submission of Research Project Grant (R01) applications from institutions and organizations to validate the clinical utility of new molecular diagnostics for determining prognosis or predicting response to therapy or toxicity for cancer. The Cancer Diagnosis Program (CDP) and the Cancer Therapy Evaluation Program (CTEP) at the NCI are cooperatively sponsoring this FOA with the purpose to transition of candidate biomarkers from initial correlative observations into diagnostics that are suitable for use in clinical trials to assess the clinical validity of a marker. This program will support research projects to improve clinical decision-making in the care of cancer patients and as such will support studies that use tumor specimens linked to specific treatment and clinical outcome information. This FOA is not appropriate for molecular diagnostics discovery projects. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 90931 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R01) Contact: Andrew N Freedman, Ph.D. Tel: 301-435-6819 Email: freedmaa@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-025.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites research applications from clinicians, epidemiologists, geneticists, statisticians, and translational researchers working in the field of cancer control and prevention to improve existing models for cancer risk and prognosis by developing innovative research projects that use existing data; develop new models for cancer risk and prognosis; and validate new models and evaluate their utility in research and clinic settings. To explore this opportunity, the NCI Division of Cancer Control and Population Sciences (DCCPS) and the Division of Cancer Treatment and Diagnosis (DCTD) encourage applications for research projects to develop, apply, and evaluate new and existing cancer risk and prognostic prediction models for use by researchers, clinicians, and the general public. This FOA is designed to provide a mechanism of support for investigators to address two major challenges in model development, which are: integrating diverse types of data (e.g., clinical, demographic, pathologic, environmental, epidemiologic, outcomes, and genetic data from varied data marts or warehouses); and ensuring adequate validation (i.e., using multiple separate populations to define sensitivity, specificity, and positive and negative predictive values). This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 91013 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Prioritizing Molecular Targets for Cancer Prevention with Nutritional Combinations (R01) Contact: Cindy D. Davis, Ph.D. Tel: 301-594-9692 Email: davisci@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-035.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 05, June 05, and October 05 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites research applications to enhance our understanding about the dynamic interrelationship that exists between bioactive food components (and/or combinations thereof) and cancer prevention. Although much evidence exists that dietary components are linked to cancer prevention, the interactions among dietary bioactive compounds and food combinations remains under-investigated. Applications are encouraged to consider either multiple dietary bioactive components, intact foods or multiple foods utilizing physiologically relevant concentrations of the agents. New genetic technologies may be employed to study the impact of dietary components on complex cellular and molecular networks, as part of the effort to better understand the basis for the multifaceted interactions of food components with cancer prevention mechanisms. Specifically, applications that apply new high-throughput genomic, epigenomic, proteomic, and metabolomic technologies to prioritize molecular targets of dietary components are highly encouraged. The sites of action that may be evaluated include carcinogen metabolism, DNA repair, cell proliferation, apoptosis, differentiation, hormonal regulation, energetics, inflammation, and/or angiogenesis. In addition, applications should either evaluate multiple molecular targets within a cancer process or multiple processes in order to prioritize which process(es) is/are most involved in bringing about a phenotypic change. It is hoped that advances in this area may assist in optimizing cancer prevention while minimizing potential toxicity due to food components. The resulting information will help define which foods or food components should be considered in isolation or in combination when developing dietary strategies to reduce cancer risk and/or modify tumor behavior. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 91832 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Academic-Industrial Partnerships for Development and Validation of In Vivo Imaging Systems and Methods for Cancer Investigations (R01) Contact: Houston Baker, Ph.D. Tel: 301-594-9117 Email: bakerhou@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-169.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications from research partnerships formed by academic and industrial investigators to accelerate the translation of either animal or human in vivo imaging, image guided, and/or spectroscopic systems and methods designed to solve targeted cancer problems for cancer research, clinical trials, and/or clinical practice. The partners on each application will establish an inter-disciplinary, multi-institutional research team to work in a strategic alliance to implement a coherent strategy to develop and translate the proposed system or methods with potential for significant impact on preclinical, single, or multisite clinical studies. Partnerships must include at least one lead academic and one lead industrial organization large or small among their numbers. For either preclinical or clinical research, funding may be requested for limited additional copies of prototype systems and methods in order to optimize and validate them across different platforms and/or research sites. Each partnership is encouraged to plan to solve its choice of targeted cancer problem within the five year funding period. This FOA supports clinical trials that emphasize optimization and validation of the performance of imaging systems, including devices, agents and/or methods. It will not support commercial production. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 98141 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) Contact: Robert J. Nordstrom, Ph.D. Tel: 301-496-3428 Email: nordstrr@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-150.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. This FOA will expire on May 8, 1014. SYNOPSIS: The sponsor provides support for research on quantitative imaging of tumor response to cancer therapies in clinical trial settings, with the overall goal of facilitating clinical decision making. Proposed projects should include the appropriate development and adaptation/implementation of quantitative imaging methods, protocols and software solutions/tools (using existing commercial imaging platforms and instrumentation), and their application in current and planned Phase 1-2 clinical therapy trials. The proposed projects must focus on imaging-derived quantitative measurements of responses to drugs and/or radiation therapy, and/or image-guided interventions. It is anticipated that these research goals will require multidisciplinary efforts. Therefore, this FOA solicits applications from multi-disciplinary teams to include oncologists as well as clinical and basic imaging scientists. The involvement of industrial partners in the development of the quantitative imaging methods is not required, but is strongly encouraged. Awardees will form a Quantitative Imaging Network (QIN) to share ideas and approaches to validate and standardize imaging data and related imaging metadata for quantitative measurements of responses to cancer therapies. This FOA will utilize the NIH U01 cooperative agreement mechanism. --------------------------------------------------------------- Program Number: 93621 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Center for Complementary and Alternative Medicine/NIH/DHHS Title: Biology of Manual Therapies (R01) Contact: Partap Khalsa, D.C., Ph.D., D.A.B.C.O.,Program Officer Tel: 301-594-3462 Email: khalsap@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-209.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invites applications that propose to investigate the basic science and mechanisms of action underlying the biomechanical, immunological, endocrinological and/or neurophysiological consequences of manual therapies, such as spinal manipulation, mobilization and massage therapy. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 02478 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Eye Institute/NIH/DHHS Title: NEI Clinical Vision Research (U10) Contact: Donald F. Everett, M.A. Tel: 301-451-2020 Email: dfe@nei.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-207.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications for clinical vision research projects, including clinical trials and large-scale epidemiologic studies in vision research. The intent of this funding opportunity announcement is to provide a framework for applicants proposing clinical vision research projects, including clinical trials and epidemiological studies. This FOA will utilize the NIH cooperative agreement (U10) grant mechanism. --------------------------------------------------------------- Program Number: 04735 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Nutrition and Physical Activity Research to Promote Cardiovascular and Pulmonary Health (R01) Contact: Catherine Loria, Ph.D. Tel: 301-435-0702 Email: loriac@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-243.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications that propose research on the roles of nutrition and physical activity in the development, prevention, and management of cardiovascular diseases (CVD) or pulmonary diseases. In particular, the FOA aims to (1) improve knowledge of the contribution of diet and physical activity to these conditions and how sleep influences these relationships, (2) increase the evidence base for refining public health recommendations and clinical guidelines regarding these lifestyle behaviors, and (3) develop and test strategies to improve the adoption of these recommendations. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 07587 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R01) Contact: Abby G. Ershow, Sc. D., FAHA Tel: 301-435-0550 Email: ershowa@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-211.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites hypothesis-testing research applications that capitalize on the unique capabilities of Virtual Reality (VR) technologies to visualize outcomes, teach, motivate, and to extend the health care and learning environments, in order to foster to foster desirable eating, physical activity, self-care, and other health-related behaviors necessary for prevention and management of obesity and diabetes. Of highest interest are well-designed multidisciplinary projects drawing on expertise in VR technologies and biomedical behavioral and pedagogical sciences. The overall goal is to develop the potential of VR technologies as research tools for behavioral science-oriented studies in diabetes and obesity, and as practical tools for clinical and public health-level prevention and management of obesity and diabetes. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 07852 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Investigator Initiated Multi-Site Clinical Trials (Collaborative R01) Contact: David Gordon, M.D., Ph.D., Special Assistant for Clinical Studies Tel: 301-435-0564 Email: gordond@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-096.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor provides support for investigator-initiated multi-site Phase II or Phase III randomized, controlled clinical trials. The trials may address any research question related to the mission and goals of NHLBI and may test clinical or behavioral interventions. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 11840 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Ribosomal Disorders and Their Role in Inherited Bone Marrow Failure Syndromes (R01) Contact: Pankaj Qasba, Ph.D. Tel: 301-435-0050 Email: qasbap@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-121.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications that propose collaborative research projects by multi-disciplinary teams to advance our understanding of molecular and cellular mechanisms underlying ribosomal dysfunction. These research areas include effects on hematopoiesis and their role in bone marrow failure syndromes. Multi-disciplinary expertise across basic and clinical components is encouraged. To meet the objectives of this FOA applicants are encouraged to integrate ribosomal biology with bone marrow failure to develop and characterize models of ribosomopathies. The FOA will support projects that integrate multi-investigator, multidisciplinary approaches with a high degree of interplay between clinical components of Bone Marrow Failure (BMF) and experimental approaches to ribosome biology. Collaborative teams supported by this FOA could include researchers from such fields as biomedical, physical, and informatics disciplines. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 19695 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Etiology and Pathophysiology of Sleep Disordered Breathing in Pregnancy (R01) Contact: Aaron D. Laposky, Ph.D. Tel: 301-435-0193 Email: laposkya@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-122.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors invite applications investigating: (1) mechanisms underlying the etiology of incident sleep disordered breathing (SDB) in pregnancy; (2) mechanisms coupling SDB to maternal heart, lung, and blood pathophysiology; (3) mechanisms through which SDB affects placental development and function and associated adverse pregnancy outcomes; and (4) mechanisms linking SDB to conditions in the intrauterine environment that result in altered fetal development and predispose offspring to obesity, metabolic, and cardiovascular disease. The goal of this program is to identify clinically relevant mechanisms of SDB etiology and pathophysiology that will open new avenues to develop therapeutic strategies to reduce the maternal and fetal risks of SDB exposure during pregnancy. Multi-disciplinary research teams are strongly encouraged. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20022 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Getting from Genes to Function in Lung Disease (R01) Contact: Susan Banks-Schlegel, Ph.D. Tel: 301-435-0202 Email: schleges@nhlbi.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-110.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadline for receipt of standard R01 applications under this announcement is June 5, 2012, by 5:00 PM local time of applicant organization. The deadline for receipt of AIDS-related applications is September 7, 2012, by 5:00 PM local time of applicant organization. This program will expire on September 8, 2012. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) invites applications that propose to characterize the function of gene(s) and their associated variants identified by genome-wide association studies (GWAS) or other genetic approaches to be involved in lung diseases. Studies should use integrated approaches across scientific disciplines to determine the pathobiological function of these genes. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20023 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Toward an Improved Understanding of HDL Function (R01) Contact: Lijuan Liu, Ph.D. Tel: 301-435-0550 Email: lliu@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-143.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadline for receipt of standard R01 applications under this announcement is June 5, 2012, by 5:00 PM local time of applicant organization. The deadline for receipt of AIDS-related applications is September 7, 2012, by 5:00 PM local time of applicant organization. This program will expire on September 8, 2012. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) invites applications that propose to develop, validate, and standardize assays to measure HDL function and biomarkers for HDL function and to identify new pathways and potential HDL targets in the relationship to HDL function. Innovative methods to determine HDL functional properties such as in vivo reverse cholesterol transport (RCT), anti-oxidant, anti-inflammatory, and antithrombotic activities, and biomarkers for HDL function are encouraged. Projects that will explore HDL novel functional pathways and therapeutics related to HDL function are also encouraged. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 23549 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Effects of Secondhand Smoke on Cardiovascular and Pulmonary Disease Mechanisms (R01) Contact: William T. Riley, PhD Tel: 301-435-0407 Email: wiriley@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-244.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually.This program will expire on September 8, 2014 . SYNOPSIS: The sponsor invites applications that propose to better characterize the dose-response relationship between secondhand smoke (SHS) exposure and the cardiovascular and pulmonary diseases by improving our understanding of the mechanisms by which SHS contributes to these diseases. The recent Institute of Medicine (IOM) report on “Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence” serves as the basis for this initiative. A wide range of research including animal and human laboratory studies, cohort and case control studies, and natural experiments resulting from home, workplace, and/or community changes in SHS exposure are consistent with this initiative. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 91116 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Nutrition and Diet in the Causation, Prevention, and Management of Heart Failure (R01) Contact: Abby G. Ershow, Sc.D., FAHA Tel: 30-435-0550 Email: ErshowA@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-165.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications on the role of nutrition and diet in the causation, prevention, and treatment of cardiomyopathies and heart failure. Mechanistic, translational, and applied interdisciplinary research applications with rigorous hypothesis-testing designs for projects in humans or animals are of interest. The overall goal is to develop a satisfactory science base for rational nutritional management of patients in various stages of heart failure and for preventive approaches in high-risk individuals. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 58262 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: Ethical Legal and Social Implications (ELSI) of Genomic Research Regular Research Program (R01) Contact: Dr. Jean E. McEwen Tel: 301-402-4997 Email: jean.mcewen@nih.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-250.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors provide support for applications from institutions/organizations that propose to study the ethical, legal and social implications (ELSI) of human genome research. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 51302 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute for Occupational Safety & Health/CDC/DHHS Title: Occupational Safety and Health Research (R01) Contact: Viji Potula, Ph.D., Scientific Program Official Tel: 404-498-2551 Email: VPotula@cdc.gov Website:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-188.html Full Program:          http://www.grants.gov/search/search.do?oppId=54412&mode=VIEW Deadline Note: Applications for new awards are due on February, June, and October 5. This notice will expire on May 8, 2013. SYNOPSIS: The sponsor provides support to encourage applications that address a broad range of topics in the area of workplace safety and health. Some areas of interest for each participating Institute are highlighted below. These areas of interest serve as examples only and are not intended to constitute an exhaustive list. The R01 award mechanism will be used. --------------------------------------------------------------- Program Number: 25969 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Research to Advance Vaccine Safety (R01) Contact: Barbara Mulach, Ph.D. Tel: 301-496-1884 Email: bmulach@niaid.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-037.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) invites studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems, or 5) the application of genomic/molecular technologies to improve knowledge of vaccine safety. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25980 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Investigations on Primary Immunodeficiency Diseases (R01) Contact: David R. Johnson, Ph.D. Tel: 301-496-7104 Email: drjohnson@niaid.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-036.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. The Jeffrey Modell Foundation (JMF) will consider applications for independent JMF awards. Interested investigators should send a copy of their application materials to the following address: Jeffrey Modell Foundation 780 Third Avenue New York, NY 10017 Tel: (212) 819-0200 Fax: (212) 764-4180 Email:info@jmfworld.org SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) invites applications for innovative investigations in primary immunodeficiency diseases. Of particular interest are the detection of primary immunodeficiency diseases, the identification of the molecular basis of these diseases, and the design and pre-clinical development of innovative therapies for these diseases. Clinical trials will not be supported by this FOA. Studies using samples obtained from humans and studies on animal models are encouraged. Investigators who have not received independent NIH funding in this field are encouraged to apply. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27204 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Enhancing Cellular Immunity in the Female Reproductive Tract (R01) Contact: Alan Embry, Ph.D. Tel: 301-435-3751 Email: embrya@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-104.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after April 7, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) invites applications for research focused on the discovery of mechanisms that mediate the induction and maintenance of effective antigen-specific CD8+ memory T cells in the female reproductive tract (FRT). The ultimate goal is to develop the knowledge base needed to facilitate the development of future vaccines that generate effective and persistent T lymphocyte responses against infection by HIV and other mucosal pathogens in the FRT. This program is not intended to support evaluation of mucosal vaccines or therapies, or research primarily focused on pathogens. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27206 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Functional Glycomics in HIV Vaccine Design (R01) Contact: Thandi M. Onami, Ph.D Tel: 301-594-1321 Email: onamit@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-105.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after April 7, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) invites applications for research to 1) investigate structural and conformational features of glycosylation that may lead to novel HIV vaccine design approaches, and 2) to elucidate the impact of differential glycosylation on the quality of the immune response to HIV. Ultimately, the discovery of a safe, effective, prophylactic vaccine that provides long-term protection from HIV infection may depend on novel approaches that incorporate new knowledge of the key role glycans play in the elicitation and maturation of broadly neutralizing antibodies and effector immune responses. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27207 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Mucosal Environment and HIV Prevention (MEHP) (R01) Contact: Jim A. Turpin, Ph.D. Tel: 301-451-2732 Email: jturpin@niaid.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-106.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after April 7, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) invites applications that address the long term goal and objectives of increasing the safety and efficacy of non-vaccine biomedical prevention, such as microbicides and PrEP, through a better understanding of their interactions with the tissue micro- and macro-environments of the genital (male and female) and gastrointestinal mucosa. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27244 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Delivering Therapeutics to Residual Active HIV Reservoirs (R01) Contact: Karl Salzwedel, Ph.D. Tel: 301-496-5332 Email: salzwedelkd@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-107.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after April 7, 2012 . The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of Mental Health (NIMH) invite applications to encourage new ideas for eliminating cellular reservoirs of HIV that continue to actively produce virus in tissue compartments despite suppression of plasma viremia with antiretroviral therapy. New approaches to delivering antiretrovirals or other anti-HIV agents to these tissues or to specific cell types are needed to block virus production, limit inflammation, and facilitate clearance of these reservoir cells. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27775 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS Title: Improving Translational and Basic Research to Control Itch in Humans (ITCH) (R01) Contact: Hung Tseng, Ph.D. Tel: 301-496-0810 Email: tsengh@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-131.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) invites applications for basic and translational studies aimed at understanding the mechanisms of itch sensation and developing methods to modulate and control itch sensation in disease and rehabilitation. The purpose is to accelerate discovery in this nascent field and to apply new knowledge to improve human conditions relevant to the NIAMS mission. This FOA intends to support a broad range of investigations using animal and human models, with an emphasis on multidisciplinary collaboration for rapid bench-to-bedside exchange of information and therapy development. This FOA is not intended to support applications proposing clinical trials. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05470 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Biomedical Imaging and Bioengineering/NIH/DHHS Title: Bioengineering Research Grants (BRG) (R01) Contact: Dr. Christine Kelley, Director Tel: 301-451-4778 Email: kelleyc@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-009.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor provides support for Bioengineering Research Grants (BRGs) for basic and applied multi-disciplinary research that addresses important biological, bioengineering or medical research problems. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 06164 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Biomedical Imaging and Bioengineering/NIH/DHHS Title: Development of Multifunctional Drug and Gene Delivery Systems (R01) Contact: Lori A. Henderson, Ph.D. Tel: 301-451-4778 Email: hendersonlori@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-048.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications from institutions/organizations that propose the engineering of novel, multifunctional drug and gene delivery systems that can target therapies to particular cells and intracellular compartments and can monitor delivery and determine therapeutic efficacy through the integration of advanced imaging and/or sensing technologies into the delivery system. Applications should propose to develop at least one prototype system by the end of the project period. Applications that are submitted to this FOA should include investigators from both the drug/gene delivery and imaging fields. Applicants are strongly encouraged to use the Multi-PD/PI model to meet the imaging and drug/gene delivery expertise. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16108 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Biomedical Imaging and Bioengineering/NIH/DHHS Title: Bioengineering Research Partnerships (BRP)[R01] Contact: Albert Lee, Ph.D. Tel: 301-451-4781 Email: alee@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-234.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications for R01 awards to support Bioengineering Research Partnerships (BRPs) for basic, applied, and translational multi-disciplinary research that addresses important biological, clinical or biomedical research problems. In the context of this program, a partnership is a multi-disciplinary research team, that applies an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior. The partnership must operate according to a clear leadership plan and include appropriate bioengineering or allied quantitative sciences in combination with biomedical and/or clinical components. BRPs may propose, within a 12-page research strategy section, design-directed, developmental, discovery-driven, or hypothesis-driven research at universities, national laboratories, medical schools, large or small businesses, or other public and private entities or combinations of these entities, and will be evaluated against expanded review criteria. It is expected that a BRP will have a well-defined goal or deliverable that will be achieved in a 5-10 year timeframe based on objective milestones specified in the initial application. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 71649 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Biomedical Imaging and Bioengineering/NIH/DHHS Title: Nanoscience and Nanotechnology in Biology and Medicine (R01) Contact: Piotr Grodzinski Tel: 301-594-4177 Email: grodzinp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-148.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications that apply nanoscience and nanotechnology approaches to address problems in biology and medicine. The purpose of this FOA is to provide support for cutting-edge nanoscience and nanotechnology research that can lead to biomedical breakthroughs and new investigations into the diagnosis, treatment and management of an array of diseases and traumatic injuries. Nanoscience and nanotechnology have the capacity to drive a new wave of medical innovation through the engineering of bioactive nanoscale structures, processes and systems based on the advancement of our understanding of biology at the nanoscale. Therefore, this FOA will also support research projects that develop new or improved nanotechnology and nanoscience-based tools, methods, concepts, and devices that lead to a better understanding of basic biology in addition to conducting translational biomedical studies. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 00969 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Studies in Neonatal Hypoglycemia (R01) Contact: Tonse N. K. Raju, MD Tel: 301-402-1872 Email: rajut@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-053.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications that propose studies related to basic, applied and translational research in neonatal hypoglycemia. While much progress has been made in understanding the causes and mechanisms of altered neonatal glucose homeostasis, major gaps remain. Through this FOA, the NICHD is hoping to fill-in such knowledge gaps, which may lead to better monitoring and treatment strategies for altered neonatal glucose homeostasis. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 11079 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research Opportunities in Obstetric Fistula (R01) Contact: Susan F. Meikle, M.D., M.S.P.H. Tel: 301- 273-8541 Email: meikles@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-141.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications that propose to investigate epidemiologic, clinical, social, and behavioral interventions to improve the identification, prevention, treatment, and social circumstances of women at risk for or with obstetric fistula. The purpose of this FOA is not to address service delivery issues that have been outlined in the obstetric fistula program development materials distributed by WHO although it is recognized that improving financial access to care, transportation of women in labor, and obstetric service coverage is critical for reducing and eliminating the obstetric fistula rate. Rather, this FOA requests research applications that complement the programmatic efforts to deliver better and more timely health care during labor, delivery, and post partum. Obstetric fistula is a critical maternal and child health issue in developing countries. Multiple approaches including both improving emergency obstetric care and improved clinical, social and behavioral care are needed to reduce its toll on women and children. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20447 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Understanding and Treating Co-Morbid Conditions in Adolescents with Intellectual and Developmental Disabilities (R01) Contact: Mary Lou Oster-Granite, Ph.D.. Tel: 301-435-6866 Email: mo96o@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-039.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose to focus investigator-initiated research upon the factors that impact functioning and quality of life in individuals with intellectual and developmental disabilities (IDD) during adolescence. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20703 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Outcome Measures for Use in Treatment Trials for Individuals with Intellectual and Developmental Disabilities (R01) Contact: Melissa A. Parisi, MD, PhD Tel: 301-435-6880 Email: parisima@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-045.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors invite applications that propose to develop, validate, and/or calibrate informative outcome measures for use in clinical trials for individuals with intellectual and developmental disabilities (IDD). This funding opportunity will address a significant need in the field, one that is especially apparent in efforts to develop pharmacological treatments for these populations. This solicitation will focus ongoing clinical and translational research on a neglected area essential for therapy and pharmacological treatment development. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 22020 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research on Children in Military Families: The Impact of Parental Military Deployment and Reintegration on Child and Family Functioning (R01) Contact: Valerie Maholmes, PhD., CAS Tel: 301-496-1514 Email: maholmev@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-200.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite interdisciplinary studies on the impact of parental military deployment, combat-related stress, and reintegration with the family on child social and affective development outcomes as well as on family functioning. Longitudinal prospective studies with diverse samples would address important gaps in the literature and are highly encouraged. Descriptive studies addressing the particular concerns of early childhood, middle childhood and adolescence are also encouraged. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 23693 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Pregnancy in Women with Disabilities (R01) Contact: Caroline Signore, MD, MPH Tel: 301-496-5577 Email: signorec@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-258.html Deadline Note: Submission of letters of intent are strongly encouraged. Optional letters of intent may be submitted thirty days prior to the application due date(s). The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications investigating the incidence, course, and outcomes of pregnancy among women with disabilities. Areas of interest also include studies to inform preconceptional and antenatal counseling and strategies for addressing barriers to prenatal care, and management of pregnancy, the puerperium, and the transition to parenthood in order to optimize outcomes for women with physical, intellectual and developmental, and/or sensory disabilities and their families. Applicants are encouraged to include women with disabilities and members of the community in the design and conduct of their research. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 23908 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Health Promotion for Children With Physical Disabilities Through Physical Activity and Diet: Developing An Evidence Base (R01) Contact: Ralph Nitkin, Ph.D., Director Tel: 301-402-4206 Email: rn21e@hin.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-288.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 05, 2011. The sponsor will accept optional letters of intent thirty days prior to the applicable receipt date. The deadlines for receipt of standard applications under this announcement are: February 05, June 05, and October 05 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications that will improve our understanding of how patterns of physical activity and dietary choice affect the health and fitness of children with physical disabilities. Proposed research should account for the functional limitations of children with disabilities and their nutritional needs, as well as the physiological, psychosocial, and environmental factors that play a role in determining the health of this population. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24043 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01) Contact: George P. Giacoia, M.D. Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-301.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. Optional letters of intent may be submitted thirty days prior to the application due date(s). The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications for the development and acceptability of pediatric drug formulations in different age groups. Development and testing of novel pediatric drug delivery systems is also part of this initiative. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24408 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Gamete Quality in Natural and Assisted Reproduction (R01) Contact: Stuart B. Moss, PhD Tel: 301-435-6979 Email: mossstua@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-326.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications to support outstanding research in the area of female and male gamete quality. For both natural and assisted reproduction, a focal point of the initiative is on the production, identification, and use of healthy gametes. In this regard, the identification and validation of biomarkers that assess gamete quality is critical. Additional areas of interest are the impact of nutrition, environmental exposures, disease states, and aging on oocyte and sperm quality. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24410 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Biomarkers: Bridging Pediatric and Adult Therapeutics (R01) Contact: George P. Giacoia, MD Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-322.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. Letters of intent may be submitted thirty days prior to the application deadline(s). The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsors invite applications from institutions or organizations that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity and response to therapy. Projects supported by this FOA will be confined to those biomarkers that correlate with a clinical observation, have been extensively studied in adults, and for which there is solid evidence that they have pediatric applications. Discovery of new biomarkers for use in new drug development or in preclinical studies are not part of this FOA. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 61230 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research on the Health of LGBTI Populations [R01] Contact: Susan Newcomer, PhD Tel: 301-435-6981 Email: newcomes@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-111.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institutes of Health (NIH) and its participating Institutes and Centers invite applications for research that will increase scientific understanding of the health status of various population groups and improve the effectiveness of health interventions and services for individuals within those groups. High priority is placed on research on populations that appear to have distinctive health risk profiles but have received insufficient attention from investigators. This Funding Opportunity Announcement (FOA) highlights a particular community: lesbian, gay, bisexual, transgender, intersex, and related populations (designated here as LGBTI populations). Basic, social, behavioral, clinical, and services research relevant to the missions of the sponsoring Institutes and Centers may be proposed. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 82115 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Mechanisms of Adverse Drug Reactions in Children (R01) Contact: George P. Giacoia, MD Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-051.html Deadline Note: The sponsor requests that optional letters of intent be submitted thirty days prior to the application due date. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications for projects that enhance the state-of-the-science on the molecular and cellular, genetic and epigenetic mechanisms involved in the production of adverse drug reactions in children. The objective of this announcement includes research on the role of ontogeny and the characterization of pharmacogenetic and developmental variations of drug metabolizing enzymes (DMEs), transporters, ion channels, receptors and signaling pathways that are responsible for drug toxicity in the pediatric population. This FOA will use the NIH Research Project Grant (R01) award mechanism. --------------------------------------------------------------- Program Number: 82960 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research on Emergency Medical Services for Children (EMSC) [R01] Contact: Lynne Haverkos, M.D., M.P.H. Tel: 301-435-6881 Email: lh179r@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-141.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute of Child Health and Human Development (NICHD) and National Institute of Mental Health (NIMH) invite applications dealing with the following areas of research included under the term EMSC: prevention research to reduce the need for emergency care; clinical research to ensure that children receive high-quality and appropriate medical, nursing and mental health care in an emergency; health systems research, from pre-hospital care, to the emergency department, to in-patient care and return to the community; models to improve service and cost efficiency in pediatric emergency care; and methodological studies to improve the quality of research conducted. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 85922 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Innovative Therapies and Tools for Screenable Disorders in Newborns (R01) Contact: Tiina Urv, PhD Tel: 301-402-7015 Email: urvtiin@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-230.html Deadline Note: Optional Letters of Intent will be accepted 30 days prior to the application due date. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invite applications from institutions/ organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and “high priority” genetic conditions for which screening could be possible in the near future. In this FOA, a “high priority” condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 93887 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Developmental Pharmacology (R01) Contact: George P. Giacoia, M.D. Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-11-057.html Deadline Note: The sponsor requests that optional letters of intent be submitted 30 days prior to the application receipt date. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors invite applications from institutions/ organizations that propose to encourage multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology with particular emphasis on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways activity across developmental periods from fetal life to adolescence. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 94876 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Genetic Susceptibility and Variability of Human Structural Birth Defects (R01) Contact: Lorette C. Javois, Ph.D. Tel: 301-496-5541 Email: javoisl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-085.html Deadline Note: This program will expire on January 8, 2014. SYNOPSIS: The sponsors provide support for innovative investigator-initiated R01 applications using animal models in conjunction with translational/clinical approaches that take advantage of advances in genetics, biochemistry, molecular, and developmental biology to identify the specific genetic, epigenetic, environmental, or gene/environment interactions associated with the susceptibility to and variability of structural birth defects in human populations. Applicants funded through this FOA will join the NICHD Birth Defects Working Group and participate in annual meetings designed to provide a forum to discuss research progress, exchange ideas, share resources, and foster collaborations relevant to the goals of the NIHCD's Birth Defects Initiative. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20708 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: Competitive Revision Applications for NIDCR-funded Cooperative Agreements (U01) Contact: Lynn Mertens King, Ph.D. Tel: 301-594-5006 Email: lynn.king@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-144.html Deadline Note: The deadlines for optional letters of intent are: April 26, 2011 (passed); and four weeks prior to submission thereafter. The deadlines for receipt of standard applications under this announcement are: May 26,2011; thereafter February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: May 26,2011; thereafter January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites submission of competitive revision applications for active, NIDCR-funded single project U01 awards. The NIDCR uses the U01 Cooperative Agreement funding mechanism for a variety of projects requiring significant input from and oversight by NIDCR program staff. Although some requests for expansion/redirection of a project can be handled administratively, more substantial changes in direction and increases in funding require peer review. This FOA will utilize the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 24227 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: Building a Genetic and Genomic Knowledge Base in Dental, Oral, and Craniofacial Diseases and Disorders (R01) Contact: Emily L. Harris, PhD, MPH Tel: 301-594-4846 Email: emily.harris@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-317.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications for research into dental, oral, and craniofacial diseases and disorders for which there is evidence for genetic heritability but for which we do not have a strong understanding of the genetics/genomics of the disease or disorder. Applicable areas of investigation include identification of promising areas of the genome, and characterization and elucidation of the function(s) of genetic variants that affect disease risk in humans. The ultimate goal of these studies will be to drive development of effective diagnostic, therapeutic, and preventive approaches. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24548 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: Immunopathogenesis of HIV/AIDS-related Oral Manifestations and Host Immunity (R01) Contact: Isaac R. Rodriguez-Chavez, Ph.D., M.S., M.H.S. Tel: 301-594-7985 Email: isaac@nidcr.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-334.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after December 7, 2011. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose studies to translate new scientific insights about HIV infection, oral pathogen co-infections (viruses, bacteria and fungi) and AIDS-related oral opportunistic infections (viruses, bacteria, and fungi) into better understanding of the immunopathogenesis of these infectious agents to guide translational research focused on the development of novel, oral mucosal prophylactic HIV vaccines as well as therapeutic strategies against HIV, oral co-infections and oral opportunistic infections. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 91196 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: Pathophysiology and Clinical Studies of Osteonecrosis of the Jaw (R01) Contact: Jane C. Atkinson, D.D.S., Director Tel: 301-435-7908 Email: jatkinso@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-082.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose to study the underlying pathophysiology of osteonecrosis of the jaw (ONJ), identify risk factors for this condition, establish the natural history of the disease, and generate evidence for its treatment. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 97846 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: NIDCR Clinical Trial Implementation or Biomarker Clinical Evaluation Study Cooperative Agreement (U01) Contact: Jane C. Atkinson, DDS, Program Director Tel: 301-435-7908 Email: jatkinson@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-339.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after October 18, 2011. Optional letters of intent may be submitted thirty days prior to the applicable receipt date(s). The first receipt date is November 18, 2011, then deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015 . SYNOPSIS: The sponsor will support investigator-initiated Phase I, II, III or IV clinical trial cooperative agreement applications or biomarker evaluation studies that require prospective collection of clinical outcomes and clinical specimens. All applicants must have received an NIDCR Clinical Trial Planning (R34) award to plan the proposed cooperative agreement study (see PAR-11-338 [SPIN Program # 97843] for information about NIDCR Clinical Trial or Biomarker Clinical Evaluation Study Planning Grants). NIDCR may consider an exception. A unique application is required for each proposed study, and must include a final draft of the study protocol, a Manual of Procedures and other supporting materials such as the Investigator’s Brochure. These documents must meet all National Institutes of Health (NIH), Food and Drug Administration (FDA), and Office of Human Research Protections (OHRP) requirements. All awards will be made as cooperative agreements. This program will use the NIH single project (U01) cooperative agreement award grant mechanism. --------------------------------------------------------------- Program Number: 01007 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Health Disparities in NIDDK Diseases (R01) Contact: Lawrence Agodoa, M.D., Director Tel: 301-894-9650 Email: la21j@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-262.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides support for research to understand and mitigate issues of health disparities in high priority diseases within its scope, including diabetes, obesity, nutrition-related disorders, hepatitis C, gallbladder disease, H. Pylori infection, sickle cell disease, kidney diseases, and metabolic, gastrointestinal, hepatic, and renal complications from infection with HIV. This program will use the NIH R01 grant mechanism. --------------------------------------------------------------- Program Number: 01322 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Development and Validation of Disease Biomarkers (R01) Contact: Maren R. Laughlin, Ph.D. Tel: 301-534-8802 Email: ml33q@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-204.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor offers support for the validation of candidate biomarkers for well-defined human diseases of liver, kidney, urological tract, digestive and hematologic systems, as well as endocrine and metabolic disorders, diabetes and its complications, and obesity, for which there are no or very few biomarkers, or for which standard biomarkers are currently prohibitively invasive or expensive. A biomarker is an indicator of a disease process, and could replace hard clinical end points as a measure of the effect of new therapies. Appropriate studies will validate candidate biomarkers in well-defined patient populations, provide new technologies to monitor biomarkers or establish reliable assays for validated markers. This PA will use the NIH R01 award mechanism. --------------------------------------------------------------- Program Number: 02644 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Advances in Polycystic Kidney Disease (R01) Contact: Deborah K, Hoshizaki, Ph.D. Tel: 301-594-7712 Email: dkhosh@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-202.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites experienced and new investigators to submit research grant applications to pursue basic and applied investigations in order to better understand the etiology and pathogenesis of Polycystic Kidney Disease (PKD), in both its autosomal dominant and autosomal recessive forms. The intent of this funding opportunity is to intensify investigator-initiated research, to attract new investigators to the field, and to increase interdisciplinary research. The ultimate aim is to facilitate PKD-related research studies, which will provide the basis for new therapeutic approaches. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 03330 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Calcium Oxalate Stone Diseases (R01) Contact: Rebekah S. Rasooly, Ph.D. Tel: 301-594-6007 Email: rr185i@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-213.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides support to increase investigator interest in research into oxalate metabolism, transport and homeostasis, and oxalate stone diseases. This initiative encourages basic, clinical or epidemiological studies that utilize new and innovative approaches to study the diagnosis, treatment and prevention of these disorders. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 04618 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Erythropoiesis: Components and Mechanisms (R01) Contact: Terry Rogers Bishop, Ph.D. Tel: 301-594-7726 Email: tb232j@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-255.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 08, 2012. SYNOPSIS: The sponsors invite applications that propose hypothesis-driven research using erythroid cells. The aim of this program is to support research efforts towards a complete description of the molecular and cellular components of erythropoiesis and how these components contribute to erythropoiesis. Components include genes that are expressed (transcriptome) in erythroid cells, either during development or during differentiation, and the proteins (proteome) that are translated in erythroid cells, especially with post-translational modifications or subcellular localizations that are unique to erythroid cells. A long range goal of this program is to generate a concise description of erythropoiesis that unifies genetics, molecular processes and cytokine determinants in the erythroid lineages so that new therapeutics may be developed to measure and combat anemia. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 06030 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Stimulating Hematology Investigation: New Endeavors (SHINE) (R01) Contact: Terry Rogers Bishop, Ph.D. Tel: 301-594-7726 Email: tb232j@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-046.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: TThe Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high quality hematology research relevant to the mission of The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). In the SHINE program, NIDDK invites investigator-initiated research project grant applications in specific areas of basic and translational hematology research where needs and opportunities for progress are particularly timely. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 09637 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Home and Family Based Approaches for the Prevention or Management of Overweight or Obesity in Early Childhood (R01) Contact: Robert J. Kuczmarski, Dr.P.H. Tel: 301-451-8354 Email: Robert.Kuczmarski@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-127.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors invite applications from institutions/organizations that propose randomized clinical trials testing novel home- or family-based interventions for the prevention or management of overweight in infancy and early childhood. Tested interventions can use behavioral (including dietary and physical activity), environmental, or other relevant approaches. Applications should focus on infants and young children (to age six years) and emphasize the role of home environment and the influence of family/extended family members and parents (including guardians/substantial care-providers) within the child’s home environment. The direct goal of this initiative is to fund research that will advance knowledge for innovative approaches to the prevention or management of overweight in children less than 6 years of age, with potential for future translation to applications either in the home or linked to a community setting. Research should consider the familial mechanisms of behavior such as the role of families in the initiation, support, and reinforcement of fundamental food and beverage consumption, physical activity practices, and sedentary behaviors. In addition it is of interest to elucidate various underlying behavioral determinants that are crucial to initiate or sustain changes in behaviors that impact energy balance. Research designs may include linkages with other settings (e.g., daycare, pre-school, or other community venues) or other care providers (e.g., health care providers or teachers) but must include infants or children less than age six years as the primary study participant along with parents, and/or other family members residing with the child. The overarching goal is to identify interventions that influence parent and child behaviors that contribute to inappropriate weight gain, and thereby improve subsequent health status in childhood, adolescence, and adulthood for which overweight is a known risk factor. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 10378 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Diet Composition and Energy Balance (R01) Contact: Susan Z. Yanovski, M.D. Tel: 301-594-8882 Email: sy29f@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-152.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 2, May 1, and September 1 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors invite applications investigating the role of diet composition in energy balance, including studies in both animals and humans. Both short and longer-term studies are encouraged, ranging from basic studies investigating the impact of micro-or macronutrient composition on appetite, metabolism, and energy expenditure through clinical studies evaluating the efficacy of diets differing in micro- or macronutrient composition, absorption, dietary variety, or energy density for weight loss or weight maintenance. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20610 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: NIDDK Multi-Center Clinical Study Cooperative Agreement (U01) Contact: Marva Moxey-Mims, M.D Tel: 301-594-7717 Email: mimsm@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-157.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2011. SYNOPSIS: The sponsor invites applications for investigator-initiated, multi-center clinical studies through a two-part process that includes an implementation planning grant (U34; see PAR-10-197 SPIN Program # 95376). NIDDK will accept, peer review and consider for funding applications for investigator-initiated, multi-center clinical studies only from U34 grant awardees, except in cases where an exemption from the requirement has been given by NIDDK. Completion of the required products of a U34 grant is a prerequisite for submission of a multi-center clinical cooperative agreement (U01) application under this FOA. see SPIN Program # 95376). This program use the the NIH U01 grant mechanism. --------------------------------------------------------------- Program Number: 21483 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Ancillary Studies to the NIDDK Intestinal Stem Cell Consortium (R01) Contact: Jill L. Carrington, Ph.D. Tel: 301-402-0671 Email: carringj@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-107.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications to conduct ancillary studies to the NIDDK Intestinal Stem Cell Consortium (ISCC). Studies will make use of consortium collaborations, techniques, and resources to accelerate research into intestinal stem cells. The proposed ancillary study must be designed to advance the scientific research mission of the NIDDK by focusing on diseases and areas of interest to the Institute and commensurate with the interests and intent of the ISCC. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 78588 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Development of Assays for High-Throughput screening for use in Probe and Pre-therapeutic Discovery (R01) Contact: Ronald Margolis, Ph.D. Tel: 301-594-8819 Email: margolisr@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-213.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations that propose the development of assays for high throughput screening (HTS) relevant to processes and diseases specific to its mission with the intent of using them to screen for small molecule compounds that show desired properties as probes for use in advancing knowledge about the relevant target, identifying new targets, or serving as pre-therapeutic leads. The NIH launched a Molecular Libraries and Imaging initiative as part of the NIH Roadmap for Medical Research to establish a network of HTS screening centers which provide access to a large compound library, robotics to carry out the assays, and informatics to interpret the results (http://mli.nih.gov/mli/). This FOA seeks to establish a stream of scientifically and technologically outstanding assays for screening by these and other academic centers. Assays may involve targets indirectly related to disease, but which might provide insight into the biology of relevant diseases. Other targets might be associated with rare and neglected diseases, an area of increasing focus for the NIH (http://www.nih.gov/news/health/may2009/nhgri-20.htm). Assays should be relevant to the scope of the research for at least one of the sponsoring NIH Institutes. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 78876 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01) Contact: John W. Jusek, Ph.D. Tel: 301-594-7735 Email: jk61x@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-247.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications from qualified investigators to conduct ancillary studies to major ongoing clinical research studies, including clinical trials, epidemiological studies and disease databases supported by the National Institute of Diabetes and Digestive and Kidney Diseases. Major studies include multi-center investigations, national databases and Phase 3 clinical trials. Examples of NIDDK-supported major clinical research studies eligible for ancillary studies may be found at http://www2.niddk.nih.gov/Research/ClinicalResearch/AncillaryStudies/ . This FOA also encourages grant applications for ancillary studies utilizing major clinical research studies supported by other Institutes and Centers of the National Institutes of Health, other government agencies and the private sector. However, the proposed ancillary study must be designed to advance the scientific research mission of the NIDDK by focusing on diseases and areas of interest of the Institute. This program will use the NIH Research Project Grant (R01) award mechanism. --------------------------------------------------------------- Program Number: 87094 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Basic and Clinical Studies of Congenital Urinary Tract Obstruction (R01) Contact: Marva M. Moxey-Mims, M.D. Tel: 301-594-7717 Email: mm726k@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-226.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides support to encourage and facilitate research in congenital obstructive uropathy including the development of objective prognostic markers; the genetic determinants of this congenital disorder; the development of reliable animal models of the disorder; and, evaluation of the long-term effectiveness of various treatment strategies. This PA will use the NIH R01 award mechanism. --------------------------------------------------------------- Program Number: 87095 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Ancillary Studies of Acute Kidney Injury, Chronic Kidney Disease, and End Stage Renal Disease Accessing Information from Clinical Trials, Epidemiological Studies, and Databases (R01) Contact: Paul W. Eggers, Ph.D. Tel: 301-594-8305 Email: pe39h@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-196.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite investigator-initiated research project applications for ancillary studies to ongoing or completed clinical trials, existing administrative and clinical databases and epidemiological studies of kidney disease as well as clinical trials and epidemiological studies for other diseases or populations that lend themselves to the study of acute kidney injury and chronic kidney disease. These studies may range from new analyses of existing datasets of completed studies to additional collection of data and biological specimens in ongoing investigations. The goal of these studies should be to extend our understanding of the risk factors for developing kidney disease and their associated co-morbid illnesses such as malnutrition and cardiovascular disease, factors associated with rapid decline in kidney function among persons with chronic kidney disease, and the impact of these diseases on quality of life and mental and physical functioning. Investigations of acute kidney injury, including biomarkers is also an appropriate topic for investigation. Studies ancillary to both government and non-government supported clinical trials and epidemiological studies are encouraged. Analysis of large public access databases and other databases is also encouraged. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 92836 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Grants for Research in Glomerular Diseases (R01) Contact: Marva Moxey-Mims, M.D. Tel: 301-594-7717 Email: mm726k@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-113.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications from new or established investigators to pursue exploratory investigations of glomerular disease, which would foster development of new ideas enhancing the understanding of disease detection, pathogenesis, pre-emption and/ or treatment. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 28028 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Environmental Health Sciences/NIH/DHHS Title: Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01) Contact: Symma Finn, PhD Tel: 919-541-4258 Email: finns@niehs.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-153.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2015. SYNOPSIS: National Institute of Environmental Health Sciences (NIEHS) and National Institute of Nursing Research (NINR) invite applications using community-engaged research methods to investigate the potential health risks of environmental exposures of concern to the community and to implement an environmental public health action plan based on research findings. The overall goal is to support changes to prevent or reduce exposure to harmful environmental exposures and improve the health of a community. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 28136 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Food and Agriculture/Department of Agriculture Title: Agriculture and Food Research Initiative -- Childhood Obesity Prevention --Integrated Approaches to Prevent Childhood Obesity Contact: Dr. Jane Clary Tel: 202-720-3891 Email: jclary@nifa.usda.gov Full Program:          http://www.nifa.usda.gov/funding/rfas/pdfs/12_afri_child_obes_prevent.pdf SYNOPSIS: NIFA invites applications for Integrated Projects for research, education, and extension work in the Childhood Obesity Prevention Challenge Area. The Childhood Obesity Prevention Challenge Area RFA focuses on the societal challenge to end child obesity. A total of approximately $5.0 million is available. --------------------------------------------------------------- Program Number: 02699 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Innovations in Biomedical Computational Science and Technology (R01) Contact: Peter Lyster, Ph.D. Tel: 301-451-6446 Email: lysterp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-218.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors offer support for research and developments in computational science and technology that will support rapid progress in areas of scientific opportunity in biomedical research. As defined here, biomedical computing or biomedical information science and technology includes database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic collaboration, as well as computational and mathematical research including the development of structural, functional, integrative, and analytical models and simulations. This program will use the NIH R01 award mechanism. --------------------------------------------------------------- Program Number: 05492 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Technology Development for High-Throughput Structural Biology Research (R01) Contact: Charles. G. Edmonds, Ph.D. Tel: 301-594-4428 Email: edmondsc@nigms.nin.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-073.html Deadline Note: This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations that propose to develop novel technologies and methodologies underpinning high-throughput structural biology. Applications for new ideas and approaches for protein production and structure determination for classes of challenging proteins are appropriate. Projects related to high-throughput structure determination by X-ray crystallography and NMR, as well as projects addressing other constituent tasks of structural biology, including structural genomics, are relevant to this FOA. Applications should focus on methods development to solve challenging proteins that are not currently amenable to high-throughput structural biology. These challenging proteins include, but are not limited to, membrane proteins, small protein complexes, and proteins from human and other higher eukaryotes. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 06816 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Technology Development for Protein Modeling (R01) Contact: Ward Smith, Ph.D. Tel: 301-443-9375 Email: smithwar@nigms.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-076.html Deadline Note: This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites from institutions/organizations that propose to develop novel technologies that will significantly improve the accuracy of comparative modeling methods for protein structure prediction. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 45344 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Structural Biology of Membrane Proteins (R01) Contact: Jean Chin, Ph.D. Tel: 301-594-0828 Email: chinj@nigms.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-228.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsors provide support to develop research and methods to enhance the rate of membrane protein structure determination and to determine specific membrane protein structures. Innovative methods for expression, oligomerization, solubilization, stabilization, purification, characterization, crystallization, isotopic labeling, and structure determination of unique and biologically significant membrane proteins by x-ray diffraction, nuclear magnetic resonance (NMR), electron microscopic, mass spectrometry, and other biophysical techniques are encouraged. Projects that will lead in the near term to determining the structures of biologically important membrane proteins are also encouraged. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 68933 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Continued Development and Maintenance of Software (R01) Contact: Peter Lyster, Ph.D. Tel: 301-451-6446 Email: lysterp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-028.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor provides support for the continued development, maintenance, testing and evaluation of existing software. The proposed work should apply best practices and proven methods for software design, construction, and implementation to extend the applicability of existing biomedical informatics/computational biology software to a broader biomedical research community. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 82572 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Collaborations with National Centers for Biomedical Computing (R01) Contact: Peter Lyster, PhD Tel: 301-451-6446 Email: lysterp@nigms.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-001.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The sponsor invites applications for projects from individualinvestigators or small groups to collaborate with the NIH Common Fund for Medical Research National Centers for Biomedical Computing (NCBCs). For a description of the NCBCs see http://www.ncbcs.org/. The intention of the collaborating projects is to engage researchers across the nation in building an excellent biomedical computing environment, using the computational tools and biological and behavioral application drivers of the funded NCBCs as foundation stones. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 85825 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Collaborative Research for Molecular and Genomic Studies of Basic Behavior in Animal Models (R01) Contact: Laurie Tompkins, Ph.D. Tel: 301-594-0943 Email: tompkinL@nigms.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-125.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors offer support for collaborative research, involving behavioral scientists and investigators with expertise in molecular biology and/or genomics, which addresses questions about basic mechanisms of behavior in animal models. This PA will use the R01 award mechanism. --------------------------------------------------------------- Program Number: 00320 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Collaborative R01s for Clinical and Services Studies of Mental Disorders, AIDS and Alcohol Use Disorders (R01) Contact: Joel Sherrill, Ph.D. Tel: 301-443-2477 Email: jsherril@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-153.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors offer support for collaborative intervention trials in the treatment, prevention or rehabilitation of those with mental disorders and alcohol use disorders and comorbid mental disorders. Support is also sought for other collaborative clinical studies, including but not limited to mental health services research, AIDS, genetics, psychopathology, stigma, and cultural and social processes. This initiative should be used when two or more sites are needed to complete the study. The collaborating studies share a specific protocol across the sites and are organized as such in order to increase sample size, accelerate recruitment, or increase sample diversity and representation. In studies with a large number of sites, it is expected that one site will be submitted as a coordinating site for data management and/or other centralized administration. This initiative also supports projects involving collaboration between community-based organizations such as consumer or advocacy groups, state or local governments, and Tribal governments with universities and colleges. This program will use the NIH Collaborative Research Project Grant (Collaborative R01) award mechanism. --------------------------------------------------------------- Program Number: 23772 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R01) Contact: Christopher Gordon, PhD Tel: 301-443-6100 Email: cgordon1@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-271.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after August 7, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications for research designed to increase the impact of effective HIV/AIDS-related interventions for prevention and treatment. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan (Objective 4): To strengthen the public health impact of NIMH-supported research. That is, through research, evaluation, and collaboration, to develop the capacity of NIMH to help close the gap between the development of new, research-tested interventions and their widespread use by those most in need. The two overarching goals of this FOA are to encourage projects that will 1) improve the uptake of efficacious interventions and 2) conduct research to inform and enhance the effectiveness and efficiency of interventions, in order to maximize community impact. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 23775 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R01) Contact: Pim Brouwers, Ph.D. Tel: 301-433-6000 Email: ebrouwer@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-275.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after August 7, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications for innovative intervention development research to advance HIV prevention and care. This FOA encourages research designed to (a) conduct tests of the efficacy of novel behavioral and/or integrated behavioral and biomedical interventions, (b) conduct basic behavioral and social science research that is needed to advance the development of innovative interventions, and (c) translate and operationalize the findings from these basic studies to develop interventions and assess their feasibility. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24033 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Molecular and Cellular Substrates of Complex Brain Disorders (R01) Contact: Chiiko Asanuma, Ph.D. Tel: 301-443-5288 Email: cs2j@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-299.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsor invites applications directed toward the discovery of the impact of alterations associated with complex brain disorders on the fundamental cellular and molecular substrates of neuronal function. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25661 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Innovative Pilot Studies of Novel Mechanism of Action Compounds for Treating Psychiatric Disorders (U01) Contact: Lois Winsky, Ph.D. Tel: 301-443-5288 Email: lwinsky@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-007.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012 . Optional letters of intent may be submitted thirty days prior to the application due date(s). The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The sponsor invites applications for experimental medicine-based first in human (FIH) and proof of concept (POC) studies of new mechanism of action, IND-ready candidate medications to treat mental disorders. The objective of the FOA is to accelerate the development of innovative pharmacological treatments through support of early phase human clinical testing. FIH pharmacology studies should assess target engagement, pharmacological effects, safety, and tolerability of novel compounds in order to build a pipeline for initial POC or efficacy trials in patients. POC studies of novel compounds should use pharmacologically based dosing, with assessment of target engagement and evaluation of the impact of compounds on clinically relevant physiological systems as well as clinical indicators of effect. The overall objective is to facilitate rapid collection of data to "de-risk" novel mechanism of action or combination treatments and to attract private funding for further clinical and commercial development of candidate medications. Partnerships between academia and industry are strongly encouraged. This FOA will utilize the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 26143 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Solicitation of Assays for High Throughput Screening (HTS) to Discover Chemical Probes (R01) Contact: Yong Yao, Ph.D. Tel: 301-443-6102 Email: yyao@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-058.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. Optional letters of intent may be submitted thirty days prior to the relevant application deadline. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: NIH invites applications to form collaborations with an established academic, nonprofit, or commercial high throughput screening (HTS) facility that has the requisite expertise and experience to implement HTS-ready assays for the discovery and development of small molecule chemical probes. Through this FOA, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to the missions of the participating NIH Institutes, and 2) discovery and/or validation of novel, biological targets that will inform studies of disease mechanisms. Emphasis will be placed on assays that provide new insight into important disease targets and processes. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 26152 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Solicitation of Validated Hits for the Discovery of in vivo Chemical Probes (R01) Contact: Yong Yao, Ph.D. Tel: 301-443-6102 Email: yyao@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-060.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. Optional letters of intent may be submitted thirty days prior to the relevant application deadline. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: NIH invites applications to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to the missions of the participating NIH Institutes, and 2) discovery and/or validation of novel, biological targets that will inform studies of disease mechanisms. Emphasis will be placed on assays that provide new insight into important disease targets and processes. This FOA intends to support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes. It is expected that applicants will have in hand the starting compounds (“validated hits”) for chemical optimization and bioassays for testing new analog compounds. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 48066 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Dissemination and Implementation Research in Health (R01) Contact: David A. Chambers, Ph.D. Tel: 301-443-3747 Email: dchamber@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-10-038.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. Optional letters of intent may be submitted 30 days prior to the anticipated receipt date. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications that will identify, develop, and refine effective and efficient methods, structures, and strategies to disseminate and implement research-tested health behavior change interventions and evidence-based prevention, early detection, diagnostic, treatment, and quality of life improvement services into public health and clinical practice settings. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 59812 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Research On Autism And Autism Spectrum Disorders (R01) Contact: Lisa Gilotty, Ph.D. Tel: 301-443-3825 Email: gilottyl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-158.html Deadline Note: This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to autism spectrum disorders (ASD). Basic, clinical, and applied studies are encouraged. This FOA is intended to support the broad research goals of the Strategic Plan for ASD Research (http://iacc.hhs.gov/reports/2009/iacc-strategic-plan-for-autism-spectrum-disorder-research-jan26.shtml). This program will use the NIH Research Project Grant (R01) award mechanism. --------------------------------------------------------------- Program Number: 90982 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Drug Discovery for Nervous System Disorders (R01) Contact: Jamie Driscoll Tel: 301-443-5288 Email: jdrisco1@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-001.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invites research grant applications from applicant organizations directed toward the discovery and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 10115 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: NINDS Cooperative Program in Translational Research for Resistant Epilepsy and Epileptogenesis (U01) Contact: Randall Stewart, PhD Tel: 301-496-1917 Email: stewartr@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-154.html Deadline Note: Optional letters of intent will be accepted 30 days prior to each submission date. This FOA will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications to support preclinical development of new therapies to cure epilepsy, prevent the emergence of epilepsy following brain injury (including status epilepticus, traumatic brain injury, stroke, encephalitis, or other injury) or in other high-risk groups, or to better treat individuals with intractable epilepsy. The program will facilitate solicitation, development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing. This program is specifically directed at projects that include therapeutic leads with demonstrated activity against the intended disease target. The program supports preclinical optimization and testing of these leads and projects must be sufficiently advanced that an IND or IDE application to the FDA can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as high throughput screening. The program also excludes clinical research, basic research, and studies of disease mechanism. This is a milestone-driven cooperative agreement program involving participation of NIH staff in the development of the project plan and monitoring of research progress. This FOA will utilize the U01 Cooperative Agreement mechanism. --------------------------------------------------------------- Program Number: 12236 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: Validation of Novel Therapeutic Targets for Huntington’s Disease (R01) Contact: Margaret Sutherland, PhD Tel: 301-496-5680 Email: sutherlandm@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-183.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: June 30, 2010 for the first receipt date, then standard receipt dates of February 5, June 5, and October 5 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications aimed at validating novel molecular targets for disease-modifying therapeutic intervention in Huntington’s disease. This FOA is for support of new projects, and not the continuation of projects that have already been initiated with NIH funding. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 12841 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: NINDS PHASE III Investigator-Initiated Multi-Site Clinical Trials (U01) Contact: Scott Janis, Ph.D. Tel: 301-496-9135 Email: janiss@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-173.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadline for receipt of standard applications under this FOA are: February 5, June 5 and October 5 annually. The deadline for receipt of AIDS-related applications are January 7, May 7 and September 7 annually. This FOA will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications for investigator-initiated, multi-site, randomized, controlled Phase III clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials may address any research question related to the mission and goals of the NINDS. Information about the mission, strategic plan and research interests of the NINDS can be found at the NINDS website (http://www.ninds.nih.gov/). This FOA will utilize the Cooperative Agreement (U01) grant mechanism. --------------------------------------------------------------- Program Number: 12843 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: NINDS Exploratory Clinical Trials (R01) Contact: Peter R. Gilbert, Sc.M. Tel: 301-496-0870 Email: pgilbert@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-199.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications for exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address research questions related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or surgical, behavioral or rehabilitation therapies. Information about the mission, strategic plans and research interests of the NINDS can be found at the NINDS website (http:\\www.ninds.nih.gov). This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20370 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: Collaborative Studies on The Central Nervous System and Glycemia (R01) Contact: Merrill M. Mitler, Ph.D. Tel: 301-496-99614 Email: mitlerm@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-11-029.html Deadline Note: This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applcations for new interdisciplinary collaborations by researchers in neuroscience and in diabetes/metabolism to further understanding of the mechanisms by which the CNS controls glucose levels and the consequences to the CNS of derangements in these mechanisms. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 23969 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: NINDS Cooperative Program in Translational Research Single-Component Research Projects (U01) Contact: Thomas Miller, Ph.D. Tel: 301-496-1779 Email: tm208y@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-294.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications for preclinical development and testing of new therapies for neurological disorders. The program will facilitate encouragement , development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing. To be eligible for support, projects must include therapeutic leads and in vivo proof of concept on efficacy. The program supports preclinical optimization and testing of the leads, and projects must be sufficiently advanced that an Investigational New Drug (IND) or Investigational Device Exemption (IDE) application to the Food and Drug Administration (FDA) can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as screening. The program also excludes clinical research, basic research, and studies of disease mechanism. The scope includes only therapy development activities, so development of diagnostics, biomarkers, or rehabilitation strategies cannot be supported. This is a milestone-driven cooperative agreement program involving participation of NINDS staff in the development of the project plan and monitoring of research progress. This FOA will utilize the U01 Research Project Cooperative Agreements grant mechanism. --------------------------------------------------------------- Program Number: 26103 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: Advanced Neural Prosthetics Research and Development (U01) Contact: Kip Ludwig, Ph.D. Tel: 301-496-1447 Email: kip.ludwig@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-053.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. Optional letters of intent will be accepted one month prior to the appropriate application due date. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: NIH invites applications to pursue translational and pilot clinical studies for neural prosthetics. The program will utilize the cooperative agreement mechanism to enable support for milestone-driven projects for the design, development, and demonstration of clinically-useful neural prosthetic devices. Activities supported in this program include implementation of clinical prototype devices, preclinical safety and efficacy testing, design verification and validation activities, pursuit of regulatory approval for clinical study, and proof-of-concept or pilot clinical studies. This FOA will utilize the U01 Research Project Cooperative Agreement grant mechanism. --------------------------------------------------------------- Program Number: 91465 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: Neurobiology of Migraine (R01) Contact: Linda L. Porter, Ph.D. Tel: 301-496-9964 Email: porter@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-258.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations that intend to perform innovative research that will expand our current knowledge of neurobiological mechanisms underlying migraine headache, examine the role of neuromodulators, genetic and environmental influences in migraine susceptibility, and explore new targets for therapy development. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05218 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Mechanisms, Models, Measurement and Management in Pain Research (R01) Contact: Dr. Susan Marden, Ph.D., Program Director Tel: 301-496-9623 Email: mardens@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-006.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16302 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Health Promotion Among Racial and Ethnic Minority Males (R01) Contact: Paul A Cotton, PhD, RD Tel: 301-402-6423 Email: cottonp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-236.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor solicits Research Project (R01) grant applications from applicants that propose to stimulate and expand research in the health of minority men. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 23550 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Obesity and Asthma: Awareness and Management (R01) Contact: Karen Huss, PhD, RN, APRN-BC, FAAN, FAAAI Tel: 301-594-5970 Email: hussk@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-245.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on . SYNOPSIS: The sponsor invites applications for research to examine the interconnections of asthma and obesity. The prevalences of both asthma and obesity have significantly risen in the past few decades. Although the association between these 2 conditions has been found in many studies, the exact mechanisms for how this association arises are unresolved. Because both of these conditions have their beginnings in early life, an aspect of the association between them that requires more understanding is their common exposures in early life. Studies that investigate the molecular pathways linking asthma and obesity are encouraged. In addition, intervention studies targeting asthma or obesity and their effects on each one, and possible mechanisms of action are encouraged. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24461 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R01) Contact: Linda S. Weglicki, Ph.D., R.N., M.S.N. Tel: 301-594-6908 Email: weglickils@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-327.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsors invite applications that employ innovative research to identify mechanisms of influence and/or promote positive sustainable health behavior(s) in children and youth (birth to age 18). Positive health behaviors may include: developing healthy sleep patterns, developing effective self-regulation strategies, adaptive decision-making in risk situations, practicing proper dental hygiene, eating a balanced and nutritious diet, engaging in age-appropriate physical activity and/or participating in healthy relationships. Applications to promote positive health behavior(s) should target social and cultural factors, including, but not limited to: schools, families, communities, population, food industry, age-appropriate learning tools and games, social media, social networking, technology and mass media. Topics to be addressed in this announcement include: effective, sustainable processes for influencing young people to make healthy behavior choices; identification of the appropriate stage of influence for learning sustainable lifelong health behaviors; the role of technology and new media in promoting healthy behavior; identification of factors that support healthy behavior development in vulnerable populations, identification of barriers to healthy behaviors; and, identification of mechanisms and mediators that are common to the development of a range of habitual health behaviors. Given the many factors involved in developing sustainable health behaviors, applications from multidisciplinary teams are strongly encouraged. The ultimate goal of this FOA is to promote research that identifies and enhances processes that promote sustainable positive behavior or changes social and cultural norms that influence health and future health behaviors. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24464 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: mHealth Tools to Promote Effective Patient–Provider Communication, Adherence to Treatment and Self Management of Chronic Diseases In Underserved Populations (R01) Contact: Paul Cotton, Ph.D., RD Tel: 301-402-6423 Email: cottonp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-330.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications to stimulate research utilizing Mobile Health (mHealth) tools aimed at the improvement of effective patient–provider communication, adherence to treatment and self-management of chronic diseases in underserved populations. With the rapid expansion of cellular networks and substantial advancements in Smartphone technologies, it is now possible - and affordable - to transmit patient data digitally from remote areas to specialists in urban areas, receive real-time feedback, and capture that consultation in a database. mHealth tools, therefore, may facilitate more timely and effective patient-provider communication through education communication around goal setting, treatment reminders, feedback on patient progress and may improve health outcomes. This announcement encourages the development, testing and comparative effective analysis of interventions utilizing mHealth technologies in underserved populations. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 26219 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01) Contact: Xenia Tigno, PhD, Program Director Tel: 301-594-2775 Email: tignoxt@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-061.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute of Nursing Research (NINR) invites applications to improve health outcomes for women, infants and children, by stimulating interdisciplinary research focused on maternal nutrition and pre-pregnancy obesity. Maternal health significantly impacts not only the mother but also the intrauterine environment, and subsequently fetal development and the health of the newborn. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27871 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Environmental Exposures and Health: Exploration of Non-Traditional Settings, (R01) Contact: Karen Huss, PhD, RN, APRN-BC, FAAN, FAAAAI Tel: 301-594-5970 Email: hussk@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-133.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2016. SYNOPSIS: National Institute of Nursing Research (NINR) and National Institute of Environmental Health Sciences (NIEHS) invite applications for interdisciplinary research aimed at promoting health, limiting symptoms and disease, and reducing health disparities in children and older adults living or spending time in non-traditional settings. These settings result in exposure to environmental pollutants and toxins that result in health risks, symptoms, and other health conditions/diseases including lower respiratory diseases, chronic obstructive pulmonary disease, and cardiovascular diseases. Risk identification and symptom management include prevention and behavior changes and actions to maintain health and prevent disease with an emphasis on the individual, family, and community which will advance nursing science. For purposes of this FOA, non-traditional settings, for children and older adults, include, but are not limited to places such as community centers, pre-school and non-traditional school environments (e.g., churches, daycare, home-based schools, dormitories, and alternative schools), child and older adult foster care facilities, older adult day care facilities, half-way homes, assisted living and long-term care facilities. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 90980 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Focal Cognitive Deficits in CNS Disorders (R01) Contact: Lois A. Tully, Ph.D. Tel: 301-594-5968 Email: tullyla@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-067.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications to expand basic and translational research, including intervention research, on the types, nature, and functional consequences of focal or specific cognitive deficits experienced by persons with central nervous system disorders. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this FOA. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 91008 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Chronic Illness Self-Management in Children and Adolescents (R01) Contact: Dr. Linda S. Weglicki, PhD, RN, MSN Tel: 301-594-6908 Email: weglickils@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-070.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications for research to improve self-management and quality of life in children and adolescents with chronic illnesses. Children diagnosed with a chronic illness and their families have a life-long responsibility for self-management, to maintain and promote health and prevent complications. Biobehavioral studies of children in the context of family and family-community dynamics are encouraged. Research related to biological/technological factors, as well as, sociocultural, environmental, and behavioral mechanisms that contribute to successful and ongoing self-management of chronic illnesses in children is also encouraged. This FOA is restricted to studies of chronic illnesses in children and adolescents ages 8 to 21 grouped by developmental stages according to the discretion of the investigator. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 93601 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Reducing Health Disparities Among Minority and Underserved Children (R01) Contact: Dr. Linda S. Weglicki, PhD, RN, MSN Tel: 301-594-6908 Email: weglickils@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-104.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invites applications to conduct research to reduce health disparities among minority and underserved children. Specifically, this initiative focuses on ethnic and racial minority children and underserved populations of children such as: children from low literacy, rural and low-income populations, geographically isolated children, hearing and visually impaired children, physically or mentally disabled children, children of migrant workers, children from immigrant and refugee families, and language minority children. Specific targeted areas of research include biobehavioral studies that incorporate multiple factors that influence child health disparities such as biological (e.g., genetics, cellular, organ systems), lifestyle factors, environmental (physical and family environments), social (e.g., peers), economic, institutional, and cultural and family influences; studies that target the specific health promotion needs of children with a known illness and/or disability; and studies that test and evaluate the comparative effectiveness of health promotion interventions conducted in traditional and nontraditional settings. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 02502 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R01) Contact: Wen G. Chen, Ph.D. Tel: 301496-9350 Email: chenw@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-193.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 6, 2012. SYNOPSIS: The sponsors invite applications from institutions/organizations that propose to (1) study biological, neurobiological, psychosocial, and clinical mechanisms and processes by which aging and/or age-related diseases affect the experience of pain, (2) examine biological, neurobiological, psychosocial, and clinical factors that impact pain experience and prevalence in older people, (3) evaluate existing pain assessment and/or management approaches in older adults, or (4) develop new assessment methods and/or management strategies for pain with particular attention to the needs of older adults. Studies involving animal models or human subjects are appropriate under this program announcement. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 02634 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Bioenergetics, Fatigability, and Activity Limitations in Aging (R01) Contact: Basil Eldadah, M.D., Ph.D. Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-190.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications proposing to study bioenergetic factors underlying increased fatigability and activity limitations in aging. Increased fatigability is a significant cause of restricted physical and cognitive activity in older adults. Alterations in bioenergetics—the production and utilization of energy, and the regulation of these processes—may contribute significantly to increased fatigability. This FOA encourages applications that propose to 1) elucidate specific alterations in bioenergetics related to increased fatigability and activity limitations; 2) develop and evaluate improved measures of fatigability related to bioenergetics; 3) evaluate interventions for increased fatigability and activity limitations that target alterations in bioenergetics and lead to improved quality of life. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 03346 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms Underlying the Links Between Psychosocial Stress, Aging, the Brain and the Body (R01) Contact: Suzana S. Petancesksa, Ph.D. Tel: 301-496-9350 Email: petanceskas@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-216.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite multidisciplinary and interdisciplinary research to elucidate the mechanistic links between psychosocial stress and health in aging, as well as how the aging process and age-related diseases affect the responses to psychosocial stressors. Generally, research should be focused on (1) aging and how neural mechanisms respond to psychosocial stress and affect other body systems, (2) characterizing the behavioral, psychological and social mechanisms and pathways involved in transducing psychosocial stressors into health outcomes, (3) how stressors modulate physiological process underlying life-span, immune mechanisms, and metabolism, and (4) how psychosocial stress contributes to the development or progression of geriatric syndromes, chronic medical conditions, and disabilities in later life. Research is strongly encouraged that aims to identify appropriate targets for intervention, at any level of analysis, from societal to molecular. Research spanning multiple levels of analysis is particularly encouraged. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 03421 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: The Role of Apolipoprotein #, Lipoprotein Receptors and CNS Lipid Homeostasis in Brain Aging and Alzheimer's Disease (R01) Contact: Suzana S. Petancesksa, Ph.D. Tel: 301-496-9350 Email: petanceskas@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-217.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites multidisciplinary and interdisciplinary research to elucidate how Apolipoprotein E, lipoprotein receptors and CNS lipid homeostasis influence brain aging and the transition to neurodegeneration in Alzheimer’s disease (AD). The ultimate goal is to gain an in depth understanding of the mechanisms by which the Apolipoprotein E e4 allele confers increased AD risk for the purpose of advancing the overall search for efficacious AD treatments and Apolipoprotein E e4-directed therapeutics in particular. To this end we encourage research spanning multiple levels of analysis in multiple species (from mice to man). Studies aimed at identifying new therapeutic targets for the treatment of AD and other age-related neurodegenerative conditions associated with lipid neurobiology are strongly encouraged. Also of great interest are projects that aim to use lipidomics, various types of imaging and other cutting edge technologies to identify and develop early biomarkers of neurodegeneration associated lipid dyshomeostasis. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05092 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Secondary Analyses of Existing Data Sets and Stored Biospecimens to Address Clinical Aging Research Questions (R01) Contact: Chhanda Dutta, Ph.D. Tel: 301-435-3048 Email: duttac@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-265.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications to support short term projects involving secondary analysis of existing data sets or stored biospecimens, to address clinically-related issues on aging changes influencing health across the life span, and/or on diseases and disabilities in older persons. This funding opportunity announcement (FOA) will support activities addressing specific hypotheses in clinical aging research and/or to inform the design and implementation of future epidemiologic or human intervention studies, or current geriatric practice in maintenance of health, management of disease, and prevention of disability. Existing data sets may also be used to develop and test new statistical analytical approaches. Costs for archiving of data to be made publicly available may be included in the budget, as long as the archival activities are related to the proposed secondary analyses. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05622 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Development and Characterization of Animal Models for Aging Research (R01) Contact: Mahadev Murthy, Ph.D., M.B.A. Tel: 301-402-7749 Email: mmurthy@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-014.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications for research that develops, characterizes, refines and enhances model systems for aging research, including but not limited to animal models, cell lines, and informatics. This FOA encourages applications that propose to: characterize aging at the physiological, biochemical and functional levels in existing animal models, including but not limited to animal models currently used in other scientific fields that have potential to benefit aging research; develop new animal models for aging research; develop unique cell lines for aging research; use comparative biology to identify models of highest priority for aging research; or develop informatics that enhance the utilization of animals for aging research. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05962 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Critical Illness and Injury in Aging (R01) Contact: Basil Eldadah, M.D., Ph.D. Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-10-042.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 05, June 05, and October 05 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications for proposing to study mechanisms and management of critical illness and injury, including trauma and neurotrauma, in aging. Studies may be mechanistic, observational, or interventional in nature. Secondary analyses of existing datasets, such as from large observational studies or clinical trials, may be proposed. Animal studies are appropriate in cases where human studies are not feasible. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 12226 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Aging Studies in the Pulmonary System (R01) Contact: Mahadev Murthy, Ph.D., M.B.A. Tel: 301-496-6402 Email: mmurthy@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-179.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors invite esearch project grant applications that explore age-associated changes in pulmonary physiology, pathology and function, and their relationship to respiratory conditions and diseases that occur commonly in older populations. The goal of this FOA is to support basic, clinical and translational research to address physiological mechanisms underlying progressive functional declines in the pulmonary system. This research will likely enhance our basic understanding of molecular and cellular aspects of pulmonary aging, which may translate into improvements in the prevention and management of pulmonary diseases in older persons. Projects involving in vitro studies, animal models, and/or human subjects are of significant interest to NIA and NHLBI. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 17824 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Asthma in Older Adults (R01) Contact: Basil Eldadah, MD, PhD Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-263.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsors invite applications that propose to study the pathophysiology, epidemiology, diagnosis, and/or management of asthma in older adults. Much of what is known about asthma in adults is based on studies in younger adult populations; however, the mechanisms underlying asthma in some older adults may differ, which may impact on diagnostic, treatment, and prevention strategies. This FOA is intended to stimulate research to address knowledge gaps and research opportunities in asthma in later life. A variety of study approaches are encouraged with this FOA including basic, translational, clinical, and epidemiological studies. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20787 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Translational Research to Help Older Adults Maintain their Health and Independence in the Community (R01) Contact: Dr. Sidney Stahl Tel: 301-402-4156 Email: StahlS@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-123.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications for translational research that moves evidence-based research findings towards the development of new interventions, programs, policies, practices, and tools that can be used by community-based organizations to help elderly individuals remain healthy and independent, and living in their own homes and communities. The goal of this FOA is to support translational research involving collaborations between academic research centers and community-based organizations with expertise serving the elderly (such as city and state health departments, city/town leadership councils, and Area Agencies on Aging) that will enhance our understanding of practical tools, techniques, programs and policies that communities across the nation can use to more effectively respond to needs of their aging populations. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 22558 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: NIA Limited Competition: Renewals of, and Revisions to, Existing Cooperative Agreement Awards (U01) Contact: Robin A. Barr Tel: 301-496-9322 Email: BarrR@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-213.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after June 5, 2011. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications for renewal from current NIA-supported cooperative agreements and revision applications from current NIA supported cooperative agreements (U01 awards). This FOA will utilize the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 23705 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Social and Behavioral Research on the Elderly in Disasters (R01) Contact: John G. Haaga, Ph.D. Tel: 301-496-3131 Email: HaagaJ@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-263.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications that propose to conduct research in the behavioral and social sciences on the consequences of natural and man-made disasters for the health and well-being of the elderly, with an ultimate goal of preventing or mitigating harmful consequences. Disasters include weather-related events, earthquakes, tsunamis, large-scale attacks on civilian populations, technological catastrophes, and pandemics. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24238 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Behavioral and Social Genomics of Aging: Opportunities in the Health and Retirement Study (R01) Contact: Erica L. Spotts, Ph.D. Tel: 301-496.3136 Email: spottse@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-318.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications taking advantage of newly available genetic data to advance the understanding of how genetic, behavioral, and psychosocial factors affect the health and well-being of older Americans. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24276 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Single Cell Studies in Aging Research (R01) Contact: Dr. Jose Velazquez Tel: 301-496-6428 Email: jvelazqu@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-320.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications hat propose to develop research on single cell biology to enhance the understanding of the mechanisms of normal aging and of age-related diseases. Applications using -omics technologies, imaging, optofluidic platforms, mass spectroscopy, whole genome sequencing, and other tools and technologies at the single cell level are encouraged since it is expected that the single cell approach will improve the determination of unique and biologically significant properties of tissues and organs during the aging process. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25659 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Implications of the Economic Downturn for Health, Wealth, and Work at Older Ages (R01) Contact: John W. R. Phillips, PhD Tel: 301-496-3138 Email: john.phillips@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-009.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The sponsor invites applications for research on the implications of exogenous shocks, such as those produced by the recent economic downturn, for health, economic circumstances, and planning throughout the life-cycle. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25845 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms Mediating Osteoarthritis in Aging (R01) Contact: John P. Williams, Ph.D. Tel: 301-496-6402 Email: williamsj6@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-019.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015 . SYNOPSIS: The National Institute on Aging and the National Institute of Arthritis and Musculoskeletal and Skin Diseases invite applications intended to encourage and accelerate the characterization of new or underutilized models and the testing of hypotheses that will lead to an improved understanding of the mechanisms mediating osteoarthritic progression. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 46815 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Alzheimer's Disease Pilot Clinical Trials (R01) Contact: Laurie M. Ryan, Ph.D. Tel: 301-496-9350 Email: ryanl@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-100.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 18, 2011; and then the standard deadlines of June 5, October 5 and February 5 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite qualified investigators to submit research grant applications for pilot clinical trials using pharmacologic and/or behavioral interventions directed toward the prevention and treatment of the cognitive and behavioral symptoms of mild cognitive impairment (MCI), Alzheimer's disease (AD), and age-related cognitive decline. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 84872 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Alzheimer's Disease Drug Development Program (U01) Contact: Suzana Petanceska, Ph.D. Tel: 301-496-9350 Email: petanceskas@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-015.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Institute on Aging (NIA) invites applications for pre-clinical development of new therapies aimed at modifying the behavioral symptoms in Alzheimer's disease (AD); or delaying the onset or slowing the progression of AD, mild cognitive impairment (MCI), or age-related cognitive decline. This program is specifically directed at projects focused on the optimization of therapeutic leads with demonstrated activity against an intended disease target. Projects must be sufficiently advanced that an IND or IDE application to the FDA can be submitted by the end of the funding period. The program does not support early-stage therapeutic discovery activities such as high throughput screening. The program also excludes clinical research and basic, mechanistic research. This is a milestone-driven cooperative agreement program involving participation of NIA program staff both in the development of the project plan and monitoring of research progress. This FOA will utilize the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 98216 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Translational Research at the Aging/Cancer Interface (TRACI) (R01) Contact: Susan G. Nayfield, M.D., M.Sc., Chief Tel: 301-496-6761 Email: nayfiels@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-136.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: >National Institute on Aging (NIA)and National Cancer Institute (NCI) invite applications for translational research proposals in the overlapping areas of human aging and cancer, linking basic and clinical research relevant to the care of older cancer patients through both bench-to-bedside and bedside-to-bench approaches. Ultimately, information from the research supported by this initiative should improve the health and well-being of elderly patients at risk for, or diagnosed with, cancer and decrease the functional impairment and morbidity associated with cancer in this population. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 01699 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Mechanistic Studies of Pain and Alcohol Dependence (R01) Contact: Mark Egli, Ph.D. Tel: 301-594-6382 Email: megli@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-267.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose to conduct mechanistic studies on the relationship between alcohol drinking, alcohol dependence and pain. An association between chronic pain conditions and alcohol dependence has been revealed in numerous studies with episodes of alcohol abuse antedating chronic pain in some people and alcohol dependence emerging after the onset of chronic pain in others. Pain transmission and alcohol’s reinforcing effects share overlapping neural substrates giving rise to the possibility that chronic pain states significantly affect alcohol use patterns and promote the development of dependence and addiction. In addition, long term alcohol intoxication and alcohol dependence induce pain symptoms and may exacerbate chronic pain arising from other sources. The objective of this FOA is to understand genetic, pharmacological and learning mechanisms underlying the association between the propensity to drink alcohol and pain responses. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 09872 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: The Role of Cellular Organelles in Alcohol-Induced Tissue Injury (R01) Contact: Max Guo, Ph.D. Tel: 301-443-0639 Email: Max.Guo@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-085.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications that propose to study biological processes involving the cellular organelles in alcohol-induced tissue injury. Excessive alcohol consumption can damage many organ systems including the liver, heart, pancreas, brain, and lung. However, the mechanisms for these injuries are currently not fully understood. Cellular organelles play an important role in cellular functions and are significantly involved in alcohol-induced tissue injury. Thus, studies of alcohol’s effects on the structure and function of cellular organelles are critical to better understand the mechanisms of alcohol-induced injuries and to develop new strategies for their diagnosis and treatment. The purpose of this FOA is to: (1) better understand how acute or chronic alcohol consumption affects the structure and function of cellular organelles, and in turn, how these changes contribute to alcohol-induced injury; (2) investigate how variations of proteins in cellular organelles, or their regulation and function, including cellular signaling pathways, contribute to an individual’s response to acute or chronic alcohol intake and alcohol-induced tissue injury; (3) develop potential biomarkers for prognosis and diagnosis of tissue injury, or identify new targets for therapeutic interventions. This FOA aims to foster the utilization of innovative experimental design and emerging technologies, such as genomics, proteomics, metabolomics, bioinformatics, as well as novel microscopic imaging techniques that illuminate functions in intact cells and tissues, to generate new mechanistic and clinical insights into alcohol-induced tissue injuries. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 09877 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Stress Pathways in Alcohol Induced Organ Injury and Protection (R01) Contact: Andras Orosz, Ph.D. Tel: 301-443-2193 Email: orosza@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-093.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications that propose studying the role of cellular stress responses, the cytoplasmic classical stress response or heat shock response (HSR) and the endoplasmic reticulum (ER) stress, in alcohol-induced tissue injury and tissue protection. While excessive alcohol use causes organ damage, moderate alcohol consumption may be beneficial. The underlying molecular mechanisms for this apparent dichotomy of alcohol’s harmful and salutary effects are currently not fully understood. Alcohol induces cellular stress pathways in the cytoplasm and in the endoplasmic reticulum that may significantly be involved in alcohol-induced tissue injury or mediate tissue protection depending on the quantity, frequency, duration, and temporal pattern of drinking. Hence, studies of the effects of alcohol on cellular stress pathways are critical to understand the mechanisms of alcohol-induced injuries or protection to develop new strategies for prevention, diagnosis and treatment. The purpose of this FOA is to: (1) acquire insight into how acute or chronic alcohol consumption affects cellular stress pathways and in turn, how these changes contribute to alcohol-induced injury/protection; (2) investigate how alcohol induced stress responses mediate cell survival and death signaling pathways at macromolecular, organelle, cellular and organism level contributing to alcohol-induced tissue injury/protection; (3) develop potential stress related biomarkers for prognosis, diagnosis of tissue injury/protection, furthermore identify new targets for their therapeutic interventions. Utilizing innovative experimental design and emerging technologies, such as deep sequencing, genomics, proteomics, metabolomics, bioinformatics, and novel imaging techniques these investigations are expected to provide a more comprehensive understanding of how alcohol affects the evolutionally conserved stress pathways and elucidate their roles in tissue injuries and repair. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16033 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Secondary Analysis of Existing Alcohol Epidemiology Data (R01) Contact: Wenxing Zha, Ph.D. Tel: 301-443-0633 Email: zhaw@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-308.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose to conduct secondary analysis of existing data sets. NIAAA seeks to enhance the understanding of the patterns of alcohol consumption and the epidemiology of alcohol-related problems. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16240 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Endocannabinoid Signaling in Alcohol Consumption, Intoxication and Alcohol Use Disorders (R01) Contact: Qi-Ying Liu, M.D. Tel: 301-443-2678 Email: liuqiy@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-249.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications that propose to study the roles and underlying mechanisms of endocannabinoid signaling in alcohol preference, consumption, intoxication and alcohol use disorders, and to explore endocannabinoid signaling system as potential targets for alcohol pharmacotherapy. With increasing knowledge of the function of eCBs in the developing and adult brain and recent behavioral and pharmacological evidence linking alcohol and eCB signaling system, there is now great potential to explore the role of eCB signaling system in alcohol-related behaviors and alcohol use disorders. Studies supported with this FOA will help to gain knowledge about the role and underlying mechanisms of eCB signaling in alcohol preference and consumption; the interactions of acute and chronic alcohol exposure with eCBs at synapses; the effects of such interactions on short- and long-term synaptic plasticity; the role of eCB signaling in the development and maturation of the central nervous system; and the eCB signaling system in fetal alcohol spectrum disorders. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16837 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Strategies for Treatment of Young Adults with Alcohol Use Disorders (R01) Contact: Margaret E. Mattson, Ph.D. Tel: 301-443-0638 Email: mmattson@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-246.html Deadline Note: The sponsor encourages optional letters of intent, to be submitted not more than thirty days before the application receipt date. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications to support new research on the treatment of young adults (18-25 years of age) with alcohol use disorders. Compared to all other age groups, the prevalence of periodic heavy or high-risk drinking is greatest among young adults aged 18 to 25. Alcohol use disorders, including alcohol dependence, also peak during this critical period during which profound developmental changes occur. Despite having the highest prevalence of drinking, interventions for this group have been understudied. Gaps exist in understanding how to effectively engage this group in treatment, which treatments are the most effective, and how to maintain treatment gains in the longer term after treatment. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16840 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Strategies for Treatment of Young Adults with Alcohol Use Disorders (R03) Contact: Margaret E. Mattson, Ph.D. Tel: 301-443-0638 Email: mmattson@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-247.html Deadline Note: The sponsor encourages optional letters of intent, to be submitted not more than thirty days before the application receipt date. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16 and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications to support new research on the treatment of young adults (18-25 years of age) with alcohol use disorders. Compared to all other age groups, the prevalence of periodic heavy or high-risk drinking is greatest among young adults aged 18 to 25. Alcohol use disorders, including alcohol dependence, also peak during this critical period during which profound developmental changes occur. Despite having the highest prevalence of drinking, interventions for this group have been understudied. Gaps exist in understanding how to effectively engage this group in treatment, which treatments are the most effective, and how to maintain treatment gains in the longer term after treatment. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 16841 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Strategies for Treatment of Young Adults with Alcohol Use Disorders (R21) Contact: Margaret E. Mattson, Ph.D. Tel: 301-443-0638 Email: mmattson@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-248.html Deadline Note: The sponsor encourages optional letters of intent, to be submitted not more than thirty days before the application receipt date. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16 and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications to support new research on the treatment of young adults (18-25 years of age) with alcohol use disorders. Compared to all other age groups, the prevalence of periodic heavy or high-risk drinking is greatest among young adults aged 18 to 25. Alcohol use disorders, including alcohol dependence, also peak during this critical period during which profound developmental changes occur. Despite having the highest prevalence of drinking, interventions for this group have been understudied. Gaps exist in understanding how to effectively engage this group in treatment, which treatments are the most effective, and how to maintain treatment gains in the longer term after treatment. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 16842 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Treatment of Co-Occurring Alcohol Use Disorders and Depression/Anxiety Disorders (R01) Contact: Deidra Roach, M.D. Tel: 301-443-5820 Email: droach@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-251.html Deadline Note: The sponsor encourages optional letters of intent no more than thirty days before the application due date. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on September 8, 2010. SYNOPSIS: The sponsor invites applications to support research on the treatment of individuals with co-occurring alcohol use disorders and depression/anxiety. Anxiety disorders include generalized anxiety disorder, social phobia, and posttraumatic stress disorder. The scope of interest includes innovative pharmacological and behavioral treatments based on biological, psychological, behavioral, and social/cultural models of etiology and treatment of comorbid alcohol use disorders and depression/anxiety. In addition, this FOA accepts Comparative and Effectiveness Research applications which compare two or more different existing treatments in this comorbid population. This FOA is limited to depression and anxiety because of the high prevalence of these psychiatric disorders in individuals with alcohol use disorders. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16989 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Behavioral Regulation Mechanisms of Alcohol Dependence and Related Phenotypes (R01) Contact: Ivana Grakalic, Ph.D. Tel: 301-443-7600 Email: igrakalic@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-255.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications that propose to examine the mechanisms of behavioral regulation contributing to the behavioral characteristics of alcohol dependence. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 19685 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Epidemiology and Prevention in Alcohol Research (R01) Contact: Marcia Scott, Ph.D. Tel: 301-402-6328 Email: mscott@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-016.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications to support research investigating the epidemiology of alcohol use, alcohol-related harms, and alcohol use disorders and the prevention of underage drinking, alcohol-related harms, and alcohol use disorders. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20840 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Research Into The Impact Of Economic Fluctuations On Alcohol Consumption, Drinking Patterns, And Prevention And Treatment Of Problem Drinking And Related Problems (R01) Contact: Robert C. Freeman, Ph.D. Tel: 301-443-8820 Email: rfreeman@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-061.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications from institutions/ organizations that propose to investigate the impact of national or local economic fluctuations on alcohol consumption, alcohol drinking patterns, and the prevention and treatment of problem drinking. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20844 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Neuroimmune Mechanisms Of Alcohol Related Disorders (R01) Contact: Changhai Cui, PhD Tel: 301-443-1678 Email: changhai.cui@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-064.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose study the neuroimmune mechanisms of alcohol related disorders. Studies supported by this FOA will provide fundamental insights of neuroimmune mechanisms underlying brain functional and behavioral changes induced by alcohol. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25814 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Alcohol Impairment of Immune Function, Host Defense and Tissue Homeostasis (R01) Contact: M. Katherine Jung, PhD Tel: 301-443-8744 Email: jungma@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-025.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015 . SYNOPSIS: The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications from researchers with broad ranges of expertise to study the consequences of alcohol consumption on immune function with the ultimate goal of alleviating infection and reversing alcohol-induced organ damage. Susceptibility to infection and organ damage are the two most common causes of alcohol-related morbidity and mortality. These consequences of alcohol abuse are closely associated with profound impairment of the host innate and adaptive immune systems. The mechanisms of these immune alterations and their link with alcohol-related medical problems are, in most cases, poorly understood. The goal of this FOA is to attract applications on basic and translational research: 1) to identify how alcohol alters immune function; 2) to establish functional links between immune alterations and alcohol related infections and organ damage; and 3) to develop means for mitigating immune impairment with the goal of alleviating alcohol-induced pathology. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25819 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Effects of Adolescent Binge Drinking on Brain Development (R01) Contact: Dr. Lawrence Baizer Tel: 301-443-9334 Email: baizerl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-027.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications proposing to conduct mechanistic studies on the effects of adolescent binge alcohol consumption on synaptic maturation and myelin formation in the developing brain. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 28360 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Alcohol Abuse, Sleep Disorders and Circadian Rhythms (R01) Contact: Dr. Lindsey Grandison Tel: 301-443-0606 Email: lindsey.grandison@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-177.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on June 6, 2015. SYNOPSIS: National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications proposing to conduct mechanistic studies in humans and animal models on the relationships between alcohol abuse, circadian rhythms and sleep disorders. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 84861 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Structural Interventions, Alcohol Use, and Risk of HIV/AIDS (R01) Contact: Robert C. Freeman, Ph.D. Tel: 301-443-8820 Email: rfreeman@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-242.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors offer support for research on the effectiveness of structural interventions that reduce the risk of HIV/AIDS transmission by changing the environment of alcohol use. This PA will use the NIH Research Project Grant (R01) award mechanism. --------------------------------------------------------------- Program Number: 87302 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Alcohol Use Disorders: Treatment, Services Research, and Recovery (R01) Contact: Page Chiapella, Ph.D. Tel: 301-443-4715 Email: pchiapel@wilco.niaaa.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-100.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations that propose to support research on behavioral and pharmacological treatment for alcohol use disorders; organizational, financial, and management factors that facilitate or inhibit the delivery of services for alcohol use disorders; and phenomenon of recovery from alcohol use disorders. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 93775 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Nutrition and Alcohol-Related Health Outcomes (R01) Contact: Rosalind Breslow, Ph.D., M.P.H., R.D. Tel: 301-594-6231 Email: rbreslow@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-239.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsors provide support for Research Grant (R01) applications from institutions/organizations that propose to examine associations between nutrition and alcohol-related health outcomes in humans and animal models. The goal of this program announcement is to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including alcohol dependence and psychiatric co-morbidities, chronic and acute diseases, and organ function and damage. Study designs may include biomedical research, epidemiologic approaches, and intervention studies. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 93813 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01) Contact: Mariela C. Shirley, Ph.D. Tel: 301-443-9787 Email: shirleym@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-031.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard applications under this announcement are: February 05, June 05, and October 05 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications for research on screening and brief interventions to prevent and/or reduce alcohol use and alcohol-related harms. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 94055 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Research on Alcohol-Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R01) Contact: Gregory Bloss, M.A. Tel: 301-443-3865 Email: gbloss@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-087.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications to conduct research on the effects of alcohol-related public policies on health, economic, and social behaviors and outcomes. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 94742 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: International Research Collaboration on Alcohol and Alcoholism (U01) Contact: Peggy Murray, PhD Tel: 301-443-2594 Email: pmurray@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-282.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011 The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 2, May 1, and September 1 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications for the purpose of fostering international collaborations between alcohol research investigators within the United States and investigators located at non-United States laboratories and performance sites for the mutual advancement of our understanding of alcohol problems and of clinical and public health approaches to their solutions. The program is intended to provide funds for research activities to be undertaken jointly between the U.S. and non-U.S. laboratory that expands the research direction of both the U.S. and non-U.S. laboratories in a collaborative manner. This FOA will utilize the NIH U01 Research Project – Cooperative Agreement award mechanism. --------------------------------------------------------------- Program Number: 94749 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Program for Extramural/Intramural Alcohol Research Collaborations (U01) Contact: Peter Silverman, Ph.D., J.D., Deputy Director Tel: 301-402-6966 Email: psilverm@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-11-189.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor provides support to encourage collaboration between alcohol researchers in the extramural community and those within the NIAAA intramural research program. The objective of this Funding Opportunity Announcement is to bring together the research expertise that, as a functioning collaborative unit, will address key alcohol-based research questions that would not otherwise be possible by the same individuals working towards similar goals in isolation. The goal of the research proposed by the collaborating investigators should address questions that advance the alcohol research field with respect to issues surrounding alcohol use disorders including dependence, and the effects of alcohol on health. This program will use the NIH U01 cooperative agreement award mechanism. --------------------------------------------------------------- Program Number: 10467 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: Research Opportunities on Spasmodic Dysphonia (R01) Contact: Lana Shekim, Ph.D. Tel: 301-496-5061 Email: shekiml@nidcd.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-157.html Deadline Note: The deadlines for receipt of standard R21 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications designed to improve our understanding of the pathogenesis & pathophysiology of spasmodic dysphonia (SD) for its prevention and improved treatment. This FOA invites basic, translational and clinical studies to accelerate research into promising therapeutic approaches for spasmodic dysphonia and to stimulate progress in spasmodic dysphonia research through encouraging and facilitating transdisciplinary interactions. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16983 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: NIDCD Research on Hearing Health Care (R01) Contact: Amy Donahue, Ph.D. Tel: 301-402-3458 Email: donahuea@nidcd.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-253.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations to support research leading to accessible and affordable hearing health care (HHC). The overarching emphasis is on the acquisition of knowledge that can be rapidly translated into new or enhanced approaches for access, assessment or interventions with a goal to delivering better hearing health care outcomes. Applications should seek quality approaches that are effective, affordable and deliverable to those who need them as well as implementable and sustainable in settings beyond the research environment. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 74352 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: The Central Processing of Taste Information (R01) Contact: Barry J. Davis, Ph.D., Director Tel: 301-402-3464 Email: davisb1@nidcd.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-201.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations studying the role of the central nervous system in the processing of taste information and the perception of taste quality. The purpose of this FOA is to foster basic and clinical research on the central mechanisms underlying the perception of taste quality. A broad range of experimental approaches is encouraged. The NIDCD encourages applications from investigators who are conducting research outside the field of gustation and who are using methodological approaches that have not been typically applied to but which would greatly promote scientific progress within the field. The NIDCD also encourages applications from new investigators in the early stages of establishing an independent research program. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 88582 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: Proteomics in Auditory Developmental and Disease Processes (R01) Contact: Nancy L. Freeman, Ph.D., Scientific Program Director Tel: 301-402-3458 Email: FreemanN@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-228.html Deadline Note: This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications that focus on “Proteomics in Auditory Developmental and Disease Processes”. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 02097 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Accelerating the Pace of Drug Abuse Research Using Existing Epidemiology, Prevention, and Treatment Research Data (R01) Contact: Marsha F. Lopez, Ph.D., M.H.S. Tel: 301-443-6504 Email: lopezmar@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-018.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications to support the innovative analysis of existing social science and behavioral data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, and other drug), HIV risk behaviors, related disorders, prevention and treatment of these behaviors, and health service utilization including quality, access, and costs. NIDA and NCI encourage coordinated analyses of substance abuse research data that are in public use or that are privately held by a principal investigator. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its effort to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this announcement. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 04292 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R01) Contact: Albert Avila, Ph.D. Tel: 301-496-8804 Email: aavila@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-236.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: This announcement encourages research to identify the role(s) that drug abuse plays in fueling the epidemic in vulnerable groups and to develop effective interventions to prevent new infections and to improve the health and well-being of those living with HIV/AIDS. To do this, it is essential that research be directed toward understanding the factors (biological, behavioral, psychosocial, environmental, institutional, etc.) responsible for the profoundly disproportionate burden of HIV/AIDS among vulnerable groups (racial/ethnic minorities, men who have sex with men, youth) in the United States. This program will use the (R01) grant mechanism. --------------------------------------------------------------- Program Number: 07860 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Technology-Based Interventions to Promote Engagement in Care and Treatment Adherence for Substance Abusing Populations with HIV (R01) Contact: Shoshana Y. Kahana, Ph.D. Tel: 301-443-2261 Email: kahanas@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-117.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after April 7, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute on Drug Abuse (NIDA) invites applications to test the utility and implementation of technological tools, including mobile devices, to promote engagement in Human Immunodeficiency Virus (HIV) care among substance abusing populations with HIV. Research projects may focus on (a) the use of technology to directly improve patient-level outcomes (i.e., adherence); (b) the capacity of HIV treatment providers and related service delivery organizations to adopt and integrate such technologies to promote HIV treatment outcomes; or (c) the use of technology to improve the organization and delivery of HIV treatment and services. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 10625 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Neuroscience Research on Drug Abuse (R01) Contact: Nancy S. Pilotte, Ph.D., Chief Tel: 301-435-1317 Email: npilotte@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-268.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction, withdrawal, and treatment, and may be conducted using model systems, animals, and/or humans. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24138 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Drug Abuse Prevention Intervention Research (R01) Contact: Kevin P. Conway, Ph.D., Acting Branch Chief Tel: 301-443-6504 Email: kconway@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-311.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose to advance the science of drug abuse and drug-related HIV prevention through 1) the development of novel prevention approaches, 2) the testing of novel and adapted prevention intervention approaches 3) the elucidation of processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions, and 4) the development of new methodologies suitable for the design and analysis of prevention research studies. Programs of research are intended to provide pathways toward the discovery of population-level approaches for the prevention of drug abuse and dependence, drug-related problems (such as mental health, interpersonal violence, criminal involvement, and productivity loss), and drug-related disorders (e.g., comorbid drug and psychiatric disorders; infections such as HIV, hepatitis B, and hepatitis C). This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25972 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: International Research Collaboration on Drug Abuse and Addiction Research (R01) Contact: Steven Gust, Ph.D., Director Tel: 301-443-6480 Email: ipdirector@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-040.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This FOA will expire on January 8, 2015. SYNOPSIS: The National Institute on Drug Abuse (NIDA) solicits collaborative research proposals on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects should have relevance to the mission of NIDA and where feasible should address NIDAs scientific priority areas. While the priorities will change from year to year, in FY12 priority areas include: linkages between HIV/AIDS and drug abuse, and prevention, initiation, and treatment of nicotine and tobacco use (especially among vulnerable populations such as children, adolescents, pregnant women, and those with co-morbid disorders). This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 32276 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Epidemiology of Drug Abuse (R01) Contact: Marsha F. Lopez, Ph.D., M.H.S. Tel: 301-443-6504 Email: lopezmar@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-230.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor offers support for research projects to enhance our understanding of the nature, extent, distribution, etiology, and consequences of drug use, abuse, and addiction across individuals, families, communities, and diverse population groups. This Program strongly encourages applications that address multiple levels of causation, reflecting the breadth of epidemiology research, that are transdisciplinary in nature and apply novel methods that allow for the advancement of science (e.g., those that investigate interplay among genetic, environmental, and developmental factors, or those that examine how aspects of social environments affect health outcomes), as well as those that take advantage of the investments made by NIH and other funders by using existing data to inform our understanding of drug abuse epidemiology and etiology in a creative and cost efficient manner. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 39381 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: The Development Of Frontal Cortex And Limbic System And Their Roles In Drug Abuse (R01) Contact: Da-Yu Wu, PhD, Program Director Tel: 301-443-1887 Email: wudy@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-027.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose to study the development of the frontal and prefrontal cortices, together with the subcortical areas of the limbic system, that play significant roles in mediating emotional and motivated behavior. This initiative is designed to support the basic neuroscience research into the fundamental mechanisms of development of the frontal and prefrontal cortices, as well as the midbrain and basal forebrain structures that mediate a number of functions related to drug abuse and psychiatric disorders including: the euphoric properties of drugs, actions of psychotherapeutic agents, and memory, cognitive and emotional functions. An additional major goal of this initiative is to understand how exposure to drugs of abuse affects the cellular and molecular mechanisms underlying nervous system development of circuits implicated in drug reward and addiction. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 61237 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01) Contact: Redonna Chandler, Ph.D. Tel: 301-443-8768 Email: rchandle@nida.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-127.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: The sponsors invite applications for health services and economic research to improve the quality of prevention, treatment, and recovery support services for drug, alcohol and tobacco abuse. Such research projects might emphasize any of the following subjects: (1) clinical quality improvement; (2) organization and delivery of services; (3) implementation research; (4) economic and cost studies; or (5) development or improvement of research methodology, analytic approaches, and measurement instrumentation used in the study of drug, alcohol, and tobacco prevention, treatment, and recovery services. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 72593 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Behavioral & Integrative Treatment Development Program (R01) Contact: Lisa Onken, Ph.D. Tel: 301-443-2235 Email: Lisa_Onken@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-012.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invites applications for Stage II or Stage III research to conduct clinical trials, examine mechanisms of behavior change, determine dose-response, optimize combinations, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 75292 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01) Contact: Cora Lee Wetherington, Ph.D. Tel: 301-435-1319 Email: cwetheri@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-11-047.html Deadline Note: Applicants may be submitted through Grants.gov on or after January 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 75875 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01) Contact: Joni L. Rutter, Ph.D. Tel: 301-443-1887 Email: jrutter@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-026.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications for research projects that identify and/or validate chromosomal loci and variations in genes that are associated with vulnerability to addiction and that inform the likelihood of responsiveness to treatment. Applications that propose to examine intermediate phenotypes or endophenotypes to assess the molecular genetics of drug addiction, addiction vulnerability and/or their associated co-morbidities and how they are related to drug addiction are especially encouraged. Also encouraged are genetic as well as computational and large-scale genomic approaches, which may include but are not limited to linkage, linkage disequilibrium, case-control or family-based studies, and integration of data from other databases that may supplement substance abuse genetics and genomics data. Data may be collected from the general population, special populations, recent admixed populations, and/or animal models. Investigators are encouraged to include, as a component of their project and as appropriate, gene x gene interactions, gene x environment interactions, gene x environment x development interactions, pharmacogenetics, and non-human models. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 78758 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Collaborative Clinical Trials in Drug Abuse (Collaborative R01) Contact: Jamie Biswas, Ph.D. Tel: 301-443-8096 Email: jbiswas@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-099.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor seeks to support collaborative clinical trials in drug abuse (CCTDA) through the funding of “linked” Research Project Grant (R01) applications across different study sites (e.g., different institutions, organizations, and/or multiple campuses within a single institution or university system). Each research group must submit a separate R01 application, but should conduct clinical trials utilizing one common research plan. A lead group should be designated as the coordinating site. Although a foreign institution may be included as a participating site, the coordinating site must be a domestic institution/organization. This FOA will use the NIH Collaborative Research Project Grant (Collaborative R01) award mechanism. --------------------------------------------------------------- Program Number: 91125 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Functional Genetics, Epigenetics, and Non-coding RNAs in Drug Addiction Functional (R01) Contact: John Satterlee, Ph.D. Tel: 301-435-1020 Email: satterleej@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-033.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications for basic functional genomic research in two areas: 1. functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in addictive processes, and 2. detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 93878 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Gene-Environment Interplay in Substance Use Disorders (R01) Contact: Naimah Weinberg, M.D. Tel: 301-402-1908 Email: nw46w@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-235.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors provide support to stimulate and expand research on the interplay of genetic and environmental factors in the genesis, course, and outcomes of substance and alcohol use disorders (SUDs). Previous work in genetic epidemiology and molecular genetics has established that SUDs are highly heritable, developmental disorders with important genetic substrates. Building on these findings, new studies using genetically informative approaches are needed to elucidate the complex interplay of genetic and environmental factors in developmental trajectories of SUDs and comorbid conditions, deepen and refine phenotypic definitions of SUDs, and meet the methodologic challenges of the field. Such studies hold great potential to promote understanding of the true contributions of both genetic and environmental factors to initiation, progression, comorbidity, adverse outcomes, and desistance of SUDs; to elucidate mechanisms of risk; and to enhance opportunities for translation to treatment, prevention, gene-finding and molecular studies. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 23722 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institutes of Health/DHHS Title: Research Project Grant (Parent R01) Contact: Tel: 301-496-4000 Email: grantsinfo@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-260.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The Research Project Grant (R01) is an award to support a discrete, specified, circumscribed project to be performed by named Project Directors/Principal Investigators (PDs/PIs) in areas representing the investigators ’ specific interests and competencies, based on the mission of the NIH, to support health-related research and development. --------------------------------------------------------------- Program Number: 18247 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Library of Medicine/NIH/DHHS Title: NLM Express Research Grants in Biomedical Informatics (R01) Contact: Dr. Hua-Chuan Sim Tel: 301-594-4882 Email: simh@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-208.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor provides support for research grants that advance the science of biomedical informatics. Informatics is concerned with the optimal organization, management, dissemination and use of information. Biomedical informatics can be defined as the intersection of computer and information sciences with an application domain such as health care, public health, basic biomedical research, or clinical translational research. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 28140 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Library of Medicine/NIH/DHHS Title: NLM Administrative Supplements for Informationist Services in NIH-funded Research Projects (Admin Supp) Contact: Valerie Florance, Ph.D. Tel: 301-496-4621 Email: florancev@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-158.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The sponsor will not accept letters of intent under this FOA. The deadline for receipt of full applications is June 5, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Library of Medicine (NLM) and other participating Institutes of NIH invite applications for Administrative Supplements available to eligible NIH awardees with active R01 grants and, in some cases, with active P01, P30, P50 and U01 grants. These administrative supplements provide funds to supported research and center grants in order to enhance the storage, organization, management and use of electronic research data through the involvement of informationists, also known as in-context information specialists. The purposes of this administrative supplement program are (1) to enhance collaborative, multi-disciplinary basic and clinical research by integrating an information specialist into the research team in order to improve the capture, storage, organization, management, integration, presentation and dissemination of biomedical research data and (2) to assess and document the value and impact of the informationist’s participation. --------------------------------------------------------------- Program Number: 17057 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Office of Behavioral and Social Sciences Research/NIH/DHHS Title: Translating Basic Behavioral and Social Science Discoveries into Interventions to Improve Health-Related Behaviors (R01) Contact: Wendy J. Nilsen, Ph.D. Tel: 301-496-0979 Email: nilsenwj@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-063.html Deadline Note: The deadlines for receipt of optional letters of intent for standard applications are: January 5, May 5 and September 5 annually. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of optional letters of intent for AIDS-related applications are: April 7, August 7, and December 7 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications that propose to translate findings from basic research on human behavior into effective clinical, community, or population-based behavioral interventions to improve health. Specifically, this FOA will support interdisciplinary teams of basic and applied biological, behavioral and/or social science researchers in developing and refining novel behavioral interventions with high potential impact to improve health-promoting behaviors (e.g., healthy dietary intake, sun safety, physical activity, or adherence to medical regimens), and/or reduce problem health behaviors (e.g., smoking, tanning or physical activity or alcohol or substance use, abuse or dependence). This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24151 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Office of Behavioral and Social Sciences Research/NIH/DHHS Title: PAR-11-314--Systems Science and Health in the Behavioral and Social Sciences (R01) Contact: Patricia L. Mabry, PhD Tel: 301-402-1753 Email: mabryp@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-314.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. Letters of intent may be submitted thirty days prior to application receipt dates. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications for that propose to develop basic and applied projects utilizing systems science methodologies relevant to human behavioral and social sciences and health. This FOA is intended to encourage a broader scope of topics to be addressed with systems science methodologies, beyond those encouraged by existing open FOAs. Research projects applicable to this FOA are those that are either applied or basic in nature (including methodological development), have a human behavioral and/or social science focus, and feature systems science methodologies. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25793 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Office of Behavioral and Social Sciences Research/NIH/DHHS Title: Practical Interventions to Improve Medication Adherence in Primary Care (R01) Contact: Wendy Nilsen, PhD Tel: 301-496-0979 Email: nilsenwj@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-022.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: This FOA seeks applications that propose practical interventions to improve adherence to medication. This FOA will support research to test interventions with the potential to significantly improve medication adherence in patients with chronic health conditions in settings where primary health care is delivered (including, dental and eye care settings). Applications may target medication adherence in the context of treatment for a single illness or chronic condition (e.g., hypertension) or multiple comorbid conditions (e.g., hypertension and HIV/AIDS). Studies should use the most rigorous design and methodology possible given the populations and settings in which the study is taking place. Primary outcomes of the research should include: a patient self-report of medication adherence, and at least one other non-self-report measure of medication adherence (e.g., pharmacy refill records, electronic monitoring, etc.). In addition, applications should include a health outcome or biomarker (e.g., blood pressure, viral load in HIV patients, cholesterol levels, HbA1c) that is expected to be affected by changes in the targeted adherence behavior. Researchers should address the capacity of the tested approach for wide dissemination, the sustainability of the approach once the research is concluded, and are encouraged to include measurement and costs of the intervention characteristics and contextual factors that affect implementation and adoption. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25809 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Office of Behavioral and Social Sciences Research/NIH/DHHS Title: Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care (R01) Contact: Wendy Nilsen, PhD Tel: 301-496-0979 Email: nilsenwj@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-024.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: This funding opportunity announcement (FOA) seeks Research Project Grant (R01) applications that propose to use a common conceptual model to develop behavioral interventions to modify health behaviors and improve health outcomes in patients with comorbid chronic diseases and health conditions. Specifically, this FOA will support research in primary care that uses a multi-disease care management approach to behavioral interventions with high potential impact to improve patient-level health outcomes for individuals with three or more chronic health conditions. The proposed approach must modify behaviors using a common approach rather than administering a distinct intervention for each targeted behavior and/or condition. Diseases and health conditions can include, but are not limited to: mental health disorders (e.g., depression), diabetes, smoking, obesity, chronic pain, alcohol and substance abuse and dependence, chronic obstructive pulmonary disorder, cancer and hypertension. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 06810 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: Department of the Army Title: Prostate Cancer Research Program--Exploration - Hypothesis Development Award Contact: Congressionally Directed Medical Research Program Tel: 301-682-5507 Email: help@cdmrp.org Website:          http://cdmrp.army.mil/funding/prgdefault.shtml Full Program:          http://www07.grants.gov/search/search.do;jsessionid=wRwyPs2W6s1xLQtC111rXN2bCpnGyF1YYDNcnY6wzCC3qgyjt0jG!1869518295?oppId=157753&mode=VIEW Deadline Note: Pre-application Submission Deadline is 5:00 p.m. Eastern time (ET), June 6, 2012. Invited Application Submission Deadline is 11:59 p.m. ET, June 20, 2011 SYNOPSIS: The Exploration - Hypothesis Development Award supports the exploration of highly innovative, untested, potentially high-gain concepts, theories, paradigms, and/or methods that address an important problem in prostate cancer. Results of studies conducted through this award may provide the scientific rationale upon which a new hypothesis can be based or initial proof-of-principle of an innovative hypothesis. This award is designed to provide investigators the opportunity to pursue serendipitous observations that may reveal entirely new avenues for investigation. Presentation of preliminary data is inconsistent with the intent of this award mechanism and is therefore strongly discouraged. However, logical reasoning and a sound scientific rationale for the proposed work must be described. The PCRP seeks applications from the wide spectrum of basic, population-based, translational, and clinical research. In addition, applicants are required to address at least one of the PCRP focus areas and are highly encouraged to address one of the PCRP overarching challenges. --------------------------------------------------------------- Program Number: 08022 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: Department of the Army Title: Peer Reviewed Medical Research Program--Technology/Therapeutic Development Award Contact: Congressionally Directed Medical Research Program Tel: 301-682-5507 Email: help@cdmrp.org Website:          http://cdmrp.army.mil/funding/prgdefault.shtml Full Program:          http://www07.grants.gov/search/search.do;jsessionid=JQLZP0BFSHKJ3XyL2nTxgWK1zlLjTJTv86123jnn014BQ7WT4vRr!-335065855?oppId=159914&mode=VIEW Deadline Note: Pre-application Submission Deadline: 5:00 p.m. Eastern time (ET), June 6, 2012. Invited Application Submission Deadline is 11:59 p.m. ET, June 26, 2012. SYNOPSIS: The PRMRP Technology/Therapeutic Development Award is product-driven award intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, patient care, and/or quality of life, in at least one of the Congressionally directed FY12 PRMRP topic areas. Products in development should be responsive to the health care needs of military service members, veterans, and/or beneficiaries. The product(s) to be developed may be pharmacologic agents (drugs or biologics), devices, and/or clinical guidance for standard of care. The Principal Investigator (PI) must provide a transition plan (including potential funding and resources) showing how the product will progress to clinical trials and/or delivery to the military or civilian market after the completion of the PRMRP award. Examples of the types of research that may be supported include, but are not limited to: Developing and validating clinical guidance/guidelines for standard of care; Testing new therapeutic modalities (agents, delivery systems, and chemical modification of lead compounds) using established or validated preclinical systems (PIs seeking funding for establishing or validating preclinical systems should apply to the Investigator-Initiated Award mechanism); Designing and implementing pilot or full-scale Good Manufacturing Practice (GMP) production of therapeutics and/or delivery systems for use in advanced preclinical and initial clinical trials; Developing pharmacologic agents through adsorption, distribution, metabolism, excretion, and toxicity (ADMET) studies; Developing pharmacologic agents to Investigational New Drug (IND) stage for initiation of Phase I clinical trials; Developing prototype devices to Investigational Device Exemption (IDE) stage for initiation of clinical trials; and Optimizing diagnostic or treatment devices for field deployment. Applications must include relevant data that supports the rationale for the proposed study. These data may be unpublished and/or from the published literature. The vision of the FY12 PRMRP is to improve the health and well-being of all military service members, veterans, and beneficiaries. The PRMRP challenges the scientific and clinical communities to address one of the FY12 topic areas with original ideas that foster new directions along the entire spectrum of research and clinical care. The program seeks applications in laboratory, clinical, behavioral, epidemiologic, and other areas of research to advance knowledge in disease etiology, improve detection, diagnosis, treatment, and quality of life for those affected by a relevant disease or condition, and to develop and validate clinical care or public health guidelines. --------------------------------------------------------------- Program Number: 08025 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: Department of the Army Title: Peer Reviewed Medical Research Program--Clinical Trial Award Contact: Congressionally Directed Medical Research Program Tel: 301-682-5507 Email: help@cdmrp.org Website:          http://cdmrp.army.mil/funding/prgdefault.shtml Full Program:          http://www07.grants.gov/search/search.do;jsessionid=JQLZP0BFSHKJ3XyL2nTxgWK1zlLjTJTv86123jnn014BQ7WT4vRr!-335065855?oppId=159913&mode=VIEW Deadline Note: Pre-application Submission Deadline: 5:00 p.m. Eastern time (ET), June 6, 2012. Invited Application Submission Deadline: 11:59 p.m. ET, June 26, 2012. SYNOPSIS: The PRMRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in at least one of the Congressionally directed FY12 PRMRP topic areas. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept (i.e., pilot, first in human, or Phase 0) trials to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations. All studies must be responsive to the health care needs of the military service members, veterans, and/or beneficiaries; however, the use of military populations is not required. The vision of the FY12 PRMRP is to improve the health and well-being of all military service members, veterans, and beneficiaries. The PRMRP challenges the scientific and clinical communities to address one of the FY12 topic areas with original ideas that foster new directions along the entire spectrum of research and clinical care. The program seeks applications in laboratory, clinical, behavioral, epidemiologic, and other areas of research to advance knowledge in disease etiology, improve detection, diagnosis, treatment, and quality of life for those affected by a relevant disease or condition, and to develop and validate clinical care or public health guidelines.. --------------------------------------------------------------- Program Number: 27854 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: Department of the Army Title: DoD Prostate Cancer Collaborative Undergraduate HBCU Student Summer Training Program Award Contact: Congressionally Directed Medical Research Program Tel: 301-682-5507 Email: help@cdmrp.org Full Program:          http://www07.grants.gov/search/search.do;jsessionid=wRwyPs2W6s1xLQtC111rXN2bCpnGyF1YYDNcnY6wzCC3qgyjt0jG!1869518295?oppId=157613&mode=VIEW Deadline Note: Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), June 6, 2012. Invited submissions are due 11:59 p.m. ET, June 20, 2012. SYNOPSIS: The PCRP Collaborative Undergraduate HBCU1 Student Summer Training Program Award (STPA) supports the training of the next generation of prostate cancer researchers. This award funds new or existing summer training programs in prostate cancer research for undergraduate students from Historically Black Colleges and Universities (HBCU) at host institutions with ongoing prostate cancer research. Training programs are highly encouraged to include, among the projects proposed, exposure to and/or experiences in prostate cancer health disparity research. This award also requires the Program Director [designated as the Principal Investigator (PI)], who should be an established prostate cancer researcher at the host institution, to collaborate with faculty advisors from the undergraduate trainees’ HBCU. Applicants must enroll a minimum of four undergraduate HBCU trainees per year, who may be recruited from multiple HBCU. --------------------------------------------------------------- Program Number: 27855 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: Department of the Army Title: DoD Prostate Cancer Postdoctoral Training Award Contact: Congressionally Directed Medical Research Program Tel: 301-682-5507 Email: help@cdmrp.org Website:          http://cdmrp.army.mil/funding/default.shtml Full Program:          http://www07.grants.gov/search/search.do;jsessionid=wRwyPs2W6s1xLQtC111rXN2bCpnGyF1YYDNcnY6wzCC3qgyjt0jG!1869518295?oppId=157674&mode=VIEW Deadline Note: Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), June 6, 2012. Invited Application Submission Deadline is 11:59 p.m. ET, June 20, 2012. SYNOPSIS: The Postdoctoral Training Award supports prostate cancer research training opportunities for recent doctoral graduates. These awards primarily provide salary support for the Principal Investigator (PI); the postdoctoral trainee is considered the PI of the application. The PI must exhibit strong potential for, and commitment to, pursuing a career as an investigator at the forefront of prostate cancer research; however, the PI is not required to have previous prostate cancer research experience. Applications must include at least one mentor, appropriate to the proposed training and research project, who has experience in prostate cancer research and training as demonstrated by a record of funding, publications, and successful mentorship. The selected mentor(s) should demonstrate a clear commitment to the PI’s training and be well qualified to contribute significantly to the development of the PI toward independence as a prostate cancer researcher. The PI must outline an individualized, prostate cancer-focused training plan, which may include coursework, laboratory techniques, conferences, seminars, journal clubs, teaching responsibilities, clinical responsibilities, and/or other activities that will provide the PI with experience in key areas relevant to the proposed work and foster the PI’s development as a prostate cancer researcher. An environment appropriate to the proposed training and research project must be clearly described. All applications for the Postdoctoral Training Award are to be written by the PI, with appropriate direction from the mentor(s). --------------------------------------------------------------- Program Number: 72400 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: Department of the Army Title: Prostate Cancer Research Program--Physician Research Training Award (CDMRP) Contact: Congressionally Directed Medical Research Program Tel: 301-682-5507 Email: help@cdmrp.org Website:          http://cdmrp.army.mil/funding/prgdefault.shtml Full Program:          http://www07.grants.gov/search/search.do;jsessionid=wRwyPs2W6s1xLQtC111rXN2bCpnGyF1YYDNcnY6wzCC3qgyjt0jG!1869518295?oppId=157653&mode=VIEW Deadline Note: Pre-application Submission Deadline: 5:00 p.m. Eastern time (ET), June 6, 2012. Invited submissions are due 11:59 p.m. ET, June 20, 2012. SYNOPSIS: The PCRP Physician Research Training Award (PRTA) supports a mentored training experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research. This award emphasizes equally the quality of both the research and the training proposed. The trainee is considered the Principal Investigator (PI) of the application. All applications for the PRTA are to be written by the PI, with appropriate direction from the mentor(s). The PI must demonstrate a commitment to a career as an investigator at the forefront of prostate cancer research and clinical practice; however, the PI is not required to have previous prostate cancer research experience. Applications must include a robust description of an individualized, prostate cancer-focused training plan that will provide the PI with experience in key areas relevant to the proposed work and foster the PI’s development as a prostate cancer researcher. This award requires the involvement of at least one designated mentor with an established research program in prostate cancer, evidenced by publications, funding, and successful mentorship. The PI and mentor(s) should work together to design robust training and mentoring plans, which may include coursework, laboratory techniques, conferences, seminars, journal clubs, teaching responsibilities, clinical responsibilities, and/or other activities appropriate to the area of study. Training plans inclusive of basic and population-based research, in addition to or in lieu of translational or clinical research, are highly encouraged. In --------------------------------------------------------------- Program Number: 19016 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (UM1) Contact: Deborah Winn, Ph.D. Tel: 301-594-9499 Email: winnde@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-167.html Deadline Note: The deadlines for receipt of optional letters of intent are:June 6, 2012, October 8, 2012, February 8, 2013, June 10, 2013, October 8, 2013. The deadlines for receipt of full applications are: July 6, 2012, November 8, 2012, March 8, 2013, July 10, 2013, November 8, 2013. This FOA will expire on November 9, 2013. SYNOPSIS: The sponsor invites applications to provide targeted infrastructure support for the core functions of Cancer Epidemiology Cohorts (CECs) and methodological research. This infrastructure can support existing or new CECs. This FOA will support core functions for CECs currently funded through other grant mechanisms by the Epidemiology and Genetics Program (EGRP) and other components of the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI). This FOA will utilize the UM1 Multi-Component Research Project Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 28089 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: National Center on Birth Defects and Developmental Disabilities/CDC/DHHS Title: Surveillance of Congenital Heart Defects (CHDs) Focusing on Adolescents and Adults Contact: Tineka Yowe-Conley, Project Officer Tel: 404-498-3941 Email: TYoweConley@cdc.gov Full Program:          http://www.grants.gov/search/search.do;jsessionid=G61PPCpSRNnSr8Y11pJVQRTYhTMmH1T29JgkKGv7fGLb27ngs43t!-335065855?oppId=162113&mode=VIEW Deadline Note: The deadline for receipt of optional letters of intent is May 1, 2012. The deadline for receipt of full applications is June 6, 2012. SYNOPSIS: National Center on Birth Defects and Developmental Disabilities (NCBDDD) invites applications collaborative pilot projects to develop and implement innovative approaches for conducting population-based surveillance of structural, congenital heart defects (CHDs) focusing on adolescents and adults and examining healthcare utilization and referral to timely and appropriate services. A total of approximately $4,275,000 is available. --------------------------------------------------------------- Program Number: 24943 --------------------------------------------------------------- ***Deadlines: 6/7/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Research Using Subjects From The Type 1 Diabetes TrialNet Natural History Study (Living Biobank) (DP3) Contact: Lisa M. Spain, Ph. D, Director Tel: 301-451-9871 Email: spainl@niddk.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-349.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after November 7, 2011. The deadlines for receipt of optional letters of intent are: November 7, 2011; and May 7, 2012 . The deadlines for receipt of full applications are: December 7, 2011; and June 7, 2012 by 5:00 PM local time of applicant organization. This FOA will expire on June 8, 2012. SYNOPSIS: The sponsor invites applications for ancillary studies that use subjects enrolled in (or screened for participation in) the Type 1 Diabetes TrialNet clinical trials network. Studies are expected to generate scientific discoveries on disease mechanisms, disease pathogenic processes, and biomarkers of disease progression or clinical responses. This FOA is not intended to fund clinical trials with endpoints for clinical efficacy (including but not limited to C-peptide preservation). This FOA will utilize the NIH DP3 Type 1 Diabetes Targeted Research Award. --------------------------------------------------------------- Program Number: 25007 --------------------------------------------------------------- ***Deadlines: 6/7/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3) Contact: Lisa M. Spain, Ph. D, Director Tel: 301-451-9871 Email: spainl@niddk.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-350.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after November 7, 2011. The deadlines for receipt of optional letters of intent are: November 7, 2011; and May 7, 2012 . The deadlines for receipt of full applications are: December 7, 2011; and June 7, 2012 by 5:00 PM local time of applicant organization. This FOA will expire on June 8, 2012. SYNOPSIS: The sponsor invites applications for ancillary studies using archived samples from selected type 1 diabetes clinical trials and studies. Ancillary studies are expected to generate scientific discoveries on disease mechanisms, disease pathogenic processes, and biomarkers of disease progression or clinical responses. This FOA will utilize the NIH DP3 Type 1 Diabetes Targeted Research Award. --------------------------------------------------------------- Program Number: 03947 --------------------------------------------------------------- ***Deadlines: 6/7/2012 Sponsor: Natural Resources Conservation Service/Department of Agriculture Title: Conservation Innovation Grants - New Hampshire Contact: Deborah Weymouth Tel: 603-868-9931 x 102 Email: deb.weymouth@nh.usda.gov Full Program:          http://www07.grants.gov/search/search.do;jsessionid=nKWPP0mKDPJpRyLD2lJ09W0CnbCFDxQyYdtQLNgQ4k12DK5ZrdFT!109354571?oppId=170999&mode=VIEW SYNOPSIS: The New Hampshire State Office of the USDA Natural Resources Conservation Service (NRCS) requests applications for Conservation Innovation Grants (CIG) to stimulate the development and adoption of innovative conservation approaches and technologies. Applications will be accepted from any eligible entity for projects within the State of New Hampshire. Funds will be awarded through a statewide competitive grants process. Applications are requested from eligible government or non-government organizations or individuals within the State of New Hampshire for competitive consideration of grant awards for projects between one and three years in duration. NRCS anticipates the availability of up to $134,000 of funds during fiscal year 2012 for the New Hampshire CIG program competition. --------------------------------------------------------------- Program Number: 28085 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: Department of the Air Force Title: RFP -- AMENDMENT--Quick Reaction USAFSAM Assessments, Studies, Analysis, Evaluation and Research (QUASAR) Contact: Kimberly Rhoads, Contract Negotiator Tel: Email: kimberly.rhoads@wpafb.af.mil Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=8dea3a7c6570a8d6c16a8188ccea52a9&tab=core&_cview=0 SYNOPSIS: A -- QUICK REACTION USAFSAM ASSESSMENTS, STUDIES, ANALYSIS, EVALUATION AND RESEARCH (QUASAR) - BAA-12-01-HPW SOL BAA-12-01-HPW POC Kimberly Rhoads,,Nicholas J Voiles, WEB: FBO.gov Permalink https://www.fbo.gov/spg/USAF/AFMC/AFRLWRS/BAA-12-01-HPW/listing.html E-MAIL: kimberly.rhoads@wpafb.af.mil, nicholas.voiles@wpafb.af.mil kimberly.rhoads@wpafb.af.mil, nicholas.voiles@wpafb.af.mil NAICS: 541712 Attachment 7 DD-254 Attachment 6 CDRL's Attachment 5 SampleTaskOrder0004 Attachment 4 SampleTaskOrder0003 Attachment 3 SampleTaskOrder0002 Attachment 2 TaskOrder0001 Attachment 1 - QUASAR BASIC SOW BAA-12-01-HPW 711 HPW/USAFSAM conducts medical research in response to Air Force Medical Service (AFMS) needs.AFMS has grouped these needs into five major thrust areas: Enroute Care, Force Health Protection, Expeditionary Medicine, Operational Medicine and Human Performance. Enroute Care - Focus is on continuum of care during transport of patientsfrom point of injury to point of definitive care. Force Health Protection - Focus is on prevention of injury and illness and the early recognition or detectionof emerging threats. Expeditionary Medicine/In Garrison - Focus is on improvingexpeditionary medical care during contingency operations including medical countermeasures against combat and operational stressors to maximize warrior health,performance and well-being. Operational Medicine - Focus is on definitive patient care/treatment in garrison. Human Performance: Focus is on operational human performance across the spectrum of Air Force warfighter operations. The AFMS gathers medical research needs from Air Force major commands (MAJCOMs) and these form the basis for medical research projects. United States Air Force School of Aerospace Medicine (USAFSAM) performs applied medical research (6.2), medical technology development (6.3) and advanced component development (6.4) to: (1) develop capabilities for detection, prevention, diagnosis, and treatment of infectiousdiseases of military significance and detection and identification of chemical and biological agents of mass destruction (WMD) that possess the capability to decrease military operational effectiveness, or disorders associated with trauma and/or debilitating morbidity or mortality; (2) seek novel ways to enhance biological or chemical agent surveillance and detection systems to gain the ability to rapidly detect pre-symptomatic infectious disease in order to mitigate the outbreak of naturally occurring endemic diseases and/or the covert or overt releaseof biological and chemical agents; (3) improve health surveillance situational awareness or increase new technology detection by integrating advanced diagnostics and other innovative technologies for rapid pathogen identification and detection with relevant information systems currently in operations; (4) develop automated monitoring of indoor structures and ventilation systems with self-regeneration capabilities and‘real time' monitoring rather than reaction development with secondary signal monitoring. This requirement also includes pursuing research in the areas of deployed combat casualty care optimization and improvements in methods/techniques of remote patient monitoring, triage systems, and treatment of emerging threat injuries including operations involving irregular warfare, contingency operations and humanitarian relief operations. Other areas of research include: Pathophysiology of critical illness/injury during evacuation; complication of wounds/critical injury/critical illness by confounding factors introduced by aeromedical evacuation (AE) transport; mitigation of confounding factors introduced by AE transport; assessment of physiologic/neurophysiologic and inflammatory marker changes in flight; and multiple-patient monitoring. USAFSAM conducts research pertaining to acceleration and altitude research, including aircrew training in these areas. Additional research interests are selected epidemiological studies and projects to advance aeromedical knowledge and performance-enhancement/protection in air and ground operations, and aerospace medicine and related fields. And finally, Clinical and Translational Research that will transition scientific findings from the laboratory to the clinical setting (e.g., operational environment/patient bedside: pre-hospital, clinic, or hospital; in-garrison, deployed, enroute care; includes education, training, and readiness) into best practice. The types of requests for medical research are as diverse as the customer base. The projects may often involve the use of human subjects or live models due to the medical aspect of the research, which adds an additional layer ofcomplexity. Please see the full BAA announcement for the complete details. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=8dea3a7c6570a8d6c16a8188ccea52a9&tab=core&_cview=0 Posted 04/06/12 (W-SN02716458). (0097) --------------------------------------------------------------- Program Number: 02922 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: Environmental Protection Agency Title: State Environmental Enforcement Training Grant Program Contact: Arthur Horowitz Tel: 303-236-6790 Email: horowitz.arthur@epa.gov Website:          http://www.grants.gov/search/search.do;jsessionid=tQ7mPbKJtJZX0RHpSZkJtTXL2p9FQrLfJkNm8Hy4xhnLx3SspkVJ!267572332?oppId=167473&mode=VIEW Full Program:          http://www.epa.gov/compliance/state/grants/seet.html SYNOPSIS: This Request for Applications (RFA) is issued by the National Environmental Training Institute (NETI) in the Office of Compliance (OC) in EPA’s Office of Enforcement and Compliance Assurance (OECA) to strengthen states’ ability to address environmental and public health threats through training of state environmental enforcement personnel. The purpose of the grant is to expand environmental enforcement training opportunities on a nationwide basis throughout the 50 states, covering all statutory environmental media programs. --------------------------------------------------------------- Program Number: 28432 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: Food & Drug Administration Title: RFA-FD-12-019--Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products (U01) Contact: Sau (Larry) Lee Tel: 240-276-9321 Email: Sau.Lee@fda.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-FD-12-019.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 1, 2012. The sponsor will not accept letters of intent under this FOA . The deadline for receipt of full applications is Jun 08, 2012. SYNOPSIS: FDA invites applications to develop a computational fluid dynamics (CFD) model of orally inhaled drug products that can account for drug product characteristics (aerodynamic particle size distribution, APSD) and physiological parameters (breathing pattern and airway geometry) on total and regional deposition in the lungs. Specifically, the CFD model will be capable of predicting highly localized deposition of pharmaceutically relevant polydisperse aerosols from metered dose inhalers (MDIs) and dry powder inhalers (DPIs). The results obtained in this study will be used in developing a linked CFD-compartment model that can predict the effects of lung deposition on safety (systemic exposure) and efficacy (local delivery) for locally acting orally inhaled drugs. This program will use the U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 28436 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: Food & Drug Administration Title: RFA-FD-12-021--Pharmacokinetics Studies of Tacrolimus in Transplant Patients (U01) Contact: Wenlei Jiang Tel: 240-276-8607 Email: wenlei.jiang@fda.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-FD-12-021.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 1, 2012. The sponsor will not accept letters of intent under this FOA . The deadline for receipt of full applications is June 8, 2012 by 5:00 PM local time of applicant organization. FDA invites applications to compare the pharmacokinetics of two sources of generic tacrolimus capsules to Prograf in stable transplant patients. Patients will be switched between both brand and generic and generic and brand. The outcome of this study can help address the public concerns regarding the quality of generic tacrolimus and improve review practices of generic tacrolimus if necessary. This FOA will utilize the U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 14833 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: National Aeronautics & Space Administration Title: National Space Biomedical Research Institute Postdoctoral Fellowship Contact: Amanda Smith Hackler Tel: 713-798-7412 Email: postdoc@nsbri.org Website:          http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={0F3A5A9E-7921-979A-D273-43B749592F7A}&path=open Full Program:          http://nspires.nasaprs.com/external/viewrepositorydocument/cmdocumentid=309512/solicitationId=%7B0F3A5A9E-7921-979A-D273-43B749592F7A%7D/viewSolicitationDocument=1/NSBRI-RFA-12-02%20Post%20Doc.pdf SYNOPSIS: NSBRI is a NASA-funded, nonprofit research consortium charged with developing biomedical countermeasures and technologies for potential health problems that could occur in astronauts either during long-duration spaceflight, on exploration missions or on their return to Earth. NSBRI’s current program, aligned with NASA’s exploration objectives, consists of approximately 50 science and technology projects organized into research teams. NSBRI invites ground-based research applications. Proposals can address one of the seven existing NSBRI research teams, which has importance to both NSBRI and the NASA Human Research Program (HRP). --------------------------------------------------------------- Program Number: 28134 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: National Center for Emerging and Zoonotic Infectious Diseases/CDC/DHHS Title: Strengthening Surveillance for Diseases Among Newly-Arrived Immigrants and Refugees Contact: Heather Burke, Project Officer Tel: 404-639-3408 Email: HBurke@cdc.gov Full Program:          http://www.grants.gov/search/search.do;jsessionid=pvnTPFTTZj62yzxnpQp4s5pxQj1CH6WQgyCKBsTVhCSWWcTkjzGy!545677704?oppId=162755&mode=VIEW Deadline Note: The deadline for receipt of optional letters of intent is May 9, 2012. The deadline for receipt of full applications is June 8, 2012. SYNOPSIS: National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) invites applications to conduct surveillance to detect, prevent and control diseases and evaluate existing health programs to improve the health of refugees and/or immigrants that are newly arrived in the United States. A total of approximately $4.0 million is available. --------------------------------------------------------------- Program Number: 28852 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Title: PPHF 2012 Viral Hepatitis, Early Education, and Linkage to Care for Persons with Chronic HBV and HCV Infections Financed Solely by 2012 Prevention and Public Health Fund Contact: Gilberto Ramirez, Project Officer Tel: 404-718-8535 Email: ghr0@cdc.gov Full Program:          http://www.grants.gov/search/search.do;jsessionid=GQ0KP7GQJPZ6hSTXCvt7YJZT2wTyrvWgFXm1Pvk1d9XX1Z8Hv9Hw!-541990005?oppId=171575&mode=VIEW Deadline Note: The deadline for receipt of optional letters of intent is June 8, 2012. The deadline for receipt of full applications is July 2, 2012. SYNOPSIS: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention invites applications to improve early identification of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in clinical and community settings and to enhance linkage to care, treatment, and preventive services for infected persons. To meet this prevention goal, the FOA includes two (2) categories: Category A - Early Identification and Linkage to Care for Foreign-born Persons with Hepatitis B; and Category B - Testing for HCV Infection and Enhancing Linkage to Care for Persons with Hepatitis C. A total of approximately $1.5 million is available under Category A, and $19.5 million is available for Category B. --------------------------------------------------------------- Program Number: 28000 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: RFP -- AMENDMENT -- NICHD Contraceptive Clinical Trials Network - Male Sites Contact: Katharine Minker, Contracting Officer Tel: 301-402-7571 Email: km571h@nih.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=f9415bcaddbed158658f77878d922956&tab=core&_cview=0 A -- NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK - MALE SITES SOL NI-NICHD-CRHB-2012-04 POC Katharine Minker, Phone: 301-402-7571, Alice M. Pagán, Phone: 301-435-6959 WEB: FBO.gov Permalink https://www.fbo.gov/spg/HHS/NIH/NICHD/NIH-NICHD-CRHB-2012-04/listing.html E-MAIL: km571h@nih.gov, alice.pagan@nih.govkm571h@nih.gov, alice.pagan@nih.gov NAICS: 541712 THIS IS NOT A REQUEST FOR PROPOSALS (RFP). THIS IS A PRE-SOLICITATION ANNOUNCEMENT ONLY. A REQUEST FOR PROPOSALS WILL BE ISSUED VIA FEDBIZOPPS ON OR ABOUT APRIL 17, 2012. The National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Healthand Human Development (NICHD) is planning to issue an RFP for multiple Indefinite/Delivery, Indefinite/Quantity (IDIQ) Task Order contracts for the NICHD Contraceptive Clinical Trials Network (CCTN). The NIH, NICHD is the lead Federal agency for the conduct of basic, clinical and epidemiological research to develop new contraceptives and to evaluate existing methods of contraception and reproductive health. The Center for Population Research (CPR), within NICHD, was established in 1968 by the Secretary of Health Education and Welfare, with the important goal of developing new contraceptives through the use of contracts and grants. Within CPR, the Contraception and Reproductive Health Branch (CRHB) has long supported several preclinical contraceptive testing facilities, as well as facilities for chemical and peptide synthesis. To further expand their contraceptive development capabilities, in 1996 CRHB established the initial NICHD CCTN in order to conduct Phase I, II, and III clinical trials of new contraceptive methods. The NICHD CCTN is an important component of the CRHB contraceptive development capability. Products that have undergone formulation and successful pre-clinical testing, either through the CRHB formulation and testing facilities or through outside sources, are candidates for clinical testing in the NICHD CCTN. The NICHD CCTN is particularly valuable for providing a venue for testing new contraceptive drugs and devices that have been developed by small companies that lack the resources to support large-scale clinical trials. This acquisition is for a re-competition of the male sites that will operate under an Indefinite/Delivery, Indefinite/Quantity (IDIQ) Task Order contracts. The male sites will be able to work with the CCTN Statistical and Clinical Coordinating Center (SCCC) and NICHD to rapidly develop protocols and initiate clinical trials shortly after candidate products have completed the necessary preclinical testing. The resultant IDIQ contracts will be for a seven (7) year period of performance. The CCTN male sites contractors will evaluate systematically the safety and efficacy of new male contraceptive drugs and devices as well as drug treatments for conditions in Phase I, II, III and IV trials. The results of these clinical trials would be the basis for advancing candidate drugs and devices through development with the ultimate goal of submission to the FDA in support of a New Drug Application (NDA), Premarket notification 510k, Premarket Approval (PMA) or Investigational Device Exemptions (IDE). It is estimated that the new NICHD CCTN will consist of up to 4 sites capable of performing male contraceptive clinical trials and up to 16 female sites. Please be advised that the NICHD is issuing separate RFPs for each CCTN Topic Area (Male Contraceptive Clinical Trials & Female Contraceptive Clinical Trials) and the SCCC for the CCTN. This Pre-Solicitation announcement is for the RFP for the Male Sites for the only. The RFP will be made available electronically only via the FedBizOpps website (http://www.fbo.gov). Offerors are responsible for routinely checking the FedBizOpps website for any possible solicitation amendments that may be issued. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=f9415bcaddbed158658f77878d922956&tab=core&_cview=0 Posted 04/02/12 (W-SN02711268). (0093) --------------------------------------------------------------- Program Number: 28002 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: RFP -- SBSA -- AMENDMENT -- Statistical and Clinical Coordinating Center Contact: David Fitton Tel: 301-443-5239 Email: fittond@mail.nih.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=4be37cae425c618f9069609e60c95da1&tab=core&_cview=0 A -- STATISTICAL AND CLINICAL COORDINATING CENTER SOL NIH-NICHD-CRHB2012-05 POC David Fitton, Phone: 301-443-5239 WEB: FBO.gov Permalink https://www.fbo.gov/spg/HHS/NIH/NICHD/NIH-NICHD-CRHB-2012-05/listing.html E-MAIL: fittond@mail.nih.gov fittond@mail.nih.gov NAICS: 541712 THIS IS NOT A REQUEST FOR PROPOSALS (RFP). THIS IS A PRE-SOLICITATION ANNOUNCEMENT ONLY. A REQUEST FOR PROPOSALSWILL BE ISSUED VIA FEDBIZOPPS ON OR ABOUT April 17, 2012 The National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is planning to issue an RFP for an Indefinite/Delivery, Indefinite/Quantity (IDIQ) Task Order contract for the NICHD Contraceptive Clinical Trials Network (CCTN) Statistical and Clinical Coordinating Center (SCCC). This will be a 100% small business set-aside IDIQ Task Order contract. The NIH, NICHD is the lead Federal agency for the conduct of basic, clinical and epidemiological research to develop new contraceptives and to evaluate existing methods of contraception and reproductive health. The Center for Population Research (CPR), within NICHD, was established in 1968 by the Secretary of Health Education and Welfare, with the important goal of developing new contraceptives through the use of contracts and grants. Within CPR, the Contraception and Reproductive Health Branch (CRHB) has long supported several preclinical contraceptive testing facilities, as well as facilities for chemical and peptide synthesis. To further expand their contraceptive development capabilities, in 1996 CRHB established the initial NICHD CCTN in order to conduct Phase I, II, and III clinical trials of new contraceptive methods. The NICHD CCTN is an important component of the CRHB contraceptive development capability. Products that have undergone formulation and successful pre-clinical testing, either through the CRHB formulation and testing facilities or through outside sources, are candidates for clinical testing in the CCTN. The CCTN is particularly valuable for providing a venue for testing new contraceptive drugs and devices that have been developed by small companies that lack the resources to support large-scale clinical trials. This acquisition is for a re-competition of the SCCC that will operate under an Indefinite/Delivery, Indefinite/Quantity (IDIQ) Task Order contract. The SCCC will be assisting with protocol development, preparation of study materials, regulatory document coordination, clinical monitoring, coordination of laboratory services, data collection and data analysis for the Female and Male sites. The resultant IDIQ contract will be for a seven (7) year period of performance. The results of these clinical trials would be the basis for advancing candidate drugs and devices through development with the ultimate goal of submission to the FDA in support of aNew Drug Application (NDA), Premarket notification 510k, Premarket Approval (PMA) or Investigational Device Exemptions (IDE). It is estimated that the new NICHD CCTN will consist of up to 16 sites capable of performing female contraceptive clinical trials and approximately 4 sites capable of performing male contraceptive clinical trials. Please be advised that the NICHD is issuing separate RFPs for each CCTN Topic Area (Female Contraceptive Clinical Trials & Male Contraceptive Clinical Trials) and the SCCC for the CCTN. This Pre-Solicitation announcement is for the RFP for the Statistical and Clinical Coordinating Center only. The RFP will be made available electronically only via the FedBizOpps website (http://www.fbo.gov). Offerors are responsible for routinely checking the FedBizOpps website for any possible solicitation amendments that may be issued. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=4be37cae425c618f9069609e60c95da1&tab=core&_cview=0 Posted 04/02/12 (W-SN02711332). (0093) --------------------------------------------------------------- Program Number: 27301 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: RFA-NS-13-003--NIH Blueprint for Neuroscience Research Grand Challenge: Discovering Novel Drugs for Disorders of the Nervous System (U01) Contact: Jill Heemskerk, PhD Tel: 301-496-1779 Email: jill.heemskerk@nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-13-003.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 8, 2012. The deadline for receipt of optional letters of intent is May 8, 2012. The deadline for receipt of full applications is June 8, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institutes of Health (NIH) and its participating Centers and Institutes invite applications from investigators working with small molecule compounds to gain access to a robust ‘virtual pharma’ network to discover neurotherapeutic drugs. Successful applicants to this FOA will become collaborative participants in this network, receiving both funding and no-cost access to contracted drug discovery services that are not typically available to the academic research community. Funding will be provided through a U01 cooperative agreement mechanism to conduct biological testing of compound analogs in disease assays and models in the investigator’s laboratory. No-cost drug discovery services will also be provided, including medicinal chemistry optimization, IND-directed pharmacology and toxicology, and Phase I clinical testing. Researchers in possession of disease assays and small molecule compounds that show promise for treating nervous system and psychiatric disorders, but that are not yet suitable for clinical testing, are strongly encouraged to apply. This program will use the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 62945 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Mechanism for Time-Sensitive Research Opportunities (R01) Contact: Redonna K. Chandler, Ph.D. Tel: 301-443-6504 Email: rchandle@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-072.html Deadline Note: Although not required, and not binding, a letter of intent is requested four weeks prior to the planned submission date. This FOA will expire on December 11, 2012. SYNOPSIS: The sponsor invites applications to support substance abuse prevention and treatment services research in rapidly evolving areas (e.g., changes in service systems, health care financing, policy, natural/man-made disasters, etc) where opportunities for empirical study are, by their very nature, only available through expedited review and award of support. There are three distinguishing features of an eligible study: 1) the study's scientific value and feasibility are clear, 2) rapid review and funding are required in order for the scientific question to be answered, and 3) the knowledge gained from the study is time-sensitive and seeking funding through the regular NIH cycle of review and award would result in a missed opportunity to conduct the research. It should be clear that the research question offers an uncommon and scientifically significant research opportunity that could only become available if the project is initiated with minimum delay. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 28551 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: Office of Public Health and Science/DHHS Title: Youth Empowerment Program (YEP) Contact: Tel: 240-453-8822 Website:          http://www.grants.gov/search/search.do;jsessionid=mV5YPnFbzRJDhT9916sfMqQVM4bbCCzBh6BQ6y52Whkc8SGQVsVq!1020059110?oppId=169220&mode=VIEW Full Program:          https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=14371 SYNOPSIS: The YEP seeks to address unhealthy behaviors in at-risk minority youth and provide them with opportunities to learn skills and gain experiences that contribute to more positive lifestyles and enhance their capacity to make healthier life choices. It is intended to demonstrate the effectiveness of a highly innovative and multi-partnership collaborative approach involving institutions of higher education, primary and secondary schools, sports organizations, youth clubs, other related community organizations and institutions, and the community at-large on reducing risky behaviors among targeted minority youth 10 to 18 years of age. --------------------------------------------------------------- Program Number: 28075 --------------------------------------------------------------- ***Deadlines: 6/9/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: RFA-HL-13-020--Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25) Contact: Drew Carlson, Ph.D. Tel: 301-435-0535 Email: carlsonde@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-HL-13-020.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after June 9, 2012. The deadlines for receipt of optional letters of intent are: June 9, 2012; January 7, 2013; January 7, 2014. The deadlines for receipt of full applications are: July 9, 2012; February 7, 2013; February 7, 2014, by 5:00 PM local time of applicant organization. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) invites applications to promote diversity in undergraduate and health professional participant populations by providing short-term research education support to stimulate career development in cardiovascular, pulmonary, hematologic, and sleep disorders research. The overall goal of the program is to provide research opportunities for individuals from backgrounds underrepresented in biomedical science, including individuals from disadvantaged backgrounds, individuals from underrepresented racial and ethnic groups, and individuals with disabilities that will significantly contribute to a diverse research workforce in the future. The research opportunities should be of sufficient depth to enable the participants, upon completion of the program, to have a thorough exposure to the principles underlying the conduct of research, and help prepare participants interested in research to pursue competitive fellowships, or other research training or career development awards. This FOA will utilize the NIH R25 Education Projects award mechanism. --------------------------------------------------------------- Program Number: 28620 --------------------------------------------------------------- ***Deadlines: 6/10/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Native American Research Centers for Health (NARCH) (S06) Contact: Sheila A. Caldwell, PhD Tel: 301-435-0760 Email: caldwells@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-182.html Deadline Note: The deadline for receipt of optional letters of intent is June 10, 2012. The deadline for receipt of full applications is July 10, 2012 . This FOA will expire on July 11, 2012. SYNOPSIS: NIH and its participating Institutes and Centers invite applications for new or continued Native American Research Centers for Health (NARCH). The NARCH program supports opportunities for conducting research and research training to meet the needs of American Indian/Alaska Native (AI/AN) communities. This FOA is issued by the National Institute of General Medical Sciences in conjunction with the other Institutes/Centers of the National Institutes of Health (NIH) and the Indian Health Service (IHS). This FOA will utilize the NIH S06 Research-Related Programs award mechanism. --------------------------------------------------------------- Program Number: 27970 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: RFA-CA-12-503--A Data Resource for Analyzing Blood and Marrow Transplants (Limited Competition U24) Contact: William D. Merritt, Ph.D. Tel: 301-496-8866 Email: merrittw@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-503.html Deadline Note: The deadline for receipt of optional letters of intent is May 11, 2012. The deadline for receipt of full applications is June 11, 2012. SYNOPSIS: National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI) and National Institute of Allergy and Infectious Diseases (NIAID) invite applications to continue the support for the Center for International Blood and Marrow Transplant Research (CIBMTR). This database resource collects consecutive outcomes data from transplant centers worldwide and makes them accessible to transplant investigators, patients, and healthcare policy makers. In addition, the CIBMTR provides quality data to transplant researchers for observational research studies on patients who had blood and marrow transplants. This FOA will utilize the NIH U24 Resource-Related Research Projects – Cooperative Agreements mechanism. --------------------------------------------------------------- Program Number: 48493 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Paul Calabresi Career Development Award For Clinical Oncology (K12) Contact: Dorkina Myrick, M.D., Ph.D., Program Director Tel: 301-496-8580 Email: myrickd@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-155.html Deadline Note: This program will expire on July 12, 2012. SYNOPSIS: The sponsor invites applications for institutional research career development (K12) programs from applicant organizations that propose to promote the training and career development of translational and clinical trials researchers. The purpose of the Paul Calabresi Career Development Award in Clinical Oncology (PCACO) K12 (NIH Institutional Research Career Development K12 grant mechanism) is to increase the number of clinicians (M.D.s, D.O.s, Pharm.D.s) and basic research scientists (Ph.D.s. or equivalents) who are trained to design and administer hypothesis-based pilot/Phase I, Phase II, and Phase III cancer therapeutic clinical trials in team research settings. A PCACO can support the research career development of clinicians only (single-track program) or clinicians and Ph.D. basic research scientists (dual-track program). Clinical and basic research scientists will collaborate and interact to expedite the translation of basic science research discoveries into patient-oriented therapeutic cancer research. This PAR will use the NIH Mentored Clinical Scientist Development Program (K12) award mechanism. --------------------------------------------------------------- Program Number: 28168 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: National Center for Emerging and Zoonotic Infectious Diseases/CDC/DHHS Title: Continuing Enhanced National Surveillance for Prion Diseases in the United States Contact: Dr. Ermias Belay, Project Officer Tel: 404-639-4655 Email: EBelay@cdc.gov Full Program:          http://www.grants.gov/search/search.do;jsessionid=2hYBPLvYLd1nQLGhnMxvR7Dx7P2QTrfDckyQYnTJLtMrH2Cx4vsy!98924490?oppId=164195&mode=VIEW Deadline Note: The deadline for receipt of optional letters of intent is April 27, 2012. The deadline for receipt of full applications is June 11, 2012. SYNOPSIS: National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) invites applications for a cooperative agreement program to continue enhanced national surveillance for prion diseases in the United States. A total of approximately $12,750,000 is available. --------------------------------------------------------------- Program Number: 05677 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: RFA-HL-12-024--Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R41/R42) Contact: Abby G. Ershow, Sc. D., FAHA Tel: 301-435-0550 Email: ershowa@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-HL-12-024.html Deadline Note: The deadlines for receipt of optional letters of intent are: June 13, 2011 (passed) and June 11, 2012. The deadlines for receipt of full applications are: July 11, 2011 and July 11, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: The sponsor invites applications that capitalize on the unique capabilities of Virtual Reality (VR) technologies to teach, motivate, visualize outcomes, and to extend the health care and learning environments for patients with obesity and diabetes. The VR technology proposed should foster desirable eating, physical activity, self-care, and other health-related behaviors necessary for prevention and management of obesity and diabetes. Of highest interest are well-designed multidisciplinary projects drawing on expertise in VR technologies and biomedical behavioral and pedagogical sciences. The overall goal is to develop the potential of Virtual Reality technologies as research tools for behavioral science-oriented studies in diabetes and obesity, and as practical tools for clinical and public health-level prevention and management of obesity and diabetes. This FOA will utilize the NIH R41/R42 Small Business Technology Transfer (STTR) Grants - Phase I, Phase II, and Fast-Track award mechanisms. --------------------------------------------------------------- Program Number: 28142 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: Administrative Supplements for Collaborative Science: Opportunities for Existing NIDCR Grants and Cooperative Agreements (Admin Supp) Contact: Tel: Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-159.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 11, 2012. The sponsor will not accept letters of intent under this FOA. The deadlines for receipt of full applications are: June 11, 2012; January 30, 2013; May 30, 2013; January 30, 2014; May 30, 2014, by 5:00 PM local time of applicant organization. This FOA will expire on June 1, 2014. SYNOPSIS: National Institute of Dental and Craniofacial Research (NIDCR) invites applications for Administrative Supplements to NIDCR-funded research projects. These funds are intended to enhance ongoing research by enabling NIDCR-funded researchers to form new collaborations that were not anticipated at the time of submission, review and funding of the NIDCR parent grant. These collaborative activities must be within the scope of the approved aims of the parent award and are expected to provide novel scientific approaches to the research plan for the NIDCR grantee and collaborators. Collaborations that bring together ideas, theories, methods and approaches from disparate scientific disciplines are particularly encouraged, as are those involving individuals from groups that are currently underrepresented in the biomedical and biobehavioral sciences. Additional funds may be awarded as supplements to parent awards using the following Activity Code(s): P01 Research Program Projects; U54 Specialized Center- Cooperative Agreements; R01 Research Project Grant; R37 Method to Extend Research in Time (MERIT) Award; R15 Academic Research Enhancement Award (AREA); and U01 Research Project – Cooperative Agreements. --------------------------------------------------------------- Program Number: 27202 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: National Institute on Minority Health and Health Disparities/NIH/DHHS Title: RFA-MD-12-004--NIMHD Basic and Applied Biomedical Research on Minority Health and Health Disparities (R01) Contact: Nishadi Rajapakse, PhD, MHS Tel: 301-796-4338 Email: chandima.rajapakse@nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-12-004.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 11, 2012. The deadline for receipt of optional letters of intent is May 11, 2012. The deadline for receipt of full applications is June 11, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute on Minority Health and Health Disparities (NIMHD) invites innovative grant applications on: 1. Biological and genetic research to explore disease mechanisms or pathways that influence health outcomes in minority and health disparity populations; and 2. Clinical and translational research linking basic science discovery with effective treatment or clinical practice. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 03814 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: Office of Public Health and Science/DHHS Title: Request for Applications for the HIV/AIDS Prevention and Support Services for Women Partners of Incarcerated/Recently Released Men Contact: Mary L. Bowers Tel: 202-260-0020 Email: mary.bowers@hhs.gov Website:          http://www.grants.gov/search/search.do;jsessionid=vVdwPr7B1QYGfx1Cczh6l2ygVRJTxDQj5FvDw4pc2qG62TBgGz2L!1020059110?oppId=169873&mode=VIEW Full Program:          https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=14378 SYNOPSIS: The Office on Women’s Health announces the anticipated availability of funds for Fiscal Year (FY) 2012 under the authority of 42 U.S.C. 300u-2(a). This notice solicits applications for competing grant awards to serve women partners of incarcerated and or recently released males in geographic areas with high incidence rates of HIV/AIDS. --------------------------------------------------------------- Program Number: 28167 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: Office of Public Health and Science/DHHS Title: Training and Technical Assistance Projects Supported by the Office of Population Affairs and the Division of STD Prevention Contact: Steven J Shapiro Tel: 404-639-8868 Email: sjs4@cdc.gov Website:          http://www.grants.gov/search/search.do?oppId=164153&mode=VIEW Full Program:          https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=14334 SYNOPSIS: This announcement is issued by the Office of Population Affairs (OPA) within the Office of the Assistant Secretary for Health in collaboration with the Division of STD Prevention within the Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (CDC), and seeks applications from public and private nonprofit entities to establish and operate training and technical assistance projects. --------------------------------------------------------------- Program Number: 28629 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: Office of Public Health and Science/DHHS Title: Request for Applications for the In Community Spirit - Prevention of HIV/AIDS for Native/American Indian and Alaska Native Women Living in Rural1 and Frontier Indian Country Program Contact: Mary L. Bowers Tel: 202-260-0020 Email: mary.bowers@hhs.gov Website:          http://www.grants.gov/search/search.do;jsessionid=vVdwPr7B1QYGfx1Cczh6l2ygVRJTxDQj5FvDw4pc2qG62TBgGz2L!1020059110?oppId=169876&mode=VIEW Full Program:          https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=14380 SYNOPSIS: The Office on Women’s Health announces the anticipated availability of funds for Fiscal Year (FY) 2012 cooperative agreement under the authority of 42 U.S.C. 300u-2(a). This notice solicits applications for competing grant awards to serve Native/American Indian and Alaska Native Women Living in Rural and Frontier Indian Country. --------------------------------------------------------------- Program Number: 28630 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: Office of Public Health and Science/DHHS Title: HIV Prevention for Women Living in the U.S. Virgin Islands Contact: Mary L. Bowers Tel: 202-260-0020 Email: mary.bowers@hhs.gov Website:          http://www.grants.gov/search/search.do;jsessionid=vVdwPr7B1QYGfx1Cczh6l2ygVRJTxDQj5FvDw4pc2qG62TBgGz2L!1020059110?oppId=169875&mode=VIEW Full Program:          https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=14379 SYNOPSIS: The Office on Women’s Health announces the anticipated availability of funds for Fiscal Year (FY) 2012 Cooperative Agreement under the authority of 42 U.S.C. 300u-2(a). This notice solicits applications for competing grant awards to serve women living in the U.S. Virgin Islands. --------------------------------------------------------------- Program Number: 51663 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: Independent Scientist Award (K02) Contact: Kay Anderson, Ph.D. Tel: 301-427-1555 Email: Kay.Anderson@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-086.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. NOTE: AHRQ has suspended the submission of individual career development grant applications for the February 12, 2012 application receipt date for new applications and March 12, 2012 receipt date for re-submission applications. SYNOPSIS: The sponsor provides support to foster the development of outstanding health service researchers and enable them to expand their potential to make significant contributions to their field of research. The award provides three, four, or five years of salary support and “protected time” for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Applicants must focus their research careers on areas that would have a significant impact on the quality, safety, efficiency, and effectiveness of health care for all Americans. This program represents the continuation of an AHRQ program. This FOA will utilize the Independent Scientist Award (K02) mechanism. --------------------------------------------------------------- Program Number: 52645 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: AHRQ Mentored Clinical Scientist Research Career Development Award (K08) Contact: Kishena Wadhwani, Ph.D., M.P.H. Tel: 301-427-1556 Email: Kishena.Wadhwani@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-085.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. NOTE: AHRQ has suspended the submission of individual career development grant applications for the February 12, 2012 application receipt date for new applications and March 12, 2012 receipt date for re-submission applications. SYNOPSIS: The sponsor provides support to prepare qualified individuals for careers that have a significant impact on the quality, safety, efficiency, and effectiveness of health care for all Americans. This program represents the continuation of an AHRQ program that provides support and “protected time” to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in health services research. The award can be used both by individuals who propose to newly embark in heath services research training and those who had a hiatus in their research careers because of illness or family circumstances. The award is also available to promote research workforce diversity by providing enhanced research career development opportunities. Candidates interested in pursuing careers in patient-oriented research are eligible to apply for this award at AHRQ. This FOA will utilize the Mentored Clinical Scientist Research Career Development Award (K08) mechanism. --------------------------------------------------------------- Program Number: 94994 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: Mentored Research Scientist Reseach Career Development Award (K01) Contact: Kay Anderson, PhD. Tel: 301-427-1555 Email: Kay.Anderson@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-087.html Deadline Note: This FOA will expire on January 8, 2013. SYNOPSIS: The sponsor provides to help ensure that a diverse pool of highly trained health services researchers are available in adequate numbers and in appropriate research areas to address the mission and priorities of AHRQ. The primary purpose of the AHRQ Mentored Research Scientist Research Career Development Awards (K01) program is to prepare qualified individuals for careers that have a significant impact on the quality, safety, efficiency, and effectiveness of health care for all Americans. This program represents the continuation of an AHRQ program that provides support and “protected time” to individuals with a research doctoral degree for an intensive, supervised research career development experience in health services research. This FOA will utilize the Mentored Research Scientist Research Career Development Award (K01) mechanism. --------------------------------------------------------------- Program Number: 27833 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: Defense Advanced Research Projects Agency Title: RFP -- Biologically-derived Medicines on Demand Contact: Geoffrey Ling Tel: Email: DARPA-BAA-12-37@darpa.mil Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=f4802bc6a78b9da23571344bfbdfe62b&tab=core&_cview=0 SYNOPSIS: A -- BIOLOGICALLY-DERIVED MEDICINES ON DEMAND - DARPA-BAA-12-37 SOLARPA-BAA-12-37 POC Geoffrey Ling, WEB: FBO.gov Permalink https://www.fbo.gov/spg/ODA/DARPA/CMO/DARPA-BAA-12-37/listing.html E-MAIL: DARPA-BAA-12-37@darpa.mil DARPA-BAA-12-37@darpa.mil NAICS: 541712 DARPA-BAA-12-37 The Bio-MOD program seeksto develop devices and techniques to produce multiple protein biologics in response to specific battlefield threats and medical needs. This will be achieved byinvesting in (1) novel, flexible methodologies for genetic engineering/modification of microbial strains, eukaryotic strains, and/or cell-free systems to synthesize multiple protein-based therapeutics; and (2) flexible and portable device platforms for manufacturing multiple biologics with high purity, efficacy and potency at the point-of-care, in short timeframes, when the specific need arises. Consequently, Bio-MOD will provide a battlefield medical supply for military medics at the front lines of support that is responsive to far-forward emergency settings and emergent in-theater needs. See attached DARPA-BAA-12-37. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=f4802bc6a78b9da23571344bfbdfe62b&tab=core&_cview=0 Posted 03/21/12 (W-SN02702151). (0081) --------------------------------------------------------------- Program Number: 26221 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Contact: John O. Ojeifo, MD, PhD, MBA. Tel: 301-496-8589 Email: ojeifojo@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-050.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Cancer Institute (NCI) invites applications for the Mentored Research Scientist Development Award (K01)to provide support and “protected time” (three, four, or five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. This Funding Opportunity Announcement (FOA) will utilize the NIH Mentored Research Scientist Development Award (K01) mechanism. --------------------------------------------------------------- Program Number: 26222 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) Contact: John O. Ojeifo, MD, PhD, MBA. Tel: 301-496-8589 Email: ojeifojo@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-051.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Cancer Institute (NCI) invites applications for the NCI Mentored Clinical Scientist Research Career Development Awards (K08). The primary purpose to support and protected time to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research. This NCI-sponsored K08 award is specifically designed to promote career development of clinical scientists from diverse backgrounds that have been shown to be underrepresented in health-related science and for those who are committed to a career in basic biomedical, behavioral or translational cancer research, including research on cancer health disparities. This Funding Opportunity Announcement (FOA) will utilize the NIH K08 Clinical Investigator Award (CIA) mechanism. --------------------------------------------------------------- Program Number: 26223 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: NCI Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23) Contact: John O. Ojeifo, MD, PhD, MBA. Tel: 301-496-8589 Email: ojeifojo@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-052.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Cancer Institute (NCI) invites applications for the NIH Mentored Patient-Oriented Research Career Development Award (K23). The primary purpose is to support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented cancer research. This Funding Opportunity Announcement (FOA) will utilize the NIH K23 Mentored Patient-Oriented Research Career Development Award mechanism. --------------------------------------------------------------- Program Number: 26228 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: The NCI Transition Career Development Award to Promote Diversity (K22) Contact: Anil Wali, Ph.D. Tel: 301-496-8589 Email: walia@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-062.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Cancer Institute (NCI) invites applications for the National Cancer Institute (NCI) Career Transition Award. The purpose of the award is to help ensure that a diverse pool of highly trained scientists are available in adequate numbers and in appropriate research areas to address the nation's biomedical, behavioral, and clinical research needs. The Diversity Training Branch (DTB), the Center to Reduce Cancer Health Disparities (CRCHD) (http://crchd.cancer.gov/) invites applications from recipients of the NCI Mentored Career Development Award to Promote Diversity, or from advanced postdoctoral and/or newly independent research scientists representative of groups that are underrepresented in biomedical, behavioral, clinical, and/or social sciences. This award will provide "protected time" for recipients to develop and receive support for their initial cancer research program. In addition, this award can provide a two-year mentored experience in NCI intramural programs for interested individuals. This program will use the NIH Transition Career Development Award (K22) mechanism. --------------------------------------------------------------- Program Number: 26296 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: NCI Established Investigator Award in Cancer Prevention and Control (K05) Contact: Shannon M. Lemrow, Ph.D. Tel: 301-496-8580 Email: lemrows@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-065.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The NCI Established Investigator Award (K05) provides qualified cancer prevention, control, behavioral, and/or population scientists with protected time to devote to research and to mentoring new investigators. This FOA will utilize the NIH Senior Scientist Award (K05) mechanism. --------------------------------------------------------------- Program Number: 26358 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) Contact: Susan N. Perkins, Ph.D., Program Director Tel: 301-496-8580 Email: perkinsu@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-067.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Cancer Institute (NCI) invites applications for the Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award. The award is intended to support the career development of junior investigators with research or health professional doctoral degrees who want to become cancer-focused academic researchers in cancer prevention, cancer control, or the behavioral or population sciences. This FOA will utilize the NIH Academic Career Award (K07) mechanism. --------------------------------------------------------------- Program Number: 27879 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: NHLBI Career Transition Award (K22) Contact: Herbert M. Geller, Ph.D. Tel: 301-451-9440 Email: direducation@nhlbi.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-137.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 7, 2015. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) provides highly qualified postdoctoral fellows with an opportunity to receive mentored research experience in the NHLBI Division of Intramural Research and then to provide them with bridge funding to facilitate the transition of their research programs as new investigators at extramural institutions. This Funding Opportunity Announcement (FOA) will utilize the NIH Career Transition Award (K22) mechanism. --------------------------------------------------------------- Program Number: 79555 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute for Occupational Safety & Health/CDC/DHHS Title: Mentored Research Scientist Development Award (K01) Contact: Mary Pat Shanahan Tel: 412-386-4453 Email: LKumar@cdc.gov Website:          http://www.grants.gov/search/search.do?oppId=53346&mode=VIEW Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-132.html Deadline Note: This FOA will expire on May 8, 2013. SYNOPSIS: The sponsor invites grant applications for research career development related to occupational safety and health. The goal of the NIOSH research program is to support research that is relevant and of high quality, and that will have an impact in reducing occupational disease and injury. This program is intended to contribute to this goal by facilitating the preparation of the next generation of occupational safety and health researchers and educators. Emphasis for funding is placed on projects that specifically address the priority goals of the NIOSH National Occupational Research Agenda (NORA) which is described at http://www.cdc.gov/niosh/programs/. This industrial sector-based agenda has been developed to focus resources on priority problems that significantly impact the illness and injury burden on United States (US) workers. Research training supported by this announcement may include a wide range of training modalities reflecting the diverse approaches needed to effectively address occupational safety and health problems effectively. --------------------------------------------------------------- Program Number: 28133 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: NIAID Career Transition Award (K22) Contact: Katrin Eichelberg, PhD Tel: 301-496-0818 Email: keichelberg@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-156.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2012. SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) provides support for the NIAID Research Scholar Development Award (RSDA) , which is intendedto increase and maintain a strong cohort of new and talented NIH-supported independent investigators that will address the health needs of the Nation. The NIAID RSDA is specifically designed to facilitate the transition from a postdoctoral research position to an independent research position. This Funding Opportunity Announcement (FOA) will utilize the NIH Career Transition Award (K22) mechanism. --------------------------------------------------------------- Program Number: 20953 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS Title: Mentored Patient-Oriented Research Career Development Award in Muscular Dystrophy Research (K23) Contact: Amanda Taylor Boyce, Ph.D. Tel: 301-594-5055 Email: boycea@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-076.html Deadline Note: This FOA will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications for mentored career development awards for clinical scientist engaged in patient-oriented research (POR). It is expected that this career development program will increase the number of investigators in basic, translational, and clinical research on muscular dystrophy, and will also increase the quality of their research and training. Diseases for this program announcement include, but are not limited to, Duchenne, myotonic, facioscapulohumeral, and congenital muscular dystrophies. This FOA will utilize the K23 grant mechanism. --------------------------------------------------------------- Program Number: 20960 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS Title: Mentored Clinical Scientist Research Career Development Award in Muscular Dystrophy Research (K08) Contact: Amanda Taylor Boyce, Ph.D. Tel: 301-594-5055 Email: boycea@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-077.html Deadline Note: This FOA will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications for mentored career development awards for clinical scientist engaged in laboratory research. It is expected that this career development program will increase the number of investigators in basic, translational, and clinical research on muscular dystrophy, and will also increase the quality of their research and training. Diseases for this program announcement include, but are not limited to, Duchenne, myotonic, facioscapulohumeral, and congenital muscular dystrophies. This FOA will utilize the K08 grant mechanism. --------------------------------------------------------------- Program Number: 20963 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS Title: NIH Pathway to Independence Award in Muscular Dystrophy Research (K99/R00) Contact: Amanda Taylor Boyce, Ph.D. Tel: 301-594-5055 Email: boycea@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-078.html Deadline Note: This FOA will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications for mentored career development awards for clinical scientist engaged in laboratory research. It is expected that this career development program will increase the number of investigators in basic, translational, and clinical research on muscular dystrophy, and will also increase the quality of their research and training. Diseases for this program announcement include, but are not limited to, Duchenne, myotonic, facioscapulohumeral, and congenital muscular dystrophies. This FOA will utilize the K99 grant mechanism. --------------------------------------------------------------- Program Number: 04623 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: NIDCR Dentist Scientist Pathway to Independence Award (K99/R00) Contact: Leslie A. Frieden, Ph.D. Tel: 301-496-4263 Email: friedenla!mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-256.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications for the Pathway to Independence Award (K99/R00). The primary purpose of the Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented NIH-supported independent investigators. The program is designed to facilitate a timely transition from a mentored postdoctoral research position to a stable independent research position with independent NIH or other independent research support at an earlier stage than is currently the norm. This Funding Opportunity Announcement (FOA) will utilize the NIH Pathway to Independence Award (K99/R00) mechanism. --------------------------------------------------------------- Program Number: 24883 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22) Contact: James E. Melvin, DDS, PhD Tel: 301-402-1706 Email: james.melvin@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-004.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012. Applications may be submitted to Grants.gov in response to this announcement on or after . The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The sponsor invites applications for the NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22) program. The program is designed is to provide highly-qualified dentists in NIH Intramural postdoctoral fellowship positions with an opportunity to receive further mentored research experience in the NIH Intramural program, and then to provide them with independent funding to facilitate the transition of their research programs as new investigators at extramural institutions. To achieve these objectives, the NIDCR Dentist Scientist Career Transition Award for Intramural Investigators will support two phases of research: a mentored intramural phase of up to two years, and an independent extramural phase of up to three years. Transition from the intramural phase of support to the extramural phase is not automatic. Approval of the transition will be based on the success of the awardee’s research program as determined by an NIDCR progress review, which will include an evaluation of a research plan to be carried out at the extramural institution. This FOA will utilize the NIH K22 Career Transition Award mechanism. --------------------------------------------------------------- Program Number: 93747 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute of Environmental Health Sciences/NIH/DHHS Title: Short Term Career Development Award in the Environmental Health Sciences for Established Investigators (K18) Contact: Carol Shreffler, Ph.D. Tel: 919-541-1445 Email: shreffl1@niehs.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-090.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides funding for short term career development awards to allow established, well funded clinician investigators to expand research programs to answer questions relevant to the environmental health sciences, and to provide established environmental health sciences research investigators the tools to expand their efforts to translational research. This FOA will utilize the NIH Career Enhancement Award (K18) mechanism. --------------------------------------------------------------- Program Number: 04518 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: NIMH Career Transition Award for Intramural Investigators (K22) Contact: Tel: Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-246.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides up to three years of support to career intramural investigators at NIMH who aim to transition from the Division of Intramural Research Programs (DIRP) to a research position in the extramural community. Principal investigators will have a demonstrated record of meritorious research in mental health-related fields. This Funding Opportunity Announcement (FOA) will utilize the NIH Career Transition (K22) award mechanism. --------------------------------------------------------------- Program Number: 28010 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) Contact: Michelle D. Jones-London, Ph.D., Program Director Tel: 301-451-7966 Email: jonesmiche@ninds.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-152.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program expires on May 8, 2015. SYNOPSIS: National Institute of Neurological Disorders and Stroke (NINDS) provides the Career Development Award to Promote Diversity in Neuroscience Research to provide junior faculty support and protected time (up to three years) for an intensive, supervised career development experience in neuroscience research. This Funding Opportunity Announcement (FOA) will utilize the NIH Mentored Research Scientist Development Award (K01) mechanism. --------------------------------------------------------------- Program Number: 28166 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22) Contact: Michelle Jones-London, Ph.D. Tel: 301-451-7966 Email: jonesmiche@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-163.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12, annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute of Neurological Disorders and Stroke (NINDS) invites applications for the NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity. This opportunity provides individuals from diverse backgrounds with strong training in neuroscience with the resources and tools that will help facilitate a transition to a stable and productive independent research position. Individuals from diverse backgrounds underrepresented in neuroscience research are eligible for support under this award if they have doctoral research degrees (Ph.D., P.h.D./M.D. or equivalent) and between 2 and 5 years of postdoctoral research experience at the time of application. The primary objectives of this Funding Opportunity Announcement (FOA) are to: (1) assist talented underrepresented scientists to transition from postdoctoral training to a secure, independent research position and (2) enhance the conditions that promote establishing a strong and innovative independent program of research. This FOA will utilize the NIH K22 Career Transition Award mechanism. --------------------------------------------------------------- Program Number: 01250 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Senior Scientist Research Award (K05) Contact: Gary J. Murray, Ph.D. Tel: 301-443-9940 Email: gary.murray@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-148.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute on Alcohol Abuse and Alcoholism (NIAAA) and National Institute on Drug Abuse (NIDA) invite applications for the Senior Scientist Research Award. The award is intended to provide protected time for outstanding senior scientists who have demonstrated a sustained high level of productivity conducting biomedical research relevant to the scientific mission of the appropriate institute to focus on their research and to provide mentoring of new investigators. This program will use the NIH Research Scientist Award mechanism. --------------------------------------------------------------- Program Number: 10134 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: NIDCD Research Career Enhancement Award for Established Investigators (K18) Contact: Daniel A. Sklare, Ph.D. Tel: 301-496-1804 Email: skalred@nidcd.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-150.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications for the NIDCD Research Career Enhancement Award for Established Investigators (K18) program, which is designed to enable established, proven investigators to augment or redirect their research programs through the acquisition of new research skills to answer questions relevant to the hearing, balance, smell, taste, voice, speech and language sciences. This FOA will utilize the NIH Career Enhancement Award (K18) mechanism. --------------------------------------------------------------- Program Number: 10483 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: NIDCD Research Career Enhancement Award for Established Investigators (K18) Contact: Daniel A. Sklare, Ph.D. Tel: 301-496-1804 Email: skalred@nidcd.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-162.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications for the NIDCD Research Career Enhancement Award for Established Investigators (K18) program to enable established, proven investigators to augment or redirect their research programs through the acquisition of new research skills to answer questions relevant to the hearing, balance, smell, taste, voice, speech and language sciences. This FOA will utilize the NIH Career Enhancement Award (K18) mechanism. --------------------------------------------------------------- Program Number: 19244 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) Contact: Debra Grossman, M.A. Tel: 301-443-2249 Email: dgrossman@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-177.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications for institutional research career development (K12) programs that propose to support intensive supervised research training and career development experiences for clinician scientists (scholars) leading to research independence in the area of drug abuse and addiction. Candidates selected for support as scholars must hold a clinical or research doctorate and can commit a minimum of 9 person-months (equivalent to 75% of full-time professional effort) conducting clinical research and career development activities associated with the proposed program. This FOA will use the NIH Institutional Research Career Development K12 grant mechanism. --------------------------------------------------------------- Program Number: 05945 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institutes of Health/DHHS Title: Academic Career Award (Parent K07) Contact: Tel: Email: grantinfo@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-192.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 12, 2011. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The purpose of the NIH Academic Career Award is to provide support to increase the pool of individuals with academic and research expertise to become academic researchers and to enhance the educational or research capacity at the grantee sponsoring grantee institution. The Academic Career Award supports Development awards for more junior level candidates and Leadership awards for more senior individuals with acknowledged scientific expertise and leadership skills. This program will use the NIH K07 award mechanism. --------------------------------------------------------------- Program Number: 07877 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institutes of Health/DHHS Title: Mentored Clinical Scientist Research Career Development Award (Parent K08) Contact: Tel: 301-496-8580 Email: grantinfo@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-193.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 8, 2011. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors offer support for Mentored Clinical Scientist Research Career Development Awards, to support didactic study and mentored research for individuals with clinical doctoral degrees (e.g., M.D., D.D.S., D.M.D., D.O., D.C., O.D., N.D., D.V.M., Pharm.D., or Ph.D. in clinical disciplines). This award provides support and “protected time” for an intensive, supervised research career development experience in the fields of biomedical or behavioral research, including translational research. This program will use the Mentored Clinical Scientist Research Career Development Award (K08). --------------------------------------------------------------- Program Number: 21056 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institutes of Health/DHHS Title: Mentored Patient-Oriented Research Career Development Award (Parent K23) Contact: Tel: Email: grantinfo@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-194.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 8, 2011. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor provides support for the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented research. This PA will use the NIH Mentored Patient-Oriented Research Career Development Award (K23) mechanism. --------------------------------------------------------------- Program Number: 21218 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institutes of Health/DHHS Title: Midcareer Investigator Award in Patient-Oriented Research (Parent K24) Contact: Lester Gorelic, Ph.D. Tel: 301-496-8580 Email: gorelicl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-195.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor provides support to mid-career health-professional doctorates or equivalent who are typically at the Associate Professor level or the equivalent for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty. This FOA will utilize the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) mechanism. --------------------------------------------------------------- Program Number: 21903 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institutes of Health/DHHS Title: Mentored Research Scientist Development Award (Parent K01) Contact: Tel: Email: grantsinfo@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-190.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors provide support for career development programs to ensure that diverse pools of highly trained scientists are available in adequate numbers and in appropriate research areas to address the Nation's biomedical, behavioral and clinical research needs. The Mentored Research Scientist Development Award provides support and "protected time" (three, four or five years) for an intensive, supervised career development experience in the biomedical, behavioral or clinical sciences, leading to research independence. This FOA will use the NIH K01 award mechanism. --------------------------------------------------------------- Program Number: 21906 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institutes of Health/DHHS Title: Independent Scientist Award (Parent K02) Contact: Tel: Email: grantinfo@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-191.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 12, 2011. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor provides support for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. This FOA will utilize the NIH Independent Scientist Award (K02) mechanism. --------------------------------------------------------------- Program Number: 21909 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institutes of Health/DHHS Title: Mentored Quantitative Research Development Award (Parent K25) Contact: Tel: Email: grantinfo@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-196.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 8, 2011. The deadlines for receipt of standard applications are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor provides support for the Mentored Quantitative Research Career Development Award (K25), to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. This FOA will utilize the Mentored Quantitative Research Development Award (K25) mechanism. --------------------------------------------------------------- Program Number: 21911 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institutes of Health/DHHS Title: NIH Pathway to Independence Award (Parent K99/R00) Contact: Tel: Email: grantinfo@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-197.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors offer support for the Pathway to Independence (PI) Award program, which is designed to increase and maintain a strong cohort of new and talented NIH-supported independent investigators. The award program is designed to facilitate a timely transition from a mentored postdoctoral research position to a stable independent research position with independent NIH or other independent research support at an earlier stage than is currently the norm. This program will use the NIH combination K99/R00 funding mechanism. --------------------------------------------------------------- Program Number: 12571 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Library of Medicine/NIH/DHHS Title: NLM Independent Career Development Award for Biomedical Informatics (K22) Contact: Dr. Hua-Chuan Sim Tel: 301-594-4882 Email: simh@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-195.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications for the NLM Independent Career Development Award for Biomedical Informatics (K22) program, which is designed to facilitate the transition of investigators from the mentored to the independent stage of their careers by providing "protected time" for newly independent investigators to develop and receive support for their initial research programs. The award applies to biomedical informaticians who are pursuing research in clinical informatics, public health informatics or translational informatics. Preference will be given to candidates who received their informatics training at one of NLM’s university-based training programs in biomedical informatics. This FOA will utilize the NIH Career Transition Award (K22) mechanism. --------------------------------------------------------------- Program Number: 25798 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: Office of Research Infrastructure Programs/NIH/DHHS Title: Midcareer Investigator Award in Mouse Pathobiology and Comprehensive Phenotyping Research (K26) Contact: Oleg Mirochnitchenko, Ph.D. Tel: 301-435-0744 Email: oleg.mirochnitchenko@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-021.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Center for Research Resources (NCRR) invites applications for the Midcareer Investigator Award in Mouse Pathobiology and Comprehensive Phenotyping Research Award. The NCCR seeks to support established, outstanding scientists by providing protected time for mouse pathobiology research and comprehensive phenotyping of genetically modified mice as well as mentoring of junior investigators, thus relieving them of time-consuming institutional service obligations and administrative responsibilities. This FOA will utilize the NIH K26 Midcareer Investigator Award in Biomedical and Behavioral Research. --------------------------------------------------------------- Program Number: 25547 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: Office of Science/Department of Energy Title: Community Sequencing Program - Quarterly Microbial Proposals Contact: Jim Bristow Tel: 925-296-5609 Website:          http://www.jgi.doe.gov/CSP/index.html Full Program:          http://www.jgi.doe.gov/CSP/user_guide/propschedule.html Deadline Note: Proposals for microbial isolates and resequencing proposals (<10 isolates) are accepted on a continuous basis and will be reviewed every quarter. Letters of intent are not required. Deadline for submission is 30 days prior to the review date. SYNOPSIS: The Community Sequencing Program (CSP) was created to provide the scientific community at large with access to high-throughput sequencing at the Department of Energy Joint Genome Institute (JGI) for projects of relevance to DOE missions. Sequencing projects will be chosen based on scientific merit--judged through independent peer review--and relevance to issues in global carbon cycling, alternative energy production, and biogeochemistry. --------------------------------------------------------------- Program Number: 28614 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: Substance Abuse & Mental Health Services Administration Title: National Child Traumatic Stress Initiative- Category III Community Treatment and Services Centers (CTS) Contact: Gwendolyn Simpson Tel: 240-276-1408 Email: gwendolyn.simpson@samhsa.hhs.gov Website:          http://www.samhsa.gov/grants/2012/sm_12_007.aspx Full Program:          http://www.grants.gov/search/search.do?oppId=169713&mode=VIEW The Substance Abuse and Mental Health Services Administration, Center for Mental Health Services (CMHS) is accepting applications for fiscal year (FY) 2012 National Child Traumatic Stress Initiative (NCTSI), Category III, Community Treatment and Services Center grants. The purpose of this program is to provide trauma treatment and services in communities for children, adolescents and their families who experience or witness traumatic events; and to increase access to effective trauma-focused treatment and services for children and adolescents throughout the nation. --------------------------------------------------------------- Program Number: 27919 --------------------------------------------------------------- ***Deadlines: 6/13/2012 Sponsor: Directorate for Biological Sciences/NSF Title: Core Techniques and Technologies for Advancing Big Data Science & Engineering (BIGDATA) Contact: Vasant G. Honavar Tel: 703-292-7129 Email: vhonavar@nsf.gov Full Program:          http://www.nsf.gov/pubs/2012/nsf12499/nsf12499.htm Deadline Note: Deadlines are as follows: June 13, 2012 -- Mid-Scale Projects; and July 11, 2012 -- Small Projects. SYNOPSIS: The Core Techniques and Technologies for Advancing Big Data Science & Engineering (BIGDATA) solicitation aims to advance the core scientific and technological means of managing, analyzing, visualizing, and extracting useful information from large, diverse, distributed and heterogeneous data sets so as to: accelerate the progress of scientific discovery and innovation; lead to new fields of inquiry that would not otherwise be possible; encourage the development of new data analytic tools and algorithms; facilitate scalable, accessible, and sustainable data infrastructure; increase understanding of human and social processes and interactions; and promote economic growth and improved health and quality of life. The new knowledge, tools, practices, and infrastructures produced will enable breakthrough discoveries and innovation in science, engineering, medicine, commerce, education, and national security-laying the foundations for US competitiveness for many decades to come. --------------------------------------------------------------- Program Number: 27972 --------------------------------------------------------------- ***Deadlines: 6/13/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: RFA-HL-13-017--Core Clinical Centers for the Cardiothoracic Surgical Trials Network, CTSN (UM1) Contact: Marissa A. Miller, D.V.M., M.P.H. Tel: 301-594-1542 Email: millerma2@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-017.html Deadline Note: The deadline for receipt of optional letters of intent is May 13, 2012. The deadline for receipt of full applications is June 13, 2012. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) and Institute of Circulatory and Respiratory Health (ICRH/CIHR) invite applications for participation as a Core Clinical Center in a continuation of the Cardiothoracic Surgical Trials Network (CTSN). Highly innovative approaches to patient recruitment and retention for challenging cardiothoracic (CT) surgical trials, as well as a strong track record of prior trial performance, are sought. The goal of the CTSN is to evaluate CT surgical interventions and related management approaches for the treatment of cardiovascular disease and conditions in adult patients. The network provides support to maintain an infrastructure to develop, coordinate, and conduct multiple collaborative surgical trials designed to improve cardiovascular outcomes and optimize post-operative neurological function. This program will use the NIH UM1 Multi-Component Research Project Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 27976 --------------------------------------------------------------- ***Deadlines: 6/13/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: RFA-HL-13-022--Limited Competition: Data Coordinating Center for Cardiothoracic Surgical Trials Network (CTSN) (U01) Contact: Marissa A. Miller, D.V.M., M.P.H. Tel: 301-594-1542 Email: millerma2@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-022.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 13, 2012. The sponsor will not accept letters of intent under this FOA. The deadline for receipt of full applications is June 13, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) and National Institute of Neurological Disorders and Stroke (NINDS) invite applications to support the Data Coordinating Center (DCC) for the Cardiothoracic Surgical Trials Network (CTSN). The goal of the CTSN is to evaluate CT surgical interventions and related management approaches for the treatment of cardiovascular disease and conditions in adult patients. The network provides support to maintain an infrastructure to develop, coordinate, and conduct multiple collaborative surgical trials designed to improve cardiovascular outcomes and optimize post-operative neurological function. This program will use the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 28025 --------------------------------------------------------------- ***Deadlines: 6/13/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: RFA-HL-13-011--Limited Competition: NHLBI Research Centers at Minority Serving Institutions - Phase II (P50) Contact: Dina N. Paltoo, Ph.D., M.P.H. Tel: 31-435-00513 Email: paltood@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-011.html Deadline Note: The deadline for receipt of optional letters of intent is May 13, 2012. The deadline for receipt of standard full applications is June 13, 2012. The deadline for receipt of full AIDS-related applications is September 7, 2012. This program will expire on September 8, 2012. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) announces a limited competition to solicit applications from investigators funded under Phase I of the NHLBI Research Centers at Minority-Serving Institutions program. http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-11-019.html The purpose is to establish research centers to augment and strengthen research capabilities and resources in biomedical and behavioral research related to heart, lung, and blood diseases and disorders, with the ultimate goal to increase diversity in the biomedical and behavioral research enterprise. The program is intended to occur in two phases: Phase I (the recruitment/retention phase and establishment of the External Advisory Board, 2 years) and Phase II (the development of the research program and research operations, 5 years). This FOA is intended to support Phase II only, and is dependent upon the success from Phase I. This FOA will utilize the NIH P50 Specialized Center award mechanism. --------------------------------------------------------------- Program Number: 27305 --------------------------------------------------------------- ***Deadlines: 6/13/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: RFA-AI-12-020--Partnerships for Interventions to Treat Chronic, Persistent and Latent Infections (R21/R33) Contact: Christopher Beisel, Ph.D. Tel: 301-496-7453 Email: cbeisel@niaid.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-020.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after June 13, 2012. The deadline for receipt of optional letters of intent is June 13, 2012. The deadline for receipt of full applications is July 13, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) invites applications for basic and early-stage translational research focused on development of novel intervention strategies to clear persistent, chronic or latent infectious agents from the host. Responsive applications will define and address a therapeutic need specific to a targeted pathogen. This program will use the NIH R21/R33 Phased Innovation Award grant mechanism. --------------------------------------------------------------- Program Number: 55833 --------------------------------------------------------------- ***Deadlines: 6/13/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: HIV Vaccine Research and Design (HIVRAD) Program (P01) Contact: Alan M Schultz, Ph.D. Tel: 301-594-2518 Email: schultzam@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-087.html Deadline Note: The deadline for receipt of optional letters of intent is May 13 annually. The corresponding deadline for receipt of full applications is June 13 annually. This program will expire on July 14, 2014. SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) invites applications for the HIV Vaccine Research and Design (HIVRAD) Program, a multi-component, multi-disciplinary projects that address important scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive modeling of vaccine concepts in non-human primates may be included. The NIH Program Project (P01) mechanism will be used. --------------------------------------------------------------- Program Number: 01721 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: Bureau of Justice Assistance/Department of Justice Title: Adult Drug Court Planning, Training, Technical Assistance, and Resource Center Initiatives Contact: Tel: 877–927–5657 Email: JIC@telesishq.com Website:          http://www.grants.gov/search/search.do;jsessionid=JBs5PZXbq8nc6QbTy4W9vLcjJgdqFNklTnn9Zdqs9nTgkpNC8hZG!482729280?oppId=166413&mode=VIEW Full Program:          https://www.bja.gov/Funding/12DrugCourtTTAsol.pdf SYNOPSIS: The purpose of the Adult Drug Court Discretionary Grant Program is to provide financial and technical assistance to states, state courts, local courts, units of local government, and Indian tribal governments to develop and implement drug courts that effectively integrate evidenced-based substance abuse treatment, mandatory drug testing, sanctions and incentives, and transitional services in a judicially supervised court setting with jurisdiction over substance-abusing offenders. Selected providers under this solicitation will support the Adult Drug Court Discretionary Grant Program grantees as well as the adult drug court field-at-large. BJA is seeking providers for the following five categories of activities: 1. Delivery of population-specific drug court planning training (adult, veterans, and tribal). 2. Delivery of a menu of 22 approved onsite and online adult drug court curricula. 3. Provision of jurisdictional or site-specific technical assistance. 4. Provision of state-based technical assistance. 5. Management of the National Drug Court Resource Center. Providers selected for all five categories are expected to participate as part of a drug court TTA collaborative to assist state, tribal, and local justice system officials and treatment professionals to implement evidence-based drug court practices. --------------------------------------------------------------- Program Number: 27683 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: Centers for Medicare and Medicaid Services/DHHS Title: Initiative to Reduce Avoidable Hospitalizations among Nursing Facility Residents Contact: Melissa Seeley Tel: 212-616-2329 Email: Melissa.Seeley@cms.hhs.gov Website:          http://www.grants.gov/search/search.do;jsessionid=S5gwPj6TtZR2k1P9ZmJTfzVJxGb5R2vSphpdxKntB5G1RcKVf3Qm!-916096435?oppId=153873&mode=VIEW Full Program:          http://apply07.grants.gov/apply/opportunities/instructions/oppCMS-1E1-12-002-cfda93.621-cidCMS-1E1-12-002-014033-instructions.pdf Deadline Note: Potential applicants must submit a non-binding Notice of Intent to Apply by April 30, 2012 in order to be eligible for a funding award. All applications are due by June 14, 2012. SYNOPSIS: The purpose of this funding opportunity announcement is to solicit applications for participation as “enhanced care & coordination providers” in the Initiative to Reduce Avoidable Hospitalizations among Nursing Facility Residents. Under this Initiative, the Centers for Medicare & Medicaid Services (CMS) will select eligible organizations to test a series of evidence-based clinical interventions. The goal of these interventions is to improve the health and health care among nursing facility residents and ultimately reduce avoidable inpatient hospital admissions. --------------------------------------------------------------- Program Number: 87490 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Centers for AIDS Research and Developmental Centers for AIDS Research (P30) Contact: Ann Namkung Lee, M.P.H. Tel: 301-496-9176 Email: an107z@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-108.html Deadline Note: The deadlines for receipt of optional letters of intent are: May 13, 2011, May 14, 2012 and May 14, 2013. The corresponding deadlines for receipt of full applications are: June 14, 2011, June 14, 2012 and June 14, 2013 , by 5:00 PM local time of applicant organization. This program will expire on June 15, 2013. SYNOPSIS: The sponsors invite applications for Center Core grants (P30) to support Centers for AIDS Research as either standard CFARs (CFAR) or Developmental CFARs (D-CFAR). CFAR and D-CFAR cores provide infrastructure and promote basic, clinical, behavioral and translational HIV/AIDS research activities at institutions that receive significant HIV/AIDS funding from NIH Institutes or Centers. CFARs and D-CFARs can foster synergy and improve coordination of research, support emerging research opportunities, and promote efficiencies through resources shared by multiple independent laboratories. CFARs and D-CFARs are intended to promote all HIV/AIDS research efforts at CFAR institutions. D-CFARs provide support to assist investigators in the development of a competitive standard CFAR. This FOA will utilize the NIH Center Core Grants (P30) assistance mechanism. --------------------------------------------------------------- Program Number: 26017 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Prevention and Treatment of Obesity, Diabetes, and Chronic Kidney Disease in Military Populations (R01) Contact: Christine M. Hunter, Ph.D. Tel: 301-594-4728 Email: ch514c@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-048.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 14, 2012 . The deadlines for receipt of optional letters of intent are: January 14, 2012; May 14, 2012; September 15, 2012; January 14, 2013; May 14, 2013; September 11, 2013; January 14, 2014; May 13, 2014; September, 2014. The deadlines for receipt of full applications are: February 14, 2012; June 14, 2012; October 15, 2012; February 14, 2013; June 14, 2013; October 11, 2013; February 14, 2014; June 13, 2014; October 15, 2014, by 5:00 PM local time of applicant organization. This program will expire on October 16, 2014. SYNOPSIS: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications on prevention and treatment of obesity, diabetes, and chronic kidney disease in military personnel (active duty and retired) and their families. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27447 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: RFA-GM-13-004--Collaborations for Macromolecular Interactions in Cells (R01) Contact: James F. Deatherage, Ph.D. Tel: 301-594-0828 Email: deatherj@nigms.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-GM-13-004.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 14, 2012. The deadline for receipt of optional letters of intent is May 14, 2012. The deadline for receipt of full applications is June 14, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute of General Medical Sciences (NIGMS) invites applications for inter-disciplinary collaborative projects to advance studies of macromolecular interactions and their relationship to function in cells. These collaborations are designed to integrate additional research strategies into NIGMS' research base of laboratories specializing in macromolecular function in living systems. Grantees may use this funding opportunity to (i) complement each other's capabilities (for example, in biochemistry, genetics, chemistry, or pharmacology), where the innovation is in the biology rather than in the technology; (ii) apply proven technologies that are technically challenging, expensive, or not yet widely used in cell biology and allied fields (for example, mass spectrometry, high-throughput screening); (iii) develop, pilot, evaluate, and/or apply emerging technologies (for example, superresolution light microscopy); (iv) carry out feasibility studies or upstream research and development of new technological concepts that are unproven, but potentially useful for study of macromolecular interactions. This FOA invites unconventional research strategies, including exploratory, descriptive, and statistical approaches, and encourages discovery and hypothesis generation as research objectives. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27449 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: RFA-GM-13-005--Research Networks for Macromolecular Interactions in Cells (U54) Contact: James F. Deatherage, Ph.D. Tel: 301-594-0828 Email: deatherj@nigms.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-GM-13-005.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 14, 2012. The deadline for receipt of optional letters of intent is May 14, 2012. The deadline for receipt of full applications is June 14, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute of General Medical Sciences (NIGMS) invites applications for iinter-disciplinary collaborative research networks to advance studies of macromolecular interactions and their relationship to function in cells. These networks are designed to integrate additional research strategies into NIGMS' research base of laboratories specializing in macromolecular function in living systems. Invetigators may use this funding opportunity to (i) complement each other's capabilities (for example, in biochemistry, genetics, chemistry, or pharmacology), where the innovation is in the biology rather than in the technology; (ii) apply proven technologies that are technically challenging, expensive, or not yet widely used in cell biology and allied fields (for example, mass spectrometry, high-throughput screening); (iii) develop, pilot, evaluate, and/or apply emerging technologies (for example, superresolution light microscopy); (iv) carry out feasibility studies or upstream research and development of new technological concepts that are unproven, but potentially useful for study of macromolecular interactions. This FOA invites unconventional research strategies, including exploratory, descriptive, and statistical approaches, and encourages discovery and hypothesis generation as research objectives. This FOA will use the NIH U54 Specialized Center- Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 09589 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: Office of Postsecondary Education/Department of Education Title: Fulbright-Hays Doctoral Dissertation Research Abroad (DDRA) Fellowship Program Contact: Amy Wilson Tel: 202-502-7689 Email: ddra@ed.gov Website:          http://www.gpo.gov/fdsys/pkg/FR-2012-05-15/pdf/2012-11681.pdf Full Program:          http://www07.grants.gov/search/search.do?&mode=VIEW&oppId=170796 SYNOPSIS: The Fulbright-Hays DDRA Fellowship Program provides opportunities to doctoral candidates to engage in full-time dissertation research abroad in modern foreign languages and area studies. The program is designed to contribute to the development and improvement of the study of modern foreign languages and area studies in the United States. --------------------------------------------------------------- Program Number: 28587 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Bureau of Health Professions/HRSA/DHHS Title: Mental and Behavioral Health Education and Training Grants Program Contact: Sadie Silcott Tel: 301-443-0133 Email: ssilcott@hrsa.gov Website:          http://www.grants.gov/search/search.do;jsessionid=rF1cPpWGVqy2WD9Fy0qlGqSp83hJCQcLnXJTMd4BQwL8Cp1MhpTn!917914427?oppId=168854&mode=VIEW Full Program:          https://grants.hrsa.gov/webExternal/FundingOppDetails.asp?FundingCycleId=4ADFE828-290C-46A0-88CF-3A0D6F5BC827&ViewMode=EU&GoBack=&PrintMode=&OnlineAvailabilityFlag=&pageNumber=&version=&NC=&Popup= SYNOPSIS: The Mental and Behavioral Health Education and Training Grants (MBHETG) Program aims to increase the number of social workers and psychologists who pursue clinical work with high need and high demand populations. For this funding opportunity, high need and high demand refers to rural, vulnerable, and/or underserved populations, and veterans, military personnel and their families. --------------------------------------------------------------- Program Number: 28135 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Center for Global Health/CDC/DHHS Title: Advancing the Control and Elimination of Neglected Tropical Diseases Contact: Hoang Dang, Project Officer Tel: 404-718-4785 Email: HDang@cdc.gov Full Program:          http://www.grants.gov/search/search.do;jsessionid=pvnTPFTTZj62yzxnpQp4s5pxQj1CH6WQgyCKBsTVhCSWWcTkjzGy!545677704?oppId=163393&mode=VIEW SYNOPSIS: Center for Global Health invites applications to: (1) promote and strengthen NTD control and elimination efforts, (2) support the scale up and scale down of national NTD programs through technical assistance, and (3) improve monitoring and evaluation (M&E) tools for measuring program impact and performance of national NTD programs. A total of approximately $1,750,000 is available. --------------------------------------------------------------- Program Number: 27922 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Centers for Disease Control and Prevention/DHHS Title: RFP -- Clinical Immunization Safety Assessment (CISA) Contact: Jeff A Miller Tel: 770-488-2651 Email: afx2@cdc.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=746bc22f703754b88f3eb30c137d210c&tab=core&_cview=0 SYNOPSIS: B -- CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) SOL 2012-N-14296POC Jeff A Miller, Phone: 770-488-2651, Nancy M. Norton, Phone: 770-488-2056 WEB: FBO.gov Permalink https://www.fbo.gov/spg/HHS/CDCP/PGOA/2012-N-14296/listing.html E-MAIL: afx2@cdc.gov, ftg8@cdc.gov afx2@cdc.gov, ftg8@cdc.gov NAICS: 621399Contractor shall provide all labor, supervision, equipment, materials, supplies, travel, transportation, and perform all work necessary to provide public health, scientific, and technical services in support of advancing vaccine safety activities or what is commonly known as Clinical Immunization Safety Assessment (CISA), as specifically required by individual task orders awarded under the resulting contract. The two (2) main requirements for this CISA project include: 1. Clinical case reviews and evaluation of vaccine safety issues, and coordination activities to support this function. 2. Research studies to advance knowledge of vaccine safety and inform clinical and public health practice. This contract willbe awarded for a base year and will include four (4) one (1) year option periods. RFP 2012-N-14296 will be posted in FedBizOpps on or about May 14, 2012. Full and open competition will be used in soliciting offers for this requirement. This requirement is not set-aside for small business. USG anticipates making more than one (1) award (multiple awards). All responsible sources may submit a proposal, which shall be considered by the agency. The scheduled proposal due date will be approximately thirty (30) days after the posting of the solicitation. Any amendments or attachments issued to the solicitation will also be made at the same website. A draft Statement of Work (SOW) and four (4) draft task orders which are anticipated to be issued with the solicitation will be issued in FedBizOpps by April 2, 2012. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=746bc22f703754b88f3eb30c137d210c&tab=core&_cview=0 Posted 03/28/12 (W-SN02707719). (0088) --------------------------------------------------------------- Program Number: 28190 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Health Resources and Services Administration/DHHS Title: RFP -AMENDMENT - Stem Cell Therapeutic Outcomes Database Contact: Greg Ribovich, Contract Specialist Tel: 301-443-4175 Email: gribovich@hrsa.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=69f6685094899d98a39ef817ad04c7b4&tab=core&_cview=0 SYNOPSIS: R -- STEM CELL THERAPEUTIC OUTCOMES DATABASE SOL 12HSB63-SOL-GR POCreg Ribovich, Phone: 301-443-4175, Francis R Murphy, Phone: (301) 443-5165 POP5600 Fishers Lane, Rockville, Maryland, 20857, United States 20857 WEB: FBO.govPermalink https://www.fbo.gov/notices/69f6685094899d98a39ef817ad04c7b4 E-MAIL: gribovich@hrsa.gov, fmurphy@hrsa.gov gribovich@hrsa.gov, fmurphy@hrsa.gov NAICS:541990 The Health Resources and Services Administration (HRSA) will be soliciting proposals to establish and operate a Stem Cell Therapeutic Outcomes Database,one component of the C.W. Bill Young Cell Transplantation Program (Program). The government is seeking proposals from organizations with the capability to collect and maintain information related to patients who have received stem cell therapeutic products in a standardized electronic format. This includes informationthat is necessary to conduct an ongoing evaluation of the scientific and clinical status of transplantation involving recipients of a stem cell therapeutic product from a donor. The organization should also have the capability to: 1) prepare and submit an annual report on patient outcomes at each transplant center and, 2) make scientific information available to the public in the form of summaries and data sets. The scope of data collection under this contract will include: 1. allogeneic transplantation for hematopoietic reconstitution using cells from donors not related to the patient; 2. allogeneic transplantation for hematopoietic reconstitution using cells from donors who are related to the patient; and, 3. emerging clinical applications of cells derived from bone marrow, peripheral blood, and umbilical cord blood. The period of performance will be a one-year base, and four one-year options. These services are defined under NAICS code 541990. It is anticipated that a Cost Reimbursement type contract will result from this requirement. This acquisition is being conducted under Full and Open competition. The solicitation will be posted on or about May 1, 2012. It will be available at this website as an attachment to this announcement (www.fbo.gov under HHS, Health Resources and Services Administration). It is the offeror's responsibility to monitor the site for amendments to the solicitation. The agency will consider proposals from all responsible sources. Should you have any questions contactGreg Ribovich, Contract Specialist, Phone 301-443-4175, Fax 301-443-5462, Emailgribovich@hrsa.gov. Please indicate the solicitation number and title in all communications. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=69f6685094899d98a39ef817ad04c7b4&tab=core&_cview=0 Posted 04/13/12 (W-SN02721821). (0104) --------------------------------------------------------------- Program Number: 28191 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Health Resources and Services Administration/DHHS Title: RFP -- Cord Blood Coordinating Center Contact: Greg Ribovich, Contract Specialist Tel: 301-443-4175 Email: gribovich@hrsa.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=239c142347956b879711c399f85768ca&tab=core&_cview=0 SYNOPSIS: R -- CORD BLOOD COORDINATING CENTER SOL 12HSB65-SOL-GR POC Greg Riboich, Phone: 301-443-4175, Francis R Murphy, Phone: (301) 443-5165 POP 5600 Fishers Lane, Rockville, Maryland, 20857, United States 20857 WEB: FBO.gov Permalink https://www.fbo.gov/notices/239c142347956b879711c399f85768ca E-MAIL: gribovich@hrsa.gov, fmurphy@hrsa.gov gribovich@hrsa.gov, fmurphy@hrsa.gov NAICS: 541611 The Health Resources and Services Administration (HRSA) will be soliciting proposals to establish and operate a Cord Blood Coordinating Center, one component of the C.W. Bill Young Cell Transplantation Program (Program). The government is seeking proposals from organizations with the capability to collaborate with cord blood banks and the Office of Patient Advocacy/Single Point of Access for the Program to identify and make available, through a single point of access, information on cord blood units suitably matched for unrelated donor transplantation. Other responsibilities include the ability to: 1) Establish a system for identifying, matching, and facilitating the distribution of donated cord blood units thatare suitably matched to candidate patients. In so doing, provide standardized information describing available cord blood units to the Program's Single Point of Access; 2) Facilitate tissue typing and infectious disease marker testing of cord blood units; 3) Facilitate the collection, verification, and analyses of outcome data from unrelated cord blood transplants and make these data available inthe public domain; 4) Support and expand new and existing studies and demonstration and outreach projects for the purpose of increasing cord blood unit donation and collection; and 5) Provide information to physicians, other health care professionals, and the public regarding cord blood transplants from donors as a treatment option. It is anticipated that an award resulting from this solicitationwill have a period of performance of one-year base, and four one-year options. These services are defined under NAICS code 541611. It is anticipated that a Cost Sharing type contract will result from this requirement. This acquisition is being conducted under Full and Open competition. The solicitation will be posted on or about May 1, 2012. It will be available at this website as an attachment to this announcement (www.fbo.gov under HHS, Health Resources and Services Administration). It is the offeror's responsibility to monitor the site for amendmentsto the solicitation. The agency will consider proposals from all responsible sources. Should you have any questions contact Greg Ribovich, Contract Specialist,Phone 301-443-4175, Fax 301-443-5462, Email gribovich@hrsa.gov. Please indicatethe solicitation number and title in all communications. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=239c142347956b879711c399f85768ca&tab=core&_cview=0 Posted 04/13/12 (W-SN02721854). (0104) --------------------------------------------------------------- Program Number: 28346 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Maternal and Child Health Bureau/HRSA/DHHS Title: Maternal and Child Health Doctoral Training Program Contact: Jessica R. Jones, MPH Tel: 301-443-0872 Email: jjones2@hrsa.gov Website:          http://www.grants.gov/search/search.do;jsessionid=JPp9PYbBsf2yJWjrCz9htyp5JX02Q3XV33bTt7bypLfxpQK32XTJ!482729280?oppId=166633&mode=VIEW Full Program:          https://grants.hrsa.gov/webExternal/FundingOppDetails.asp?FundingCycleId=90EE70FD-5E4E-461A-976D-73C3C0CB1F3C&ViewMode=EU&GoBack=&PrintMode=&OnlineAvailabilityFlag=&pageNumber=&version=&NC=&Popup= SYNOPSIS: The purpose of this funding opportunity is to solicit applications for the Maternal and Child Health (MCH) Doctoral Training Program. This program meets the Maternal and Child Health Bureau (MCHB) goals of training the MCH workforce, and especially to enhance the epidemiologic capacity for assessment, planning, and delivery of health services to the MCH population. The Office of Epidemiology and Research (OER) is continuing support of this training grant under the Special Projects of Regional and National Significance (SPRANS) grant. Grants to institutions of higher learning will support doctoral students who elect a relevant MCH applied epidemiologic analysis as the basis for their research and dissertation, utilizing program information and data from a state, county, or city department of health. Of particular interest is to improve the science of evaluating health care by refining, augmenting, collecting, and analyzing both traditional (disease and intervention) measures and measures of overall maternal and child well-being (measures of health-related quality of life). --------------------------------------------------------------- Program Number: 08665 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Strategic Partnering to Evaluate Cancer Signatures [SPECS II] (U01) Contact: Tracy Lively, Ph.D. Tel: 301-496-1591 Email: livelyt@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-151.html Deadline Note: The deadline for receipt of optional letters of intent is May 15 annually. The deadline for receipt of full applications is June 15 annually. This FOA will expire on June 16, 2012. SYNOPSIS: The sponsor invites applications for support of the clinical application of multi-analyte molecular signatures derived from comprehensive molecular annotation of tumors. There is growing recognition in the clinical cancer research community that annotation of tumor specimens with data that integrates information about molecular alterations at the levels of DNA, RNA, and protein provides not only a more complete understanding of tumor biology but also provides a significant opportunity for developing new clinical tools to improve cancer treatment. Translating the knowledge gained from this molecular annotation into tools that can be used in clinical decision-making remains a major challenge. The purpose of this initiative is to build on recent demonstrations that molecular signatures correlate with important clinical parameters in cancer. The goal of this initiative is also to create publications and data sets that will be available and accessible to the scientific community in order to further the development, design, and conduct of future clinical trials (e.g., incorporation of molecular signatures into future clinical trials and large clinical validation studies) and to encourage appropriate commercialization to benefit the public health. The NCI invites investigators to form strategic partnerships that will bring together the multi-disciplinary expertise and resources needed to determine how the information derived from comprehensive molecular analyses can be used to improve patient care and, ultimately, patient outcomes. This FOA will utilize the NIH U01 cooperative agreement mechanism. --------------------------------------------------------------- Program Number: 28144 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: National Center for Complementary and Alternative Medicine/NIH/DHHS Title: Collaborative Activities to Promote Research on Integrative Approaches to Symptom Management in Military Populations (Administrative Supplement) Contact: Kristen Huntley, Ph.D. Tel: 301-594-9346 Email: huntleyk@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-160.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 15, 2012. The sponsor will not accept letters of intent under this FOA. The deadline for receipt of full applications is June 15, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Center for Complementary and Alternative Medicine (NCCAM) nnounces the availability of one-year administrative supplements for NCCAM-funded grantees to stimulate collaborations for research on integrative approaches to pain and symptom management in military populations. The proposed activities must be within the scope of the peer-reviewed activities specified within the NIH parent award. Additional funds may be awarded as supplements to parent awards using the following Activity Code(s): P01 Research Program Projects; R01 Research Project Grant; R34 Clinical Trial Planning Grant Program; U01 Research Project – Cooperative Agreements; and U19 Research Program – Cooperative Agreements. --------------------------------------------------------------- Program Number: 28378 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Title: Enhancing HIV Mobilization among Organizations Serving Gay, Bisexual and other Men Who Have Sex with Men Contact: Sophia Minor, Project Officer Tel: 404-639-4622 Email: HIT9@cdc.gov Full Program:          http://www07.grants.gov/search/search.do;jsessionid=bVGyPhGdjQc0JHtDynJy13PwRcQq5VGgWNyrXqQ2zsRvJHD1pnt4!712472910?oppId=167773&mode=VIEW SYNOPSIS: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) invites applications to enhance HIV mobilization among organizations serving gay, bisexual and other men who have sex with men. --------------------------------------------------------------- Program Number: 28440 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: National Center for Immunization and Respiratory Diseases/CDC/DHHS Title: Increasing Adult Immunization Rates through Healthcare Provider Partnerships Contact: Susan Farrall, Project Officer Tel: 404-639-8852 Email: sfarrall@cdc.gov Full Program:          http://www.grants.gov/search/search.do;jsessionid=Z4WbPh3KgFYPYMTGL0yfT5Q4FSGXC0SQ0hvlSQ2Pn5nhqwh2cbjF!-253887325?oppId=168714&mode=VIEW SYNOPSIS: National Center for Immunization and Respiratory Diseases invites applications to develop and implement programs designed to increase adult immunization rates through healthcare provider partnerships. The aim is to bring about measurable increases in the number of providers assessing vaccination needs for their patients and recommending vaccination for their patients. A total of approximately $1,575,000 is available. --------------------------------------------------------------- Program Number: 28441 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: National Center for Immunization and Respiratory Diseases/CDC/DHHS Title: Increasing Adolescent Immunization Rates through Healthcare Provider Partnerships Contact: Susan Farrall, Project Officer Tel: 404-639-8852 Email: sfarrall@cdc.gov Full Program:          http://www07.grants.gov/search/search.do;jsessionid=Wtk2Pp4H3dMvytLTm6fGdx2Y5RGLRsnnmyyk80vxQgz0dhyHhptc!-668392920?oppId=168713&mode=VIEW SYNOPSIS: National Center for Immunization and Respiratory Diseases invites applications develop and implement programs designed to increase adolescent immunization rates through healthcare provider partnerships. The intent of this Funding Opportunity Announcement (FOA) is to solicit applications from healthcare provider groups to provide strong effective actions designed to increase adolescent immunization rates. A total of approximately $1,575,000 is available. --------------------------------------------------------------- Program Number: 12262 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: National Institute of Food and Agriculture/Department of Agriculture Title: Farm Business Management and Benchmarking Competitive Grants Program Contact: Susan S. Shockey, Ph.D Tel: 202-690-2674 Email: sshockey@nifa.usda.gov Website:          http://www.nifa.usda.gov/funding/rfas/pdfs/12_fbmb.pdf Full Program:          http://www07.grants.gov/search/search.do;jsessionid=tJ8TPyTH1v1SQy7bLbsVDJHbQ3P48fbRfq224R9M3wL3Gng66V0x!-668392920?oppId=169153&mode=VIEW SYNOPSIS: NIFA announces the availability of grant funds and requests applications for the Farm Business Management and Benchmarking (FBMB) Competitive Grants Program for fiscal year (FY) 2012 to improve the farm management knowledge and skills of agricultural producers; and maintain a national, publicly available farm financial management database to support improved farm management. The amount available for support of this program in FY 2012 is approximately $1.3 million. --------------------------------------------------------------- Program Number: 11334 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: AHRQ Small Research Grant Program (R03) Contact: Lia Hotchkiss, M.P.H. Tel: 301-427-1620 Email: Lia.Hotchkiss@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-168.html Deadline Note: This FOA will expire on March 17, 2014. SYNOPSIS: The sponsor encourages Small Research Grant (R03) applications, and expresses AHRQ portfolio priority areas of interest for ongoing small research projects. The R03 grant mechanism supports different types of health services research projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and, development of new research technology. --------------------------------------------------------------- Program Number: 99421 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: Small Research Grant to Improve Health Care Quality through Health Information Technology (IT) (R03) Contact: Angela Lavanderos Tel: 301-427-1505 Email: Angela.Lavanderos@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-08-268.html Deadline Note: This program will expire on November 17, 2012. SYNOPSIS: The sponsor provides support for a wide variety of research designs in order to improve the quality, safety, effectiveness, and efficiency of health care through the implementation and use of health IT. These designs include: small pilot and feasibility or self-contained health IT research projects; secondary data analysis of health IT research; and economic (prospective or retrospective) analyses of health IT implementation and use. Through economic analyses estimates of health IT implementation and use costs and benefits will be generated. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 99425 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: Exploraratory and Developmental Grant to Improve Health Care Quality through Health Information Technology (IT) (R21) Contact: Angela Lavanderos Tel: 301-427-1505 Email: Angela.Lavanderos@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-08-269.html Deadline Note: This program will expire on November 17, 2012. SYNOPSIS: The sponsor provides support for short-term preparatory, pilot or feasibility studies that will inform larger scale real world health IT implementation and use or the conduct of more comprehensive health IT implementation research. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 02626 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Biomarkers for Early Detection of Hematopoiietic Malignancies (R21) Contact: Lynn Sorbara, Ph.D. Tel: 301-435-0584 Email: lynns@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-198.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites research grant applications from institutions/organizations for the development and validation of biomarkers for: a) early detection, prediction of progression, and recurrence of hematopoietic malignancies, especially in high-risk individuals; and, b) for risk assessment of primary and secondary hematopoietic malignancies. This FOA is also encourages the development and improvement of specific technologies and methods for quantitative detection of novel biomarkers associated with hematopoietic malignancies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 02628 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Identifying Non-coding RNA Targets for Cancer Early Detection and Prevention (R21) Contact: Wendy Wang, Ph.D., M.Sc. Tel: 301-594-7607 Email: wangw@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-200.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications from institutions/organizations on the discovery and characterization of non-coding (nc) RNAs in preneoplasias and early stage cancers to: 1) improve early cancer detection, intervention, and prevention; 2) predict risk of progression from preneoplasia to cancer, and 3) distinguish benign lesions from precancerous lesions. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 04214 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Diet, Epigenetic Events, and Cancer Prevention (R21) Contact: Sharon A. Ross, PH.D., M.P.H. Tel: 301-594-7547 Email: rosssha@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-235.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications for clinical and preclinical research to determine how diet and dietary factors, including dietary supplements, impact DNA methylation, histone posttranslational modification, noncoding RNA, and other epigenetic processes involved in cancer prevention and development. Another important aim of this FOA is to encourage collaborations between nutrition and epigenetic experts to study bioactive food components with cancer-preventative properties and to examine key epigenetic events in cancer processes (e.g., carcinogen metabolism, cell division, differentiation, and apoptosis) in order to begin to establish linkages between epigenetics, methylation patterns, and tumor incidences/behaviors. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 05827 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Obesity Policy Research: Evaluation and Meaures (R21) Contact: Robin McKinnon, Ph.D., MPA Tel: 301-594-3599 Email: mckinnonr@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-028.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications that propose to: (1) conduct evaluation research on obesity-related “natural experiments” (defined here as community and other population-level public policy interventions that may affect diet and physical activity behavior), and/or (2) develop and/or validate relevant community-level measures (instruments and methodologies to assess the food and physical activity environments at the community level). The overarching goal of this FOA is to inform public policy and research relevant to (1) diet and physical activity behavior, and (2) weight and health outcomes of Americans. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 05832 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Obesity Policy Research: Evaluation and Meaures (R03) Contact: Robin McKinnon, Ph.D., MPA Tel: 301-594-3599 Email: mckinnonr@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-029.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications that propose to: (1) conduct evaluation research on obesity-related “natural experiments” (defined here as community and other population-level public policy interventions that may affect diet and physical activity behavior), and/or (2) develop and/or validate relevant community-level measures (instruments and methodologies to assess the food and physical activity environments at the community level). The overarching goal of this FOA is to inform public policy and research relevant to (1) diet and physical activity behavior, and (2) weight and health outcomes of Americans. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 05914 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Epigenetic Approaches in Cancer Epidemiology (R21) Contact: Mukesh Verma, Ph.D., M.P.H. Tel: 301-594-7344 Email: vermam@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-032.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites research applications that propose to evaluate profiles of methylation, histone modifications and micro RNA (miRNA) and their association with risk of developing cancer in different populations. The overarching goal of this FOA is to provide support for population based studies to define the role of epigenetic markers (methylation, histone and micro RNA profiles) changes to understand cancer etiology. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 07216 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Research On Ethical Issues In Human Subjects Research (R03) Contact: Ann Hardy Tel: 301-435-2690 Email: hardyan@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-181.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications that propose to study high priority bioethical challenges and issues associated with the types of biomedical, social, and behavioral research supported by the participating NIH Institutes/Centers. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this FOA. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 10518 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Research On Ethical Issues In Human Subjects Research (R21) Contact: Ann Hardy Tel: 301-435-2690 Email: hardyan@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-182.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications that propose to study high priority bioethical challenges and issues associated with the types of biomedical, social, and behavioral research supported by the participating NIH Institutes/Centers. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this FOA. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 12299 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R03) Contact: Vickie L. Shavers, Ph.D. Tel: 301-594-1725 Email: shaversv@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-164.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor offers support for research to: improve the measurement of racial /ethnic discrimination in health care delivery systems through improved instrumentation, data collection and statistical/analytical techniques; enhance understanding of the influence of racial/ethnic discrimination in health care delivery and its association with disparities in disease incidence, treatment and outcomes among disadvantaged racial/ethnic minority groups; and reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination on health care delivery systems in the United States. program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 16444 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Biomarkers of Infection-Associated Cancers (R21) Contact: Karl Krueger, Ph.D. Tel: 301-435-1594 Email: kruegerk@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-159.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor offers support for research proposals focused on identifying protein biomarkers for cancers where etiology of the disease is attributed to infectious agents. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 20894 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R21) Contact: Mukesh Verma, Ph.D. Tel: 301-594-7344 Email: vermam@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-074.html Deadline Note: The deadlines for receipt of standard R21 applications under this announcement are: June 16, October 16, and February 16 annually. The deadlines for AIDS and AIDS-related applications are: May 7, September 7, and January 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose to develop and validate new mitochondrial-related biomarkers for cancer early detection, diagnosis, prognosis, risk assessment, and response to preventive and ameliorative treatments. This program will use the NIH Research Project (R21) award mechanism. --------------------------------------------------------------- Program Number: 20999 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R21) Contact: Young S. Kim, Ph.D. Tel: 301-496-0126 Email: yk47s@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-161.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications for research efforts aimed at establishing the physiological significance of dietary components in modulating the tumoricidal cell activity of natural killer (NK) cells for cancer prevention. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 21407 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R21) Contact: Vickie L. Shavers, Ph.D. Tel: 301-594-1725 Email: shaversv@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-163.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor offers support for research to: improve the measurement of racial /ethnic discrimination in health care delivery systems through improved instrumentation, data collection and statistical/analytical techniques; enhance understanding of the influence of racial/ethnic discrimination in health care delivery and its association with disparities in disease incidence, treatment and outcomes among disadvantaged racial/ethnic minority groups; and reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination on health care delivery systems in the United States. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23225 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Spatial Uncertainty: Data, Modeling, and Communication (R21) Contact: Li Zhu, Ph.D. Tel: 301-594-6546 Email: li.zhu@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-239.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invites applications for innovative research that identifies sources of spatial uncertainty (i.e., inaccuracy or instability of spatial or geographic information) in public health data, incorporates the inaccuracy or instability into statistical methods, and develops novel tools to visualize the nature and consequences of spatial uncertainty. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23226 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Spatial Uncertainty: Data, Modeling, and Communication (R03) Contact: Li Zhu, Ph.D. Tel: 301-594-6546 Email: li.zhu@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-240.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invites applications for innovative research that identifies sources of spatial uncertainty (i.e., inaccuracy or instability of spatial or geographic information) in public health data, incorporates the inaccuracy or instability into statistical methods, and develops novel tools to visualize the nature and consequences of spatial uncertainty. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 24009 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Pilot Studies in Pancreatic Cancer (R21) Contact: Mukesh Verma, Ph.D. Tel: 301-594-7344 Email: vermam@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-297.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The sponsor invites applications that propose to promote innovative research across multiple disciplines for a better understanding of the biology, etiology, detection, prevention, and treatment of pancreatic cancer. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24013 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Pilot studies in Pancreatic Cancer (R03) Contact: Mukesh Verma, Ph.D. Tel: 301-594-7344 Email: vermam@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-298.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The sponsor invites applications that propose to promote innovative research across multiple disciplines for a better understanding of the biology, etiology, detection, prevention, and treatment of pancreatic cancer. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 26622 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Biomechanisms of Peripheral Nerve Damage by Anti-Cancer Therapy (R21) Contact: Joanna M. Brell, M.D. Tel: 301-496-8541 Email: brelljm@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-083.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadline for receipt of optional letters of intent is May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institutes of Health (NIH) invites basic biologic research on damage to the peripheral nervous system instigated by pharmacologic cancer treatments, known as chemotherapy-induced peripheral neuropathy (CIPN). The majority of acquired peripheral neuropathy research has focused on diabetic and inherited diseases; this FOA intends to stimulate neuroscience researchers to apply their expertise from studying these other neuropathies to the injuries incurred by cancer treatments. More data is necessary to understand the mechanisms of neuronal damage and to identify the targets instrumental to CIPN initiation and maintenance. Preclinical research that focuses not only on peripheral neuropathic pain but also on neurosensory symptoms such as paresthesias and peripheral anesthesias is invited. The ultimate goal of this FOA is to lead to a molecular understanding of CIPN that allows for the rational development of interventions that will treat or prevent CIPN. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 27983 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: NCI Small Grants Program for Cancer Research (NCI Omnibus R03) Contact: Tel: Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-144.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2015. SYNOPSIS: National Cancer Institute (NCI) invites applications for small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 27984 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21) Contact: Tel: Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-145.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2015. SYNOPSIS: National Cancer Institute (NCI) invites applications fdevelopment of new research activities in all areas of cancer research. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical). This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 77733 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Exfoliated Cells and Circulating DNA in Cancer Detection and Diagnosis (R21) Contact: Lynn Sorbara, Ph.D. Tel: 301-435-0584 Email: lynns@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-238.html Deadline Note: This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides support for the development of novel technologies for capturing, enriching, and preserving exfoliated abnormal cells from body fluids or effusions as well as methods for concentrating the tumor-derived sub-cellular material for use in biomarker studies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 87105 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Improving Diet and Physical Activity Assessment (R21) Contact: Amy Subar, Ph.D. Tel: 301-594-0831 Email: subara@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-225.html Deadline Note: The deadlines for receipt of optional letters of intent for new standard applications are: January 16, 2011 (passed); September 16, 2011; May 16, 2012. The corresponding deadlines for receipt of full (new) applications are: February 16, 2011; October 16, 2011; June 16, 2012. This program will expire on September 8, 2012 SYNOPSIS: The sponsors provide support for innovative research to enhance the quality of measurements of dietary intake and physical activity. Applications may include development of: novel assessment approaches; better methods to evaluate instruments; assessment tools for culturally diverse populations across various age-groups including children and older adults; improved technology or applications of existing technology; statistical methods to assess or correct for measurement errors or biases, methods to investigate the multidimensionality of diet and physical activity behavior through pattern analysis; or integrated measurement of diet and physical activity along with the environmental context of such behaviors. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 87502 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials (R21) Contact: Magdalena Thurin, Ph.D. Tel: 301-496-1591 Email: thurinm@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-014.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI) encourages the submission of Research Project Grant (R01) applications from institutions and organizations to validate the clinical utility of new molecular diagnostics for determining prognosis or predicting response to therapy or toxicity for cancer. The Cancer Diagnosis Program (CDP) and the Cancer Therapy Evaluation Program (CTEP) at the NCI are cooperatively sponsoring this FOA with the purpose to transition of candidate biomarkers from initial correlative observations into diagnostics that are suitable for use in clinical trials to assess the clinical validity of a marker. This program will support research projects to improve clinical decision-making in the care of cancer patients and as such will support studies that use tumor specimens linked to specific treatment and clinical outcome information. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 89221 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Nanoscience and Nanotechnology in Biology and Medicine (R21) Contact: Piotr Grodzinski Tel: Email: grodzinp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-149.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications that apply nanoscience and nanotechnology approaches to address problems in biology and medicine. The purpose of this FOA is to provide support for cutting-edge nanoscience and nanotechnology research that can lead to biomedical breakthroughs and new investigations into the diagnosis, treatment and management of an array of diseases and traumatic injuries. Nanoscience and nanotechnology have the capacity to drive a new wave of medical innovation through the engineering of bioactive nanoscale structures, processes and systems based on the advancement of our understanding of biology at the nanoscale. Therefore, this FOA will also support research projects that develop new or improved nanotechnology and nanoscience-based tools, methods, concepts, and devices that lead to a better understanding of basic biology in addition to conducting translational biomedical studies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 90711 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Understanding and Promoting Health Literacy (R21) Contact: Erica Breslau, Ph.D. Tel: 301-435-2839 Email: breslaue@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-135.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors offer support for empirical research on health literacy concepts, theory and interventions as these relate to the U.S. Department of Health and Human Services’ public health priorities that are outlined in its HealthierUS and Healthy People 2010 initiatives. Health literacy is defined as the degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 90713 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Understanding and Promoting Health Literacy (R03) Contact: Erica Breslau, Ph.D. Tel: 301-435-2839 Email: breslaue@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-134.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors offer support for empirical research on health literacy concepts, theory and interventions as these relate to the U.S. Department of Health and Human Services’ public health priorities that are outlined in its HealthierUS and Healthy People 2010 initiatives. Health literacy is defined as the degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 90756 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) Contact: Andrew N Freedman, Ph.D. Tel: 301-435-6819 Email: freedmaa@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-026.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites research applications from clinicians, epidemiologists, geneticists, statisticians, and translational researchers working in the field of cancer control and prevention to improve existing models for cancer risk and prognosis by developing innovative research projects that use existing data; develop new models for cancer risk and prognosis; and validate new models and evaluate their utility in research and clinic settings. To explore this opportunity, the NCI Division of Cancer Control and Population Sciences (DCCPS) and the Division of Cancer Treatment and Diagnosis (DCTD) encourage applications for research projects to develop, apply, and evaluate new and existing cancer risk and prognostic prediction models for use by researchers, clinicians, and the general public. This FOA is designed to provide a mechanism of support for investigators to address two major challenges in model development, which are: integrating diverse types of data (e.g., clinical, demographic, pathologic, environmental, epidemiologic, outcomes, and genetic data from varied data marts or warehouses); and ensuring adequate validation (i.e., using multiple separate populations to define sensitivity, specificity, and positive and negative predictive values). This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 92792 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Exploratory Cancer Prevention Studies Involving Molecular Targets for Bioactive Food Components (R21) Contact: Young S. Kim, Ph.D. Tel: 301-496-0126 Email: yk47s@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-088.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications for exploratory research on the role of nutrition in cancer prevention. Specifically, this FOA seeks to promote cancer prevention research to identify and characterize molecular targets for bioactive food components. For the purpose of this FOA, a bioactive food component is defined as a dietary constituent that has a health benefit by altering one or more cellular processes when provided in quantities over and beyond that needed for basic nutrition. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 99326 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21) Contact: James V. Tricoli, Ph.D. Tel: 301-496-1591 Email: tricolij@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-08-267.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides support for applications from institutions and organizations that are interested in developing and testing innovative methods in cancer detection, diagnosis, and prognosis. The NCI is especially interested in research studies that focus on the development and testing of improved methods for detecting specific characteristics of cancer, which can be subsequently used for the clinical management of cancer patients or individuals who are at risk for (developing) cancer. It is important that research studies focus on the search for molecular and cellular differences between tumors, pre-malignant, or normal tissues. The studies should determine the clinical translational significance of these differences by correlation with clinical parameters, in order to answer clinical problems related to detection, diagnosis, treatment, and prognosis. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 07174 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Center for Complementary and Alternative Medicine/NIH/DHHS Title: Preliminary Clinical Studies in Preparation for Large Interventional Trials of Complementary and Alternative Medicine (CAM) Therapies (R34) Contact: Wendy Weber, ND, PhD, MPH Tel: 301-402-1272 Email: weberwj@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-163.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications early phase clinical research and development on high priority CAM interventions. This mechanism is intended to support the development of methodology and the preliminary data needed for planning and design of subsequent, larger randomized clinical trials, cluster randomized trials or cohort studies. This mechanism is not appropriate for support of randomized clinical trials to test or determine efficacy. It is appropriate for development of preliminary studies that will contribute to the design of either efficacy or real-world effectiveness studies. This FOA will utilize the R34 grant mechanism. --------------------------------------------------------------- Program Number: 87574 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Center for Complementary and Alternative Medicine/NIH/DHHS Title: Biology of Manual Therapies (R21) Contact: Partap Khalsa, D.C., Ph.D., D.A.B.C.O., Program Officer Tel: 301-594-3462 Email: khalsap@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-210.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invites applications that propose to investigate the basic science and mechanisms of action underlying the biomechanical, immunological, endocrinological and/or neurophysiological consequences of manual therapies, such as spinal manipulation, mobilization and massage therapy. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 00883 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Eye Institute/NIH/DHHS Title: NEI Clinical Study Planning Grant Program (R34) Contact: Donald F. Everett, M.A. Tel: 301-451-2020 Email: dfe@nei.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-017.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications for large-scale clinical vision research projects, including randomized clinical trials and epidemiologic studies. At the time of submission, applications requesting support for these activities are expected to provide detailed information regarding the study’s rationale, design, analytic techniques, protocols and procedures, facilities and environment, organizational structure, and collaborative arrangements. This information is best conveyed in a well-documented Manual of Procedures (MOP), the development of which represents a costly and time-consuming activity. The Clinical Study Planning Grant is designed to facilitate activities central to the refinement of a study’s protocol and procedures and the development of a detailed MOP. The NEI Clinical Study Planning Grant may be used to support the development of a MOP, as well as to conduct preliminary studies to refine study procedures and/or assess recruitment potential. The Clinical Study Planning Grant is applicable to both epidemiologic and clinical trial research studies. This FOA will utilize the Clinical Study Planning Grant Program for Clinical Trials (R34) mechanism. --------------------------------------------------------------- Program Number: 06863 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Eye Institute/NIH/DHHS Title: NEI Research Grants for Secondary Data Analysis (R21) Contact: Natalie Kurinji, Ph.D. Tel: 301-451-2020 Email: kurinijn@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-252.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications from institutions/organizations that propose to conduct secondary data analyses utilizing existing database resources. Applications may be related to, but must be distinct from, the specific aims of the original data collection. The NEI supports an extensive portfolio of clinical trials and large-scale epidemiologic research projects, wherein numerous data collection activities are required to meet each project’s specific aims. The resultant wealth of data generated by these studies often provides unique, cost-effective opportunities to investigate additional research questions or develop new analytical approaches secondary to a project’s originally intended purpose. Data are not limited to that collected under NEI support but these data are of highest programmatic interest. The R21 may be used to develop new statistical methodologies or to test hypotheses using existing data. Applicants should consider the relevance of their proposed analyses to NEI programs and priorities as described in the “National Plan for Eye and Vision Research” available at http://www.nei.nih.gov. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 04736 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Nutrition and Physical Activity Research to Promote Cardiovascular and Pulmonary Health (R21) Contact: Catherine Loria, Ph.D. Tel: 301-435-0702 Email: loriac@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-244.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications that propose research on the roles of nutrition and physical activity in the development, prevention, and management of cardiovascular diseases (CVD) or pulmonary diseases. In particular, the FOA aims to (1) improve knowledge of the contribution of diet and physical activity to these conditions and how sleep influences these relationships, (2) increase the evidence base for refining public health recommendations and clinical guidelines regarding these lifestyle behaviors, and (3) develop and test strategies to improve the adoption of these recommendations. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 05193 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: NHLBI Clinical Trial Pilot Studies (R34) Contact: David J. Gordon, M.D., Ph.D. Tel: 301-435-0564 Email: gordond@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-005.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications proposing pilot studies to obtain data that is critical for the design of robust clinical trials. This Funding Opportunity Announcement (FOA) should be used to fill gaps in scientific knowledge necessary to develop a competitive full-scale clinical trial. Appropriate pilot studies might demonstrate feasibility of an intervention or an experimental design, estimate intervention parameters, or gather other data important for the design of a trial. Applications must demonstrate that the proposed pilot studies are both necessary and sufficient to permit the design of the clinical trial. During the evaluation of applications in response to this FOA, the review group will also consider the significance and potential public health impact of the full-scale clinical trial that would be proposed following the R34 award period. The NHLBI anticipates that the R34 award period will yield more competitive investigator-initiated clinical trial grant applications and more robust and successful clinical trials that evaluate interventions for the treatment or prevention of heart, lung, blood, or sleep disorders. This FOA will utilize the R34 grant mechanism. --------------------------------------------------------------- Program Number: 08320 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R21) Contact: Abby G. Ershow, Sc. D., FAHA Tel: 301-435-0550 Email: ershowa@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-212.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites exploratory/developmental research applications that capitalize on the unique capabilities of Virtual Reality (VR) technologies to visualize outcomes, teach, motivate, and to extend the health care and learning environments, in order to foster desirable eating, physical activity, self-care, and other health-related behaviors necessary for prevention and management of obesity and diabetes. Of highest interest are well-designed multidisciplinary projects drawing on expertise in VR technologies and biomedical behavioral, and pedagogical sciences. The overall goal is to develop the potential of VR technologies as research tools for behavioral science-oriented studies in diabetes and obesity, and as practical tools for clinical and public health-level prevention and management of obesity and diabetes. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 82113 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Directed Stem Cell Differentiation for Cell-Based Therapies for Heart, Lung, and Blood Diseases (R21) Contact: John W. Thomas, Ph.D. Tel: 301-435-0065 Email: ThomasJ@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-248.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications that propose to define the factors and mechanisms controlling the differentiation of embryonic or adult stem or progenitor cells, either in vitro or in vivo. It is designed to stimulate new scientific advances in stem cell differentiation including technology research that may not be hypothesis driven. The long range goal of this program is the development of methods to direct the differentiation or development of stem cells along specific cell lineages to yield replacement cells for clinical use, whether the replacement cells are formed in vitro for delivery or formed in vivo in the tissue or organ environment. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23663 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: Ethical, Legal, and Social Implications (ELSI) of Genomic Research Exploratory/Developmental Research Grant Award (R21) Contact: Dr. Jean E. McEwen Tel: 301-402-4997 Email: jean.mcewen@nih.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-251.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. These applications should propose exploratory or novel studies that break new ground or extend previous discoveries toward new directions or applications. Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 58251 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: Ethical, Legal, and Social Implications (ELSI) of Genomic Research Small Research Grant Program (R03) Contact: Dr. Jean E. McEwen Tel: 301-402-4997 Email: jean.mcewen@nih.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-249.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications to study the ethical, legal and social implications (ELSI) of human genome research. These applications should be for small, self-contained research projects. Of particular interest are projects that propose focused legal, economic, philosophical or historical analyses of new or emerging issues. This FOA will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 77653 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute for Occupational Safety & Health/CDC/DHHS Title: NIOSH Exploratory and/or Developmental Grant Program (R21) Contact: Maryann Monroe Tel: 412-386-4453 Email: MPMonroe@cdc.gov Website:          http://www07.grants.gov/search/search.do?oppId=46756&mode=VIEW Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-139.html Deadline Note: This program expires September 8, 2012 SYNOPSIS: The sponsor provides support for research related to occupational safety and health. Eligible applicants are domestic and foreign for-profit or non-profit organizations, public or private institutions, such as universities, colleges, hospitals, and laboratories, units of state and local governments, eligible agencies of the federal government, faith-based or community based organizations, and Indian Tribes, Tribal Government, and/or Organizations. The R21 award mechanism will be used. --------------------------------------------------------------- Program Number: 88007 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute for Occupational Safety & Health/CDC/DHHS Title: NIOSH Small Research Grant Program (R03) Contact: Susan B. Board, M.S., Scientific Program Officer Tel: 404-498-2530 Email: sboard@cdc.gov Website:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-138.html Full Program:          http://www07.grants.gov/search/search.do?oppId=46753&mode=VIEW Deadline Note: This FOA will expire on September 8, 2012. SYNOPSIS: The sponsor provides support for projects designed to develop an understanding of the risks and conditions that are associated with occupational diseases and injuries, to explore methods for reducing risks and for preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. This FOA will utilize the NIH Small Research Grant (R03) award mechanism, --------------------------------------------------------------- Program Number: 25971 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Research to Advance Vaccine Safety (R01) Contact: Barbara Mulach, Ph.D. Tel: 301-496-1884 Email: bmulach@niaid.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-038.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) invites studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems, or 5) the application of genomic/molecular technologies to improve knowledge of vaccine safety. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 90985 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) Contact: Edward McSweegan, Ph.D. Tel: 301-402-8370 Email: emcsweegan@niaid.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-115.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor offers support for collaborative vaccine-related research projects that ultimately reduce the burden of infectious diseases of importance in India, the U.S., the South Asian region and globally. Applications are encouraged from organizations/institutions that propose to conduct vaccine-related research through well-established collaborations with Indian investigators on the following: dengue, influenza (including avian influenza), HIV/AIDS, and tuberculosis. Basic, translational, clinical, or epidemiological vaccine research may be proposed. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 94374 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21) Contact: David R. Johnson, Ph.D. Tel: 301- 496-7104 Email: drjohnson@niaid.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAS-10-148.html Deadline Note: This program will expire on February May 8, 2013. SYNOPSIS: The sponsors provide support for innovative exploratory/developmental investigations in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 94375 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Small Grants on Primary Immunodeficiency Diseases (R03) Contact: David R. Johnson, Ph.D. Tel: 301- 496-7104 Email: drjohnson@niaid.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-147.html Deadline Note: This FOA will expire on May 8, 2013. SYNOPSIS: The sponsors invite applications for small grants in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. Investigators who have no prior history of receiving independent NIH funding or no prior history of receiving independent NIH funding in primary immunodeficiency diseases research, are encouraged to apply to this FOA. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 27786 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS Title: Improving Translational and Basic Research to Control Itch in Humans (ITCH) (R21) Contact: Hung Tseng, Ph.D. Tel: 301-496-0810 Email: tsengh@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-132.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. TThis program will expire on May 8, 2015. SYNOPSIS: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) invites applications for basic and translational studies aimed at understanding the mechanisms of itch sensation and developing methods to modulate and control itch sensation in disease and rehabilitation. The purpose is to accelerate discovery in this nascent field and to apply new knowledge to improve human conditions relevant to the NIAMS mission. This FOA intends to support a broad range of investigations using animal and human models, with an emphasis on multidisciplinary collaboration for rapid bench-to-bedside exchange of information and therapy development. This FOA is not intended to support applications proposing clinical trials. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 05471 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Biomedical Imaging and Bioengineering/NIH/DHHS Title: Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21) Contact: Dr. Christine Kelley, Director Tel: 301-451-4778 Email: kelleyc@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-010.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor provides support for Bioengineering Research Grants (BRGs) for basic and applied multi-disciplinary research that addresses important biological, bioengineering or medical research problems. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 11710 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Studies in Neonatal Hypoglycemia (R21) Contact: Tonse N. K. Raju, MD Tel: 301-402-1872 Email: rajut@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-055.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications that propose studies related to basic, applied and translational research in neonatal hypoglycemia. While much progress has been made in understanding the causes and mechanisms of altered neonatal glucose homeostasis, major gaps remain. Through this FOA, the NICHD is hoping to fill-in such knowledge gaps, which may lead to better monitoring and treatment strategies for altered neonatal glucose homeostasis. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 12171 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Studies in Neonatal Hypoglycemia (R03) Contact: Tonse N. K. Raju, MD Tel: 301-402-1872 Email: rajut@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-054.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications that propose studies related to basic, applied and translational research in neonatal hypoglycemia. While much progress has been made in understanding the causes and mechanisms of altered neonatal glucose homeostasis, major gaps remain. Through this FOA, the NICHD is hoping to fill-in such knowledge gaps, which may lead to better monitoring and treatment strategies for altered neonatal glucose homeostasis. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 20458 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Understanding and Treating Co-Morbid Conditions in Adolescents with Intellectual and Developmental Disabilities (R03) Contact: Mary Lou Oster-Granite, Ph.D.. Tel: 301-435-6866 Email: mo96o@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-040.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose to focus investigator-initiated research upon the factors that impact functioning and quality of life in individuals with intellectual and developmental disabilities (IDD) during adolescence. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 20462 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Understanding and Treating Co-Morbid Conditions in Adolescents with Intellectual and Developmental Disabilities (R21) Contact: Mary Lou Oster-Granite, Ph.D.. Tel: 301-435-6866 Email: mo96o@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-041.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose to focus investigator-initiated research upon the factors that impact functioning and quality of life in individuals with intellectual and developmental disabilities (IDD) during adolescence. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 20685 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research Opportunities in Obstetric Fistula (R03) Contact: Susan F. Meikle, M.D., M.S.P.H. Tel: 301- 273-8541 Email: meikles@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-142.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications that propose to investigate epidemiologic, clinical, social, and behavioral interventions to improve the identification, prevention, treatment, and social circumstances of women at risk for or with obstetric fistula. The purpose of this FOA is not to address service delivery issues that have been outlined in the obstetric fistula program development materials distributed by WHO although it is recognized that improving financial access to care, transportation of women in labor, and obstetric service coverage is critical for reducing and eliminating the obstetric fistula rate. Rather, this FOA requests research applications that complement the programmatic efforts to deliver better and more timely health care during labor, delivery, and post partum. Obstetric fistula is a critical maternal and child health issue in developing countries. Multiple approaches including both improving emergency obstetric care and improved clinical, social and behavioral care are needed to reduce its toll on women and children. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 20693 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research Opportunities in Obstetric Fistula (R21) Contact: Susan F. Meikle, M.D., M.S.P.H. Tel: 301- 273-8541 Email: meikles@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-143.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications that propose to investigate epidemiologic, clinical, social, and behavioral interventions to improve the identification, prevention, treatment, and social circumstances of women at risk for or with obstetric fistula. The purpose of this FOA is not to address service delivery issues that have been outlined in the obstetric fistula program development materials distributed by WHO although it is recognized that improving financial access to care, transportation of women in labor, and obstetric service coverage is critical for reducing and eliminating the obstetric fistula rate. Rather, this FOA requests research applications that complement the programmatic efforts to deliver better and more timely health care during labor, delivery, and post partum. Obstetric fistula is a critical maternal and child health issue in developing countries. Multiple approaches including both improving emergency obstetric care and improved clinical, social and behavioral care are needed to reduce its toll on women and children. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 22027 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research on Children in Military Families: The Impact of Parental Military Deployment and Reintegration on Child and Family Functioning (R21) Contact: Valerie Maholmes, PhD., CAS Tel: 301-496-1514 Email: maholmev@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-202.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite developmental and exploratory studies on the impact of parental military deployment, combat-related stress, and reintegration with the family on child social and affective development as well as family functioning. Intervention studies targeting the particular concerns of early childhood, middle childhood, and adolescence are also encouraged, as are the development and testing of measures to assess family functioning and child development outcomes. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23694 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Pregnancy in Women with Disabilities (R21) Contact: Caroline Signore, MD, MPH Tel: 301-496-5577 Email: signorec@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-259.html Deadline Note: Submission of letters of intent are strongly encouraged. Optional letters of intent may be submitted thirty days prior to the application due date(s). The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications investigating the incidence, course, and outcomes of pregnancy among women with disabilities. Areas of interest also include studies to inform preconceptional and antenatal counseling and strategies for addressing barriers to prenatal care, and management of pregnancy, the puerperium, and the transition to parenthood in order to optimize outcomes for women with physical, intellectual and developmental, and/or sensory disabilities and their families. Applicants are encouraged to include women with disabilities and members of the community in the design and conduct of their research. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23906 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Health Promotion for Children With Physical Disabilities Through Physical Activity and Diet: Developing An Evidence Base (R21) Contact: Ralph Nitkin, Ph.D., Director Tel: 301-402-4206 Email: rn21e@hin.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-284.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The sponsor will accept optional letters of intent thirty days prior to the applicable receipt date. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications that will improve our understanding of how patterns of physical activity and dietary choice affect the health and fitness of children with physical disabilities. Proposed research should account for the functional limitations of children with disabilities and their nutritional needs, as well as the physiological, psychosocial, and environmental factors that play a role in determining the health of this population. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24045 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Development of Appropriate Pediatric Formulations and Drug Delivery Systems (R03) Contact: George P. Giacoia, M.D. Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-302.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. Optional letters of intent may be submitted thirty days prior to the application due date(s). The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications for the development and acceptability of pediatric drug formulations in different age groups. Development and testing of novel pediatric drug delivery systems is also part of this initiative. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 24046 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R21) Contact: George P. Giacoia, M.D. Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-303.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. Optional letters of intent may be submitted thirty days prior to the application due date(s). The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications for the development and acceptability of pediatric drug formulations in different age groups. Development and testing of novel pediatric drug delivery systems is also part of this initiative. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24411 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Biomarkers: Bridging Pediatric and Adult Therapeutics (R03) Contact: George P. Giacoia, MD Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-323.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. Letters of intent may be submitted thirty days prior to the application deadline(s). The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsors invite applications from institutions or organizations that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity and response to therapy. Projects supported by this FOA will be confined to those biomarkers that correlate with a clinical observation, have been extensively studied in adults, and for which there is solid evidence that they have pediatric applications. Discovery of new biomarkers for use in new drug development or in preclinical studies are not part of this FOA. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 24414 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Biomarkers: Bridging Pediatric and Adult Therapeutics (R21) Contact: George P. Giacoia, MD Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-324.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. Letters of intent may be submitted thirty days prior to the application deadline(s). The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsors invite applications from institutions or organizations that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity and response to therapy. Projects supported by this FOA will be confined to those biomarkers that correlate with a clinical observation, have been extensively studied in adults, and for which there is solid evidence that they have pediatric applications. Discovery of new biomarkers for use in new drug development or in preclinical studies are not part of this FOA. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 27339 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research on the Health of LGBTI Populations [R03] Contact: Susan Newcomer, PhD Tel: 301-435-6981 Email: newcomes@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-112.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institutes of Health (NIH) and its participating Institutes and Centers invite applications for research that will increase scientific understanding of the health status of various population groups and improve the effectiveness of health interventions and services for individuals within those groups. High priority is placed on research on populations that appear to have distinctive health risk profiles but have received insufficient attention from investigators. This Funding Opportunity Announcement (FOA) highlights a particular community: lesbian, gay, bisexual, transgender, intersex, and related populations (designated here as LGBTI populations). Basic, social, behavioral, clinical, and services research relevant to the missions of the sponsoring Institutes and Centers may be proposed. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 27340 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research on the Health of LGBTI Populations (R21) Contact: Susan Newcomer, PhD Tel: 301-435-6981 Email: newcomes@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-113.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institutes of Health (NIH) and its participating Institutes and Centers invite applications for research that will increase scientific understanding of the health status of various population groups and improve the effectiveness of health interventions and services for individuals within those groups. High priority is placed on research on populations that appear to have distinctive health risk profiles but have received insufficient attention from investigators. This Funding Opportunity Announcement (FOA) highlights a particular community: lesbian, gay, bisexual, transgender, intersex, and related populations (designated here as LGBTI populations). Basic, social, behavioral, clinical, and services research relevant to the missions of the sponsoring Institutes and Centers may be proposed. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 27982 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research on Emergency Medical Services for Children (EMSC) [R21] Contact: Lynne Haverkos, M.D., M.P.H. Tel: 301-435-6881 Email: lh179r@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-142.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute of Child Health and Human Development (NICHD) and National Institute of Mental Health (NIMH) invite applications dealing with the following areas of research included under the term EMSC: prevention research to reduce the need for emergency care; clinical research to ensure that children receive high-quality and appropriate medical, nursing and mental health care in an emergency; health systems research, from pre-hospital care, to the emergency department, to in-patient care and return to the community; models to improve service and cost efficiency in pediatric emergency care; and methodological studies to improve the quality of research conducted. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 85920 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Innovative Therapies and Clinical Studies for Screenable Disorders (R21) Contact: Tiina Urv, PhD Tel: 301-402-7015 Email: urvtiin@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-232.html Deadline Note: The deadlines for receipt of full applications are February 16, June 16, and October 16. Non-binding letters of intent are requested thirty days prior to the application receipt date. This program will expire on September 8, 2013. SYNOPSIS: >The sponsor invites applications from institutions/ organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and “high priority” genetic conditions for which screening could be possible in the near future. In this FOA, a “high priority” condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening. This PAR will use the NIH exploratory/developmental research grant (R21) award mechanism. --------------------------------------------------------------- Program Number: 85923 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Innovative Therapies and Tools for Screenable Disorders in Newborns (R03) Contact: Tiina Urv, PhD Tel: 301-402-7015 Email: urvtiin@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-231.html Deadline Note: he deadlines for receipt of full applications are February 16, June 16, and October 16. Non-binding letters of intent are requested thirty days prior to the application receipt date. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/ organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and “high priority” genetic conditions for which screening could be possible in the near future. In this FOA, a “high priority” condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening.The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 98036 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Developmental Pharmacology (R03) Contact: George P. Giacoia, M.D. Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-11-058.html Deadline Note: The sponsor requests that optional letters of intent be submitted 30 days before application receipt date. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite grant applications for research related to developmental pharmacology. A major aim of this FOIA is to encourage multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology with particular emphasis on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways activity across developmental periods from fetal life to adolescence. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 98448 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Mechanisms of Adverse Drug Effects in Children (R03) Contact: George P. Giacoia, M.D. Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-052.html Deadline Note: The sponsor requests that optional letters of intent be submitted thirty days prior to the application due date. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications that propose to study the molecular, cellular and genetic mechanisms involved in the production of adverse drug reactions in children. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 01128 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: NIDCR Small Research Grants for Data Analysis and Statistical Methodology Applied to Genome-wide Data (R03) Contact: Emily L. Harris, Ph.D., M.P.H. Tel: 301-594-4846 Email: emily.harris@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-10-041.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications for research projects that involve secondary data analyses or development of statistical methodology using existing genome-wide data, relevant to human dental or craniofacial conditions or traits. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 18248 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: NIDCR Small Grant Program for New Investigators (R03) Contact: Dr. Melissa Riddle Tel: 301-451-3888 Email: md74u@nih.govriddleme@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-275.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor provides funding to scientists who are in the early stages of establishing an independent research career in dental and craniofacial research. --------------------------------------------------------------- Program Number: 24546 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: Immunopathogenesis of HIV/AIDS-related Oral Manifestations and Host Immunity (R21) Contact: Isaac R. Rodriguez-Chavez, Ph.D., M.S., M.H.S. Tel: 301-594-7985 Email: isaac@nidcr.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-333.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after December 7, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose studies to translate new scientific insights about HIV infection, oral pathogen co-infections (viruses, bacteria and fungi) and AIDS-related oral opportunistic infections (viruses, bacteria, and fungi) into better understanding of the immunopathogenesis of these infectious agents to guide translational research focused on the development of novel, oral mucosal prophylactic HIV vaccines as well as therapeutic strategies against HIV, oral co-infections and oral opportunistic infections. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 79254 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03) Contact: Dena Fischer, DDS, MSD, MS Tel: 301-594-4876 Email: dena.fischer@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-120.html Deadline Note: This program will expire on May 8, 2012, unless reissued. SYNOPSIS: National Institute of Dental and Craniofacial Research (NIDCR) provides support for meritorious research projects that involve secondary data analyses using existing dental or craniofacial database resources. This program will use the Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 90126 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: Pathophysiology and Clinical Studies of Osteonecrosis of the Jaw (R21) Contact: Jane C. Atkinson, D.D.S., Director Tel: 301-435-7908 Email: jatkinso@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-083.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose to study the underlying pathophysiology of osteonecrosis of the jaw (ONJ), identify risk factors for this condition, establish the natural history of the disease, and generate evidence for its treatment. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 97843 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: NIDCR Clinical Trial or Biomarker Clinical Evaluation Study Planning Grant (R34) Contact: Jane C. Atkinson, DDS, Program Director Tel: 301-435-7908 Email: jatkinson@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-338.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications for clinical trial planning (R34) grants for the planning and design of clinical trials or biomarker clinical evaluation studies. The R34 grant award will provide support for activities that include, but are not limited to: the establishment of the research team; the development of the clinical protocol and Clinical Investigators Brochure (or equivalent); the development of tools for data management, safety and operational oversight of the research; the definition of recruitment strategies; and all essential elements of the study such as a Manual of Procedures for the clinical trial or biomarker clinical evaluation study, or a draft of the manualized behavioral, community, or services intervention. (See Scope for more detail.) The Clinical Trial or Biomarker Clinical Evaluation Study Planning Grant is not designed for the collection of preliminary data (clinical or pre-clinical), or the collection of prospective data to support the rationale for a clinical trial or study. This program will use the NIDCR Clinical Trial Planning (R34) grant mechanism. --------------------------------------------------------------- Program Number: 03113 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: NIDDK Small Grants for Clinical Scientists to Promote Diversity in Health-Related Research (R03) Contact: Lawrence Agodoa, M.D., FACP Tel: 301-594-1932 Email: la21j@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-223.html Deadline Note: The deadlines for receipt of standard R03 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The purpose of this program is to provide support for clinical scientists from underrepresented racial/ethnic backgrounds, disadvantaged backgrounds or clinical scientists with disabilities to conduct small research projects in the area of diabetes, endocrinology, metabolism, digestive diseases, hepatology, obesity, nutrition, kidney, urology, or hematology. The NIDDK and the ODS recognize the need to promote diversity in the health-related workforce by increasing the number of highly trained clinical researchers from diverse backgrounds conducting research in areas of importance to the NIDDK. This FOA is aimed at New Investigators who hold a health professional doctoral degree or other clinical doctoral degree AND who are from a group that have been shown to be underrepresented in biomedical research. This program will use the NIH Exploratory/Developmental (R03) grant mechanism. --------------------------------------------------------------- Program Number: 09642 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Home and Family Based Approaches for the Prevention or Management of Overweight or Obesity in Early Childhood (R21) Contact: Robert J. Kuczmarski, Dr.P.H. Tel: 301-451-8354 Email: Robert.Kuczmarski@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-128.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors invite applications from institutions/organizations that propose randomized clinical trials testing novel home- or family-based interventions for the prevention or management of overweight in infancy and early childhood. Tested interventions can use behavioral (including dietary and physical activity), environmental, or other relevant approaches. Applications should focus on infants and young children (to age six years) and emphasize the role of home environment and the influence of family/extended family members and parents (including guardians/substantial care-providers) within the child’s home environment. The direct goal of this initiative is to fund research that will advance knowledge for innovative approaches to the prevention or management of overweight in children less than 6 years of age, with potential for future translation to applications either in the home or linked to a community setting. Research should consider the familial mechanisms of behavior such as the role of families in the initiation, support, and reinforcement of fundamental food and beverage consumption, physical activity practices, and sedentary behaviors. In addition it is of interest to elucidate various underlying behavioral determinants that are crucial to initiate or sustain changes in behaviors that impact energy balance. Research designs may include linkages with other settings (e.g., daycare, pre-school, or other community venues) or other care providers (e.g., health care providers or teachers) but must include infants or children less than age six years as the primary study participant along with parents, and/or other family members residing with the child. The overarching goal is to identify interventions that influence parent and child behaviors that contribute to inappropriate weight gain, and thereby improve subsequent health status in childhood, adolescence, and adulthood for which overweight is a known risk factor. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 25060 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Pilot and Feasibility Clinical Research Grants in Kidney or Urologic Diseases (R21) Contact: Marva Moxey-Mims, M.D. Tel: 301-594-7717 Email: mm726k@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-352.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The sponsor invites applications that propose small scale or pilot and feasibility clinical and translational research studies, including epidemiological studies or clinical trials related to kidney or urologic disease research. Studies should address important clinical and translational questions and are potentially of high clinical and public health impact. It is anticipated that some projects supported by these grants may lead to full-scale clinical studies including diagnostic strategies, epidemiological studies, or randomized clinical trials of diagnosis, prevention, or treatment of kidney or urologic diseases. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 27738 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21) Contact: James E. Everhart, M.D., M.P.H. Tel: 301-594-8878 Email: je17g@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-125.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: The sponsors invite applications that propose to conduct secondary analysis of existing data sets relevant to diabetes and endocrine and metabolic diseases; digestive diseases and nutrition, including obesity and eating disorders; and kidney, urologic, and hematologic diseases. The goal of this program is to facilitate research that explores innovative hypotheses through the use of existing data sets. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 27873 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Pilot and Feasibility Clinical Research Studies in Digestive Diseases and Nutrition (R21) Contact: Mary Evans, Ph.D. Tel: 301-594-4578 Email: evansmary@niddk.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-139.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Cancer Institute (NCI) and Office of Dietary Supplements (ODS) invite applications for pilot and feasibility clinical and epidemiological research studies of new therapies or means of health promotion and prevention of digestive and liver diseases and nutritional disorders associated with digestive and liver diseases. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 28131 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Pilot and Feasibility Clinical Research Grants in Diabetes, and Endocrine and Metabolic Diseases (R21) Contact: Louis Martey Tel: 301-594-7733 Email: marteylk@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-157.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites pilot and feasibility clinical and behavioral studies related to the prevention or treatment of diabetes and endocrine and genetic metabolic diseases. The Pilot and Feasibility Clinical Research Grants Program is for exploratory, short-term clinical studies, so that new ideas may be investigated without stringent requirements for preliminary data. The short-term studies should focus on research questions that are likely to have high clinical impact. Studies can include testing a new prevention strategy, a new intervention or a unique combination of therapies. A high priority is the use of such studies to help stimulate the translation of promising research developments from the laboratory into clinical practice in the treatment or prevention of diabetes, endocrine diseases and genetic metabolic diseases, including cystic fibrosis. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 43051 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Small Grant Program for NIDDK K01/K08/K23 Recipients (R03) Contact: James Hyde, Ph.D. Tel: 301-594-7692 Email: jh486z@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-230.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors provides NIDDK-supported K01, K08 and K23 recipients the opportunity to apply for Small Grant (R03) support to run concurrently with the latter years of their K award. Through the use of this mechanism the sponsor is seeking to enhance the capability of its K01, K08, K23 award recipients to conduct research as they complete their transition to fully independent investigator status. --------------------------------------------------------------- Program Number: 79107 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Exploratory/Developmental Clinical Research Grants in Obesity (R21) Contact: Robert J. Kuczmarski, Dr.P.H. Tel: 301-451-8354 Email: kuczmarskir@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-179.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012 The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on May 8, 2015. SYNOPSIS: NIH and its participating Institutes and Centers invite applications that propose to conduct exploratory/developmental clinical studies that will accelerate the development of effective interventions for prevention or treatment of overweight or obesity in adults and/or children. Exploratory epidemiological research with a goal of informing translational/clinical research will also be supported within this program. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 04682 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Exploratory Innovations in Biomedical Computational Science and Technology (R21) Contact: Peter Lyster, Ph.D. Tel: 301-451-6446 Email: lysterp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-219.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invites applications for research and developments in computational science and technology that will support rapid progress in areas of scientific opportunity in biomedical research. As defined here, biomedical computing or biomedical information science and technology includes database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic collaboration, as well as computational and mathematical research including the development of structural, functional, integrative, and analytical models and simulations. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 01088 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Pilot Intervention and Services Research Grants (R34) Contact: Joel Sherrill, Ph.D. Tel: 301-443-2477 Email: jsherril@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-173.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides support to encourage research on: the development and/or pilot testing of new or adapted interventions; the adaptation and/or pilot testing of interventions with demonstrated efficacy for use in broader scale effectiveness trials; or innovative services research directions that require preliminary testing or development. NIMH intervention and services research is aimed at preventing or ameliorating mental disorders, emotional or behavioral problems, the co-occurrence of mental, physical and substance abuse problems, HIV infections, and the functional consequences of these problems across the life span. This FOA will utilize the NIMH R34 award mechanism. --------------------------------------------------------------- Program Number: 01328 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Collaborative R34s for Pilot Studies of Innovative Treatments in Mental Disorders (Collaborative R34) Contact: Mi Hillefors, M.D., Ph.D. Tel: 301-443-1692 Email: mi.hillefors@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-071.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute of Mental Health (NIMH) invites applications for collaborative preliminary intervention studies to evaluate the feasibility, tolerability, acceptability and safety of novel mechanism drug candidates, promising investigational new drugs (INDs), or novel psychosocial strategies for the treatment of mental disorders and for obtaining the preliminary data needed as a pre-requisite to larger-scale (efficacy or effectiveness) intervention or services studies. This FOA should be used when at least two but no more than three sites from different Institutions/Organizations are needed to complete the study. The collaborating studies should be organized in order to increase sample size, accelerate recruitment, and/or increase sample diversity and representation. For a linked set of collaborative R34s, each site shall have its own Program Director/Principal Investigator and provide for a mechanism for cross-site coordination, quality control, database management, statistical analysis, and reporting. This FOA will utilize the NIMH Collaborative R34 award mechanism. --------------------------------------------------------------- Program Number: 20289 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Translational Research for the Development of Novel Interventions for Mental Disorders (R21/R33) Contact: Ann Wagner, Ph.D. Tel: 301-443-5944 Email: awagner@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-177.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications o speed the translation of emerging findings on the neuroscience of mental disorders into novel intervention approaches that will ultimately reduce symptoms and/or restore function. This FOA provides support for up to two years (R21 phase) for preliminary, proof-of-principle studies in human participants, followed by up to 3 years of support (R33 phase) for pilot studies to assess the implementation of the intervention, and evaluate the feasibility of conducting a larger trial to assess the efficacy of the intervention. A range of non-pharmacologic treatment approaches will be accepted, including those based on neurophysiological, cognitive, affective, and/or social neuroscience models, basic behavioral science, and neurodevelopmental models. Applications submitted in response to this FOA must involve novel treatment targets, and/or novel and highly innovative approaches to engage and modify known targets. This FOA will utilize the NIH R21/R33 Phased Innovation Award mechanism. --------------------------------------------------------------- Program Number: 23773 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R03) Contact: Christopher Gordon, PhD Tel: 301-443-6100 Email: cgordon1@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-272.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after August 7, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications for research designed to increase the impact of effective HIV/AIDS-related interventions for prevention and treatment. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan (Objective 4): To strengthen the public health impact of NIMH-supported research. That is, through research, evaluation, and collaboration, to develop the capacity of NIMH to help close the gap between the development of new, research-tested interventions and their widespread use by those most in need. The two overarching goals of this FOA are to encourage projects that will 1) improve the uptake of efficacious interventions and 2) conduct research to inform and enhance the effectiveness and efficiency of interventions, in order to maximize community impact. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 23774 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R21) Contact: Christopher Gordon, PhD Tel: 301-443-6100 Email: cgordon1@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-273.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after August 7, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications for research designed to increase the impact of effective HIV/AIDS-related interventions for prevention and treatment. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan (Objective 4): To strengthen the public health impact of NIMH-supported research. That is, through research, evaluation, and collaboration, to develop the capacity of NIMH to help close the gap between the development of new, research-tested interventions and their widespread use by those most in need. The two overarching goals of this FOA are to encourage projects that will 1) improve the uptake of efficacious interventions and 2) conduct research to inform and enhance the effectiveness and efficiency of interventions, in order to maximize community impact. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23776 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R03) Contact: Pim Brouwers, Ph.D. Tel: 301-433-6000 Email: ebrouwer@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-276.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after August 7, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications for innovative intervention development research to advance HIV prevention and care. This FOA encourages research designed to (a) conduct tests of the efficacy of novel behavioral and/or integrated behavioral and biomedical interventions, (b) conduct basic behavioral and social science research that is needed to advance the development of innovative interventions, and (c) translate and operationalize the findings from these basic studies to develop interventions and assess their feasibility. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 23777 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R21) Contact: Pim Brouwers, Ph.D. Tel: 301-433-6000 Email: ebrouwer@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-277.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after August 7, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications for innovative intervention development research to advance HIV prevention and care. This FOA encourages research designed to (a) conduct tests of the efficacy of novel behavioral and/or integrated behavioral and biomedical interventions, (b) conduct basic behavioral and social science research that is needed to advance the development of innovative interventions, and (c) translate and operationalize the findings from these basic studies to develop interventions and assess their feasibility. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23778 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R34) Contact: Christopher Gordon, PhD Tel: 301-443-6100 Email: cgordon1@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-274.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after August 7, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications for research designed to increase the impact of effective HIV/AIDS-related interventions for prevention and treatment. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan (Objective 4): To strengthen the public health impact of NIMH-supported research. That is, through research, evaluation, and collaboration, to develop the capacity of NIMH to help close the gap between the development of new, research-tested interventions and their widespread use by those most in need. The two overarching goals of this FOA are to encourage projects that will 1) improve the uptake of efficacious interventions and 2) conduct research to inform and enhance the effectiveness and efficiency of interventions, in order to maximize community impact. This program will use the NIH R34 Clinical Trial Planning Grant Program. --------------------------------------------------------------- Program Number: 23779 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R34) Contact: Pim Brouwers, Ph.D. Tel: 301-433-6000 Email: ebrouwer@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-278.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after August 7, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications for innovative intervention development research to advance HIV prevention and care. This FOA encourages research designed to (a) conduct tests of the efficacy of novel behavioral and/or integrated behavioral and biomedical interventions, (b) conduct basic behavioral and social science research that is needed to advance the development of innovative interventions, and (c) translate and operationalize the findings from these basic studies to develop interventions and assess their feasibility. This program will use the NIH R34 Clinical Trial Planning Grant Program. --------------------------------------------------------------- Program Number: 24034 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Molecular and Cellular Substrates of Complex Brain Disorders (R21) Contact: Chiiko Asanuma, Ph.D. Tel: 301-443-5288 Email: cs2j@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-300.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsor invites applications directed toward the discovery of the impact of alterations associated with complex brain disorders on the fundamental cellular and molecular substrates of neuronal function. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24281 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Scalable Assays for Unbiased In Vitro Analysis of Neurobiological Function (R21/R33) Contact: Laurie Nadler, Ph.D. Tel: 301-443-5288 Email: lnadler@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-319.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after . The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications to develop novel, robust analytical platforms using in vitro assays to reveal changes in neuronal and/or glial function. The goal is to adapt state-of-the-art measures of basic cellular processes or molecular events that are key mediators of nervous system function with the intent to probe mechanisms and/or perturbations in an unbiased and efficient manner. The novel assay platforms would provide opportunities to measure neurobiological endpoints and build a pipeline to be used in the context of target identification and drug discovery. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 26149 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Solicitation of Assays for High Throughput Screening (HTS) to Discover Chemical Probes (R21) Contact: Yong Yao, Ph.D. Tel: 301-443-6102 Email: yyao@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-059.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. Optional letters of intent may be submitted thirty days prior to the relevant application deadline. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: NIH invites applications to form collaborations with an established academic, nonprofit, or commercial high throughput screening (HTS) facility that has the requisite expertise and experience to implement HTS-ready assays for the discovery and development of small molecule chemical probes. Through this FOA, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to the missions of the participating NIH Institutes, and 2) discovery and/or validation of novel, biological targets that will inform studies of disease mechanisms. Emphasis will be placed on assays that provide new insight into important disease targets and processes. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 74259 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) Contact: Linda Brady, Ph.D. Tel: 301-443-3563 Email: lbrady@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-023.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 85999 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Dissemination and Implementation Research in Health (R03) Contact: David A. Chambers, Ph.D. Tel: 301-443-3747 Email: dchamber@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-10-039.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. Optional letter of intent may be submitted 30 days prior to the anticipated receipt date. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications that will identify, develop, and refine effective and efficient methods, structures, and strategies to disseminate and implement research-tested health behavior change interventions and evidence-based prevention, early detection, diagnostic, treatment, and quality of life improvement services into public health and clinical practice settings. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 86002 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Dissemination and Implementation Research in Health (R21) Contact: David A. Chambers, Ph.D. Tel: 301-443-3747 Email: dchamber@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-10-040.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. Optional letters of intent may be submitted 30 days prior to the anticipated receipt date. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications that will identify, develop, and refine effective and efficient methods, structures, and strategies to disseminate and implement research-tested health behavior change interventions and evidence-based prevention, early detection, diagnostic, treatment, and quality of life improvement services into public health and clinical practice settings. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 88016 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Research on Autism and Autism Spectrum Disorders (R21) Contact: Lisa Gilotty, Ph.D. Tel: 301-443-3825 Email: gilottyl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-160.html Deadline Note: This program will expire on May 8, 2013. SYNOPSIS: >The sponsor invites applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to autism spectrum disorders (ASD). Basic, clinical, and applied studies are encouraged. This FOA is intended to support the broad research goals of the Strategic Plan for ASD Research (http://iacc.hhs.gov/reports/2009/iacc-strategic-plan-for-autism-spectrum-disorder-research-jan26.shtml). This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 89591 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (Phased Innovation Award [R21/R33]) Contact: Linda Brady, Ph.D. Tel: 301-443-3563 Email: lbrady@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-024.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies. This program will use the NIH Exploratory/Developmental Grant and Exploratory/Developmental Grant Phase II Phased Innovation Grant (R21/R33) award mechanisms. --------------------------------------------------------------- Program Number: 90921 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Drug Discovery for Nervous System Disorders (R21) Contact: Jamie Driscoll Tel: 301-443-5288 Email: jdrisco1@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-002.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invites applications from applicant organizations directed toward the discovery and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 92483 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Psychosocial/Behavioral Interventions and Services Research in Autism Spectrum Disorders (R34) Contact: Lisa Gilotty, Ph.D. Tel: 301-443-3825 Email: gilottyl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-283.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications for exploratory research on psychosocial/behavioral treatments and innovative services research for autism spectrum disorders, including the development of instruments to evaluate the impact of interventions on core features of autism spectrum disorders, and comorbid symptomatology. It is intended to encourage research on: 1) the development and/or pilot testing of new or adapted interventions or instruments, 2) pilot testing novel interventions in preparation for larger efficacy trials, or 3) innovative services research directions that require preliminary testing or development, as well as to facilitate the program goal of enhancing autism research through the broad availability of data and resource infrastructure to further scientific advancement and public health benefits. This program will use the NIH R34 award mechanism. --------------------------------------------------------------- Program Number: 10046 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: NINDS Exploratory/Developmental Projects in Translational Research for Resistant Epilepsy and Epileptogenesis (R21) Contact: Randall Stewart, PhD Tel: 301-496-1917 Email: StewartR@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-143.html Deadline Note: The deadlines for receipt of standard R21 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications for projects intended to complete preliminary steps in the pipeline for the preclinical development of therapeutics to cure epilepsy, prevent the emergence of epilepsy following brain injury (including status epilepticus, traumatic brain injury, stroke, encephalitis, or other injury) or in other high-risk groups, or to better treat individuals with intractable epilepsy. Such projects, if successful, should lead directly to a subsequent project that will include all remaining activities for submission of an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application to the Food and Drug Administration (FDA). Only Aims required for therapy development can be supported in this program. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23841 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: NINDS Exploratory/Developmental Projects in Translational Research (R21) Contact: Thomas Miller, Ph.D. Tel: 301-496-1779 Email: tm208y@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-293.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor provides funding to support preliminary steps in the preclinical development of therapeutics for neurological disorders. Such projects, if successful, should lead directly to a subsequent project that will include all remaining activities for submission of an Investigational New Drug (IND) or Investigational Device Exemption (IDE) application to the Food and Drug Administration (FDA). The scope includes only therapy development activities, so development of diagnostics, biomarkers, or rehabilitation strategies cannot be supported. Clinical research, basic research, and studies of disease mechanism are outside program scope. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 91466 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: Neurobiology of Migraine (R21) Contact: Linda L. Porter, Ph.D. Tel: 301-496-9964 Email: porter@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-259.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations that intend to perform innovative research that will expand our current knowledge of neurobiological mechanisms underlying migraine headache, examine the role of neuromodulators, genetic and environmental influences in migraine susceptibility, and explore new targets for therapy development. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 05219 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Mechanisms, Models, Measurement and Management in Pain Research (R21) Contact: Dr. Susan Marden, Ph.D., Program Director Tel: 301-496-9623 Email: mardens@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-007.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 05221 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Mechanisms, Models, Measurement and Management in Pain Research (R03) Contact: Dr. Susan Marden, Ph.D., Program Director Tel: 301-496-9623 Email: mardens@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-008.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 16309 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Health Promotion Among Racial and Ethnic Minority Males (R21) Contact: Paul A Cotton, PhD, RD Tel: 301-402-6423 Email: cottonp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-237.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor solicits Research Project (R01) grant applications from applicants that propose to stimulate and expand research in the health of minority men. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24462 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R03) Contact: Linda S. Weglicki, Ph.D., R.N., M.S.N. Tel: 301-594-6908 Email: weglickils@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-328.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsors invite applications that employ innovative research to identify mechanisms of influence and/or promote positive sustainable health behavior(s) in children and youth (birth to age 18). Positive health behaviors may include: developing healthy sleep patterns, developing effective self-regulation strategies, adaptive decision-making in risk situations, practicing proper dental hygiene, eating a balanced and nutritious diet, engaging in age-appropriate physical activity and/or participating in healthy relationships. Applications to promote positive health behavior(s) should target social and cultural factors, including, but not limited to: schools, families, communities, population, food industry, age-appropriate learning tools and games, social media, social networking, technology and mass media. Topics to be addressed in this announcement include: effective, sustainable processes for influencing young people to make healthy behavior choices; identification of the appropriate stage of influence for learning sustainable lifelong health behaviors; the role of technology and new media in promoting healthy behavior; identification of factors that support healthy behavior development in vulnerable populations, identification of barriers to healthy behaviors; and, identification of mechanisms and mediators that are common to the development of a range of habitual health behaviors. Given the many factors involved in developing sustainable health behaviors, applications from multidisciplinary teams are strongly encouraged. The ultimate goal of this FOA is to promote research that identifies and enhances processes that promote sustainable positive behavior or changes social and cultural norms that influence health and future health behaviors. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 24463 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R21) Contact: Linda S. Weglicki, Ph.D., R.N., M.S.N. Tel: 301-594-6908 Email: weglickils@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-329.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsors invite applications that employ innovative research to identify mechanisms of influence and/or promote positive sustainable health behavior(s) in children and youth (birth to age 18). Positive health behaviors may include: developing healthy sleep patterns, developing effective self-regulation strategies, adaptive decision-making in risk situations, practicing proper dental hygiene, eating a balanced and nutritious diet, engaging in age-appropriate physical activity and/or participating in healthy relationships. Applications to promote positive health behavior(s) should target social and cultural factors, including, but not limited to: schools, families, communities, population, food industry, age-appropriate learning tools and games, social media, social networking, technology and mass media. Topics to be addressed in this announcement include: effective, sustainable processes for influencing young people to make healthy behavior choices; identification of the appropriate stage of influence for learning sustainable lifelong health behaviors; the role of technology and new media in promoting healthy behavior; identification of factors that support healthy behavior development in vulnerable populations, identification of barriers to healthy behaviors; and, identification of mechanisms and mediators that are common to the development of a range of habitual health behaviors. Given the many factors involved in developing sustainable health behaviors, applications from multidisciplinary teams are strongly encouraged. The ultimate goal of this FOA is to promote research that identifies and enhances processes that promote sustainable positive behavior or changes social and cultural norms that influence health and future health behaviors. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24467 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: mHealth Tools to Promote Effective Patient–Provider Communication, Adherence to Treatment and Self Management of Chronic Diseases In Underserved Populations (R03) Contact: Paul Cotton, Ph.D., RD Tel: 301-402-6423 Email: cottonp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-331.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications to stimulate research utilizing Mobile Health (mHealth) tools aimed at the improvement of effective patient–provider communication, adherence to treatment and self-management of chronic diseases in underserved populations. With the rapid expansion of cellular networks and substantial advancements in Smartphone technologies, it is now possible - and affordable - to transmit patient data digitally from remote areas to specialists in urban areas, receive real-time feedback, and capture that consultation in a database. mHealth tools, therefore, may facilitate more timely and effective patient-provider communication through education communication around goal setting, treatment reminders, feedback on patient progress and may improve health outcomes. This announcement encourages the development, testing and comparative effective analysis of interventions utilizing mHealth technologies in underserved populations. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 24468 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: mHealth Tools to Promote Effective Patient–Provider Communication, Adherence to Treatment and Self Management of Chronic Diseases In Underserved Populations (R21) Contact: Paul Cotton, Ph.D., RD Tel: 301-402-6423 Email: cottonp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-332.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications to stimulate research utilizing Mobile Health (mHealth) tools aimed at the improvement of effective patient–provider communication, adherence to treatment and self-management of chronic diseases in underserved populations. With the rapid expansion of cellular networks and substantial advancements in Smartphone technologies, it is now possible - and affordable - to transmit patient data digitally from remote areas to specialists in urban areas, receive real-time feedback, and capture that consultation in a database. mHealth tools, therefore, may facilitate more timely and effective patient-provider communication through education communication around goal setting, treatment reminders, feedback on patient progress and may improve health outcomes. This announcement encourages the development, testing and comparative effective analysis of interventions utilizing mHealth technologies in underserved populations. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 27872 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Environmental Exposures and Health: Exploration of Non-Traditional Settings, (R21) Contact: Karen Huss, PhD, RN, APRN-BC, FAAN, FAAAAI Tel: 301-594-5970 Email: hussk@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-134.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after April 16, 2012. The deadlines for receipt of standard R21 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2016. SYNOPSIS: National Institute of Nursing Research (NINR) and National Institute of Environmental Health Sciences (NIEHS) invite applications for interdisciplinary research aimed at promoting health, limiting symptoms and disease, and reducing health disparities in children and older adults living or spending time in non-traditional settings. These settings result in exposure to environmental pollutants and toxins that result in health risks, symptoms, and other health conditions/diseases including lower respiratory diseases, chronic obstructive pulmonary disease, and cardiovascular diseases. Risk identification and symptom management include prevention and behavior changes and actions to maintain health and prevent disease with an emphasis on the individual, family, and community which will advance nursing science. For purposes of this FOA, non-traditional settings, for children and older adults, include, but are not limited to places such as community centers, pre-school and non-traditional school environments (e.g., churches, daycare, home-based schools, dormitories, and alternative schools), child and older adult foster care facilities, older adult day care facilities, half-way homes, assisted living and long-term care facilities. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 76031 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Chronic Illness Self-Management in Children and Adolescents (R03) Contact: Dr. Linda S. Weglicki, PhD, RN, MSN Tel: 301-594-6908 Email: weglickils@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-071.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications for research to improve self-management and quality of life in children and adolescents with chronic illnesses. Children diagnosed with a chronic illness and their families have a life-long responsibility for self-management, to maintain and promote health and prevent complications. Biobehavioral studies of children in the context of family and family-community dynamics are encouraged. Research related to biological/technological factors, as well as, sociocultural, environmental, and behavioral mechanisms that contribute to successful and ongoing self-management of chronic illnesses in children is also encouraged. This FOA is restricted to studies of chronic illnesses in children and adolescents ages 8 to 21 grouped by developmental stages according to the discretion of the investigator. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 90826 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Focal Cognitive Deficits in CNS Disorders (R03) Contact: Lois A. Tully, Ph.D. Tel: 301-594-5968 Email: tullyla@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-068.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2010. SYNOPSIS: The sponsors invite applications to expand basic and translational research, including intervention research, on the types, nature, and functional consequences of focal or specific cognitive deficits experienced by persons with central nervous system disorders. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this FOA. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 90827 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Focal Cognitive Deficits in CNS Disorders (R21) Contact: Lois A. Tully, Ph.D. Tel: 301-594-5968 Email: tullyla@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-069.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2010. SYNOPSIS: The sponsors invite applications to expand basic and translational research, including intervention research, on the types, nature, and functional consequences of focal or specific cognitive deficits experienced by persons with central nervous system disorders. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this FOA. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 91009 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Chronic Illness Self-Management in Children and Adolescents (R21) Contact: Dr. Linda S. Weglicki, PhD, RN, MSN Tel: 301-594-6908 Email: weglickils@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-072.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications for research to improve self-management and quality of life in children and adolescents with chronic illnesses. Children diagnosed with a chronic illness and their families have a life-long responsibility for self-management, to maintain and promote health and prevent complications. Biobehavioral studies of children in the context of family and family-community dynamics are encouraged. Research related to biological/technological factors, as well as, sociocultural, environmental, and behavioral mechanisms that contribute to successful and ongoing self-management of chronic illnesses in children is also encouraged. This FOA is restricted to studies of chronic illnesses in children and adolescents ages 8 to 21 grouped by developmental stages according to the discretion of the investigator. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 93596 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Reducing Health Disparities Among Minority and Underserved Children (R21) Contact: Dr. Linda S. Weglicki, PhD, RN, MSN Tel: 301-594-6908 Email: weglickils@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-105.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invites applications to conduct research to reduce health disparities among minority and underserved children. Specifically, this initiative focuses on ethnic and racial minority children and underserved populations of children such as: children from low literacy, rural and low-income populations, geographically isolated children, hearing and visually impaired children, physically or mentally disabled children, children of migrant workers, children from immigrant and refugee families, and language minority children. Specific targeted areas of research include biobehavioral studies that incorporate multiple factors that influence child health disparities such as biological (e.g., genetics, cellular, organ systems), lifestyle factors, environmental (physical and family environments), social (e.g., peers), economic, institutional, and cultural and family influences; studies that target the specific health promotion needs of children with a known illness and/or disability; and studies that test and evaluate the comparative effectiveness of health promotion interventions conducted in traditional and nontraditional settings. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 00898 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Critical Illness and Injury in Aging (R03) Contact: Basil Eldadah, M.D., Ph.D. Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-10-043.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications for proposing to study mechanisms and management of critical illness and injury, including trauma and neurotrauma, in aging. Studies may be mechanistic, observational, or interventional in nature. Secondary analyses of existing datasets, such as from large observational studies or clinical trials, may be proposed. Animal studies are appropriate in cases where human studies are not feasible. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 00900 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Critical Illness and Injury in Aging (R21) Contact: Basil Eldadah, M.D., Ph.D. Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-10-044.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications for proposing to study mechanisms and management of critical illness and injury, including trauma and neurotrauma, in aging. Studies may be mechanistic, observational, or interventional in nature. Secondary analyses of existing datasets, such as from large observational studies or clinical trials, may be proposed. Animal studies are appropriate in cases where human studies are not feasible. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 01031 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Clinical Trial Planning Grants for Critical Illness and Injury in Aging (R34) Contact: Basil Eldadah, M.D., Ph.D. Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-10-045.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications to develop research protocols for Phase III and IV clinical trials related to critical illness and injury in aging. The planning grant mechanism is intended to permit early peer review of the rationale and design of the proposed Phase III or IV clinical trial, and to support development of a research team, tools for data management and research oversight, recruitment strategies, detailed protocol and Manual of Procedures (MOP), and other essential components necessary for a competitive clinical trial application. This FOA will utilize the Clinical Trial Planning Grant (R34) mechanism. --------------------------------------------------------------- Program Number: 02509 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R21) Contact: Wen G. Chen, Ph.D. Tel: 301496-9350 Email: chenw@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-194.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications from institutions/organizations that propose to (1) study biological, neurobiological, psychosocial, and clinical mechanisms and processes by which aging and/or age-related diseases affect the experience of pain, (2) examine biological, neurobiological, psychosocial, and clinical factors that impact pain experience and prevalence in older people, (3) evaluate existing pain assessment and/or management approaches in older adults, or (4) develop new assessment methods and/or management strategies for pain with particular attention to the needs of older adults. Studies involving animal models or human subjects are appropriate under this program announcement. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 02510 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R03) Contact: Wen G. Chen, Ph.D. Tel: 301496-9350 Email: chenw@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-195.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications from institutions/organizations that propose to (1) study biological, neurobiological, psychosocial, and clinical mechanisms and processes by which aging and/or age-related diseases affect the experience of pain, (2) examine biological, neurobiological, psychosocial, and clinical factors that impact pain experience and prevalence in older people, (3) evaluate existing pain assessment and/or management approaches in older adults, or (4) develop new assessment methods and/or management strategies for pain with particular attention to the needs of older adults. Studies involving animal models or human subjects are appropriate under this program announcement. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 02635 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Bioenergetics, Fatigability, and Activity Limitations in Aging (R21) Contact: Basil Eldadah, M.D., Ph.D. Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-191.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications proposing to study bioenergetic factors underlying increased fatigability and activity limitations in aging. Increased fatigability is a significant cause of restricted physical and cognitive activity in older adults. Alterations in bioenergetics—the production and utilization of energy, and the regulation of these processes—may contribute significantly to increased fatigability. This FOA encourages applications that propose to 1) elucidate specific alterations in bioenergetics related to increased fatigability and activity limitations; 2) develop and evaluate improved measures of fatigability related to bioenergetics; 3) evaluate interventions for increased fatigability and activity limitations that target alterations in bioenergetics and lead to improved quality of life. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 02643 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Bioenergetics, Fatigability, and Activity Limitations in Aging (R03) Contact: Basil Eldadah, M.D., Ph.D. Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-192.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications proposing to study bioenergetic factors underlying increased fatigability and activity limitations in aging. Increased fatigability is a significant cause of restricted physical and cognitive activity in older adults. Alterations in bioenergetics—the production and utilization of energy, and the regulation of these processes—may contribute significantly to increased fatigability. This FOA encourages applications that propose to 1) elucidate specific alterations in bioenergetics related to increased fatigability and activity limitations; 2) develop and evaluate improved measures of fatigability related to bioenergetics; 3) evaluate interventions for increased fatigability and activity limitations that target alterations in bioenergetics and lead to improved quality of life. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 05623 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Development and Characterization of Animal Models for Aging Research (R21) Contact: Mahadev Murthy, Ph.D., M.B.A. Tel: 301-402-7749 Email: mmurthy@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-015.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications for research that develops, characterizes, refines and enhances model systems for aging research, including but not limited to animal models, cell lines, and informatics. This FOA encourages applications that propose to: characterize aging at the physiological, biochemical and functional levels in existing animal models, including but not limited to animal models currently used in other scientific fields that have potential to benefit aging research; develop new animal models for aging research; develop unique cell lines for aging research; use comparative biology to identify models of highest priority for aging research; or develop informatics that enhance the utilization of animals for aging research. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 11048 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Identification and Characterization of Molecular Targets Within the mTOR Pathway With Potential to Impact Healthspan and Lifespan (R21) Contact: Nancy L. Nadon, Ph.D., Chief Tel: 301-402-7744 Email: nadonn@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-164.html Deadline Note: This program will expire on May 18, 2013. SYNOPSIS: The sponsors invite applications focused on: 1) identifying novel targets within the mTOR (mammalian target of rapamycin) signaling network, the manipulation of which has the potential to promote healthy aging, i.e. extend health span in the aged (NIA interest); and 2) identifying and characterizing dietary constituents that modulate the mTOR pathway and promote cancer prevention (NCI interest). Identification and characterization of targets can utilize a wide range of approaches, including medicinal chemistry, in vitro assays, and studies in lower organisms or mammalian models. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 17845 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Asthma in Older Adults (R21) Contact: Basil Eldadah, MD, PhD Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-264.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsors invite applications that propose to study the pathophysiology, epidemiology, diagnosis, and/or management of asthma in older adults. Much of what is known about asthma in adults is based on studies in younger adult populations; however, the mechanisms underlying asthma in some older adults may differ, which may impact on diagnostic, treatment, and prevention strategies. This FOA is intended to stimulate research to address knowledge gaps and research opportunities in asthma in later life. A variety of study approaches are encouraged with this FOA including basic, translational, clinical, and epidemiological studies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 17852 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Asthma in Older Adults (R03) Contact: Basil Eldadah, MD, PhD Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-265.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsors invite applications that propose to study the pathophysiology, epidemiology, diagnosis, and/or management of asthma in older adults. Much of what is known about asthma in adults is based on studies in younger adult populations; however, the mechanisms underlying asthma in some older adults may differ, which may impact on diagnostic, treatment, and prevention strategies. This FOA is intended to stimulate research to address knowledge gaps and research opportunities in asthma in later life. A variety of study approaches are encouraged with this FOA including basic, translational, clinical, and epidemiological studies. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 20823 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Translational Research to Help Older Adults Maintain their Health and Independence in the Community (R21) Contact: Dr. Sidney Stahl Tel: 301-402-4156 Email: StahlS@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-124.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications for translational research that moves evidence-based research findings towards the development of new interventions, programs, policies, practices, and tools that can be used by community-based organizations to help elderly individuals remain healthy and independent, and living in their own homes and communities. The goal of this FOA is to support translational research involving collaborations between academic research centers and community-based organizations with expertise serving the elderly (such as city and state health departments, city/town leadership councils, and Area Agencies on Aging) that will enhance our understanding of practical tools, techniques, programs and policies that communities across the nation can use to more effectively respond to needs of their aging populations. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23706 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Social and Behavioral Research on the Elderly in Disasters (R03) Contact: John G. Haaga, Ph.D. Tel: 301-496-3131 Email: HaagaJ@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-264.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications that propose to conduct research in the behavioral and social sciences on the consequences of natural and man-made disasters for the health and well-being of the elderly, with an ultimate goal of preventing or mitigating harmful consequences. Disasters include weather-related events, earthquakes, tsunamis, large-scale attacks on civilian populations, technological catastrophes, and pandemics. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 23707 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Social and Behavioral Research on the Elderly in Disasters (R21) Contact: John G. Haaga, Ph.D. Tel: 301-496-3131 Email: HaagaJ@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-265.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications that propose to conduct research in the behavioral and social sciences on the consequences of natural and man-made disasters for the health and well-being of the elderly, with an ultimate goal of preventing or mitigating harmful consequences. Disasters include weather-related events, earthquakes, tsunamis, large-scale attacks on civilian populations, technological catastrophes, and pandemics. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23739 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: T1 Translational Research: Novel Interventions for Prevention and Treatment of Age-Related Conditions (R21) Contact: Chhanda Dutta, PhD Tel: 301-435-3048 Email: DuttaC@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-11-280.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications for projects intended to accelerate the pace of development of novel therapeutics involving biologics, pharmacological and non-pharmacological approaches for preventing and treating key health issues affecting the elderly. For the purposes of this FOA, T1 translational research on aging is defined as the application of basic and clinical biomedical findings towards the development of new strategies for prevention and treatment of age-related pathologies. For projects proposing basic research that is being conducted in animal models, the potential to treat a clinical age-related pathology must be clearly stated in the proposal. Direct relevance of the data to a clinical aging condition must be established and clearly stated in the application. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23741 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: T2 Translational Research: Research Leading to New Health Care Practices, Community Programs and Policies Affecting Older Persons (R21) Contact: Chhanda Dutta, PhD Tel: 301-435-3048 Email: DuttaC@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-11-281.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications for projectson translational research (T2) directed towards development of health care practices, community programs and policies, including monitoring and quality improvement for pharmacological and non-pharmacological approaches for preventing and treating key health issues affecting the elderly. For the purposes of this FOA, T2 translational research on aging is defined as research to gather information needed to develop or evaluate methods of translating results from clinical studies into everyday clinical practice and health decision making (e.g., adapting an efficacious intervention for application in clinical practice and evaluating its effectiveness in different clinical settings). Methods for T2 translational research include but are not limited to intervention studies, systematic reviews, meta analysis, outcomes research and implementation research. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24277 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Single Cell Studies in Aging Research (R21) Contact: Dr. Jose Velazquez Tel: 301-496-6428 Email: jvelazqu@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-321.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications hat propose to develop research on single cell biology to enhance the understanding of the mechanisms of normal aging and of age-related diseases. Applications using -omics technologies, imaging, optofluidic platforms, mass spectroscopy, whole genome sequencing, and other tools and technologies at the single cell level are encouraged since it is expected that the single cell approach will improve the determination of unique and biologically significant properties of tissues and organs during the aging process. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 25844 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms Mediating Osteoarthritis in Aging (R21) Contact: John P. Williams, Ph.D. Tel: 301-496-6402 Email: williamsj6@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-018.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015 . SYNOPSIS: The National Institute on Aging and the National Institute of Arthritis and Musculoskeletal and Skin Diseases invite applications intended to encourage and accelerate the characterization of new or underutilized models and the testing of hypotheses that will lead to an improved understanding of the mechanisms mediating osteoarthritic progression. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 46809 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Grants for Alzheimer's Disease Drug Discovery (R21) Contact: Suzana S. Petanceska, Ph.D. Tel: 301-496-9350 Email: petanceskas@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-151.html Deadline Note: This FOA will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications to advance the discovery of new, efficacious therapies for the treatment, delay of progression, or prevention of Alzheimer’s disease (AD), mild cognitive impairment (MCI) and age-related cognitive decline. This FOA encourages the early stages of drug discovery necessary to identify promising disease-modifying therapies as well as treatments aimed at ameliorating the cognitive and neuropsychiatric/behavioral symptoms characteristic of Alzheimer’s disease. Studies aimed at the discovery and testing of therapies directed at a variety of established as well as novel therapeutic targets are encouraged. The goal is not to duplicate or compete with pharmaceutical companies but to encourage the process of discovering new, innovative, and effective therapeutics for the prevention and treatment of the cognitive impairment and behavioral symptoms associated with Alzheimer's disease. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 82577 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Aging Research Dissertation Awards to Increase Diversity (R36) Contact: Michael-David AAR Kerns, M.B.A., M.S., Ph.D. Tel: 301-402-7713 Email: kernsmd@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-291.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after October 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications for dissertation awards in all areas of research within NIA’s strategic priorities to increase diversity of the scientific research workforce engaged in research on aging and aging-related health conditions. This FOA will use the NIH R36 dissertation award mechanism. --------------------------------------------------------------- Program Number: 98218 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Translational Research at the Aging/Cancer Interface (TRACI) (R21) Contact: Basil Eldadah, MD, PhD Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-135.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute on Aging (NIA)and National Cancer Institute (NCI) invite applications for translational research proposals in the overlapping areas of human aging and cancer, linking basic and clinical research relevant to the care of older cancer patients through both bench-to-bedside and bedside-to-bench approaches. Ultimately, information from the research supported by this initiative should improve the health and well-being of elderly patients at risk for, or diagnosed with, cancer and decrease the functional impairment and morbidity associated with cancer in this population. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 03539 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Mechanistic Studies of Pain and Alcohol Dependence (R21) Contact: Mark Egli, Ph.D. Tel: 301-594-6382 Email: megli@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-268.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose to conduct mechanistic studies on the relationship between alcohol drinking, alcohol dependence and pain. An association between chronic pain conditions and alcohol dependence has been revealed in numerous studies with episodes of alcohol abuse antedating chronic pain in some people and alcohol dependence emerging after the onset of chronic pain in others. Pain transmission and alcohol’s reinforcing effects share overlapping neural substrates giving rise to the possibility that chronic pain states significantly affect alcohol use patterns and promote the development of dependence and addiction. In addition, long term alcohol intoxication and alcohol dependence induce pain symptoms and may exacerbate chronic pain arising from other sources. The objective of this FOA is to understand genetic, pharmacological and learning mechanisms underlying the association between the propensity to drink alcohol and pain responses. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 09874 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: The Role of Cellular Organelles in Alcohol-Induced Tissue Injury (R21) Contact: Max Guo, Ph.D. Tel: 301-443-0639 Email: Max.Guo@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-086.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2010. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications that propose to study biological processes involving the cellular organelles in alcohol-induced tissue injury. Excessive alcohol consumption can damage many organ systems including the liver, heart, pancreas, brain, and lung. However, the mechanisms for these injuries are currently not fully understood. Cellular organelles play an important role in cellular functions and are significantly involved in alcohol-induced tissue injury. Thus, studies of alcohol’s effects on the structure and function of cellular organelles are critical to better understand the mechanisms of alcohol-induced injuries and to develop new strategies for their diagnosis and treatment. The purpose of this FOA is to: (1) better understand how acute or chronic alcohol consumption affects the structure and function of cellular organelles, and in turn, how these changes contribute to alcohol-induced injury; (2) investigate how variations of proteins in cellular organelles, or their regulation and function, including cellular signaling pathways, contribute to an individual’s response to acute or chronic alcohol intake and alcohol-induced tissue injury; (3) develop potential biomarkers for prognosis and diagnosis of tissue injury, or identify new targets for therapeutic interventions. This FOA aims to foster the utilization of innovative experimental design and emerging technologies, such as genomics, proteomics, metabolomics, bioinformatics, as well as novel microscopic imaging techniques that illuminate functions in intact cells and tissues, to generate new mechanistic and clinical insights into alcohol-induced tissue injuries. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 09878 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Stress Pathways in Alcohol Induced Organ Injury and Protection (R21) Contact: Andras Orosz, Ph.D. Tel: 301-443-2193 Email: orosza@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-094.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications that propose studying the role of cellular stress responses, the cytoplasmic classical stress response or heat shock response (HSR) and the endoplasmic reticulum (ER) stress, in alcohol-induced tissue injury and tissue protection. While excessive alcohol use causes organ damage, moderate alcohol consumption may be beneficial. The underlying molecular mechanisms for this apparent dichotomy of alcohol’s harmful and salutary effects are currently not fully understood. Alcohol induces cellular stress pathways in the cytoplasm and in the endoplasmic reticulum that may significantly be involved in alcohol-induced tissue injury or mediate tissue protection depending on the quantity, frequency, duration, and temporal pattern of drinking. Hence, studies of the effects of alcohol on cellular stress pathways are critical to understand the mechanisms of alcohol-induced injuries or protection to develop new strategies for prevention, diagnosis and treatment. The purpose of this FOA is to: (1) acquire insight into how acute or chronic alcohol consumption affects cellular stress pathways and in turn, how these changes contribute to alcohol-induced injury/protection; (2) investigate how alcohol induced stress responses mediate cell survival and death signaling pathways at macromolecular, organelle, cellular and organism level contributing to alcohol-induced tissue injury/protection; (3) develop potential stress related biomarkers for prognosis, diagnosis of tissue injury/protection, furthermore identify new targets for their therapeutic interventions. Utilizing innovative experimental design and emerging technologies, such as deep sequencing, genomics, proteomics, metabolomics, bioinformatics, and novel imaging techniques these investigations are expected to provide a more comprehensive understanding of how alcohol affects the evolutionally conserved stress pathways and elucidate their roles in tissue injuries and repair. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 16835 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Endocannabinoid Signaling in Alcohol Consumption, Intoxication and Alcohol Use Disorders (R21) Contact: Qi-Ying Liu, M.D. Tel: 301-443-2678 Email: liuqiy@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-250.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications that propose to study the roles and underlying mechanisms of endocannabinoid signaling in alcohol preference, consumption, intoxication and alcohol use disorders, and to explore endocannabinoid signaling system as potential targets for alcohol pharmacotherapy. With increasing knowledge of the function of eCBs in the developing and adult brain and recent behavioral and pharmacological evidence linking alcohol and eCB signaling system, there is now great potential to explore the role of eCB signaling system in alcohol-related behaviors and alcohol use disorders. Studies supported with this FOA will help to gain knowledge about the role and underlying mechanisms of eCB signaling in alcohol preference and consumption; the interactions of acute and chronic alcohol exposure with eCBs at synapses; the effects of such interactions on short- and long-term synaptic plasticity; the role of eCB signaling in the development and maturation of the central nervous system; and the eCB signaling system in fetal alcohol spectrum disorders. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 16843 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Treatment of Co-Occurring Alcohol Use Disorders and Depression/Anxiety Disorders (R21) Contact: Deidra Roach, M.D. Tel: 301-443-5820 Email: droach@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-252.html Deadline Note: The sponsor encourages optional letters of intent no more than thirty days before the application due date. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications to support research on the treatment of individuals with co-occurring alcohol use disorders and depression/anxiety. Anxiety disorders include generalized anxiety disorder, social phobia, and posttraumatic stress disorder. The scope of interest includes innovative pharmacological and behavioral treatments based on biological, psychological, behavioral, and social/cultural models of etiology and treatment of comorbid alcohol use disorders and depression/anxiety. In addition, this FOA accepts Comparative and Effectiveness Research applications which compare two or more different existing treatments in this comorbid population. This FOA is limited to depression and anxiety because of the high prevalence of these psychiatric disorders in individuals with alcohol use disorders. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 16994 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Behavioral Regulation Mechanisms of Alcohol Dependence and Related Phenotypes (R21) Contact: Ivana Grakalic, Ph.D. Tel: 301-443-7600 Email: igrakalic@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-256.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications that propose to examine the mechanisms of behavioral regulation contributing to the behavioral characteristics of alcohol dependence. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 19985 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Epidemiology and Prevention in Alcohol Research (R03) Contact: Marcia Scott, Ph.D. Tel: 301-402-6328 Email: mscott@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-017.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications to support research investigating the epidemiology of alcohol use, alcohol-related harms, and alcohol use disorders and the prevention of underage drinking, alcohol-related harms, and alcohol use disorders. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 20129 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Epidemiology and Prevention in Alcohol Research (R21) Contact: Marcia Scott, Ph.D. Tel: 301-402-6328 Email: mscott@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-018.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications to support research investigating the epidemiology of alcohol use, alcohol-related harms, and alcohol use disorders and the prevention of underage drinking, alcohol-related harms, and alcohol use disorders. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 20841 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Research Into The Impact Of Economic Fluctuations On Alcohol Consumption, Drinking Patterns, And Prevention And Treatment Of Problem Drinking And Related Problems (R21) Contact: Robert C. Freeman, Ph.D. Tel: 301-443-8820 Email: rfreeman@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-062.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications from institutions/ organizations that propose to investigate the impact of national or local economic fluctuations on alcohol consumption, alcohol drinking patterns, and the prevention and treatment of problem drinking. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 20845 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Neuroimmune Mechanisms Of Alcohol Related Disorders (R21) Contact: Changhai Cui, PhD Tel: 301-443-1678 Email: changhai.cui@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-065.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose study the neuroimmune mechanisms of alcohol related disorders. Studies supported by this FOA will provide fundamental insights of neuroimmune mechanisms underlying brain functional and behavioral changes induced by alcohol. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24088 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Secondary Analysis of Existing Alcohol Epidemiology Data (R03) Contact: Wenxing Zha, Ph.D. Tel: 301-443-0633 Email: zhaw@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-309.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose to conduct secondary analysis of existing data sets. NIAAA seeks to enhance the understanding of the patterns of alcohol consumption and the epidemiology of alcohol-related problems. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 25816 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Alcohol Impairment of Immune Function, Host Defense and Tissue Homeostasis (R21) Contact: M. Katherine Jung, PhD Tel: 301-443-8744 Email: jungma@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-026.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015 . SYNOPSIS: The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications from researchers with broad ranges of expertise to study the consequences of alcohol consumption on immune function with the ultimate goal of alleviating infection and reversing alcohol-induced organ damage. Susceptibility to infection and organ damage are the two most common causes of alcohol-related morbidity and mortality. These consequences of alcohol abuse are closely associated with profound impairment of the host innate and adaptive immune systems. The mechanisms of these immune alterations and their link with alcohol-related medical problems are, in most cases, poorly understood. The goal of this FOA is to attract applications on basic and translational research: 1) to identify how alcohol alters immune function; 2) to establish functional links between immune alterations and alcohol related infections and organ damage; and 3) to develop means for mitigating immune impairment with the goal of alleviating alcohol-induced pathology. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 25822 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Effects of Adolescent Binge Drinking on Brain Development (R21) Contact: Dr. Lawrence Baizer Tel: 301-443-9334 Email: baizerl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-028.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications proposing to conduct mechanistic studies on the effects of adolescent binge alcohol consumption on synaptic maturation and myelin formation in the developing brain. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 28362 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Alcohol Abuse, Sleep Disorders and Circadian Rhythms (R21) Contact: Dr. Lindsey Grandison Tel: 301-443-0606 Email: lindsey.grandison@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-178.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on May 8, 2015. SNYOPSIS: National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications proposing to conduct mechanistic studies in humans and animal models on the relationships between alcohol abuse, circadian rhythms and sleep disorders. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 87411 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Mechanisms of Alcohol-associated Cancers (R21) Contact: M. Katherine Jung, PhD Tel: 301-443-8744 Email: jungma@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-147.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2015. SYNOPSIS: National Institute on Alcohol Abuse and Alcoholism (NIAAA) and National Cancer Institute (NCI) invite applications from researchers with broad ranges of expertise to study the mechanisms by which alcohol increases cancer risk. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 90413 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Structural Interventions, Alcohol Use, and Risk of HIV/AIDS (R21) Contact: Robert C. Freeman, Ph.D. Tel: 301-443-8820 Email: rfreeman@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-243.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor offers support for applications from institutions/ organizations that propose to investigate the effectiveness of structural interventions that reduce the risk of HIV/AIDS transmission by changing the environment of alcohol use. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 91852 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Alcohol Use Disorders: Treatment, Services Research, and Recovery (R03) Contact: Angela Martinelli, Ph.D. Tel: 301-451-8507 Email: martinellia@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-101.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations that propose to support research on behavioral and pharmacological treatment for alcohol use disorders; organizational, financial, and management factors that facilitate or inhibit the delivery of services for alcohol use disorders; and phenomenon of recovery from alcohol use disorders. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 93777 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Nutrition and Alcohol-Related Health Outcomes (R03) Contact: Rosalind Breslow, Ph.D., M.P.H., R.D. Tel: 301-594-6231 Email: rbreslow@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-240.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsors provide support for Research Grant (R03) applications from institutions/organizations that propose to examine associations between nutrition and alcohol-related health outcomes in humans and animal models. The goal of this program announcement is to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including alcohol dependence and psychiatric co-morbidities, chronic and acute diseases, and organ function and damage. Study designs may include biomedical research, epidemiologic approaches, and intervention studies. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 93778 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Nutrition and Alcohol-Related Health Outcomes (R21) Contact: Rosalind Breslow, Ph.D., M.P.H., R.D. Tel: 301-594-6231 Email: rbreslow@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-241.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsors provide support for applications from institutions/organizations that propose to examine associations between nutrition and alcohol-related health outcomes in humans and animal models. The goal of this program announcement is to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including alcohol dependence and psychiatric co-morbidities, chronic and acute diseases, and organ function and damage. Study designs may include biomedical research, epidemiologic approaches, and intervention studies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 93814 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21) Contact: Mariela C. Shirley, Ph.D. Tel: 301-443-9787 Email: shirleym@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-030.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications for research on screening and brief interventions to prevent and/or reduce alcohol use and alcohol-related harms. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 93815 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03) Contact: Mariela C. Shirley, Ph.D. Tel: 301-443-9787 Email: shirleym@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-029.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications for research on screening and brief interventions to prevent and/or reduce alcohol use and alcohol-related harms. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 94057 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Research on Alcohol-Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R21) Contact: Gregory Bloss, M.A. Tel: 301-443-3865 Email: gbloss@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-089.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014 . SYNOPSIS: The sponsor invites applications to conduct research on the effects of alcohol-related public policies on health, economic, and social behaviors and outcomes. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 94058 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Research on Alcohol-Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R03) Contact: Gregory Bloss, M.A. Tel: 301-443-3865 Email: gbloss@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-088.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014 . SYNOPSIS: TThe sponsor invites applications to conduct research on the effects of alcohol-related public policies on health, economic, and social behaviors and outcomes. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 94841 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Alcohol Use Disorders: Treatment, Services Research, and Recovery (R21) Contact: Angela Martinelli, Ph.D. Tel: 301-451-8507 Email: martinellia@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-102.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations that propose to support research on behavioral and pharmacological treatment for alcohol use disorders; organizational, financial, and management factors that facilitate or inhibit the delivery of services for alcohol use disorders; and phenomenon of recovery from alcohol use disorders. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 10458 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: Research Opportunities on Spasmodic Dysphonia (R21) Contact: Lana Shekim, Ph.D. Tel: 301-496-5061 Email: shekiml@nidcd.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-156.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2010. The deadlines for receipt of standard R21 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications designed to improve our understanding of the pathogenesis & pathophysiology of spasmodic dysphonia (SD) for its prevention and improved treatment. This FOA invites basic, translational and clinical studies to accelerate research into promising therapeutic approaches for spasmodic dysphonia and to stimulate progress in spasmodic dysphonia research through encouraging and facilitating transdisciplinary interactions. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 16986 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: NIDCD Research on Hearing Health Care (R21) Contact: Amy Donahue, Ph.D. Tel: 301-402-3458 Email: donahuea@nidcd.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-254.html Deadline Note: The deadlines for receipt of standard R21 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations to support research leading to accessible and affordable hearing health care (HHC). The overarching emphasis is on the acquisition of knowledge that can be rapidly translated into new or enhanced approaches for access, assessment or interventions with a goal to delivering better hearing health care outcomes. Applications should seek quality approaches that are effective, affordable and deliverable to those who need them as well as implementable and sustainable in settings beyond the research environment. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 75557 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: Proteomics in Auditory Developmental and Disease Processes (R21) Contact: Nancy L. Freeman, Ph.D. Tel: 301-402-3458 Email: freeman@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-078.html Deadline Note: This program will expire on January 8, 2013. SYNOPSIS: The sponsor provides support to expand support of proteomic research in the auditory system. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 04293 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R21) Contact: Albert Avila, Ph.D. Tel: 301-496-8804 Email: aavila@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-237.html Deadline Note: The deadlines for receipt of standard R21 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: This announcement encourages research to identify the role(s) that drug abuse plays in fueling the epidemic in vulnerable groups and to develop effective interventions to prevent new infections and to improve the health and well-being of those living with HIV/AIDS. To do this, it is essential that research be directed toward understanding the factors (biological, behavioral, psychosocial, environmental, institutional, etc.) responsible for the profoundly disproportionate burden of HIV/AIDS among vulnerable groups (racial/ethnic minorities, men who have sex with men, youth) in the United States. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 04580 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Optimization of Small Molecule Probes for the Nervous System (R21) Contact: Hari Singh, Ph.D., Program Director Tel: 301-435-1310 Email: hs87j@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-251.html Deadline Note: The deadlines for receipt of standard R21 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications from institutions/ organizations that propose to develop new small molecule probes for investigating biological function in the nervous system via the application of advanced medicinal chemistry and the biological testing of compounds. Eligible investigators will have identified probe candidates via screening of small molecule collections, using in vitro assays of biological activity developed to interrogate these collections, and be able to show that the structural features of these small molecules are related to their biological activity. Proposals should nominate small molecule probe candidates from distinct structural series for the further, iterative design and testing of analogues in structure-activity relationship studies, using in vitro assays of biological function adapted to the medium throughput screening requirements of this work. These studies should have the goal of developing a small molecule probe possessing the attributes (eg: affinity, selectivity, activity) required for its use in future pharmacological studies proposed by the investigator. Applicants are strongly encouraged to utilize publicly available cheminformatic capabilities for the acquisition of compounds, and semi-custom synthesis of analogues. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 05472 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Behavioral & Integrative Treatment Development Program (R34) Contact: Lisa Onken, Ph.D. Tel: 301-443-2235 Email: Lisa_Onken@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-013.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications for evidence-based treatment research through 1) the development, manualization, standardization, early-stage efficacy and/or pilot testing of novel or adapted treatments and/or interventions (i.e. Stage 1 treatment research, see below), 2) the refinement, modification, adaptation and/or pilot testing of interventions with demonstrated efficacy for use in broader scale efficacy or effectiveness trials, or 3) novel treatment research that requires preliminary testing or development. It is expected that research conducted via this R34 mechanism will primarily consist of Stage I treatment development research that will provide feasibility, tolerability, and acceptability information and/or pilot data for larger scale Stage II or Stage III behavioral and integrative treatment studies. This FOA seeks to support research, as described above, within the domains of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain. This FOA will use the R34 mechanism. --------------------------------------------------------------- Program Number: 07869 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Technology-Based Interventions to Promote Engagement in Care and Treatment Adherence and For Substance Abusing Populations with HIV (R34) Contact: Shoshana Y. Kahana, Ph.D. Tel: 301-443-2261 Email: kahanas@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-118.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after April 7, 2012. The deadlines for receipt of standard R21 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute on Drug Abuse (NIDA) invites applications to test the utility and implementation of technological tools, including mobile devices, to promote engagement in Human Immunodeficiency Virus (HIV) care among substance abusing populations with HIV. Research projects may focus on (a) the use of technology to directly improve patient-level outcomes (i.e., adherence); (b) the capacity of HIV treatment providers and related service delivery organizations to adopt and integrate such technologies to promote HIV treatment outcomes; or (c) the use of technology to improve the organization and delivery of HIV treatment and services. This FOA will utilize the R34 grant mechanism. --------------------------------------------------------------- Program Number: 09040 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Gene-Environment Interplay in Substance Use Disorders (R21) Contact: Naimah Weinberg, M.D. Tel: 301-402-1908 Email: nw46w@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-236.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors provide support to stimulate and expand research on the interplay of genetic and environmental factors in the genesis, course, and outcomes of substance and alcohol use disorders (SUDs). Previous work in genetic epidemiology and molecular genetics has established that SUDs are highly heritable, developmental disorders with important genetic substrates. Building on these findings, new studies using genetically informative approaches are needed to elucidate the complex interplay of genetic and environmental factors in developmental trajectories of SUDs and comorbid conditions, deepen and refine phenotypic definitions of SUDs, and meet the methodologic challenges of the field. Such studies hold great potential to promote understanding of the true contributions of both genetic and environmental factors to initiation, progression, comorbidity, adverse outcomes, and desistance of SUDs; to elucidate mechanisms of risk; and to enhance opportunities for translation to treatment, prevention, gene-finding and molecular studies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23177 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Epidemiology of Drug Abuse (R21) Contact: Marsha F. Lopez, Ph.D., M.H.S. Tel: 301-443-6504 Email: lopezmar@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-231.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor offers support for research projects to enhance our understanding of the nature, extent, distribution, etiology, and consequences of drug use, abuse, and addiction across individuals, families, communities, and diverse population groups. This Program strongly encourages applications that address multiple levels of causation, reflecting the breadth of epidemiology research, that are transdisciplinary in nature and apply novel methods that allow for the advancement of science (e.g., those that investigate interplay among genetic, environmental, and developmental factors, or those that examine how aspects of social environments affect health outcomes), as well as those that take advantage of the investments made by NIH and other funders by using existing data to inform our understanding of drug abuse epidemiology and etiology in a creative and cost efficient manner. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23178 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Epidemiology of Drug Abuse (R03) Contact: Marsha F. Lopez, Ph.D., M.H.S. Tel: 301-443-6504 Email: lopezmar@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-232.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor offers support for research projects to enhance our understanding of the nature, extent, distribution, etiology, and consequences of drug use, abuse, and addiction across individuals, families, communities, and diverse population groups. This Program strongly encourages applications that address multiple levels of causation, reflecting the breadth of epidemiology research, that are transdisciplinary in nature and apply novel methods that allow for the advancement of science (e.g., those that investigate interplay among genetic, environmental, and developmental factors, or those that examine how aspects of social environments affect health outcomes), as well as those that take advantage of the investments made by NIH and other funders by using existing data to inform our understanding of drug abuse epidemiology and etiology in a creative and cost efficient manner. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 24140 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Drug Abuse Prevention Intervention Research (R21) Contact: Kevin P. Conway, Ph.D., Acting Branch Chief Tel: 301-443-6504 Email: kconway@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-312.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose to advance the science of drug abuse and drug-related HIV prevention through 1) the development of novel prevention approaches, 2) the testing of novel and adapted prevention intervention approaches 3) the elucidation of processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions, and 4) the development of new methodologies suitable for the design and analysis of prevention research studies. Programs of research are intended to provide pathways toward the discovery of population-level approaches for the prevention of drug abuse and dependence, drug-related problems (such as mental health, interpersonal violence, criminal involvement, and productivity loss), and drug-related disorders (e.g., comorbid drug and psychiatric disorders; infections such as HIV, hepatitis B, and hepatitis C). This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24141 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Drug Abuse Prevention Intervention Research (R03) Contact: Kevin P. Conway, Ph.D., Acting Branch Chief Tel: 301-443-6504 Email: kconway@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-313.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose to advance the science of drug abuse and drug-related HIV prevention through 1) the development of novel prevention approaches, 2) the testing of novel and adapted prevention intervention approaches 3) the elucidation of processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions, and 4) the development of new methodologies suitable for the design and analysis of prevention research studies. Programs of research are intended to provide pathways toward the discovery of population-level approaches for the prevention of drug abuse and dependence, drug-related problems (such as mental health, interpersonal violence, criminal involvement, and productivity loss), and drug-related disorders (e.g., comorbid drug and psychiatric disorders; infections such as HIV, hepatitis B, and hepatitis C). This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 25975 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: International Research Collaboration on Drug Abuse and Addiction Research (R21) Contact: Steven Gust, Ph.D., Director Tel: 301-443-6480 Email: ipdirector@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-041.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This FOA will expire on January 8, 2015. SYNOPSIS: The National Institute on Drug Abuse (NIDA) solicits collaborative research proposals on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects should have relevance to the mission of NIDA and where feasible should address NIDAs scientific priority areas. While the priorities will change from year to year, in FY12 priority areas include: linkages between HIV/AIDS and drug abuse, and prevention, initiation, and treatment of nicotine and tobacco use (especially among vulnerable populations such as children, adolescents, pregnant women, and those with co-morbid disorders). This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 25977 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: International Research Collaboration on Drug Abuse and Addiction Research (R03) Contact: Steven Gust, Ph.D., Director Tel: 301-443-6480 Email: ipdirector@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-042.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This FOA will expire on January 8, 2015. SYNOPSIS: The National Institute on Drug Abuse (NIDA) solicits collaborative research proposals on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects should have relevance to the mission of NIDA and where feasible should address NIDAs scientific priority areas. While the priorities will change from year to year, in FY12 priority areas include: linkages between HIV/AIDS and drug abuse, and prevention, initiation, and treatment of nicotine and tobacco use (especially among vulnerable populations such as children, adolescents, pregnant women, and those with co-morbid disorders). This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 26300 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Imaging - Science Track Award for Research Transition (I/START) [R03] Contact: Steven Grant, Ph.D. Tel: 301-443-4877 Email: sgrant@nida.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-066.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute on Drug Abuse (NIDA) invites applications to facilitate the entry of investigators to the area of neuroimaging, including both new investigators and established investigators seeking to adopt neuroimaging methodologies in their research programs. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 27771 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse (R34) Contact: Lori Ducharme, Ph.D. Tel: 301-443-6504 Email: Lori.Ducharme@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-130.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute on Drug Abuse (NIDA) and National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite applications for pilot and preliminary research on (1) organizational and/or systems-level interventions that may optimize access, utilization, delivery, quality, and/or cost of treatment services for drug, tobacco, or alcohol abuse or dependence through the use of evidence-based practices; (2) organizational and/or systems-specific adaptations to existing evidence-based practices necessary to facilitate their implementation in these new contexts; and (3) novel service delivery models to be pilot tested in preparation for larger-scale effectiveness trials. This R34 award mechanism provides resources for assessing the feasibility, acceptability, utility, and sustainability of novel approaches to service delivery for drug, tobacco, or alcohol abuse or dependence, with the ultimate goal of facilitating the uptake of scientifically-supported clinical practices. This FOA supports pilot and preliminary research on service delivery models, and organizational or systems-level interventions. This FOA will not support developmental or efficacy studies for novel preventive interventions or clinical therapies, nor will it support efficacy studies on the adaptation of existing interventions for new client populations. This FOA will utilize the NIH R34 Clinical Trial Planning Grant Program award mechanism. --------------------------------------------------------------- Program Number: 28320 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34) Contact: Jacqueline Lloyd, Ph.D. Tel: 301-443-8892 Email: lloydj2@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-171.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. National Institute on Drug Abuse (NIDA) and National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite applications for (a) pilot and/or feasibility testing of new, revised, or adapted preventive intervention approaches targeting the initiation of drug and alcohol use, the progression to abuse or dependence, and the acquisition or transmission of HIV infection among diverse populations and settings; and (b) pre-trial feasibility testing for prevention services and systems research. This R34 mechanism does not support the development of intervention protocols, manuals, or the standardization of protocols. It is expected that research conducted via this R34 mechanism will consist of early stage efficacy, effectiveness or services research that will provide intervention pilot and/or feasibility data that is a pre-requisite for submitting larger drug or alcohol abuse and/or drug- or alcohol-related HIV prevention intervention studies. This FOA will utilize the NIH Planning Grant (R34) award mechanism. --------------------------------------------------------------- Program Number: 32445 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Behavioral Science Track Award for Rapid Transition (B/START) (R03) Contact: Paul Schnur, Ph.D. Tel: 301-443-1887 Email: pschnur@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-239.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides support to facilitate the entry of beginning investigators into the field of behavioral science research. To be appropriate for a B/START award, research must be primarily focused on behavioral processes and research questions. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 87529 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R21) Contact: Redonna Chandler, Ph.D. Tel: 301-443-8768 Email: rchandle@nida.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-128.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2012. SYNOPSIS: The sponsors invite applications for health services and economic research to improve the quality of prevention, treatment, and recovery support services for drug, alcohol and tobacco abuse. Such research projects might emphasize any of the following subjects: (1) clinical quality improvement; (2) organization and delivery of services; (3) implementation research; (4) economic and cost studies; or (5) development or improvement of research methodology, analytic approaches, and measurement instrumentation used in the study of drug, alcohol, and tobacco prevention, treatment, and recovery services. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 87531 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R03) Contact: Redonna Chandler, Ph.D. Tel: 301-443-8768 Email: rchandle@nida.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-129.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2012. SYNOPSIS: The sponsors invite applications for health services and economic research to improve the quality of prevention, treatment, and recovery support services for drug, alcohol and tobacco abuse. Such research projects might emphasize any of the following subjects: (1) clinical quality improvement; (2) organization and delivery of services; (3) implementation research; (4) economic and cost studies; or (5) development or improvement of research methodology, analytic approaches, and measurement instrumentation used in the study of drug, alcohol, and tobacco prevention, treatment, and recovery services. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 87632 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) Contact: Cora Lee Wetherington, Ph.D. Tel: 301-435-1319 Email: cwetheri@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-11-048.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 87634 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03) Contact: Cora Lee Wetherington, Ph.D. Tel: 301-435-1319 Email: cwetheri@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-11-049.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 89222 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Drug Abuse Dissertation Research: Epidemiology, Prevention, Treatment, Services, and Women and Sex/Gender Differences (R36) Contact: Jessica Chambers, Ph.D. Tel: 301-443-2237 Email: jessica_chambers@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-020.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications for support of drug abuse doctoral dissertation research in epidemiology, prevention, treatment, services and/or women and sex/gender differences. This FOA will use the NIH Dissertation (R36) award mechanism. --------------------------------------------------------------- Program Number: 89265 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Behavioral & Integrative Treatment Development Program (R03) Contact: Lisa Onken, Ph.D. Tel: 301-443-2235 Email: Lisa_Onken@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-011.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications for discrete, well-defined projects that can be completed within two years with limited resources. Projects of interest fall within the research domain of behavioral, combined, sequential, or integrated (behavioral/pharmacological) (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain. Specific examples include: 1) Stage I pilot or feasibility studies; 2) secondary analysis of existing data; 3) small, self-contained research projects; 4) development of research assessments or methodology; and 5) development of new research technology. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 91124 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Functional Genetics, Epigenetics, and Non-coding RNAs in Drug Addiction (R03) Contact: John Satterlee, Ph.D. Tel: 301-435-1020 Email: satterleej@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-035.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications for basic functional genomic research in two areas: 1. functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in addictive processes, and 2. detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 91126 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Functional Genetics, Epigenetics, and Non-coding RNAs in Drug Addiction (R21) Contact: John Satterlee, Ph.D. Tel: 301-435-1020 Email: satterleej@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-034.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications for basic functional genomic research in two areas: 1. functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in addictive processes, and 2. detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 91696 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) – NIDA (R21/R33) Contact: Rao S. Rapaka, Ph.D. Tel: 301-435-1304 Email: rr82u@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-274.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications for basic chemistry research applied to drug abuse and addiction. This FOA will utilize the Exploratory/Developmental Phased Innovation (R21/R33) grant mechanism. --------------------------------------------------------------- Program Number: 92005 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Neuroscience Research on Drug Abuse (R21) Contact: Nancy S. Pilotte, Ph.D., Chief Tel: 301-435-1317 Email: npilotte@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-269.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2010. SYNOPSIS: The sponsor invites applications that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction, withdrawal, and treatment, and may be conducted using model systems, animals, and/or humans. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 92008 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Neuroscience Research on Drug Abuse(R03) Contact: Nancy S. Pilotte, Ph.D., Chief Tel: 301-435-1317 Email: npilotte@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-270.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2010. SYNOPSIS: The sponsor invites applications that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction, withdrawal, and treatment, and may be conducted using model systems, animals, and/or humans. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 93879 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Gene-Environment Interplay in Substance Use Disorders (R03) Contact: Naimah Weinberg, M.D. Tel: 301-402-1908 Email: nw46w@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-237.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors provide support to stimulate and expand research on the interplay of genetic and environmental factors in the genesis, course, and outcomes of substance and alcohol use disorders (SUDs). Previous work in genetic epidemiology and molecular genetics has established that SUDs are highly heritable, developmental disorders with important genetic substrates. Building on these findings, new studies using genetically informative approaches are needed to elucidate the complex interplay of genetic and environmental factors in developmental trajectories of SUDs and comorbid conditions, deepen and refine phenotypic definitions of SUDs, and meet the methodologic challenges of the field. Such studies hold great potential to promote understanding of the true contributions of both genetic and environmental factors to initiation, progression, comorbidity, adverse outcomes, and desistance of SUDs; to elucidate mechanisms of risk; and to enhance opportunities for translation to treatment, prevention, gene-finding and molecular studies. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 23723 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institutes of Health/DHHS Title: NIH Exploratory/Developmental Research Grant Program (Parent R21) Contact: Tel: Email: grantsinfo@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-261.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The Exploratory/Developmental Grant (R21) mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. This PA will use the NIH Exploratory/Developmental Research Grant (R21) award mechanism. --------------------------------------------------------------- Program Number: 23724 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institutes of Health/DHHS Title: NIH Small Research Grant Program (Parent R03) Contact: Tel: Email: grantsinfo@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-262.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The National Institutes of Health (NIH) Investigator-Initiated Small Grant (R03) funding opportunity supports small research projects that can be carried out in a short period of time with limited resources. Investigator-initiated research, also known as unsolicited research, is research funded as a result of an investigator submitting a research grant application to NIH in an investigator’s area of interest and competency. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 24152 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: Office of Behavioral and Social Sciences Research/NIH/DHHS Title: Systems Science and Health in the Behavioral and Social Sciences (R21) Contact: Patricia L. Mabry, PhD Tel: 301-402-1753 Email: mabryp@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-315.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. Letters of intent may be submitted thirty days prior to application receipt dates. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications for that propose to develop basic and applied projects utilizing systems science methodologies relevant to human behavioral and social sciences and health. This FOA is intended to encourage a broader scope of topics to be addressed with systems science methodologies, beyond those encouraged by existing open FOAs. Research projects applicable to this FOA are those that are either applied or basic in nature (including methodological development), have a human behavioral and/or social science focus, and feature systems science methodologies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 25795 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: Office of Behavioral and Social Sciences Research/NIH/DHHS Title: Practical Interventions to Improve Medication Adherence in Primary Care (R21) Contact: Wendy Nilsen, PhD Tel: 301-496-0979 Email: nilsenwj@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-023.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: This FOA seeks applications that propose practical interventions to improve adherence to medication. This FOA will support research to test interventions with the potential to significantly improve medication adherence in patients with chronic health conditions in settings where primary health care is delivered (including, dental and eye care settings). Applications may target medication adherence in the context of treatment for a single illness or chronic condition (e.g., hypertension) or multiple comorbid conditions (e.g., hypertension and HIV/AIDS). Studies should use the most rigorous design and methodology possible given the populations and settings in which the study is taking place. Primary outcomes of the research should include: a patient self-report of medication adherence, and at least one other non-self-report measure of medication adherence (e.g., pharmacy refill records, electronic monitoring, etc.). In addition, applications should include a health outcome or biomarker (e.g., blood pressure, viral load in HIV patients, cholesterol levels, HbA1c) that is expected to be affected by changes in the targeted adherence behavior. Researchers should address the capacity of the tested approach for wide dissemination, the sustainability of the approach once the research is concluded, and are encouraged to include measurement and costs of the intervention characteristics and contextual factors that affect implementation and adoption. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 10017 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: Office of Research Infrastructure Programs/NIH/DHHS Title: Development of Animal Models and Related Biological Materials For Research (R21) Contact: Michael C. Chang, Ph.D. Tel: 301-435-0744 Email: changmic@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-138.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2010. SYNOPSIS: The sponsor solicits applications from institutions/ organizations that propose to develop, characterize or improve animal models for human disease or to improve diagnosis and control diseases of laboratory animals that may interfere with research. Models to be considered must be applicable to the research interests of two or more categorical NIH Institutes/Centers. Investigators considering applying are strongly encouraged to consult with NCRR program staff as early as possible to be advised whether this FOA is appropriate. Proposals to develop models that would not have broad applications, but would apply only to a specific disease or category of research, should be proposed to the appropriate categorical institute of the National Institutes of Health (NIH), e.g., models or model systems with primary focus on cancer or heart diseases should contact those categorical institutes at NIH to discuss alternative funding opportunities. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 27313 --------------------------------------------------------------- ***Deadlines: 6/17/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: RFA-DK-12-504--Limited Competition for the Continuation of the Clinical Centers for The Environmental Determinants of Diabetes in the Young (TEDDY) Study (UC4) Contact: Beena Akolkar, Ph.D. Tel: 301-594-8812 Email: akolkarb@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-12-504.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after June 17, 2012. The deadline for receipt of optional letters of intent is June 17, 2012. The deadline for receipt of full applications is July 17, 2012 , by 5:00 PM local time of applicant organization. SYNOPSIS: National Institutes of Health (NIH) and its participating Institutes invite applications from the Principal Investigators of the six current Clinical Centers (CCs) for The Environmental Determinants of Diabetes in the Young (TEDDY) study, an ongoing epidemiological study of type 1 diabetes (T1D) etiology. The TEDDY study involves the rigorous investigation of TEDDY subjects, including data and samples, for the identification of infectious agents, dietary factors, or other environmental factors associated with onset of T1D and/or T1D associated autoimmune markers. The six current CCs have been involved in study design and data and biosample acquisition since the inception of the TEDDY consortium. The CCs have recruited participants and followed the subjects over the past 10 years. This FOA is a one-time solicitation to support the CCs to allow them to continue to retain, follow clinically, and collect biosamples from TEDDY subjects for an additional 5 years. This FOA will utilize the NIH UC4 High Impact Research and Research Infrastructure - Cooperative Agreement Programs. --------------------------------------------------------------- Program Number: 28071 --------------------------------------------------------------- ***Deadlines: 6/17/2012 Sponsor: National Institute of Environmental Health Sciences/NIH/DHHS Title: RFA-ES-12-001--Children's Environmental Health and Disease Prevention Research Centers (P01) Contact: Kimberly Ann Gray, Ph.D. Tel: 919-541-0293 Email: gray6@niehs.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-ES-12-001.html Deadline Note: The deadline for receipt of optional letters of intent is June 17, 2012. The deadline for receipt of full applications is July 17, 2012. SYNOPSIS: National Institute of Environmental Health Sciences (NIEHS) and National Center for Environmental Research (NCER) invite applications to support a transdisciplinary program of basic and applied research to examine the effects of environmental factors on children’s health and well-being. Research conducted through the Centers should include substantive areas of science in children’s health while incorporating innovative technologies and approaches and links to the environment. The revised program encourages strong links between disciplines in the basic, applied, clinical and public health sciences to prevent disease and promote health in all children. This FOA will utilize the NIH P01 Research Program Projects award mechanism. --------------------------------------------------------------- Program Number: 27619 --------------------------------------------------------------- ***Deadlines: 6/18/2012 Sponsor: National Aeronautics & Space Administration Title: ROA 2011: System-Wide Safety Assurance Technologies Project (SSAT2) Contact: Ashok N. Srivastava Tel: Email: Ashok.N.Srivastava@nasa.gov Website:          http://www.grants.gov/search/search.do;jsessionid=wvKrPv2phP5Ljh1yWnLdxj0ycWGGxQtb5Z2cl3xzLXn1ZPGBffhX!-1021879135?oppId=168833&mode=VIEW Full Program:          http://nspires.nasaprs.com/external/solicitations/solicitationAmmendments.do?method=init&solId={2344F7C4-8CF5-D17B-DB86-018B0B184C63}&path=open Deadline Note: Notices of intent are due May 14. 2012. Full proposals will be due June 18, 2012. SYNOPSIS: The System-Wide Safety and Assurance Technologies Project (SSAT) project will identify risks and provide knowledge required to safely manage increasing complexity in the design and operation of vehicles and the air transportation systems, including advanced approaches to enable improved and cost-effective verification and validation of flight-critical systems. SSAT is focused on methods to assess and ensure system-wide safety of complex aviation systems. The project will emphasize proactive methods and technologies, and utilize a systems analysis approach to identify key issues and maintain a portfolio of research leading to potential solutions. A proactive approach to managing system safety requires (1) the ability to monitor the system continuously and to extract and fuse information from diverse data sources to identify emergent anomalous behaviors after new technologies, procedures, and training are introduced; and (2) the ability to reliably predict probabilities of the occurrence of hazardous events and of their safety risks. --------------------------------------------------------------- Program Number: 28725 --------------------------------------------------------------- ***Deadlines: 6/18/2012 Sponsor: National Council on Disability Title: Reforming Social Security's Disability Benefits System Contact: Julie Carroll, Senior Attorney Advisor Tel: 202-272-2008 Email: jcarroll@ncd.gov Website:          http://www.grants.gov/search/search.do;jsessionid=XxTfP0GHlXtXCGxCy0h7p2xBH7pRgpKJTv8MMfSzLwfPVmysnl6M!-253887325?oppId=170733&mode=VIEW Full Program:          http://www.ncd.gov/newsroom/research/051212_Notice SYNOPSIS: The National Council on Disability (NCD) is an independent federal agency charged with making recommendations to Congress and the Administration on issues, policies, and laws affecting people with disabilities. Social Security Disability Insurance (SSDI) and Supplemental Security Income (SSI) provide a vital safety net for a growing number of people with disabilities. SSDI cash benefits are payable to eligible disabled workers and their families after a five month waiting period. These benefits currently average $1,070 per month. According to the Social Security Administration (SSA), almost half of families receiving SSDI benefits rely on Social Security for the majority of their family income. Some SSDI beneficiaries who meet asset and income limitations or have extraordinary medical expenses also receive Supplemental Security Income. After a two year waiting period, most SSDI beneficiaries are also eligible for Medicare. On average, each disability benefit award is valued at $250,000 in SSDI and Medicare benefits over a beneficiary's lifetime. According to the Congressional Budget Office (CBO), between 1970 and 2009, the number of people receiving disability benefits more than tripled from 2.7 million to 9.7 million. Despite the growth in these programs and several demonstration initiatives to make it easier for people receiving these benefits to transition back to work, the research shows that these programs continue to create work disincentives for applicants and beneficiaries, erode work capacity, foster long-term dependence, and increase poverty among the very people they are intended to help. Additionally, the programs, as they now exist, are not fiscally sustainable. In their 2012 Annual Report, the Social Security Trustees projected that the Disability Insurance Trust Fund will be exhausted in 2016. The failings of current policy and the need for major structural reforms have been documented and discussed extensively. Despite repeated calls for reform of these Social Security Programs by scholars, policymakers, and government researchers, no appreciable modernization has occurred in these programs. For example, the criteria for SSI/SSDI eligibility have not changed since the early 1960s—50 years ago. Additionally, though advances in technology, workplace accommodations, and legal protections against discrimination have made it possible for many people with disabilities to work, complete inability to work remains a criterion for receiving social security benefits. In light of the importance of the Social Security Disability programs for people with disabilities, and the impending threat to the fiscal soundness of the Social Security Trust Fund, responsible reforms are needed that will ensure the fiscal integrity of these programs while preserving vital benefits for people with disabilities. NCD would like to update and build on previous work on these issues and develop recommendations to modernize and preserve the Social Security Disability Programs in ways that will optimize work opportunities for the people with disabilities who are able to work and preserve the safety net for those who will not be able to work. --------------------------------------------------------------- Program Number: 21123 --------------------------------------------------------------- ***Deadlines: 6/18/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: RFA-DC-12-002-- Improving Access to Hearing Health Care (STTR) [R41/R42] Contact: Roger L. Miller, Ph.D. Tel: 301-402-3458 Email: millerog@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-DC-12-002.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after February 18, 2011. The deadlines for receipt of optional letters of intent are: February 18, 2011; October 18, 2011; and June 18, 2012. The corresponding deadlines for receipt of full applications are: March 18, 2011; November 18, 2011; and July 18, 2012. SYNOPSIS: The sponsor invites Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose the development and translation of technologies to improve hearing healthcare outcomes. Responsive applications must seek to increase utilization of hearing health care technology by underserved patients and thus reduce health disparities. This FOA will utilize the NIH R41/R42 Small Business Technology Transfer (STTR) Grant for Phase I, Phase II, and Fast-Track applications. --------------------------------------------------------------- Program Number: 26665 --------------------------------------------------------------- ***Deadlines: 6/18/2012 Sponsor: U.S. Agency for International Development Title: Health Strategic Information (SI) Contact: USAID/Mozambique Tel: (258-1) 35 20 00 Email: apssi@usaid.gov Full Program:          http://www07.grants.gov/search/synopsis.do;jsessionid=sZBmPdZLvpDp2t3RmwzV92M8BFmm9hgzMv2L2QQNYFk53yYGxwsX!-1373114776 Deadline Note: Deadline for questions is February 1, 2012, 17:30 Maputo Time; Deadline for receipt of Concept Papers is March 1, 2012; Final Closing Date of Annual Program Statement (APS): June 18, 2012. SYNOPSIS: The United States Government as represented by the United States Agency for International Development (USAID) is seeking concept papers and eventual full applications from non-governmental organizations working in Mozambique (both registered local and international) in HIV-AIDS for a program titled: Strategic Information (SI). This APS solicits concept papers for appropriately designed monitoring and evaluation support programs to support the capacity of the Mozambican National Council for Combating AIDS (CNCS) to continue to build capacity of their existing central- and sub-national monitoring and evaluation data systems. These programs will continue to support the existing monitoring and evaluation systems that CNCS has in place, specifically the national HIV/AIDS database and the ongoing work of CNCS and affiliated international donor organizations to increase provincial level M&E capacity to use and manage data. Sub-national M&E capacity should be focused around effective data collection and reporting with both paper-based and electronic data systems and a better understanding of M&E and epidemiology concepts for enhanced program management. Special consideration will be given to concept papers proposing implementation of targeted, sustainable, evidencebased, effective capacity building activities, best practices recommendations and ways forward in terms of building provincial and community level M&E capacity. --------------------------------------------------------------- Program Number: 28132 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Integrative Omics Data Analysis for Discovery in Lung Diseases (R01) Contact: Weiniu Gan, Ph.D. Tel: 301-435-0202 Email: ganw2@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-155.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 19 annually. The deadline for receipt of optional letters of intent is May 19 annually. The deadline for receipt of full applications is June 19 annually, by 5:00 PM local time of applicant organization. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) invites applications to: (1) generate systems-level models of pulmonary pathobiology through integrative analyses of existing omics (e.g., genomics, transcriptomics, proteomics, metabolomics) data; and (2) experimentally test novel predictions of these models using human tissues/cells and/or mammalian animal models. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 28008 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: RFA-HG-12-006--Genomic Medicine Pilot Demonstration Projects (U01) Contact: Ebony Bookman, Ph.D. Tel: 919-541-0367 Email: bookmane@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-12-006.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 1, 2012 The deadline for receipt of optional letters of intent is June 19, 2012. The deadline for receipt of full applications is July 19, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Human Genome Research Institute (NHGRI) invites applications to support a consortium of collaborative genomic medicine pilot Demonstration Projects designed to demonstrate the feasibility of, and develop methods for, incorporating an individual patient’s genomic findings into his or her clinical care. This program will use the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 28009 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: RFA-HG-12-007--Genomic Medicine Pilot Demonstration Projects Coordinating Center (U01) Contact: Ebony Bookman, Ph.D. Tel: 919-541-0367 Email: bookmane@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-12-007.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 1, 2012 The deadline for receipt of optional letters of intent is June 19, 2012. The deadline for receipt of full applications is July 19, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Human Genome Research Institute (NHGRI) invites applications to support a Coordinating Center (CC) to serve as a centralized resource to facilitate and support a consortium of collaborative genomic medicine pilot Demonstration Projects designed to demonstrate the feasibility of, and develop methods for, incorporating an individual patient’s genomic findings into his or her clinical care. This program will use the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 28161 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: RFA-HG-12-005--Specialized Centers of Excellence in ELSI Research (CEER) (P50) Contact: Ms. Joy T. Boyer Tel: 301-402-4997 Email: jb40m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-HG-12-005.html Deadline Note: The deadline for receipt of optional letters of intent is June 19, 2012. The deadline for receipt of full applications is .July 19, 2012. SYNOPSIS: National Human Genome Research Institute (NHGRI) invites applications for the support of Specialized Centers (P50) of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEERs). The CEER program is designed to develop and support trans-disciplinary research teams that have the expertise and flexibility to anticipate, conduct research on, and respond quickly to a range of ELSI issues related to the rapidly increasing availability and use of genomic approaches and information. CEERs are intended to provide an opportunity to cross disciplinary boundaries and create new research opportunities between and among investigators such as those in the basic genomic and social sciences, clinical and health policy research, ethics, law, the humanities, and various stakeholder communities. In addition, CEERs will play a role in ensuring that relevant ELSI research findings and deliberations are made available to policy makers as appropriate. Finally, CEERs will be responsible for contributing to training the next generation of ELSI researchers, with particular emphasis on training researchers from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds. This FOA will utilize the NIH P50 Specialized Center award mechanism. --------------------------------------------------------------- Program Number: 28162 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: RFA-HG-12-012--Exploratory Centers of Excellence in ELSI Research (CEER) (P20) Contact: Ms. Joy T. Boyer Tel: 301-402-4997 Email: jb40m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-HG-12-012.html Deadline Note: The deadline for receipt of optional letters of intent is June 19, 2012. The deadline for receipt of full applications is .July 19, 2012. SYNOPSIS: National Human Genome Research Institute (NHGRI) invites applications for the support of Exploratory Centers (P20) of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEERs). Exploratory Centers will support expanding or modifying existing resources at an institution for the purpose of developing a Specialized Center (P50) CEER application. The CEER program is designed to develop and support trans-disciplinary research teams that have the expertise and flexibility to anticipate, conduct research on, and respond quickly to a range of ELSI issues related to the rapidly increasing availability and use of genomic approaches and information. CEERs are intended to provide an opportunity to cross disciplinary boundaries and create new research opportunities between and among investigators such as those in the basic genomic and social sciences, clinical and health policy research, ethics, law, the humanities, and various stakeholder communities. In addition, CEERs will play a role in ensuring that relevant ELSI research findings and deliberations are made available to policy makers as appropriate. Finally, CEERs will be responsible for contributing to training the next generation of ELSI researchers, with particular emphasis on training researchers from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds. This FOA will utilize the NIH P20 Exploratory Grants award mechanism. --------------------------------------------------------------- Program Number: 28288 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: National Institute on Aging: Revision Requests for Active Alzheimer's Disease Centers (P50) Contact: Creighton Phelps, PhD Tel: 301-496-9350 Email: phelpsc@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-170.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: June 19, 2012; and then January 25, May 25, and September 25 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute on Aging (NIA) invites revision applications to ongoing NIA-supported Alzheimer's Disease Centers (P50) in order to expand the scope of the existing award. Revision applications should include proposal of a new core or project. Revision applications may not request support beyond the end date of the Parent P50 award. This FOA will utilize the NIH P50 Specialized Center mechanism. --------------------------------------------------------------- Program Number: 28856 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: Administration on Developmental Disabilities/ACF/DHHS Title: Projects of National Significance: Data Collection and Information Dissemination on Residential and In Home Services for Persons with Developmental Disabilities Contact: Katherine Cargill-Willis Tel: 202-690-5791 Email: katherine.cargill-willis@acf.hhs.gov Website:          http://www.grants.gov/search/search.do;jsessionid=GrSPP7MGvTjzYwYFCVLNtvwD9wfGZQknt0M2zvm1pFWjRLJXC8JR!1571115659?oppId=171855&mode=VIEW Full Program:          http://www.acf.hhs.gov/grants/open/foa/view/HHS-2012-ACF-ADD-DN-0311 Deadline Note: Applicants are strongly encouraged to notify ACF of their intention to submit an application under this announcement. Letters of Intent are due on June 20, 2012. Full applications are due on July 20, 2012. SYNOPSIS: The purpose of this project is to maintain and extend national and state-by-state statistics on services and supports for people with I/DD. The project will include funding for supports and services financed by a variety of funds including public and non-public, Medicaid-funded and non-Medicaid funded residential and supportive services. The project will examine, report on, and provide rapid responses regarding the places people with I/DD live and the innovative ways States are supporting people with I/DD living in the community. --------------------------------------------------------------- Program Number: 28857 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: Administration on Developmental Disabilities/ACF/DHHS Title: Projects of National Significance: Data Collection on Financial and Programmatic Trends for People with Developmental Disabilities Contact: Katherine Cargill-Willis Tel: 202-690-5791 Email: katherine.cargill-willis@acf.hhs.gov Website:          www.grants.gov/search/search.do;jsessionid=GrSPP7MGvTjzYwYFCVLNtvwD9wfGZQknt0M2zvm1pFWjRLJXC8JR!1571115659?oppId=171854&mode=VIEW Full Program:          http://www.acf.hhs.gov/grants/open/foa/view/HHS-2012-ACF-ADD-DN-0291 Deadline Note: Letters of Intent are due by June 20, 2012. Full proposals are due by July 20, 2012. SYNOPSIS: The Administration on Developmental Disabilities (ADD), Administration for Children and Families (ACF), U.S. Department of Health and Human Services (HHS), announces the availability of Fiscal Year (FY) 2012 funds for a cooperative agreement authorized under Subtitle E of the Developmental Disabilities Assistance and Bill of Rights Act of 2000, Projects of National Significance. Under this Subtitle, funds will be awarded to collect, analyze, and report on data to describe services and supports for persons with intellectual and developmental disabilities (I/DD). The purpose of this project is to conduct a national study that describes changes in public services and supports for people with intellectual and developmental disabilities by examining spending, including local, State, and Federal spending, with a particular focus on long-term supports and services to people with I/DD. --------------------------------------------------------------- Program Number: 28860 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: Administration on Developmental Disabilities/ACF/DHHS Title: Projects of National Significance: Data Collection on the Employment Status of People with Developmental Disabilities Contact: Katherine Cargill-Willis Tel: 202-690-5791 Email: katherine.cargill-willis@acf.hhs.gov Website:          http://www.grants.gov/search/search.do;jsessionid=GrSPP7MGvTjzYwYFCVLNtvwD9wfGZQknt0M2zvm1pFWjRLJXC8JR!1571115659?oppId=171853&mode=VIEW Full Program:          http://www.acf.hhs.gov/grants/open/foa/view/HHS-2012-ACF-ADD-DN-0285 Deadline Note: Letters of Intent are due on June 20, 2012. Full proposals are due on July 20, 2012. SYNOPSIS: The purpose of the project is to examine the employment status of people with I/DD and related outcomes as a result of programs that support their education and employment. The project will examine, report on, and provide rapid responses regarding the employment status of people with I/DD and related outcomes, as a result of policies and programs, and support their employment. --------------------------------------------------------------- Program Number: 00725 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: Small Grant Program for Conference Support (R13) Contact: Linda Franklin Tel: 301-427-1904 Email: Linda.Franklin@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-231.html Deadline Note: This FOA will expire on October 23, 2012. SYNOPSIS: The sponsor supports conferences related to health services research through its Small Conference Grant Program, in order to further the sponsor's mission of improving the quality, safety, efficiency and effectiveness of health care for all Americans. This FOA will use the R13 conference grant award mechanism. --------------------------------------------------------------- Program Number: 74551 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: AHRQ Grant Program for Large or Recurring Conferences (R13) Contact: Linda Franklin Tel: 301-427-1904 Email: linda.franklin@ahrq.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-257.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 21, 2012; June 20, 2012; and October 22, 2012. This program will expire on January 8, 2013. SYNOPSIS: The sponsor seeks to support conferences that help to further its mission to improve the quality, safety, efficiency, and effectiveness of health care for all Americans. The types of conferences eligible for support include: 1) Research development - conferences where issues or challenges in the practice and delivery of health care are defined and a research agenda or strategy for studying them is developed; 2) Research design and methodology - conferences where methodological and technical issues of major importance to the field of health services research are addressed or new designs and methodologies are developed; 3) Dissemination and implementation - conferences where research findings and evidence-based information and tools are summarized, communicated and used by organizations and individuals that have the capability to use the information to improve the outcomes, quality, access to, and cost and utilization of health care services; and/or, 4) Research training, infrastructure and career development -conferences where faculty, trainees and students are brought together with stakeholders to develop, share or disseminate research products, experiences, curricula, syllabi, or training competencies. AHRQ is especially interested in supporting conferences that include plans for disseminating complimentary conference materials and products beyond the participants attending the event. Such strategies might include, but are not limited to, submitting articles for publication, posting information on a Web site, and seeking formal opportunities to discuss conference information with others. This FOA will use the conference grant (R13) award mechanism. --------------------------------------------------------------- Program Number: 28775 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: Bureau of Primary Health Care/HRSA/DHHS Title: State and Regional Primary Care Associations (PCA) Cooperative Agreements - Alabama and Pacific Islands Contact: Denise Nguyen Tel: 301-594-4300 Email: bphcpca@hrsa.gov Website:          http://www.grants.gov/search/search.do?oppId=171314&mode=VIEW Full Program:          http://apply07.grants.gov/apply/opportunities/instructions/oppHRSA-12-183-cfda93.129-cid5528-instructions.pdf Deadline Note: The application due date on Grants.gov is June 20, 2012. The supplemental information due date on EHB is July 10, 2012. SYNOPSIS: This announcement solicits applications for State and Regional Primary Care Associations (PCA) Cooperative Agreements. The Health Resources and Services Administration (HRSA) seeks to establish cooperative agreements with state and regional organizations to provide training and technical assistance (T/TA) to potential and existing section 330 health centers, including: Statewide/Regional Health Center T/TA Activities: Conduct statewide/regional health center T/TA activities based on the identified statewide/regional T/TA needs in the areas of Program Requirements and Performance Improvement; and Statewide/Regional Program Assistance: Conduct statewide/regional program assistance activities based on statewide/regional and/or HRSA/BPHC priorities. --------------------------------------------------------------- Program Number: 83456 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: Centers for Medicare and Medicaid Services/DHHS Title: Hispanic Health Services Research Grant Program Contact: Richard Bragg, Ph.D. Tel: 410-786-7250 Website:          http://www.grants.gov/search/search.do;jsessionid=Tmh2P2GG2mJ1vh4H9zLxy2GQhbn2T4rL6bJl5v1C3hj2LnRzsjhV!109354571?oppId=171233&mode=VIEW Full Program:          https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=14404 Deadline Note: Prospective applicants choosing to submit an LOI are asked to submit by May 25, 2012. Letters of Intent are not required. The Grants.gov application due date is June 20, 2012. Applicants must also mail a copy, which is due on June 20, 2012. SYNOPSIS: The sponsor is announcing the availability of funds under its grant program to assist researchers in conducting health services research for 2011. --------------------------------------------------------------- Program Number: 08884 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: Department of the Army Title: DoD Autism Idea Development Award Contact: Tel: Website:          http://www.grants.gov/search/synopsis.do;jsessionid=rRxQPhxQB2n1XJ228rDPBZZKvHGLXDLZXTk0mGGw6vhZxbpmsZPX!917914427 Deadline Note: The pre-application submission deadline is June 20, 2012. The invited application submission deadline is September 20, 2012. SYNOPSIS: The Idea Development Award seeks applications from all areas of basic and preclinical research. The FY12 ARP Idea Development Award encourages applications that address the critical needs of the ASD community. --------------------------------------------------------------- Program Number: 22801 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: Department of the Army Title: DoD Autism Pilot Award Contact: Tel: Website:          http://www.grants.gov/search/search.do;jsessionid=rRxQPhxQB2n1XJ228rDPBZZKvHGLXDLZXTk0mGGw6vhZxbpmsZPX!917914427?oppId=168755&mode=VIEW Deadline Note: The pre-application submission deadline is June 20, 2012. The invited application submission deadline is September 20, 2012. SYNOPSIS: The Pilot Award seeks applications from all areas of basic and preclinical research. The FY12 ARP Pilot Award encourages applications that address the critical needs of the ASD community. --------------------------------------------------------------- Program Number: 00810 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) Contact: Phillip J. Daschner, Ph.D. Tel: 301-496-1951 Email: PD93U@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-094.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after . NCI will not accept letters of intent under this FOA. The deadlines for receipt of full applications June 20 annually and November 20 annually. This program will expire on November 21, 2014. SYNOPSIS: The Center to Reduce Cancer Health Disparities (CRCHD) and the Division of Cancer Biology (DCB), at the National Cancer Institute (NCI), invite grant applications from investigators interested in conducting basic research studies into the biological causes and mechanisms of cancer health disparities. These awards will support pilot and feasibility studies, development and testing of new methodologies, secondary data analyses, and innovative mechanistic studies that investigate biological/genetic bases of cancer health disparities. This FOA is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research and to provide resources for those investigators that may need additional support on their path to successfully compete for R01 funding in basic mechanistic research in understanding cancer health disparities. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 00811 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Basic Cancer Research in Cancer Health Disparities (U01) Contact: Phillip J. Daschner, Ph.D. Tel: 301-496-1951 Email: PD93U@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-095.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after . NCI will not accept letters of intent under this FOA. The deadlines for receipt of full applications June 20 annually and November 20 annually. This program will expire on November 21, 2014. SYNOPSIS: The Center to Reduce Cancer Health Disparities (CRCHD) and the Division of Cancer Biology (DCB), at the National Cancer Institute (NCI), invite grant applications from investigators interested in conducting basic research studies into the biological causes and mechanisms of cancer health disparities. These awards will support pilot and feasibility studies, development and testing of new methodologies, secondary data analyses, and innovative mechanistic studies that investigate biological/genetic bases of cancer health disparities. This FOA is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research and to provide resources for those investigators that may need additional support on their path to successfully compete for R01 funding in basic mechanistic research in understanding cancer health disparities. This FOA will use the NIH Cooperative Agreement (U01) grant mechanism. --------------------------------------------------------------- Program Number: 02576 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21) Contact: Anil Wali, Ph.D. Tel: 301-496-7344 Email: walia@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-096.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after . NCI will not accept letters of intent under this FOA. The deadlines for receipt of full applications June 20 annually and November 20 annually. This program will expire on November 21, 2014. SYNOPSIS: The Center to Reduce Cancer Health Disparities (CRCHD) and the Division of Cancer Biology (DCB) of the National Cancer Institute (NCI), invite applications by investigators from diverse backgrounds underrepresented in basic and biomedical cancer research. The NIH recognizes a unique and compelling need to promote diversity in the NIH-funded research workforce. The purpose of this FOA is to improve the diversity of the NCI-funded research workforce by supporting and recruiting eligible investigators from groups that have been shown to be underrepresented in the biomedical, clinical, behavioral, and social sciences including individuals from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from socially, culturally, economically, or educationally disadvantaged backgrounds that have recently and demonstrably inhibited their ability to pursue a career in health-related research. This funding opportunity will also provide a bridge to investigators that have completed their research training and may need extra time to develop a research project grant application. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 27026 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: RFA-MH-13-040--Grand Challenges in Global Mental Health: Integrating Mental Health into Chronic Disease Care Provision in Low- and Middle-Income Countries (R01) Contact: Pamela Y. Collins, MD, MPH Tel: 3017 Email: globalMH2013@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-13-040.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 20, 2012. The deadline for receipt of optional letters of intent is May 20, 2012. The deadline for receipt of full applications is June 20, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute of Mental Health (NIMH) invites applications that promote the establishment of an evidence base on contextually relevant, cost-effective integrated care interventions for the treatment of patients with co-morbid mental and chronic physical illnesses in low- and middle-income countries (LMICs). Specifically, this FOA will support research that builds on existing chronic disease care and treatment platforms to incorporate management of mental illness, employs a multi-disease care management approach with potentially high impact for improving patient- and system-level outcomes (e.g., patient morbidity and functioning; improved diagnosis of mental illness among patients with chronic medical illnesses; decreased cost to the health care system; improved care coordination), and establishes feasible methods for multi-disease management in LMICs. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 28771 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: Substance Abuse & Mental Health Services Administration Title: National Center for Child Traumatic Stress - Category I Contact: Malcolm Gordon, Ph.D. Tel: 240-276-1856 Email: malcolm.gordon@samhsa.hhs.gov Website:          http://www.samhsa.gov/grants/2012/sm_12_005.aspx Full Program:          http://www.grants.gov/search/search.do?oppId=171455&mode=VIEW SYNOPSIS: The Substance Abuse and Mental Health Services Administration, Center for Mental Health Services is accepting applications for fiscal year (FY) 2012 National Child Traumatic Stress Initiative (NCTSI), National Center for Child Traumatic Stress (NCCTS) grant. This program is designed to improve the quality of trauma treatment and services in communities for children, adolescents, and their families who experience or witness traumatic events and to increase access to effective trauma-focused treatment and services for children and adolescents throughout the nation. --------------------------------------------------------------- Program Number: 27969 --------------------------------------------------------------- ***Deadlines: 6/21/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: RFA-CA-12-006--Cancer Target Discovery and Development (CTDD) Network (U01) Contact: Daniela S. Gerhard, Ph.D., Director Tel: 301-451-8027 Email: gerhardd@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-006.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 21, 2012. The deadline for receipt of optional letters of intent is May 21, 2012. The deadline for receipt of full applications is June 21, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Cancer Institute (NCI) invites applications for innovative research on high throughput approaches to the discovery and characterization of new cancer targets and their modulators. Projects resulting from this FOA are expected to bridge the gap between the enormous volumes of data generated by the comprehensive molecular characterizations of many cancer subtypes and the ability to use these data for the development of human cancer therapeutics and associated response markers. Applicants must propose research projects focused on high-throughput identification and/or characterization of potential targets for cancer therapy, and/or the identification of small molecules that modulate validated cancer targets. Proposed projects are expected to combine in-depth mining of large-scale genomic data, systems biology analyses and/or experimental approaches to provide initial characterization of functional significance. This characterization may involve the studies of modulation/perturbation of the potential targets (or target combinations) using, e.g., small molecules and/or oligonucleotides. Development and/or improvement of technologies serving the main goals of the project may also be proposed. In addition to conducting individual research projects, the CTDD awardees will also be expected to contribute to trans-Network activities, including participation in joint pilot research projects. Successful applicants will join the existing Network. This program will use the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 25484 --------------------------------------------------------------- ***Deadlines: 6/21/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: RFA-DC-12-005--Improving Access to Hearing Health Care (STTR) [R41/R42] Contact: Roger L. Miller, Ph.D Tel: 301-402-3458 Email: millerog@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-DC-12-005.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 22, 2012. The deadlines for receipt of optional letters of intent are: January 22, 2012; May 21, 2012; September 22, 2012; January 22, 2013; May 21, 2013; September 22, 2013. The deadlines for receipt of full applications are: February 22, 2012; June 21, 2012; October 22, 2012; February 22, 2013; June 21, 2013; October 22, 2013, by 5:00 PM local time of applicant organization. SYNOPSIS: The sponsor invites applications for Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose the development and translation of technologies to improve hearing healthcare outcomes. Responsive applications must seek to increase utilization of hearing health care technology by underserved patients and thus reduce health disparities. This FOA will utilize the R41/R42 Small Business Technology Transfer (STTR) Grant - Phase I, Phase II, and Fast-Track applications. --------------------------------------------------------------- Program Number: 27593 --------------------------------------------------------------- ***Deadlines: 6/21/2012 Sponsor: National Institutes of Health/DHHS Title: RFP -- AMENDMENT -- NIH Tetramer Core Facility Contact: Tom Bahrami, Contracting Officer Tel: 301-451-2654 Email: bahramit@niaid.nih.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=36a1be72bf6cb82522f12ff513b016d2&tab=core&_cview=0 SYNOPSIS: A -- NIH TETRAMER CORE FACILITY SOL RFP-NIAID-DIAT-NIHAI2011132 POCom Bahrami, Phone: 3014512654, Liem T. Nguyen, Phone: 301-496-0612 WEB: FBO.govPermalink https://www.fbo.gov/spg/HHS/NIH/NIAID/RFP-NIAID-DIAT-NIHAI2011132/listing.html E-MAIL: bahramit@niaid.nih.gov, lnguyen@niaid.nih.gov bahramit@niaid.nih.gov, lnguyen@niaid.nih.gov NAICS: 541711 Introduction The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH),of the Department of Health and Human Services (DHHS) supports research relatedto the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The NIAID, Division of Allergy, Immunology and Transplantation, has a requirement for continuing the NIH Tetramer Core Facility contract. The scope of activities to be conducted by the NIH Tetramer Core Facility Contractor include synthesis and distribution of soluble MHC-peptide tetramer and related reagents to the global research community, and performance of research and development to improve tetramer technologies and increase the types of products available to the biomedical research community. Such reagents include, but are not limited to, mouse, non-human primate, human, and other mammalian MHC class I monomers and tetramers; custom and pre-made mouse, non-human primate, human, and other mammalian class II tetramers; non-classical MHC TL, Qa-1, and mammalian CD1 monomers and tetramers; CD1d and other MHC ligands; and fluorophores for tetramer labeling/detection. Description The scope of activities to be carried out by the NIH Tetramer Core Facility Contractor is: synthesis and distribution of soluble MHC-peptide tetramer and related reagents to the global research community; and performance of research and development to improve tetramer technologies and increase the types of products available to the biomedical research community. Such reagents include, but are not limited to, mouse, non-human primate, human, and other mammalian MHC class I monomers and tetramers; custom and pre-made mouse, non-human primate, human, and other mammalian class II tetramers; non-classical MHC TL, Qa-1, and mammalian CD1 monomers and tetramers; CD1d and other MHC ligands; and fluorophores for tetramer detection. The major functions to be carried out by the contractor are: A. Operate a tetramer production facility B. Operate a distribution, tracking, and reporting system of reagents produced C. Maintain a NIH Tetramer Core Facility website and provide related maintenance D. Conduct tetramer technology research and development E. Manage the Tetramer Core Facility program While the NIH Tetramer Core Facility is responsible for providing ligands (peptidic and nonpeptidic) for all pre-made reagents (where required), the NIH Tetramer Core Facility is NOT responsible for supplying ligands for custom MHC Class I and II monomer and tetramer production. Ligands for custom monomer/tetramer synthesis will be provided by the approved requestors, where required. It is anticipated that one cost reimbursement term, level of effort contract will be awarded for a 1-year period of performance beginning on or about 3/1/2013. OPTIONS 1-6: EXTEND TERM OF THE CONTRACT. The Government may extend the contract period of performance by one year. The total period of performance resulting from base period plus exercising all term option years is seven years. If Options 1-6 are exercised, the services required will be the same as provided during the base year. OPTIONS 7-13: INCREASE IN LEVEL OF EFFORT. The level of effort may be increased by 2,254 hours up to 4 (four) times per year for a total increase of 9,016 hours in the contract base year and in each year in which Options 1-6 is exercised. Options will be evaluatedwith the base requirements of the statement of work. It is estimated that the provision of FTEs will be approximately 10.8. For this solicitation, the NIAID requires proposals to be submitted in three methods: (1) Paper, (2) Disc (CD or DVD), and (3) Online via the NIAID Electronic Contract Submission System (eCPS). The content of the paper, disc, and online proposals must be identical. Submission of proposals by facsimile or e-mail is not acceptable. For directions on usingeCPS, go to the website https://ecps.niaid.nih.gov and then click on "How to Submit." To submit online using eCPS, offerors must have a valid NIH electronic Research Administration (eRA) Commons account, which provides authentication and serves as a vehicle for secure transmission of documents and communication with the NIAID. The eRA Commons registration process may take up to 4 weeks. For more information, please see http://era.nih.gov/applicants/how-to_steps.cfm#register.Any responsible offeror may submit a proposal which will be considered by the Agency. This RFP will be available electronically on/about 3/23/2012, and may be accessed through FedBizOpps http://www.fedbizopps.gov/. This notice does not commit the Government to award a contract. No collect calls will be accepted. No facsimile transmissions will be accepted. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=36a1be72bf6cb82522f12ff513b016d2&tab=core&_cview=0 Posted 03/08/12 (W-SN02692352). (0068) --------------------------------------------------------------- Program Number: 28433 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: Food & Drug Administration Title: RFA-FD-12-020--Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability (U01) Contact: Stephanie Kim Tel: 240-276-9308 Email: Stephanie.Kim@fda.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-FD-12-020.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 1, 2012. The sponsor will not accept letters of intent under this FOA . The deadline for receipt of full applications is June 22, 2012 by 5:00 PM local time of applicant organization. SYNOPSIS: FDA invites applications to study the effect of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability. Formulations having the same active and inactive ingredients in the same concentrations may still exhibit differences in physicochemical properties due to differences in the manufacturing process. Key physicochemical properties which impact clearance, distribution, and drug release will be investigated. This FOA will utilize the U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 22255 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: National Cooperative Drug Discovery/ Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U19) Contact: Linda Brady, Ph.D., Director Tel: 301-443-3563 Email: lbrady@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-207.html Deadline Note: The deadlines for receipt of optional letters of intent are: September 26, 2011; January 24, 2012; May 22, 2012; September 24, 2012; January 22, 2013. The corresponding deadlines for receipt of full applications are: October 24, 2011; February 24, 2012; June 22, 2012; October 22, 2012; February 22, 2013 . This program will expire on February 23, 2013. SYNOPSIS: The sponsors provide support for multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness, drug or alcohol addiction. The objectives of this program are to: accelerate innovative drug discovery; develop pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction; develop and validate models for evaluating novel therapeutics for mental disorders; and support early phase human clinical testing to rapidly assess the safety and efficacy of promising drug candidates and new indications for IND-ready drugs for the treatment of mental disorders or alcohol addiction. The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite applications to advance the discovery, preclinical development, and proof of concept testing of new, rationally based candidate medications to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Partnerships between academia and industry are strongly encouraged. This FOA will utilize the NIH U19 Research Program – Cooperative Agreements award mechanisms. --------------------------------------------------------------- Program Number: 27478 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: RFA-MH-13-060--Harnessing Advanced Health Technologies to Drive Mental Health Improvement (R01) Contact: David Chambers, D.Phil Tel: 301-443-3747 Email: dchamber@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-13-060.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 22, 2012. The deadline for receipt of optional letters of intent is May 22, 2012. The deadline for receipt of full applications is June 22, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute of Mental Health (NIMH) invites applications to test the innovative use of existing technologies to significantly improve access to and quality of mental health care, and to propose the collection and use of actionable mental health information to improve outcomes of people with mental disorders. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27479 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: RFA-MH-13-061--Harnessing Advanced Health Technologies to Drive Mental Health Improvement (R34) Contact: David Chambers, D.Phil Tel: 301-443-3747 Email: dchamber@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-13-061.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 22, 2012. The deadline for receipt of optional letters of intent is May 22, 2012. The deadline for receipt of full applications is June 22, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute of Mental Health (NIMH) invites applications to test the innovative use of existing technologies to significantly improve access to and quality of mental health care, and to propose the collection and use of actionable mental health information to improve outcomes of people with mental disorders. This FOA will use the NIH R34 Clinical Trial Planning Grant Program award mechanism. --------------------------------------------------------------- Program Number: 77083 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: National Cooperative Drug Discovery/ Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (UM1) Contact: Linda Brady, Ph.D., Director Tel: 301-443-3563 Email: lbrady@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-206.html Deadline Note: The deadlines for receipt of optional letters of intent are: September 26, 2011; January 24, 2012; May 22, 2012; September 24, 2012; January 22, 2013. The corresponding deadlines for receipt of full applications are: October 24, 2011; February 24, 2012; June 22, 2012; October 22, 2012; February 22, 2013 . This program will expire on February 23, 2013. SYNOPSIS: The sponsors provide support for multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness, drug or alcohol addiction. The objectives of this program are to: accelerate innovative drug discovery; develop pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction; develop and validate models for evaluating novel therapeutics for mental disorders; and support early phase human clinical testing to rapidly assess the safety and efficacy of promising drug candidates and new indications for IND-ready drugs for the treatment of mental disorders or alcohol addiction. The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite applications to advance the discovery, preclinical development, and proof of concept testing of new, rationally based candidate medications to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Partnerships between academia and industry are strongly encouraged. This FOA will utilize the NIH UM1 Multi-Component Research Project Cooperative Agreements award mechanisms. --------------------------------------------------------------- Program Number: 81498 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: NIDCD Research Grants for Translating Basic Research into Clinical Tools for Human Health (R21) Contact: Amy M. Donahue, Ph.D. Tel: 301-402-3458 Email: donahuea@nidcd.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-004.html Deadline Note: The deadlines for receipt of optional letters of intent are: May 22, 2012, January 22, 2013 and September 22, 2013. The deadlines for receipt of full applications are: June 22, 2012, February 22, 2013 and October 22, 2013. This program will expire on October 23, 2013. SYNOPSIS: The sponsor offers support for applications which translate basic research findings into clinical tools for better human health in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech and language. The intent of this Funding Opportunity Announcement (FOA) is to provide a new avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects. The scope of this FOA includes a range of activities to encourage translation of basic research findings which will impact the diagnosis, treatment and prevention of communication disorders. Multi-institutional, multi-disciplinary, and academic-industrial collaborations studies are encouraged. This FOA is not intended for outcome studies, the extension of ongoing clinical research studies, the optimization of current clinical protocols, or pre-translational studies. Connection to the clinical condition must be clearly established and the outcomes of the grant must have practical clinical impact. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 91083 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: NIDCD Research Grants for Translating Basic Research into Clinical Tools for Human Health (R01) Contact: Amy M. Donahue, Ph.D. Tel: 301-402-3458 Email: donahuea@nidcd.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-003.html Deadline Note: The deadlines for receipt of optional letters of intent are: May 22, 2012, January 22, 2013 and September 22, 2013. The deadlines for receipt of full applications are: June 22, 2012, February 22, 2013 and October 22, 2013. This program will expire on October 23, 2013. SYNOPSIS: The sponsor offers support for applications which translate basic research findings into clinical tools for better human health in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech and language. The intent of this Funding Opportunity Announcement (FOA) is to provide a new avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects. The scope of this FOA includes a range of activities to encourage translation of basic research findings which will impact the diagnosis, treatment and prevention of communication disorders. Multi-institutional, multi-disciplinary, and academic-industrial collaborations studies are encouraged. This FOA is not intended for outcome studies, the extension of ongoing clinical research studies, the optimization of current clinical protocols, or pre-translational studies. Connection to the clinical condition must be clearly established and the outcomes of the grant must have practical clinical impact. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 82750 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: Office of Research Infrastructure Programs/NIH/DHHS Title: NCRR Science Education Partnership Award (SEPA) (R25) Contact: L. Tony Beck, Ph.D. Tel: 301-435-0805 Email: beckl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-206.html Deadline Note: The deadline for receipt of optional letters of intent is May 22, 2012. The deadline for receipt of full applications is June 22, 2012. This FOA will expire on June 23, 2012. SYNOPSIS: The sponsor invites applications to its SEPA program for the development and evaluation of innovative research education programs to improve PreK-12 research career opportunities and the community's understanding of the health science advances supported by the National Institutes of Health (NIH)-funded clinical and basic research. SEPA encourages dynamic partnerships between biomedical and clinical researchers and PreK-12 teachers and schools and other interested organizations. Particular importance will be given to applications that target PreK-12 and/or ISE/media topics that may not be addressed by existing curriculum, community-based or ISE/media activities. This FOA will use the NIH Research Education (R25) grant mechanism. --------------------------------------------------------------- Program Number: 25833 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: Office of Research on Women's Health/NIH/DHHS Title: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Etiology, Diagnosis, Pathophysiology, and Treatment (R01) Contact: Charles Wells, Ph.D. Tel: 301-402-1770 Email: wells1@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-032.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 24, 2012. The deadlines for receipt of optional letters of intent are: January 24, 2012 (passed); May 22, 2012; September 24, 2012; January 22, 2013; May 24, 2013; September 24, 2013; January 24, 2014; May 26, 2014; September 24, 2014. The deadlines for receipt of full applications under this announcement are: February 24, 2012; June 22, 2012; October 24, 2012; February 22, 2013; June 24, 2013; October 24, 2013; February 24, 2014; June 24, 2014; October 24, 2014, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on October 25, 2014. SYNOPSIS: The sponsors invite applications that propose to examine the etiology, diagnosis, pathophysiology, and treatment of chronic fatigue syndrome (CFS), sometimes referred to as myalgic encephalomyelitis (ME), in diverse groups and across the lifespan. Applications that address gaps in the understanding of the environmental and biological risk factors, the determinants of heterogeneity among patient populations, the common mechanisms influencing the multiple body systems that are affected in ME/CFS are encouraged. The NIH is particularly interested in funding interdisciplinary research that will enhance our knowledge of the disease process and provide evidence based solutions to improve the diagnosis, treatment, and quality of life of all persons with ME/CFS. This interdisciplinary research may include the building of scientific teams to study and develop biomarkers, innovative treatment modalities, and/or the modifiable risk and protective processes specifically targeted by preventive and/or treatment interventions. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25834 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: Office of Research on Women's Health/NIH/DHHS Title: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Etiology, Diagnosis, Pathophysiology, and Treatment (R21) Contact: Charles Wells, Ph.D. Tel: 301-402-1770 Email: wells1@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-033.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 24, 2012. The deadlines for receipt of optional letters of intent are: January 24, 2012 (passed); May 22, 2012; September 24, 2012; January 22, 2013; May 24, 2013; September 24, 2013; January 24, 2014; May 26, 2014; September 24, 2014. The deadlines for receipt of full applications under this announcement are: February 24, 2012; June 22, 2012; October 24, 2012; February 22, 2013; June 24, 2013; October 24, 2013; February 24, 2014; June 24, 2014; October 24, 2014, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on October 25, 2014. SYNOPSIS: The sponsors invite applications that propose to examine the etiology, diagnosis, pathophysiology, and treatment of chronic fatigue syndrome (CFS), sometimes referred to as myalgic encephalomyelitis (ME), in diverse groups and across the lifespan. Applications that address gaps in the understanding of the environmental and biological risk factors, the determinants of heterogeneity among patient populations, the common mechanisms influencing the multiple body systems that are affected in ME/CFS are encouraged. The NIH is particularly interested in funding interdisciplinary research that will enhance our knowledge of the disease process and provide evidence based solutions to improve the diagnosis, treatment, and quality of life of all persons with ME/CFS. This interdisciplinary research may include the building of scientific teams to study and develop biomarkers, innovative treatment modalities, and/or the modifiable risk and protective processes specifically targeted by preventive and/or treatment interventions. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 26359 --------------------------------------------------------------- ***Deadlines: 6/24/2012 Sponsor: Fogarty International Center/NIH/DHHS Title: Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D43) Contact: Jeanne McDermott Tel: 301-496-1492 Email: jeanne.mcdermott@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-068.html Deadline Note: The deadline for receipt of optional letters of intent is June 24 annually. The deadline for receipt of full applications is July 24 annually. This FOA will expire on July 25, 2014. SYNOPSIS: National Institutes of Health (NIH) invites applications for research training programs to strengthen the HIV research capacity at low- and middle-income country (LMIC) institutions. Each application should propose a training program that will build or strengthen research capacity in an applicant-defined HIV-related scientific topic at an identified LMIC institution. This FOA will utilize the NIH D43 International Research Training Grant award mechanism. --------------------------------------------------------------- Program Number: 26360 --------------------------------------------------------------- ***Deadlines: 6/24/2012 Sponsor: Fogarty International Center/NIH/DHHS Title: Training Programs for Critical HIV Research Infrastructure for Low- and Middle-Income Country Institutions (G11) Contact: Jeanne McDermott Tel: 301-496-1492 Email: jeanne.mcdermott@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-069.html Deadline Note: The deadline for receipt of optional letters of intent is June 24 annually. The deadline for receipt of full applications is July 24 annually. This FOA will expire on July 25, 2014. SYNOPSIS: National Institutes of Health (NIH) invites U.S. institutions with research collaborations at low-and middle-income country (LMIC) institutions to submit applications for training programs to strengthen the leadership and expertise in selected critical research infrastructure areas at their collaborating LMIC institutions. This FOA will utilize the NIH G11- Extramural Associate Research Development Award. --------------------------------------------------------------- Program Number: 26361 --------------------------------------------------------------- ***Deadlines: 6/24/2012 Sponsor: Fogarty International Center/NIH/DHHS Title: Limited Competition: Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71) Contact: Jeanne McDermott Tel: 301-496-1492 Email: jeanne.mcdermott@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-070.html Deadline Note: The deadline for receipt of optional letters of intent is June 24 annually. The deadline for receipt of full applications is July 24 annually. This FOA will expire on July 25, 2014. SYNOPSIS: National Institutes of Health (NIH) invites applications from institutions in low-and middle-income countries (LMIC) to submit an application for a planning grant under the Fogarty HIV Research Training Program. This program supports research training that will strengthen the HIV research capacity of institutions in low-and middle-income countries (LMIC). The planning grant application must propose a plan to develop the components necessary for an application for a research training program to submit in response to D43 FOA (PAR-12-068 [SPIN Program # 26359] for D43 FOA). In developing an application for a planning grant, applicants need to be familiar with the objectives and special requirements of the research training program as defined in the D43 FOA. This FOA will utilize the NIH D71 International Training Program Planning Grant award mechanism. --------------------------------------------------------------- Program Number: 22088 --------------------------------------------------------------- ***Deadlines: 6/25/2012 Sponsor: Bureau of Justice Statistics/Department of Justice Title: Visiting Fellow: Criminal Justice Statistics Program Contact: Gerard F. Ramker, Deputy Director Tel: 202-307-0765 Email: askbjs@usdoj.gov Website:          http://www.grants.gov/search/search.do;jsessionid=95ZHPthGGchjR8x2yb1wWmcJCSplpDVGXWvCL0Lh0mFCQyy5yTQJ!64499778?oppId=170194&mode=VIEW Full Program:          http://bjs.ojp.usdoj.gov/content/pub/pdf/vfcjsp12_sol.pdf Deadline Note: Registration is required prior to submission. OJP strongly encourages registering with Grants.gov several weeks before the deadline for application submission. The deadline for applying for funding is June 25, 2012. SYNOPSIS: The sponsor is seeking applications for funding for one or more BJS Visiting Fellows to work in its Criminal Justice Statistics Programs with existing BJS data. --------------------------------------------------------------- Program Number: 28723 --------------------------------------------------------------- ***Deadlines: 6/25/2012 Sponsor: Food & Drug Administration Title: Enhancing Post-Market Surveillance Through Developing Registries for Medical Device Epidemiology (U01) Contact: Mary Beth Ritchey Tel: 301-796-6638 Email: Maryelizabeth.Ritchey@fda.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-FD-12-028.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 21, 2012. The deadline for receipt of optional letters of intent is June 1, 2012. The deadline for receipt of full applications is June 25, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: FDA's Center for Devices and Radiological Health (CDRH) invites applications: (1) To develop registries and consortia in key medical device areas to implement new registry methodologies that strategically broaden the scope of the US and international postmarket surveillance system; and (2) To address identified gaps in the current postmarket surveillance system by developing new methodologies for registry data collection and linkage, or by adapting known methodologies to medical devices; and (3) To develop novel methodology that allows for use of the registry data collection infrastructure to serve multiple purposes including postmarket surveillance, device tracking through Unique Device Identifiers (UDI), prospective embedded studies, quality improvement, and other uses. This program will use the U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 06575 --------------------------------------------------------------- ***Deadlines: 6/25/2012 Sponsor: National Institutes of Health/DHHS Title: Academic Research Enhancement Award (Parent R15) Contact: Tel: Email: grantsinfo@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-006.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 25, 2012. The deadlines for receipt of standard AREA applications are: February 25, June 25 and October 25 annually. The deadlines for receipt of AIDS-related AREA applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The sponsors provide support to stimulate research in educational institutions that provide baccalaureate or advanced training for a significant number of the nation's research scientists but that have not been major recipients of National Institutes of Health support. AREA grants are intended to support small-scale research projects proposed by faculty members of eligible, domestic institutions, to expose students to meritorious research projects, and to strengthen the research environment of the applicant institution. This FOA will utilize the R15 grant mechanism. --------------------------------------------------------------- Program Number: 15165 --------------------------------------------------------------- ***Deadlines: 6/26/2012 Sponsor: Bureau of Primary Health Care/HRSA/DHHS Title: Affordable Care Act - Grants for School-Based Health Center Capital (SBHCC) Program Contact: Tel: 301-594-4300 Email: sbhc@hrsa.gov Website:          http://www.grants.gov/search/search.do?oppId=169778&mode=VIEW Full Program:          http://apply07.grants.gov/apply/opportunities/instructions/oppHRSA-13-140-cfda93.501-cid5377-instructions.pdf Deadline Note: The deadline for receipt of applications in Grants.gov is June 26, 2012. The deadline for submission of supplemental information in the EHB is July 24, 2012. SYNOPSIS: For FY 2013, the SBHCC awards will address significant and pressing capital needs to improve service delivery and support the expansion of services at school-based health centers (SBHCs) through the alteration/renovation of an existing facility(ies), construction of a new site(s) or expansion of an existing site(s), and/or the purchase of moveable equipment. Applicants must demonstrate how their proposal will support the SBHC in providing more effective, efficient and quality health care and will lead to improvements in access to health services for children at a SBHC. --------------------------------------------------------------- Program Number: 28287 --------------------------------------------------------------- ***Deadlines: 6/26/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: RFA-HG-12-008--Clinical Sequencing Exploratory Research Coordinating Center (U01) Contact: Lucia A. Hindorff, Ph.D., M.P.H. Tel: 301-496-7531 Email: hindorffl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-HG-12-008.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after June 26, 2012. The deadline for receipt of optional letters of intent is June 26, 2012. The deadline for receipt of full applications is July 26, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Human Genome Research Institute (NHGRI) invites applications for centralized support and coordination for the studies and investigators funded under the the Clinical Sequencing Exploratory Research (CSER) program (RFA-HG-10-017 and RFA-HG-12-009), who will explore, within an active clinical setting, the application of genomic sequence data to the care of patients, as well as the studies and investigators in the Return of Results (RoR) Consortium, which encompasses elements of the CSER program and studies supported under the Ethical, Legal, and Social Implications program RFA-HG-11-003 and RFA-HG-11-004. This program will use the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 26987 --------------------------------------------------------------- ***Deadlines: 6/26/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: RFA-AI-12-014--Partnerships for Development of Vaccine Technologies (R01) Contact: Dr. Michael Schaefer Tel: 301-451-3758 Email: mschaefer@niaid.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-014.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 26, 2012 . The deadline for receipt of optional letters of intent is May 26, 2012 . The deadline for receipt of full applications is June 26, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) invites research applications for projects focused on preclinical development of candidate technologies (including adjuvants) that would improve vaccine effectiveness and/or simplify vaccine delivery to patient populations during a natural outbreak of an infectious disease or following the intentional release of an infectious agent. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 02914 --------------------------------------------------------------- ***Deadlines: 6/26/2012 Sponsor: Substance Abuse & Mental Health Services Administration Title: National Child Traumatic Stress Initiative Treatment and Service Adaptation Centers (TSA) - Category II Contact: Ken Curl, M.S.W. Tel: 240-276-0401 Email: Kenneth.curl@samhsa.hhs.gov Website:          http://www.samhsa.gov/grants/2012/sm_12_006.aspx Full Program:          http://www.grants.gov/search/search.do?oppId=171457&mode=VIEW SYNOPSIS: The Substance Abuse and Mental Health Services Administration, Center for Mental Health Service is accepting applications for fiscal year (FY) 2012 National Child Traumatic Stress Initiative (NCTSI), Treatment and Service Adaptation (TSA) Centers, Category II Cooperative Agreements. The purpose of this initiative is to improve treatment and services for children and adolescents who have experienced traumatic events and to increase access to these treatments and services throughout the nation. The purpose of the Treatment and Service Adaptation Centers (TSA), Category-II cooperative agreements is to provide national expertise on specific types of traumatic events, population groups and service systems, and support the specialized adaptation of effective treatment and service approaches for communities across the nation. --------------------------------------------------------------- Program Number: 04152 --------------------------------------------------------------- ***Deadlines: 6/27/2012 Sponsor: Department of the Army Title: Peer Reviewed Orthopaedic Research Program (PRORP)--Translational Research Partnership Award Contact: Tel: 301-682-5507 Email: help@cdmrp.org Website:          http://www.grants.gov/search/search.do;jsessionid=Nzt8PzGDgCJPJ4jkyF6GJt2JjMdfD5lPVqTrc1LpN3wb5G82t0sS!-253887325?oppId=170736&mode=VIEW Deadline Note: Pre-application Submission Deadline: 5:00 p.m. Eastern time (ET), June 27, 2012. Invited applications are due 11:59 p.m. ET, September 25, 2012. SYNOPSIS: Applications for the Peer Reviewed Orthopaedic Research Program (PRORP) are being solicited by the Assistant Secretary of Defense for Health Affairs, Defense Health Program. The PRORP was established in fiscal year 2009 (FY09) to support research focused on optimizing recovery and restoration of function for military personnel with orthopaedic injuries sustained in combat or combat-related duties. Appropriations for the PRORP from FY09 through FY11 totaled $158.5 million (M). The FY12 appropriation is $30M. The FY11 PRORP challenges the scientific community to address the most significant gaps in care for the leading burden of injury and loss of fitness for military duty by funding innovative, high-impact, clinically relevant research to advance optimal treatment and rehabilitation from musculoskeletal injuries sustained during combat or combat-related activities. Applications involving multidisciplinary collaborations among academia, industry, the military services, the Department of Veterans Affairs (VA), and other Federal Government agencies are highly encouraged. --------------------------------------------------------------- Program Number: 04157 --------------------------------------------------------------- ***Deadlines: 6/27/2012 Sponsor: Department of the Army Title: Peer Reviewed Orthopaedic Research Program (PRORP)--Idea Development Award Contact: Tel: 301-619-2192 Email: help@cdmrp.org Website:          http://www.grants.gov/search/search.do;jsessionid=Nzt8PzGDgCJPJ4jkyF6GJt2JjMdfD5lPVqTrc1LpN3wb5G82t0sS!-253887325?oppId=170735&mode=VIEW Deadline Note: The deadline for the preproposal submission is 5:00 p.m. Eastern time, June 27, 2012. The deadline for full proposal submission is 11:59 p.m. Eastern time, September 25, 2012. SYNOPSIS: Applications for the Peer Reviewed Orthopaedic Research Program (PRORP) are being solicited by the Assistant Secretary of Defense for Health Affairs, Defense Health Program. The PRORP was established in fiscal year 2009 (FY09) to support research focused on optimizing recovery and restoration of function for military personnel with orthopaedic injuries sustained in combat or combat-related duties. Appropriations for the PRORP from FY09 through FY11 totaled $158.5 million (M). The FY12 appropriation is $30M. The FY12 PRORP challenges the scientific community to address the most significant gaps in care for the leading burden of injury and loss of fitness for military duty by funding innovative, high-impact, clinically relevant research to advance optimal treatment and rehabilitation from musculoskeletal injuries sustained during combat or combat-related activities. Applications involving multidisciplinary collaborations among academia, industry, the military services, the Department of Veterans Affairs (VA), and other Federal Government agencies are highly encouraged. --------------------------------------------------------------- Program Number: 04161 --------------------------------------------------------------- ***Deadlines: 6/27/2012 Sponsor: Department of the Army Title: Peer Reviewed Orthopaedic Research Program (PRORP)--Clinical Trial Award Contact: Tel: 301-682-5507 Email: help@cdmrp.org Website:          http://www.grants.gov/search/search.do;jsessionid=Nzt8PzGDgCJPJ4jkyF6GJt2JjMdfD5lPVqTrc1LpN3wb5G82t0sS!-253887325?oppId=170734&mode=VIEW Deadline Note: The deadline for the preproposal submission is 5:00 p.m. Eastern time, June 27, 2012. Preproposal submission is a required first step. An invitation letter is required to proceed to the second step of submitting a full proposal. The deadline for full proposal submission is 11:59 p.m. Eastern time, September 25, 2012. SYNOPSIS: Applications for the Peer Reviewed Orthopaedic Research Program (PRORP) are being solicited by the Assistant Secretary of Defense for Health Affairs, Defense Health Program. The PRORP was established in fiscal year 2009 (FY09) to support research focused on optimizing recovery and restoration of function for military personnel with orthopaedic injuries sustained in combat or combat-related duties. Appropriations for the PRORP from FY09 through FY11 totaled $158.5 million (M). The FY12 appropriation is $30M. The FY12 PRORP challenges the scientific community to address the most significant gaps in care for the leading burden of injury and loss of fitness for military duty by funding innovative, high-impact, clinically relevant research to advance optimal treatment and rehabilitation from musculoskeletal injuries sustained during combat or combat-related activities. Applications involving multidisciplinary collaborations among academia, industry, the military services, the Department of Veterans Affairs (VA), and other Federal Government agencies are highly encouraged. --------------------------------------------------------------- Program Number: 28123 --------------------------------------------------------------- ***Deadlines: 6/27/2012 Sponsor: National Endowment for the Humanities/Natl. Fndn. on the Arts & Humanities Title: Humanities Initiatives: Hispanic-Serving Institutions Contact: Tel: 202-606-8471 Email: hi@neh.gov Website:          http://www07.grants.gov/search/search.do;?oppId=161916&mode=VIEW Full Program:          http://www.neh.gov/grants/education/humanities-initiatives-hispanic-serving-institutions SYNOPSIS: NEH Humanities Initiatives are intended to strengthen and enrich humanities education and scholarship at Hispanic-Serving Institutions. These grants may be used to enhance the humanities content of existing programs, develop new programs, or lay the foundation for more extensive endeavors in the future.. --------------------------------------------------------------- Program Number: 83718 --------------------------------------------------------------- ***Deadlines: 6/27/2012 Sponsor: National Endowment for the Humanities/Natl. Fndn. on the Arts & Humanities Title: Humanities Initiatives for Faculty at Tribal Colleges and Universities Contact: Tel: 202-606-8471 Email: hi@neh.gov Website:          http://www.neh.gov/files/grants/humanities-initiatives-tribal-jun-27-2012.pdf Full Program:          http://www07.grants.gov/search/search.do;jsessionid=Tc5LNt8dDLhfvj8DvhtcMxsZPdYwPGpqWxD0nl6j1hFVPDGCPqGh!-1702297235?oppId=87473&mode=VIEW SYNOPSIS: Humanities Initiatives for Faculty are intended to strengthen and enrich humanities education and scholarship at tribal colleges and universities. These grants may be used to enhance the humanities content of existing programs, develop new programs, or lay the foundation for more extensive endeavors in the future. --------------------------------------------------------------- Program Number: 07006 --------------------------------------------------------------- ***Deadlines: 6/27/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: RFA-HD-13-011--Child Health Research Career Development Award (CHRCDA) Program [K12] Contact: Karen Winer, M.D. Tel: 301-435-6877 Email: winerk@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-13-011.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 27, 2012. The deadline for receipt of optional letters of intent is May 27, 2012. The deadline for receipt of full applications is June 27, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: The sponsor invites applications for institutional research career development (K12) programs from applicant organizations that propose to support a national program of mentored institutional career development programs for fellows and new investigators who have recently completed postgraduate clinical training in Pediatrics, and are committed to launching an independent research career. The program provides supervised research training to assist the transition into productive physician scientists. This FOA will utilize the NIH K12 Physician Scientist Award (Program) [PSA] mechanism. --------------------------------------------------------------- Program Number: 26420 --------------------------------------------------------------- ***Deadlines: 6/27/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: RFA-HD-13-005--Specialized Cooperative Centers Program in Reproduction and Infertility Research (U54) Contact: Stuart B. Moss, PhD Tel: 301-435-6979 Email: mossstua@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-13-005.html Deadline Note: The deadline for receipt of optional letters of intent is May 27, 2012. The deadline for receipt of full applications is June 27, 2012. SYNOPSIS: National Institute of Child Health and Human Development (NICHD) invites applications for the re-competition of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (SCCPIR). The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) provides funding for a limited number of research centers in the reproductive sciences. These centers provide an arena for multidisciplinary interactions between basic and clinical scientists interested in establishing high quality translational research programs in the area of reproductive health and infertility. The centers also serve as a national resource for the training and career development of new scientists electing to pursue careers conducting translational research in high priority areas of reproduction and infertility. Finally, center investigators are expected to participate in important community outreach and education efforts to increase awareness and convey the importance and implications of their research activities to the general public.. This FOA will utilize the NIH U54 Specialized Center- Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 28086 --------------------------------------------------------------- ***Deadlines: 6/27/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: RFP - AMENDMENT - NICHD International and Domestic Pediatric and Maternal HIV Studies Coordinating Center Contact: Lynn L Salo Tel: 301-435-6962 Email: ls59u@nih.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=cce40b21597494296d504a125ec9ec8a&tab=core&_cview=0 SYNOPSIS: A -- NICHD INTERNATIONAL AND DOMESTIC PEDIATRIC AND MATERNAL HIV STUDIES COORDINATING CENTER SOL RFP-NIH-NICHD-CRMC-2013-01 POC Lynn L Salo, Phone:01-435-6962, Elizabeth J. Osinski, Phone: 301-435-6947 WEB: FBO.gov Permalink https://www.fbo.gov/spg/HHS/NIH/NICHD/RFP-NIH-NICHD-CRMC-2013-01/listing.html E-MAIL: ls59u@nih.gov, eo43m@nih.gov ls59u@nih.gov, eo43m@nih.gov NAICS: 541712 TheEunice Kennedy Shriver National Institute of Child Health and Human Development(NICHD) requires logistical, technical, and administrative support to maintain,coordinate, train, monitor and manage a multi-site network of clinical centers conduct¬ing intervention trials and other research on treatment, prevention,diagno¬sis, epidemiology, and natural history of HIV infec¬tion and disease in pediatric, adoles¬cent, and maternal patient popula-tions, includingboth domestic and international clinical sites. The NICHD is announcing a competitive Request for Proposal for a Contractor to serve as the NICHD Internationaland Domestic Pediatric and Maternal HIV Clinical Studies Coordinating center, which encompasses clinical studies and clinical trials on the treatment and management of HIV infection and associated co-infections and co-morbidities in infants, children, adolescents and pregnant and non-pregnant women domestically and internationally. The Coordinating Center contract currently manages a network of 34 clinical research sites throughout the United States (25) and in Latin America(9) that participate in studies through multiple research networks. The currentcontractor for this effort is WESTAT, Inc. Scope of activities: Current activities conducted within the Coordinating Center contract include the following: 1) NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network The NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network ("NICHD Network") has been funded through the NICHD Coordinating Center contract since 1987. The NICHD Network consists of domestic and international clinical sites that enroll study subjects in trials related to preventing and treating HIV infection and its complications in neonates, infants, children, adolescents, and pregnant women, as well as selected clinical trials of gender-specific manifestations of HIV infection in non-pregnant women. The Network enrolls into trials conducted by the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) network and Adult AIDS Clinical Trials Group (AACTG) funded by the National Institute of Allergy and Infectious Diseases (NIAID), the NICHD-funded Adolescent HIV Medicine Trials Network (ATN), the Centers for DiseaseControls and Prevention (CDC), and Pediatric European Network for Treatment of AIDS (PENTA). Domestically, the Network consists of 25 centers, located in 18 cities, in 10 states/territories (including Puerto Rico); there are nine international clinical trials sites: eight sites in different areas of Brazil, and one inArgentina. It is anticipated that network sites will be re-competed in 2014 andwill potentially include sites in Africa, Asia and Eastern Europe in addition to Latin America and the United States. NICHD also supports laboratory-based pathogenesis-oriented research in the context of clinical trials. The Coordinating Center provides support to clinical trials site investigators with special laboratory expertise for the conduct of specialized pathogenesis-based studies in the context of PACTG protocols. The Coordinating Center provides special support to international sites, such as providing specimen transport through a central Coordinating Center contract with World Courier. 2) Site Monitoring of Phase III NICHD-Funded Investigator Initiated International trials As the NICHD internationalresearch grant portfolio has increased to include large phase III clinical trials conducted in resource-limited countries, there is an increasing need to ensure that such investigator-initiated trials are conducted ethically, in accordancewith Good Clinical Practices, and with attention to human subject safety. The Coordinating Center will conduct site monitoring for selected NICHD grantees conducting large clinical trials to ensure appropriate trial conduct. The Coordinating Center is currently conducting monitoring for clinical trials in Botswana (Mpeu trial), Kenya (OPH03 and OPH612), South Africa (NEVEREST trial); Thailand (PHPT-5 trial); and Uganda (PROMOTE trials). 3. Data Analysis from Completed NICHD-Sponsored Clinical Studies and Trials The NICHD International Site Development Initiative (NISDI) consisted of two observational studies conducted in Latin America, one study (LILAC) in HIV-infected pregnant women and their infants, and onestudy (PLACES) in HIV-infected children. This study will be completed before November 2012 but analyses of data from this study will continue into the new contract period. Additionally, the NICHD/HPTN 040-PACTG 1043 clinical trial, which evaluated infant combination antiretroviral prophylaxis when the mother did not receive antepartum antiretroviral drugs, was completed during 2011, but analyses of data from this study will continue into the new contract period. Thus, statistical/analytic capabilities for analyses of data from these completed studies are necessary for the Coordinating Center. It is anticipated that one term form cost-reimbursement contract will be awarded, for a period of performance of 5 years, beginning approximately December 1, 2012. The RFP is anticipated to be postedon or about April 20, 2012 on FedBizOpps (FBO) website: http://www.fedbizopps.gov. The due date for submission of proposals in response to the RFP is anticipated to be on or about June 27, 2012. Information in the anticipated RFP supersedes any information in this pre-solicitation announcement. This acquisition has been designated as full and open competition under the North American Industry Classification System (NAICS) code 541712. Any questions concerning this announcement must be submitted in writing to Lynn Salo at ls59u@nih.gov, or Contracting Officer or Elizabeth Osinski, Contracting Officer, at eo43m@nih.gov, or addressed to, NICHD Contracts Management Branch, Office of Acquisitions, NICHD, NIH, 6100 Executive Boulevard, Room 7A-07, MSC 7510, Bethesda, Maryland 20892-7510 (if hand-delivered or sending by delivery service--6100 Executive Boulevard, Suite 7A-07, Rockville, Maryland 20852). No collect calls will be accepted. This is not anRFP and this announcement does not commit the Government to award a contract. The reference number to be used for this announcement is: RFP NIH-NICHD-CRMC-2013-01. All correspondence must cite the reference number as provided. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=cce40b21597494296d504a125ec9ec8a&tab=core&_cview=0Posted 04/06/12 (W-SN02716696). (0097) --------------------------------------------------------------- Program Number: 05829 --------------------------------------------------------------- ***Deadlines: 6/27/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Grand Opportunity in Medications Development for Substance-Related Disorders (U01) Contact: Ivan D. Montoya, M.D., M.P.H. Tel: 301-443-8639 Email: imontoya@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-109.html Deadline Note: The deadlines for receipt of optional letters of intent are: April 26, 2011 (passed), July 26, 2011, February 27, 2012, June 27, 2012, February 27, 2013, June 26, 2013. The deadlines for receipt of full applications are: May 26, 2011, August 26, 2011, March 27, 2012, July 27, 2012, March 27, 2013, July 26, 2013. This FOA will expire on August 15, 2013. SYNOPSIS: The sponsor invites applications to support a diverse array of preclinical and/or clinical research projects. The goal is to fund medication studies that will have high impact and quickly yield the necessary results to advance medications closer to FDA approval. It is expected that these U01s will be short-term (funded for up to 3 years) and large (up to $5 million per year) cooperative agreements with close monitoring and significant scientific involvement of NIDA staff. This funding mechanism will enable critical medications development studies that would not be feasible using the traditional R01 mechanism. This FOA will utilize the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 28315 --------------------------------------------------------------- ***Deadlines: 6/27/2012 Sponsor: National Institute on Minority Health and Health Disparities/NIH/DHHS Title: RFA-MD-12-006--NIMHD Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities: Planning Phase (R24) Contact: Paula Y. Goodwin, PhD Tel: 301-594-8770 Email: goodwinpy@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-MD-12-006.html Deadline Note: The deadline for receipt of optional letters of intent is May 27, 2012. The deadline for receipt of full applications is June 27, 2012. SYNOPSIS: National Institute on Minority Health and Health Disparities (NIMHD) invites applications to plan the development of effective interventions using community based participatory research (CBPR) approaches. Support will be provided to develop and strengthen partnerships between researchers and health disparity communities to plan and pilot interventions for a disease or condition to reduce health disparities. This FOA will utilize the NIH R24 Resource-Related Research Projects award mechanism. --------------------------------------------------------------- Program Number: 14304 --------------------------------------------------------------- ***Deadlines: 6/29/2012 Sponsor: National Aeronautics & Space Administration Title: ROSES 2012: Planetary Protection Research Contact: Dr. Catharine A. Conley, Planetary Protection Officer Tel: 202-358-3912 Email: HQ-PPR@mail.nasa.gov Website:          http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={AD1F30F3-3214-8940-7338-CA5DFAE6221E}&path=open Full Program:          http://nspires.nasaprs.com/external/solicitations/solicitationAmmendments.do?method=init&solId={4DF6A47E-EDC1-20F2-11FB-8BDF6890024A}&path=open Deadline Note: Optional letters of intent are due by June 30, 2012. Full proposals are due September 3, 2012. Notices of Intent are now due on June 29, 2012, and Proposals are now due September 5, 2012. SYNOPSIS: Proposals are sought for new projects in planetary protection that are not within the scope of the Astrobiology: Exobiology and Evolutionary Biology program. Proposals submitted in response to this program element should be for new work that is not currently supported by NASA or for successor proposals that seek to extend to their next logical phase those tasks performing research in Planetary Protection that are currently funded but whose periods of performance will expire in 2012. --------------------------------------------------------------- Program Number: 26818 --------------------------------------------------------------- ***Deadlines: 6/29/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: RFA-DK-12-004--Nutrition Obesity Research Centers (P30) Contact: Mary E. Evans, Ph.D. Tel: 301-594-4578 Email: evansmary@niddk.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-12-004.html Deadline Note: The deadline for receipt of optional letters of intent is May 29, 2012. The deadline for receipt of full applications is June 29, 2012. SYNOPSIS: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications hat propose to establish core centers that are part of an integrated program of nutrition and/or obesity-research. The Nutrition Obesity Research Center (NORC) program is based on the core concept, whereby shared resources aimed at fostering productivity, synergy, and new research ideas among the funded investigators are supported in a cost-effective manner. Each proposed NORC must be organized around central themes that reflect the nutrition and/or obesity research focus of the center members. This FOA will utilize the NIH P30 Center Core Grants award mechanism. --------------------------------------------------------------- Program Number: 22712 --------------------------------------------------------------- ***Deadlines: 6/29/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: RFA-DC-12-003--NIDCD Research On Hearing Health Care (R21/R33) Contact: Amy Donahue, Ph.D. Tel: 402-3458 Email: donahuea@nidcd.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-DC-12-003.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 30, 2011. The deadlines for receipt of optional letters of intent are: September 30, 2011, May 29, 2012, January 28, 2013. The deadlines for receipt of full applications are: October 31, 2011, June 29, 2012, February 28, 2013, by 5:00 PM local time of applicant organization. SYNOPSIS: The sponsor invites applications to support research and/or infrastructure needs leading to more accessible and affordable hearing health care (HHC). For the purposes of the working group and this FOA, “hearing health care” includes assessment (including screening) and nonmedical treatment and rehabilitation of HL, including hearing aid selection and fitting and aural rehabilitation (counseling, auditory training). The proposed research aims should lead to the delivery of better healthcare access and outcomes and be directed to solutions that are effective, affordable and deliverable to those who need them. Outcomes research and health services research related to accessible and affordable hearing health care are also responsive to this FOA. This FOA will utilize the NIH R21/R33 Phased Innovation Award mechanism. --------------------------------------------------------------- Program Number: 56600 --------------------------------------------------------------- ***Deadlines: 6/29/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: NIDCD Small Grant Program (R03) Contact: Dr. Bracie Watson, Jr. Tel: 301-402-3458 Email: watsonb@nidcd.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-055.html Deadline Note: This FOA will expire on November 1, 2012. SYNOPSIS: The sponsor provides support for basic and clinical research of scientists who are in the early stages of establishing an independent research career. It cannot be used for thesis or dissertation research. The research must be focused on one or more of the areas within the biomedical and behavioral scientific mission of the NIDCD: hearing, balance, smell, taste, voice, speech, or language. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 13388 --------------------------------------------------------------- ***Deadlines: 6/29/2012 Sponsor: Office of Dietary Supplements/NIH/DHHS Title: Administrative Supplements (Revisions) to NCCAM Grants for Validation Studies of Analytical Methods for Natural Products Contact: Marguerite Klein, M.S. Tel: 301-496-0168 Email: kleinm@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-11-016.html SYNOPSIS: The sponsors invite applications for administrative supplement program to provide funds to NCCAM-supported research projects for optimization and validation studies of new analytical methods. These methods must have been developed or be under development during the active parent grant. They must be used to identify and quantify constituents (bioactive and other chemical marker constituents, adulterants, or contaminants) in products intended for oral administration in humans. As test agents they may be investigated in vitro or in vivo. The products may be dietary supplements, foods, and other orally-administered natural products, as well as their raw source materials. Candidates for validation studies may include (but are not limited to): phytochemicals; nutrients; and potentially deleterious substances such as toxic elements, pesticides, and mycotoxins. In addition, metabolites from these orally administered products found in urine, plasma or other tissues may be candidates for validation studies.